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“Thus, the task is not so much to see what no one yet has seen, 
but to think what nobody yet has thought about that which everybody sees.” 
Arthur Schopenhauer (1788-1860) 
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GENERAL CONSIDERATIONS 
 
  
 GENERAL CONSIDERATIONS 
 
The present document reflects the research performed during the last years in the field 
of sports cardiology, especially regarding the preparticipation evaluation and the CV risk 
stratification of athletes. 
My interest in research began early, during the Medicine course, while in the internship 
of cardiology it became deeper and more systematized. After joining the 
Pathophysiology Department of the NMS | FCM this interest was solidified, being 
natural the enrolment in the Doctoral Programme in Medicine in the area of Clinical 
Investigation. 
As a military doctor, the evaluation of candidates and military of the Portuguese Armed 
Forces is frequent, in which exercise training is a central component. In this setting, 
sports cardiology has been progressively established as the main area of my clinical 
practice and research. 
Under the supervision of the Professor Sanjay Sharma I had the opportunity to train and 
to acquire experience in the Sports Cardiology and Inherited Cardiac Diseases Centre of 
the St. George's Hospital, London, United Kingdom. Beyond the clinical activity, I had the 
privilege to perform research and participate in several projects developed in this 
centre. 
This background gave me the opportunity to participate in the implementation of 
dedicated sports cardiology clinics in Armed Forces Hospital and Luz Hospital - Lisbon, 
and to collaborate in the regular evaluations of athletes. 
In addition to this specific interest in sports cardiology, the role of cardiac CT in the 
improvement of CV risk stratification and early detection of CAD was an important area 
of investigation. I had the opportunity to participate in the projects of the PhD thesis of 
Professor Pedro de Araújo Gonçalves* about the usefulness of cardiac CT in evaluation 
                                               
* De Araújo Gonçalves, P. (2013). Utilidade da tomografia computorizada cardíaca na avaliação da doença coronária. 
Lisboa: NMS | FCM. Available in https://run.unl.pt 
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 of CAD. The characterization of total coronary atherosclerotic burden with cardiac CT 
and the development of angiographic scores that may improve CV primary prevention 
gave us the hypothesis that the application of this exam in evaluation of specific 
populations such as veteran athletes could be useful. The last manuscripts published 
(and included in this document) constitute a continuation of these lines of investigation.  
The curricular units and the seminars of the NMS | FCM Doctoral program were fulfilled, 
outlining as Doctoral Intention to study the CV risk stratification of veteran athletes, 
more specifically the relationship between physical exercise and CAD. 
However, consequently to the systematic publication related with the CV evaluation of 
athletes, namely the role of exams such as ECG, TTE and cardiac CT, it was decided to 
present this proposal based on scientific articles alternative to the thesis. This modality 
was chosen due to the coherence and framing of the manuscripts, as stipulated in the 
Regulations.† 
I believe that this organization is an added value for the dissemination of the work 
performed over the last years and published in peer-reviewed journals. 
 
 
  
                                               
† Artigo 20º do Regulamento aplicado ao ciclo de estudos conducente ao grau de Doutor em Medicina - Diário da 
República, 2ª série — Nº 153 — 7 de agosto de 2015.  
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*IF according to the regulations of the PhD program in NMS | FCM. 
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“Good order is the foundation of all things.” 
Edmund Burke (1729-1797) 
 
INTRODUCTION 
The benefits of physical activity and exercise training are well known, being 
recommended for primary and secondary CV prevention.1-3 In addition to merely 
changing the traditional CV risk factors, regular exercise can also improve CV health 
through non-traditional mechanisms.4 However, in individuals with some cardiac 
conditions, even in a pre-clinical stage, exercise can precipitate adverse clinical events 
including SCD. Exercise, per se, is not a cause of increased mortality, rather, it acts as a 
trigger for cardiac arrest in the presence of underlying CV diseases predisposing to life-
threatening ventricular arrhythmias during or after physical exercise. In this context, the 
preparticipation evaluation of athletes is advocated, aiming the identification of those 
with higher risk or even with ‘occult’ diseases associated with increased risk for SCD.5 
The epidemiology of SCD varies comparing young and veteran athletes (>35 years old), 
mainly caused by hereditary cardiac diseases and CAD, respectively.6 Nevertheless, 
some discrepancy persists about the incidence and the causes of SCD in athletes, 
depending on the population studied and the methods used for data collection.7-12 
In young athletes, the leading causes of SCD are cardiomyopathies and primary 
arrhythmic diseases, emphasizing the relevance of a detailed clinical history and resting 
12-lead ECG. This methodology remains controversial, especially regarding the inclusion 
of ECG. During the last years, several studies have reported that the main problem is not 
the inclusion of ECG in this evaluation, but how it should be interpreted. The scope of 
this controversy is mainly derived from the high rate of false positive cases, leading to a 
negative socioeconomic impact. The use of more restrictive criteria for ECG 
interpretation in athletes can potentially overcome this limitation.13 
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Indeed, evaluation and interpretation of the results of several diagnostic tests 
performed to athletes is somewhat challenging, due to the overlap between 
physiological adaptations (‘athlete’s heart’) and pathological conditions.14 This overlap 
occurs at electrical, structural and functional levels. The actual broad spectrum and 
heterogeneity of sports modalities and athletes’ profiles increases the difficulty of this 
evaluation. 
Albeit not routinely indicated in the preparticipation evaluation, the progressive 
development of cardiac imaging has led to a better understanding of exercise-induced 
cardiac adaptations and to the improvement in the diagnosis of pathology.14 TTE, the 
most accessible, widespread and cost-effective cardiac imaging test, assumes a central 
role in athletes’ evaluation. Beyond the traditional echocardiographic approach, ‘new 
advanced’ modalities can improve the differential diagnosis between ‘athlete’s heart’ 
and pathology, a common concern during athletes’ evaluation. 
In veteran athletes, as CAD is the main cause of SCD, preparticipation evaluation should 
be focused on CV risk stratification and early detection of CAD.2,15,16 With this purpose, 
exercise testing is traditionally the first test performed. However, the evidence has 
shown that this methodology has several limitations, both regarding the CV risk 
stratification limited to clinical characteristics and the performance of exercise testing 
for detection of CAD in populations with this profile. The inclusion of more objective 
markers, as parameters derived from imaging tests such as cardiac CT, can potentially 
increase the accuracy in athletes’ evaluation, improving CV risk stratification and early 
detection of CAD.17,18 
Otherwise, the relationship between intense lifelong exercise training and CAD has been 
deeply debated, being suggested a possible ‘U-shaped’ association between the volume 
or intensity of exercise and the prevalence and severity of CAD.19,20 Although remaining 
speculative, this association may have several implications in the evaluation and risk 
stratification of veteran athletes, which constitutes a growing subset of individuals, 
taking in consideration not only competitive but also recreational level. A deeper 
analysis is needed to clarify this specific issue. 
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This document includes 21 manuscripts, 16 original investigations, 13 as first author, 
published in a peer-review journals with a total IF of 56.723 and an IF according to the 
methodology established for PhD in NMS | FCM of 62.930. 
The publications are grouped in the following main topics: 
1. ECG IN ATHLETES 
§ Description of abnormal electrocardiographic findings. 
§ Effect of exercise-related characteristics in electrocardiographic patterns. 
§ Variability in ECG interpretation and impact of more restrictive criteria. 
2. ROLE OF ECHOCARDIOGRAPHY IN ATHLETES 
§ Characterization of cardiac remodelling induced by different exercise 
training programs. 
§ Myocardial deformation in athletes’ evaluation. 
3. CARDIAC CT IN CORONARY ATHEROSCLEROTIC BURDEN EVALUATION 
§ Detailed characterization of total coronary atherosclerotic burden. 
§ Relevance of CT-derived angiographic scores in CAD evaluation. 
§ Limitations of clinical CV risk factors for the detection of CAD. 
4. CAD IN VETERAN ATHLETES 
§ Prevalence of CAD detected by cardiac CT. 
§ Relationship between volume of exercise and CAD. 
§ Effectiveness of current preparticipation methodology to identify 
athletes with high coronary atherosclerotic burden. 
These interrelated topics about CV risk assessment in athletes were initially discussed in 
a review manuscript (MANUSCRIPT 1: The heart of competitive athletes: an up-to-date overview of 
exercise-induced cardiac adaptations)21, representing a general introduction for the following 
investigations. This first manuscript provides an up-to-date review of exercise-induced 
physiological cardiac effects and an overview of the key points that should be 
highlighted during CV assessment of athletes. Understanding these adaptations 
represents a basic and essential step for an accurate evaluation of athletes.  
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ELECTROCARDIOGRAM IN ATHLETES 
ECG constitutes an important tool in the preparticipation evaluation of athletes, being 
recommended by several medical and sports organizations.12 ECG is effective in the 
detection of several conditions as ion channel diseases or congenital accessory 
pathways and may raise suspicion for the most frequent cardiomyopathies implicated 
in SCD.22 The vast Italian experience showed an 89% reduction in the incidence of SCD 
in athletes following the inclusion of ECG in the screening programs.23 
However, some controversy persists regarding the inclusion of ECG during athletes’ 
evaluation, especially between the recommendations adopted in most of European 
countries and in United States of America, where it is still not formally recommended. 
MANUSCRIPT 121 includes several arguments for and against the use of ECG in 
preparticipation evaluation of young competitive athletes. The main obstacle in the 
interpretation of the athlete’s ECG is to distinguish abnormal patterns from physiological 
findings induced by exercise training, reflected by the high rate of false positive cases. 
Many findings that may be a cause of concern in the general population are considered 
normal in athletes. Misinterpretation of athlete’s ECG can trigger unnecessary and 
expensive further investigations or lead to inappropriate disqualification from 
competitive sports, with a negative socioeconomic implication.24  
One of the most common abnormal findings present in athlete’s ECG is T-wave 
inversion, frequently challenging and difficult to interpret. There is a general consensus 
that T-wave inversion in lateral and inferior leads warrants additional investigations due 
to its association with cardiac diseases, particularly cardiomyopathies. Recently, 
research from reference centres have suggested that some profiles of T-wave inversion, 
mainly involving the anterior leads, can be considered as non-pathological in athletes. 
There are known characteristics responsible for more pronounced adaptations, mainly 
age and ethnicity, variables to take in consideration during the ECG interpretation.25-28 
For example, convex (‘domed’) ST-segment elevation, combined with anterior T-wave 
inversion in leads V1-V4, is frequently described as physiological in Black athletes, 
representing a specific pattern of early repolarization in this population.27,28 Otherwise, 
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the significance of anterior T-wave inversion in Caucasian athletes is less well 
understood. 
To investigate this issue, a cohort of apparently healthy white adults was studied, 
including a large proportion of athletes (MANUSCRIPT 2: Anterior T-wave inversion in young 
white athletes and nonathletes: prevalence and significance).29 In this study performed in United 
Kingdom, a sample of 14646 white adults aged between 16 and 35 years, that 
underwent cardiac evaluation from 2007 to 2013, was analyzed. Of these individuals, 
2958 were competitive athletes involved in multiple sports. The prevalence and the 
extension of anterior T-wave inversion in resting 12-lead ECG were compared according 
to the gender and between athletes and non-athletes. All the subjects with anterior T-
wave inversion underwent additional investigations to detect the broader phenotypic 
features of cardiomyopathies (TTE and further tests performed case by case). 
As imaging phenotype may arise later than ECG changes and obscure underlying 
cardiomyopathy, athletes with abnormal repolarization changes and normal structurally 
hearts should be followed and evaluated with caution.30,31 In fact, to consider an ECG 
with marked T-wave inversions as a normal variant, even in the absence of structural 
abnormalities in the initial imaging evaluation, as advocated and reported in some cases, 
can be a wrong assumption.30 A critical analysis of one paradigmatic case report 
published was briefly discussed (MANUSCRIPT 3: ECG in athlete: “normal or pathologic 
variant?”).32 
Beyond the influence of demographics, several exercise-related characteristics may 
induce more pronounced ECG changes. Due to the wide spectrum of sports disciplines, 
the knowledge of these characteristics is very important during the interpretation of 
ECG. Integration of this data is frequently difficult, while the conventional dichotomy 
between endurance or dynamic and static or strength exercise seems simplistic. In fact, 
many sports combine elements of both types of exercise, and other variables as the level 
of competition and the intensity of exercise training should be considered. Different 
types of exercise training induce different hemodynamic changes and different cardiac 
adaptations, namely at electrical level. 
The association between exercise-related characteristics and abnormal ECG findings 
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were studied in a large sample of competitive athletes (MANUSCRIPT 4: Abnormal 
electrocardiographic findings in athletes: correlation with intensity of sport and level of competition).33 In this 
original study, 3423 competitive young athletes (aged between 14 and 35 years) 
evaluated in a preparticipation screening program were included. Abnormal 
electrocardiographic findings were categorized according to the Seattle criteria and the 
‘refined criteria’ and compared among four categories of variables: intensity of sport 
(low or moderate versus at least one high static or dynamic component); competitive 
level (regional versus national or international level); training volume (20 or less versus 
more than 20 hours per week); and type of sport (high static versus high dynamic 
component of exercise). 
As illustrated in the previous manuscripts, several characteristics can influence the 
findings present in the athlete’s ECG, being frequently challenging to provide a 
differential diagnosis between physiological adaptations and pathology. In 
consequence, even when experienced physicians interpret the ECG according to the 
current standards, there is a significant inter-observer variability that results in false-
positive and false-negative results.34-36 
The degree of variation and the accuracy in interpretation of the ECG in athletes in 
Portugal was unknown, leading to an original study included in this document 
(MANUSCRIPT 5: Variability in interpretation of the electrocardiogram in athletes: another limitation in pre-
competitive screening).37 In this study, 20 ECGs of competitive athletes (9 confirmed as 
pathological) were interpreted by 58 physicians (42 cardiologists) and classified as non-
pathological or pathological. Information related with demographics and the respective 
sports was provided, while the experience of physicians in the evaluation of athletes and 
the criteria used for ECG interpretation were registered. The variability in the 
interpretation of ECGs and the reproducibility of the study were assessed. 
On the same line, aiming to investigate the degree of variation in ECG interpretation 
among cardiologists with different experience and the financial implications of 
interpretation using different criteria, other original study was performed 
(MANUSCRIPT 6: Inter-rater reliability and downstream financial implications of electrocardiography 
screening in young athletes).38 Eight cardiologists, four with experience in screening athletes, 
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reported 400 ECGs of consecutively screened young athletes, according to the 2010 ESC 
recommendations, Seattle criteria and ‘refined criteria’.39-41 Additionally, the physicians 
proposed secondary investigations after traces interpretation, which the costs were 
calculated based on the United Kingdom National Health Service tariff payment system, 
allowing a financial analysis. 
To overcome some of the limitations discussed in the previously manuscripts, it is of 
utmost importance to improve the accuracy in ECG interpretation in athletes. A measure 
that may have a positive impact in the reduction of false positive cases is the application 
of more restrictive criteria. In this setting, as already cited, various specific criteria, 
progressively more restrictive, have been published in the last years.39-42 
A comparison of the main criteria - 2010 ESC recommendations, Seattle criteria and 
‘refined criteria’,39-41 was performed in a young military cohort (MANUSCRIPT 7: 
Comparison of three criteria for interpretation of electrocardiogram in athletes).43 In this study, 1380 
consecutive healthy young military of the Portuguese Armed Forces (Army, Navy and Air 
Force), with a training of at least 4 hours per week, 18% concomitantly involved in 
competitive sport, were prospectively included. Individuals with CV symptoms and 
established diagnosis of cardiac disease were excluded from this analysis. ECGs were 
interpreted and classified as normal, with physiological or abnormal changes using the 
three criteria and the rate of false positives cases was compared. The individuals with 
the ECGs classified as abnormal by any of the criteria used were referred for evaluation 
in a sports cardiology clinic and further investigations were performed accordingly. 
 
ROLE OF ECHOCARDIOGRAPHY IN ATHLETES 
Although not routinely recommended in preparticipation evaluation, TTE is frequently 
performed in some sports and before specific competitions, mainly in high level athletes 
or in military of the special forces. Otherwise, in athletes with symptoms, abnormalities 
in physical examination, pathological findings in ECG and findings in the ‘grey zone’ 
between physiological adaptations and abnormal changes, TTE constitutes the first-line 
imaging test. 
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Regular exercise training prompts complex cardiac remodelling to accommodate a state 
of enhanced CV performance.44 The advent of echocardiography provided a non-
invasive assessment of structural and functional adaptations, a constellation of changes 
traditionally known as ‘athlete´s heart’. Globally, physiological adaptations are 
characterized by an homogeneous chamber enlargement and an increased mass and 
wall thickness, mainly involving the LV.45 As for electrical adaptations, several 
demographic and exercise-related factors are associated with more pronounced 
structural remodelling.46-49 The recognition of these characteristics and its integration 
with the data derived from additional investigations is essential for a better clarification 
of the cardiac morphology and function in athletes. 
Although the Morganroth hypothesis postulates that strength exercise induces 
concentric LVH due to pressure overload and endurance exercise induces eccentric LVH 
due to volume overload, it is currently known that most sports share both types of 
exercise, leading to a mixed remodeling.50-53 Additionally, LV remodelling seems to 
follow a phasic response with increase of chamber size in an acute phase and wall 
thickness in a chronic phase of exercise training.54 In fact, TTE assumes an important role 
in the evaluation and characterization of the complex relationship between these 
variables and subsequent structural phenotypes. 
In this context, the effect of different exercise training programs in cardiac remodeling 
was prospectively investigated in two populations - competitive athletes and special 
operation forces soldiers (MANUSCRIPT 8: Exercise-induced cardiac remodeling in athletes and in 
special forces soldiers).55 In this original study, 17 soldiers who entered and finished a special 
operation forces course, and 17 basketball players, were evaluated at the beginning and 
at the end of the military course and the sport season, respectively. The structural and 
functional cardiac adaptations were analyzed and compared in the two periods and 
between both populations. Beyond the conventional TTE modalities, myocardial 
deformation was also evaluated.  
The distinction between physiological adaptations and cardiomyopathies remain a 
major challenge in the evaluation of athletes, especially when they fall in the 
morphological ‘grey zone’. Advanced and specific echocardiographic modalities, as the 
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reported 400 ECGs of consecutively screened young athletes, according to the 2010 ESC 
recommendations, Seattle criteria and ‘refined criteria’.39-41 Additionally, the physicians 
proposed secondary investigations after traces interpretation, which the costs were 
calculated based on the United Kingdom National Health Service tariff payment system, 
allowing a financial analysis. 
To overcome some of the limitations discussed in the previously manuscripts, it is of 
utmost importance to improve the accuracy in ECG interpretation in athletes. A measure 
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progressively more restrictive, have been published in the last years.39-42 
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‘refined criteria’,39-41 was performed in a young military cohort (MANUSCRIPT 7: 
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Force), with a training of at least 4 hours per week, 18% concomitantly involved in 
competitive sport, were prospectively included. Individuals with CV symptoms and 
established diagnosis of cardiac disease were excluded from this analysis. ECGs were 
interpreted and classified as normal, with physiological or abnormal changes using the 
three criteria and the rate of false positives cases was compared. The individuals with 
the ECGs classified as abnormal by any of the criteria used were referred for evaluation 
in a sports cardiology clinic and further investigations were performed accordingly. 
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in physical examination, pathological findings in ECG and findings in the ‘grey zone’ 
between physiological adaptations and abnormal changes, TTE constitutes the first-line 
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of the cardiac morphology and function in athletes. 
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concentric LVH due to pressure overload and endurance exercise induces eccentric LVH 
due to volume overload, it is currently known that most sports share both types of 
exercise, leading to a mixed remodeling.50-53 Additionally, LV remodelling seems to 
follow a phasic response with increase of chamber size in an acute phase and wall 
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analysis of LV myocardial deformation with 2D-speckle tracking and exercise 
echocardiography, can improve this evaluation.56-62 
In consequence of the previous study, in which GLS seemed to have a specific pattern in 
subjects undergoing intense exercise training, this issue deserved further investigation. 
The normal values of GLS in athletes are not established, while its relationship with 
different characteristics of exercise training and other echocardiographic parameters is 
weakly understood. For this purpose, we decided to study LV GLS profile in athletes with 
different intensities of exercise training in an original investigation (MANUSCRIPT 9: 
Myocardial deformation and volume of exercise: a new overlap between pathology and athlete’s heart?).63 
Consecutive young athletes (< 35 years old) involved in endurance sports characterized 
by high intensity dynamic component were enrolled. According to the training regimens, 
namely the level and the number of exercise training hours per week, a surrogate 
measure of exercise volume, two groups were defined: Group 1 (N=60) - high intensity 
(≥20 training-hours per week); Group 2 (N=48) - low intensity (<10 training-hours per 
week). All athletes had previously a clinical evaluation (detailed personal and family 
history, physical examination and resting 12-lead ECG) and the ones considered eligible 
performed a comprehensive TTE, before the competitive season. Positive personal or 
family history for CV disease, known CV risk factors, cardiac symptoms, positive findings 
in physical examination, abnormal changes in ECG, use of enhancing performance 
substances and TTE with inadequate image quality were exclusion criteria. TTE included 
the evaluation of LV GLS assessed by 2D-speckle-tracking, being compared between the 
two groups. GLS was correlated with other echocardiographic parameters and the 
independent predictors of abnormal GLS, defined as a value lower than 17%, were 
determined. 
The functional assessment at rest complemented by exercise echocardiography may be 
the clue for a better clarification of several conditions, mainly in the evaluation of 
athletes with symptoms induced or exacerbated by exercise.14 Exercise 
echocardiography can be useful, allowing the detection of specific conditions as the 
presence of intraventricular gradient, illustrated in a case report published 
(MANUSCRIPT 10: Symptomatic exercise-induced intraventricular gradient in competitive athlete).64 
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CARDIAC CT IN CORONARY ATHEROSCLEROTIC BURDEN EVALUATION 
CAD is the leading cause of SCD in veteran athletes, with a percentage that can go up to 
80% of the cases.5 As the majority of sports-related deaths occurs in older athletes and 
many cases are unwitnessed, the magnitude of the problem is probably 
underestimated.15 This epidemiology justifies different methodologies in the 
preparticipation evaluation according to the age range of the athletes. Additionally, the 
huge number of middle-aged individuals engaged in leisure sports makes their 
evaluation very important, aiming to rule out CAD.  
However, the methodology for CV risk stratification and detection of subclinical CAD is 
controversial, not only in athletes but also in the general population, in particular 
regarding the most appropriate exam to choose. One of the most promising exams for 
this purpose, with potential to be applied in veteran athletes, is cardiac CT, due to its 
ability to provide a non-invasive evaluation of the total coronary atherosclerotic burden 
(both obstructive and nonobstructive). 
Several preliminary studies were initially performed in the general population to 
evaluate the efficacy of cardiac CT for coronary atherosclerotic burden evaluation and 
to test some CT angiographic scores.  
CV risk stratification is recommended to identify individuals with increased risk for CV 
events that can benefit of early implementation of preventive and therapeutic 
measures.2 CV risk results from multiple, interacting factors, and from a clinical 
perspective it has been recommended the used of the SCORE risk charts, that integrates 
clinical characteristics and estimates the 10-year risk for fatal CV disease.65 The 
prognostic value of this strategy based on clinical risk factors, isolated or integrated in 
scores, has been widely recomended.66,67 Although this evidence, the association of 
clinical risk factors with the presence and extension of coronary atherosclerosis is 
sometimes controversial. 
The development of cardiac CT and its progressive adoption in clinical practice has led 
to a better characterization of this relationship. Cardiac CT can be very useful in CV risk 
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underestimated.15 This epidemiology justifies different methodologies in the 
preparticipation evaluation according to the age range of the athletes. Additionally, the 
huge number of middle-aged individuals engaged in leisure sports makes their 
evaluation very important, aiming to rule out CAD.  
However, the methodology for CV risk stratification and detection of subclinical CAD is 
controversial, not only in athletes but also in the general population, in particular 
regarding the most appropriate exam to choose. One of the most promising exams for 
this purpose, with potential to be applied in veteran athletes, is cardiac CT, due to its 
ability to provide a non-invasive evaluation of the total coronary atherosclerotic burden 
(both obstructive and nonobstructive). 
Several preliminary studies were initially performed in the general population to 
evaluate the efficacy of cardiac CT for coronary atherosclerotic burden evaluation and 
to test some CT angiographic scores.  
CV risk stratification is recommended to identify individuals with increased risk for CV 
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measures.2 CV risk results from multiple, interacting factors, and from a clinical 
perspective it has been recommended the used of the SCORE risk charts, that integrates 
clinical characteristics and estimates the 10-year risk for fatal CV disease.65 The 
prognostic value of this strategy based on clinical risk factors, isolated or integrated in 
scores, has been widely recomended.66,67 Although this evidence, the association of 
clinical risk factors with the presence and extension of coronary atherosclerosis is 
sometimes controversial. 
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stratification, providing a non-invasive evaluation of the coronary atherosclerotic 
burden in populations with low to moderate risk. 
Additionally, it was recently showed that in patients referred for the assessment of 
stable chest pain, the use of CCTA was associated with a lower subsequent risk of death 
from coronary heart disease or nonfatal myocardial infarction than standard care 
alone.68 
Among the classical clinical CV risk factors, diabetes has a paradigmatic association with 
CAD. The coronary atherosclerotic burden and severity of CAD evaluated by CCTA in 
diabetic patients was the scope of one original manuscript included in this investigation 
(MANUSCRIPT 11: Diabetes as an independent predictor of high atherosclerotic burden assessed by coronary 
computed tomography angiography: the coronary artery disease equivalent revisited).69 A detailed 
characterization of the coronary atherosclerotic burden, including localization, degree 
of stenosis and plaque composition, was evaluated by cardiac CT in 581 consecutive 
stable patients and compared according to the presence of diabetes. 
At the same time, regarding other clinical characteristics as obesity and overweight, the 
association with atherosclerotic burden and CAD is more conflicting, being even 
described an ‘obesity paradox’.70-75 The relationship between body mass index and the 
presence and severity of CAD documented by cardiac CT was evaluated in 1706 
consecutive stable patients (MANUSCRIPT 12: Body mass index as a predictor of the presence but 
not the severity of coronary artery disease evaluated by cardiac-CT).76 
CV risk stratification limited to clinical characteristics has a modest predictive accuracy 
and fails to identify a significant number of individuals with established CAD.77-79 
Consequently, the performance of traditional CV risk factors in identifying a higher than 
expected coronary atherosclerotic burden was investigated in a population of 2069 
patients undergoing cardiac CT for suspected CAD (MANUSCRIPT 13: Performance of 
traditional risk factors in identifying a higher than expected coronary atherosclerotic burden).80 The ability of 
the traditional CV risk factors to predict a higher than expected atherosclerotic burden, 
defined as CAC score >75th percentile according to age and gender-adjusted 
monograms, was assessed in a customized logistic regression model and by the 
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calculation of SCORE. The population attributable risk of CV risk factors for CAC score 
>75th percentile was calculated. 
In other original study, the performance of the SCORE to estimate CV risk in a population 
of 1628 patients presenting with ST-elevation myocardial infarction as the first 
manifestation of CAD was evaluated. The SCORE risk would classify as low risk more than 
two-thirds of the STEMI patients before the event, underlying the need for additional 
tools to better identify individuals at risk (MANUSCRIPT 14: Low previous cardiovascular risk of 
patients with ST-elevation myocardial infarction).81 
Since the rupture of non-obstructive coronary plaques is a common mechanism involved 
in acute coronary syndromes, the inclusion of more comprehensive evaluation of both 
obstructive and nonobstructive CAD, plaque location and composition (calcified, non-
calcified and mixed) reflects more closely the true pathophysiological process in the 
coronary arteries beyond the simplistic clinical risk factors approach and will certainly 
lead to a refined coronary risk assessment.82-84 In this line, several markers and scores 
mainly derived from cardiac CT have been studied to overcome the limitations of clinical 
characteristics in CV risk stratification and detection of CAD. 
The radiation dose of cardiac CT is the main limitation associated with this exam, but 
can be reduced with the use of appropriate protocols and has in fact seen impressive 
reductions in recent years, both due to software (new protocols) and also hardware 
(newer generation scanners).85 Since this is an important issue if cardiac CT is to be 
considered for CV risk screening in the future, we decided to study the factors associated 
with radiation dose and how it compares with other cardiac exams that use ionizing 
radiation. In this study, the mean dose of radiation was compared among 6196 patients 
that underwent cardiac CT, single photon emission CT or invasive coronary angiography, 
as their evolution over the time (MANUSCRIPT 15: Effective radiation dose of three diagnostic tests 
in cardiology: single photon emission computed tomography, invasive coronary angiography and cardiac computed 
tomography angiography).86 
CAC score has a superior value in discrimination and reclassification of CV risk in 
intermediate-risk individuals.87-93 On the other hand, CCTA provides a more 
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tools to better identify individuals at risk (MANUSCRIPT 14: Low previous cardiovascular risk of 
patients with ST-elevation myocardial infarction).81 
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calcified and mixed) reflects more closely the true pathophysiological process in the 
coronary arteries beyond the simplistic clinical risk factors approach and will certainly 
lead to a refined coronary risk assessment.82-84 In this line, several markers and scores 
mainly derived from cardiac CT have been studied to overcome the limitations of clinical 
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The radiation dose of cardiac CT is the main limitation associated with this exam, but 
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comprehensive evaluation on both calcified and noncalcified plaques, better lesion 
location and also the degree of stenosis, all variables that carry prognostic value. 
Our group developed and validated a coronary atherosclerotic burden score – the CT-
Leaman score, that takes in consideration all this information (plaque location, degree 
of stenosis and plaque composition)  (MANUSCRIPT 16: Coronary computed tomography 
angiography-adapted Leaman score as a tool to noninvasively quantify total coronary atherosclerotic burden).94 
In this manuscript we describe the cardiac CT-adapted Leaman score as a tool to quantify 
total coronary atherosclerotic burden with information regarding localization, type of 
plaque, degree of stenosis and to identify clinical predictors of a high coronary 
atherosclerotic burden. For this purpose, 581 stable patients referred for suspected CAD 
were included. Pre-test CAD probability was determined using both the Diamond–
Forrester extended CAD consortium method and the Morise score, while CV risk was 
assessed with the SCORE. Beyond obstructive CAD, non-obstructive plaques have 
significant prognostic impact reinforcing the role of cardiac CT for coronary risk 
assesment.95,96 
Some patients referred for cardiac CT might have a CAC score of zero. In those patients 
there are some doubts if the additional information provided by contrast enhanced 
exam is worthy of the additional cost and radiation burden of CT angiography. To answer 
this question, we decided to evaluate the prevalence of CAD in individuals with a CAC 
score of zero (MANUSCRIPT 17: Prevalence and predictors of coronary artery disease in patients with a 
calcium score of zero).97 
The experience acquired and the results shown in these studies with cardiac CT, namely 
the high negative predictive value to exclude CAD, the ability to noninvasively provide 
information on the total coronary atherosclerotic burden, the progressive reductions 
achieved in radiation dose on one hand, and also the limitations of CV risk stratification 
based on clinical characteristics alone, on the other hand, were the basis to study the 
coronary atherosclerotic burden of veteran athletes using this exam. 
 
 
 
 
CORONARY ARTERY DISEASE IN VETERAN ATHLETES 
Due to the development and widespread of CV imaging tests, namely cardiac CT, several 
studies have reported a higher than expected incidence of CAD in veteran athletes. One 
manuscript included depicts an illustrative case report of an extreme intensity exercise 
(ironman) athlete with low CV risk, normal ECG and exercise testing, but with extensive 
non-obstructive CAD in CCTA (MANUSCRIPT 18: Non-obstructive coronary artery disease 
documented by cardiac computed tomography: Discrepancy between atherosclerotic burden and cardiovascular 
risk).98 
As documented in the previous manuscripts, cardiac CT provides early detection of CAD, 
frequently not possible with exercise testing, the most requested investigation for CV 
risk stratification in veteran athletes. Although some studies had described more 
frequent coronary plaques in athletes than controls, their stable nature could mitigate 
the risk of plaque rupture.99 Additionally, it has been shown a potential ‘U-shaped’ 
relationship between the dose of exercise and the presence and severity of CAD.100-102 
This association between CAD and exercise training is controversial and was deeply 
discussed in a review manuscript (MANUSCRIPT 19: Coronary artery disease in athletes: an adverse 
effect of intense exercise?).103 
Although some exercise-related factors may be potentially involved, several questions 
remain unanswered regarding this relationship: 1) methodological inconsistences in the 
studies published, with different heterogeneity in baseline characteristics and inclusion 
criteria, samples mainly composed by high-level athletes and involved in endurance 
sports, not reflecting the wide spectrum of athletes and sports modalities; 2) it is not 
possible to establish if exercise is associated with accelerated CAD or if represents a 
protector factor for CAD in individuals with intrinsic high risk; 3) it is not possible to 
ensure the influence of unmeasurable variables as genetic characteristics, performance 
enhancing substances abuse or existence of other ‘occult’ risk factors.15 
In this setting, we undertook an original study aiming to characterize the coronary 
atherosclerotic burden by cardiac CT in veteran athletes with low to intermediate CV 
risk, predominantly involved in recreational sports, to evaluate its relationship with 
exercise-related characteristics and to analyse the value of cardiac CT in preparticipation 
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In this setting, we undertook an original study aiming to characterize the coronary 
atherosclerotic burden by cardiac CT in veteran athletes with low to intermediate CV 
risk, predominantly involved in recreational sports, to evaluate its relationship with 
exercise-related characteristics and to analyse the value of cardiac CT in preparticipation 
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evaluation (MANUSCRIPT 20: Coronary atherosclerotic burden in recreational male veteran athletes with 
low to intermediate cardiovascular risk).104 A total of 105 male veteran athletes aged ≥40 years 
old, training ≥4 hours per week during at least the last 5 years, were enrolled in this 
analytical, observational, prospective and multicentric cohort study. Among the 
exclusion criteria were the presence of symptoms, diabetes mellitus and a SCORE ³5%. 
All the individuals were evaluated in a dedicated sports cardiology clinic, with a deep 
clinical history (personal and family) and physical examination, and performed 
additional tests (12-lead rest ECG, blood tests, TTE and exercise testing). The volume of 
exercise was calculated by Metabolic Equivalent Task Score (MET-hour per week - 
product of intensity, frequency and duration), being analysed by absolute values and 
tertiles. CAD was evaluated by cardiac CT (CAC score and CCTA), being registered several 
characteristics, such as the presence, degree of stenosis, localization and type of 
coronary plaques. Several cardiac CT scores validated in other populations, as the 
Segment Involvement Score and CT-Leaman score, were employed. A high 
atherosclerotic burden was defined as the combination of: 1) CAC score >100 Agatston 
units; 2) CAC score ≥75th percentile; 3) obstructive CAD (stenosis ³50%); 4) disease in 
left main, three vessels or two vessels involving the proximal anterior descending artery; 
5) segment involvement score >5; 6) CT-adapted Leaman score ≥5. Several exercise-
related characteristics were correlated with the findings of cardiac CT. 
Using the same sample of veteran athletes, a second study was performed 
(MANUSCRIPT 21: Subclinical coronary artery disease in veteran athletes: is a new pre-participation 
methodology required?)105, with the purpose to evaluate the effectiveness of current 
preparticipation methodology (clinical risk factors and exercise testing) in the 
identification of athletes with high coronary atherosclerotic burden. The hypothesis was 
that conventional CV risk assessment had a low sensitivity for the detection of CAD in 
veteran athletes, which might be improved by the addition of data derived from cardiac 
CT. The presence of CV risk factors (isolated and integrated in SCORE) and significant 
findings in exercise testing were correlated with the presence of a high coronary 
atherosclerotic burden determined by cardiac CT.  
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Abstract Intense and regular physical exercise is responsible for various cardiac changes (elec-
trical, structural and functional) that represent physiological adaptation to exercise training.
This remodeling, commonly referred to as ‘athlete’s heart’, can overlap with several patho-
logical entities, in which sudden cardiac death may be the first clinical presentation. Although
pre-competitive screening can identify athletes with life-threatening cardiovascular abnormal-
ities, there are no widely used standardized pre-participation programs and those currently
implemented are controversial. Data from personal and family history, features of physical
examination and changes in the 12-lead electrocardiogram can raise the suspicion of cardiac
disease and lead to early detection of entities such as hypertrophic cardiomyopathy. However,
interpreting the electrocardiogram is often challenging, because some changes are considered
physiological in athletes. Thus, clinical decision-making in such cases can prove difficult: missing
a condition associated with an increased risk of life-threatening events, or conversely, mislabel-
ing an athlete with a disease that leads to unnecessary disqualification, are both situations to
avoid. This paper provides an up-to-date review of the physiological cardiac effects of exercise
training and highlights key points that should be taken into consideration in the assessment of
young competitive athletes.
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fisiológicas ao exercício. Esta remodelagem, frequentemente denominada por corac¸ão de
atleta, pode mimetizar alterac¸ões típicas de diversas patologias, nas quais a morte súbita
pode ser a primeira apresentac¸ão clínica. Apesar do rastreio pré-competic¸ão poder identi-
ficar atletas com alterac¸ões cardíacas potencialmente fatais, os programas de rastreio não
estão estandardizados e aqueles já implementados permanecem controversos. Dados da história
clínica pessoal e familiar, achados do exame físico e alterac¸ões no eletrocardiograma de
12 derivac¸ões, podem aumentar a suspeita de doenc¸a cardíaca e levar à detec¸ão precoce
de entidades como a miocardiopatia hipertrófica. Contudo, a interpretac¸ão do eletrocardio-
grama é frequentemente desafiante porque várias alterac¸ões são consideradas fisiológicas em
atletas. Assim, as decisões clínicas são por vezes difíceis: não diagnóstico de condic¸ões asso-
ciadas a um risco aumentado de eventos fatais, ou por outro lado, o diagnóstico errado de
patologia cardíaca em atletas saudáveis pode originar a realizac¸ão de exames de diagnóstico
desnecessários ou a desqualificac¸ão inapropriada do atleta. Este artigo fornece uma revisão atu-
alizada dos efeitos cardíacos fisiológicos do exercício físico e realc¸a pontos-chave que deverão
ser tidos em considerac¸ão na avaliac¸ão de atletas jovens de competic¸ão.
© 2014 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. Todos os
direitos reservados.
Introduction
A sedentary lifestyle is associated with the development of
cardiovascular (CV) risk factors, progression of coronary dis-
ease and occurrence of adverse clinical events.1,2 Health
promotion efforts aimed at CV disease prevention, empha-
sizing physical activity, have led to increased participation in
recreational and competitive sport.3 However, cases of sud-
den cardiac death (SCD) among athletes continue to raise
concerns regarding the safety of exercise. A higher risk of
coronary events and malignant arrhythmias during vigorous
exercise has been described (the so-called exercise para-
dox), but the incidence of exercise-related cardiac arrest in
individuals aged under 35 years has recently been shown
to be low.4,5 Nonetheless, some doubts persist regarding
the impact of prolonged and intense exercise training. In a
study of 102 marathon runners, 12% had myocardial scarring
on cardiac magnetic resonance imaging (MRI) with variable
patterns (ischemic and non-ischemic), a finding three times
more common than in age-matched controls.6 The role of
exercise-induced fibrosis as arrhythmogenic substrate is as
yet poorly understood. Some authors argue that a high vol-
ume of endurance exercise is responsible for adverse CV
effects and that there may be a upper limit beyond which
the adverse effects outweigh the benefits.7
Exercise training induces a constellation of physiological
CV adaptations. The first descriptions of heart enlargement
in athletes date to the 1890s, when increased cardiac size
was demonstrated with chest auscultation and percussion
in Nordic skiers and university runners.8,9 In the 1940s, a
higher prevalence of resting sinus bradycardia was reported
among Boston marathon runners.10 Nearly four decades
later, in 1975, with the development of M-mode echocar-
diography, Morganroth described different left ventricular
(LV) remodeling according to the type of exercise: concen-
tric hypertrophy for strength and eccentric for endurance
exercise,11 an observation that came to be known as the
‘Morganroth hypothesis’. However, with the increasing num-
bers of athletes being assessed, along with the development
of cardiac imaging and the growth of published data in sports
cardiology, it has been ascertained that other factors influ-
ence cardiac remodeling.
Early identification of athletes at higher risk of SCD is
a cornerstone of screening. A wrong diagnosis could have
serious adverse consequences: under-diagnosis of pathol-
ogy may lead to life-threatening events being missed,
and over-diagnosis may result in unnecessary disqualifi-
cation. The ideal balance has not been struck, and the
cost-effectiveness of current screening programs remains
controversial. While a clinical history and physical exam-
ination are consensual, the same is not true for the
electrocardiogram (ECG). Electrical and structural cardiac
remodeling can induce ECG changes considered normal in
athletes but pathological in non-athletes. Standardization
of ECG interpretation in athletes could reduce the rate of
false positives and the need for further investigations.
This paper provides an up-to-date review of exercise-
induced physiological cardiac effects and an overview of the
key points that should be highlighted in the assessment of
athletes.
Molecular mechanisms and physiology
of exercise
Several complex mechanisms have been postulated to
account for the beneficial effects of physical activity.
Continuous exercise training decreases myocardial oxy-
gen demand, improves myocardial perfusion, promotes an
antithrombotic environment, balances the autonomic sys-
tem and prevents the development of CV risk factors such as
hypertension, dyslipidemia, obesity and diabetes.3,12--15 At
themolecular level, exercise enhances antioxidant capacity,
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induces myocardial heat shock proteins, and increases nitric
oxide production and anti-apoptotic protection.15,16 Tran-
sient myocardial ischemia during regular bouts of exercise
increases tolerance to subsequent ischemic stress, limiting
ischemia-reperfusion injury and reducing the risk of lethal
arrhythmias, a mechanism known as myocardial ischemic
preconditioning.16,17
Physiological adaptations to exercise include a complex
network of mechanisms (structural, neurohumoral, auto-
nomic, metabolic and regulatory), which increase cardiac
output.15 During exertion, increased skeletal muscle blood
flow and oxygen extraction can raise cardiac output up to
six times above baseline levels. The autonomic nervous sys-
tem is involved in this process through parasympathetic
withdrawal and sympathetic activation.17 Increased stroke
volume results from increased ventricular end-diastolic vol-
ume and, to a lesser degree, from sympathetically-mediated
reduction in end-systolic volume.18 By contrast, maximum
heart rate does not significantly increase with regular
exercise training.19 Post-exercise hemodynamics returns to
baseline with vagal reactivation, a process that is enhanced
in highly trained athletes.17 The effects of prolonged exer-
cise on the right ventricle (RV) and left ventricle (LV) are
different. During exercise there is a marked biventricular
increase in cardiac output, but the decrease in vascular
resistance is less pronounced in the pulmonary circulation.
This mismatch between increased flow and vasodilation may
result in an abnormal increase in pulmonary artery pressure
and RV afterload, with a marked increase in RV workload.
La Gerche et al.20 showed that RV volumes increase after
endurance races, whereas LV volumes decrease, resulting in
decreased RV but not LV ejection fraction (LVEF). Although
short-term recovery appears to be complete, the long-term
clinical significance of these changes is unknown.
Factors influencing cardiac adaptations
to exercise training
Several factors, especially demographic and sport-related,
are associated with more pronounced cardiac remodeling
(Figure 1).
Age
Although most studies are on adult athletes (18--35 years
old), cardiac adaptation is also evident in the younger pop-
ulation. A higher prevalence of ECG changes including LV
hypertrophy, left atrial (LA) and right atrial (RA) enlarge-
ment, was shown in 1000 junior athletes compared with
non-athletic controls.21 Some changes reflect normal vari-
ations at specific ages, such as the juvenile ECG pattern
in individuals aged under 16. In a study of 1050 athletes
(9--55 years old), those under 20 had significantly more
ECG changes.22 Trained adolescents showed greater LV wall
thickness (LVWT) than non-athletes.23 The range of LVWT dif-
fered between adolescent and adult athletes, with an upper
limit of 16 mm in adults and 14 mm in adolescents, and
LVWT >12 mm in ≈2% and 0.5% respectively.23,24 This sug-
gests that LVWT limits should be lower in younger athletes.
Less skeletal muscle mass, lower accumulated training, lack
of testosterone before puberty and lower catecholamine
Age
Ethnicity
Gender
Body surface area Cardiac
Remodeling
Type of sport
Training intensity
Competitive level
Figure 1 Factors influencing cardiac remodeling in competi-
tive athletes.
responses to exercise in young athletes may help account for
these differences. Many children are involved in intensely
competitive activities early in life, but the effects of exer-
cise training in very young athletes are unknown. Conversely,
athletes are increasingly competing at older ages, and the
impact of lifelong exercise training in veteran athletes is yet
to be ascertained.
Gender
Cardiac remodeling is more pronounced among male athle-
tes. Pelliccia et al. showed 23% lower LVWT and 11% smaller
LV size in female compared to male athletes with similar
age and training intensity.25 In this study no female had
LVWT >12 mm. Sharma et al. showed similar findings in
adolescent athletes (11% lower LVWT and 6% smaller LV
size in females).25 Almost 5% of male athletes had LVWT
≥12 mm, but no females had LVWT >11 mm. Physiological
ECG changes are also more frequent in male athletes.23 It
should also be noted that a greater proportion of males
are involved in extreme endurance and competitive sports,
and hormonal factors may explain the gender-specific
differences in these studies.
Ethnicity
Black (Afro-Caribbean) athletes exhibit more pronounced
cardiac remodeling than their white counterparts. Basavara-
jaiah et al. reported LVWT >12 mm in 18% black male ath-
letes compared to 4% in white male athletes.26 Additionally,
3% of the black athletes, but none of the whites, exhibited
LVWT ≥15 mm. The predominance of physiological remodel-
ing in black athletes is not restricted to male gender. Rawlins
et al. showed LVWT >12 mm in 3.3% black female ath-
letes (all 12--13 mm), but none of their white counterparts
had LVWT >11 mm.27 The prevalence of ECG abnormali-
ties is also gender-dependent in athletes under 17 years
of age.27--29 This ethnic discrepancy can be explained
by differences in blood pressure modulation,30 endothe-
lial function,31 arterial stiffness,32 angiotensin-converting
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clínica pessoal e familiar, achados do exame físico e alterac¸ões no eletrocardiograma de
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de entidades como a miocardiopatia hipertrófica. Contudo, a interpretac¸ão do eletrocardio-
grama é frequentemente desafiante porque várias alterac¸ões são consideradas fisiológicas em
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ciadas a um risco aumentado de eventos fatais, ou por outro lado, o diagnóstico errado de
patologia cardíaca em atletas saudáveis pode originar a realizac¸ão de exames de diagnóstico
desnecessários ou a desqualificac¸ão inapropriada do atleta. Este artigo fornece uma revisão atu-
alizada dos efeitos cardíacos fisiológicos do exercício físico e realc¸a pontos-chave que deverão
ser tidos em considerac¸ão na avaliac¸ão de atletas jovens de competic¸ão.
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cardiovascular (CV) risk factors, progression of coronary dis-
ease and occurrence of adverse clinical events.1,2 Health
promotion efforts aimed at CV disease prevention, empha-
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of cardiac imaging and the growth of published data in sports
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Early identification of athletes at higher risk of SCD is
a cornerstone of screening. A wrong diagnosis could have
serious adverse consequences: under-diagnosis of pathol-
ogy may lead to life-threatening events being missed,
and over-diagnosis may result in unnecessary disqualifi-
cation. The ideal balance has not been struck, and the
cost-effectiveness of current screening programs remains
controversial. While a clinical history and physical exam-
ination are consensual, the same is not true for the
electrocardiogram (ECG). Electrical and structural cardiac
remodeling can induce ECG changes considered normal in
athletes but pathological in non-athletes. Standardization
of ECG interpretation in athletes could reduce the rate of
false positives and the need for further investigations.
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induced physiological cardiac effects and an overview of the
key points that should be highlighted in the assessment of
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induces myocardial heat shock proteins, and increases nitric
oxide production and anti-apoptotic protection.15,16 Tran-
sient myocardial ischemia during regular bouts of exercise
increases tolerance to subsequent ischemic stress, limiting
ischemia-reperfusion injury and reducing the risk of lethal
arrhythmias, a mechanism known as myocardial ischemic
preconditioning.16,17
Physiological adaptations to exercise include a complex
network of mechanisms (structural, neurohumoral, auto-
nomic, metabolic and regulatory), which increase cardiac
output.15 During exertion, increased skeletal muscle blood
flow and oxygen extraction can raise cardiac output up to
six times above baseline levels. The autonomic nervous sys-
tem is involved in this process through parasympathetic
withdrawal and sympathetic activation.17 Increased stroke
volume results from increased ventricular end-diastolic vol-
ume and, to a lesser degree, from sympathetically-mediated
reduction in end-systolic volume.18 By contrast, maximum
heart rate does not significantly increase with regular
exercise training.19 Post-exercise hemodynamics returns to
baseline with vagal reactivation, a process that is enhanced
in highly trained athletes.17 The effects of prolonged exer-
cise on the right ventricle (RV) and left ventricle (LV) are
different. During exercise there is a marked biventricular
increase in cardiac output, but the decrease in vascular
resistance is less pronounced in the pulmonary circulation.
This mismatch between increased flow and vasodilation may
result in an abnormal increase in pulmonary artery pressure
and RV afterload, with a marked increase in RV workload.
La Gerche et al.20 showed that RV volumes increase after
endurance races, whereas LV volumes decrease, resulting in
decreased RV but not LV ejection fraction (LVEF). Although
short-term recovery appears to be complete, the long-term
clinical significance of these changes is unknown.
Factors influencing cardiac adaptations
to exercise training
Several factors, especially demographic and sport-related,
are associated with more pronounced cardiac remodeling
(Figure 1).
Age
Although most studies are on adult athletes (18--35 years
old), cardiac adaptation is also evident in the younger pop-
ulation. A higher prevalence of ECG changes including LV
hypertrophy, left atrial (LA) and right atrial (RA) enlarge-
ment, was shown in 1000 junior athletes compared with
non-athletic controls.21 Some changes reflect normal vari-
ations at specific ages, such as the juvenile ECG pattern
in individuals aged under 16. In a study of 1050 athletes
(9--55 years old), those under 20 had significantly more
ECG changes.22 Trained adolescents showed greater LV wall
thickness (LVWT) than non-athletes.23 The range of LVWT dif-
fered between adolescent and adult athletes, with an upper
limit of 16 mm in adults and 14 mm in adolescents, and
LVWT >12 mm in ≈2% and 0.5% respectively.23,24 This sug-
gests that LVWT limits should be lower in younger athletes.
Less skeletal muscle mass, lower accumulated training, lack
of testosterone before puberty and lower catecholamine
Age
Ethnicity
Gender
Body surface area Cardiac
Remodeling
Type of sport
Training intensity
Competitive level
Figure 1 Factors influencing cardiac remodeling in competi-
tive athletes.
responses to exercise in young athletes may help account for
these differences. Many children are involved in intensely
competitive activities early in life, but the effects of exer-
cise training in very young athletes are unknown. Conversely,
athletes are increasingly competing at older ages, and the
impact of lifelong exercise training in veteran athletes is yet
to be ascertained.
Gender
Cardiac remodeling is more pronounced among male athle-
tes. Pelliccia et al. showed 23% lower LVWT and 11% smaller
LV size in female compared to male athletes with similar
age and training intensity.25 In this study no female had
LVWT >12 mm. Sharma et al. showed similar findings in
adolescent athletes (11% lower LVWT and 6% smaller LV
size in females).25 Almost 5% of male athletes had LVWT
≥12 mm, but no females had LVWT >11 mm. Physiological
ECG changes are also more frequent in male athletes.23 It
should also be noted that a greater proportion of males
are involved in extreme endurance and competitive sports,
and hormonal factors may explain the gender-specific
differences in these studies.
Ethnicity
Black (Afro-Caribbean) athletes exhibit more pronounced
cardiac remodeling than their white counterparts. Basavara-
jaiah et al. reported LVWT >12 mm in 18% black male ath-
letes compared to 4% in white male athletes.26 Additionally,
3% of the black athletes, but none of the whites, exhibited
LVWT ≥15 mm. The predominance of physiological remodel-
ing in black athletes is not restricted to male gender. Rawlins
et al. showed LVWT >12 mm in 3.3% black female ath-
letes (all 12--13 mm), but none of their white counterparts
had LVWT >11 mm.27 The prevalence of ECG abnormali-
ties is also gender-dependent in athletes under 17 years
of age.27--29 This ethnic discrepancy can be explained
by differences in blood pressure modulation,30 endothe-
lial function,31 arterial stiffness,32 angiotensin-converting
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enzyme gene I/D polymorphisms33 and insulin-like growth
factor-1 expression.34
Sport-related factors
Hemodynamic and cardiac adaptations vary according to
the type and intensity of exercise. Isotonic exercise, also
referred to as endurance or dynamic exercise, increases
maximum oxygen consumption and cardiac output, with nor-
mal or reduced peripheral vascular resistance. In sports such
as cross-country skiing, long-distance running, tennis or soc-
cer, volume overload is predominant. In contrast, isometric
exercise, also known as strength or static exercises, sub-
stantially increases blood pressure and peripheral vascular
resistance, with normal or only slightly elevated cardiac
output. Sports such as climbing, gymnastics, wrestling and
body-building predominantly produce pressure overload.
Endurance sports generally induce more pronounced cardiac
remodeling. However, sports cannot be classified simply on
the basis of this dichotomy. Many disciplines combine ele-
ments of both endurance and strength exercise, and it can
be difficult to identify the predominant component. Mitchell
et al. proposed a classification of sports according to the
intensity of exercise in static and dynamic components35
(Figure 2). Although widely used, this classification has
some limitations. Factors such as emotional stress during
competition and environmental conditions were not con-
sidered. Emotional stress activates the sympathetic drive,
leading to increased catecholamine concentrations, heart
rate, blood pressure and myocardial contractility. These
responses increase myocardial oxygen demand, potentially
triggering arrhythmias and myocardial ischemia. Thus, dur-
ing competition, sports associated with low myocardial
oxygen demand relative to the exercise required (e.g.
golf or billiards) can be associated with higher emotional
stress. Environmental factors such as altitude, tempera-
ture, humidity and air pollution are responsible for different
myocardial workloads, and should also be considered. Some
sports have specific risks that should be borne in mind, such
as those involving physical contact or projectiles (risk of
commotio cordis) or those involving high velocity (risk of
vertebral artery dissection due to abrupt head hyperexten-
sion).
Structural adaptations
Since the first reports by Morganroth et al.,11 several studies
have shown a direct relationship between exercise train-
ing and cardiac structural remodeling (Table 1). Compared
to non-athletes, athletes have 15--20% greater LVWT and
10--15% greater LV size. In a landmark study of 1309 Ital-
ian athletes engaged in 38 sports, 45% had LV end-diastolic
diameter ≥55 mm (≥60 mm in 14%).36 A markedly dilated
LV was more common in athletes with a larger body surface
area and in those participating in endurance sports (cycling,
cross-country skiing, and rowing/canoeing). Indexed LV mass
exceeded the upper limits in 9% of male and 7% of female
athletes. Another study of 286 professional cyclists revealed
a dilated LV in 35%, even after adjustment for body surface
area.37 Regarding LVWT, Italian studies showed LVWT >12mm
in a small percentage of elite athletes (1.1%--1.7%),23,36 with
concomitant LV dilation. It should be emphasized that LVWT
>13 mm and LV dimensions >65 mm are rare in healthy ath-
letes. Analysis of these studies raises some concerns: they
were cross-sectional in design and included mainly white
male athletes; they were performed during competitive sea-
sons, used M-mode or two-dimensional echocardiography,
and controls were age- and gender-matched sedentary indi-
viduals.
Although broadly accepted, the validity of the Morgan-
roth hypothesis is questioned by some authors.38 Spence
et al. prospectively analyzed untrained subjects random-
ized to supervised endurance (n=10) or resistance (n=13)
exercise, with assessments at baseline, after six months
of training and six weeks after detraining.39 LV adaptation,
including increased LV mass and LVWT, were only present in
endurance athletes. Despite the small sample and relatively
short training period, these results cast some doubt on the
importance of remodeling in response to resistance exercise
training.
LA dilation is also a physiological adaptation in trained
athletes. Pelliccia et al. reported a 20% increase in LA
dimensions (M-mode transverse dimension ≥40 mm) among
1777 athletes engaged in 38 disciplines,40 while D’Andrea
et al. showed a 28% increase in indexed LA volume in
615 endurance athletes.41 The increased LA size can be
explained by concomitant LV cavity enlargement and vol-
ume overload. Although not completely understood, LA
remodeling may be one of the mechanisms associated with
supraventricular arrhythmias in athletes.
Due to its unusual shape, which makes it more difficult
to image, the effects of exercise on RV structure have been
neglected. The RV also enlarges in response to continu-
ous exercise training, supporting the concept of balanced
biventricular enlargement.42 Zaidi et al. confirmed greater
RV dimensions in athletes compared to non-athletes, with
smaller dimensions in black athletes.43 MRI studies have con-
firmed RV enlargement, mainly in endurance athletes.44
The association of exercise and aortic root dilation is
inconsistent. The largest study published (n=2317) showed
that dilated aortic root is uncommon among competitive
athletes: ≥40 mm in 1.3% of males and ≥34 mm in 0.9% of
females (99th percentiles).45 Dilatation of the aortic root is
unlikely to represent a physiological adaptation, and is most
likely an expression of pathology. The observation of a 2.5-
fold increase in the aortic root over eight years of follow-up
in male athletes with enlarged aortic root at initial assess-
ment supports this fact. Other small studies report greater
diameters in strength- compared to endurance-trained ath-
letes, but also with a low prevalence of dilated aortic
root.46,47
Functional adaptation
Functional physiological adaptations to exercise training
are incompletely understood. LVEF is generally normal
among athletes. Even extreme and uninterrupted endurance
training over long periods of time appears not to be asso-
ciated with deterioration in LVEF.48 A meta-analysis of
59 studies showed no difference in systolic and diastolic LV
function among trained athletes compared with sedentary
controls.49 However, a transient reduction in LVEF has been
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Figure 2 Sports classification based on peak static and dynamic components achieved during competition. The lowest total
cardiovascular demands (cardiac output and blood pressure) are shown in green and the highest in red. Max O2: maximal oxygen
uptake; MVC: maximal voluntary contraction. *Danger of bodily collision. †Increased risk if syncope occurs (adapted from Mitchell
et al. in the report of the 36th Bethesda Conference35).
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Figure 3 Potential effects of repeated exercise bouts on RV function.
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enzyme gene I/D polymorphisms33 and insulin-like growth
factor-1 expression.34
Sport-related factors
Hemodynamic and cardiac adaptations vary according to
the type and intensity of exercise. Isotonic exercise, also
referred to as endurance or dynamic exercise, increases
maximum oxygen consumption and cardiac output, with nor-
mal or reduced peripheral vascular resistance. In sports such
as cross-country skiing, long-distance running, tennis or soc-
cer, volume overload is predominant. In contrast, isometric
exercise, also known as strength or static exercises, sub-
stantially increases blood pressure and peripheral vascular
resistance, with normal or only slightly elevated cardiac
output. Sports such as climbing, gymnastics, wrestling and
body-building predominantly produce pressure overload.
Endurance sports generally induce more pronounced cardiac
remodeling. However, sports cannot be classified simply on
the basis of this dichotomy. Many disciplines combine ele-
ments of both endurance and strength exercise, and it can
be difficult to identify the predominant component. Mitchell
et al. proposed a classification of sports according to the
intensity of exercise in static and dynamic components35
(Figure 2). Although widely used, this classification has
some limitations. Factors such as emotional stress during
competition and environmental conditions were not con-
sidered. Emotional stress activates the sympathetic drive,
leading to increased catecholamine concentrations, heart
rate, blood pressure and myocardial contractility. These
responses increase myocardial oxygen demand, potentially
triggering arrhythmias and myocardial ischemia. Thus, dur-
ing competition, sports associated with low myocardial
oxygen demand relative to the exercise required (e.g.
golf or billiards) can be associated with higher emotional
stress. Environmental factors such as altitude, tempera-
ture, humidity and air pollution are responsible for different
myocardial workloads, and should also be considered. Some
sports have specific risks that should be borne in mind, such
as those involving physical contact or projectiles (risk of
commotio cordis) or those involving high velocity (risk of
vertebral artery dissection due to abrupt head hyperexten-
sion).
Structural adaptations
Since the first reports by Morganroth et al.,11 several studies
have shown a direct relationship between exercise train-
ing and cardiac structural remodeling (Table 1). Compared
to non-athletes, athletes have 15--20% greater LVWT and
10--15% greater LV size. In a landmark study of 1309 Ital-
ian athletes engaged in 38 sports, 45% had LV end-diastolic
diameter ≥55 mm (≥60 mm in 14%).36 A markedly dilated
LV was more common in athletes with a larger body surface
area and in those participating in endurance sports (cycling,
cross-country skiing, and rowing/canoeing). Indexed LV mass
exceeded the upper limits in 9% of male and 7% of female
athletes. Another study of 286 professional cyclists revealed
a dilated LV in 35%, even after adjustment for body surface
area.37 Regarding LVWT, Italian studies showed LVWT >12mm
in a small percentage of elite athletes (1.1%--1.7%),23,36 with
concomitant LV dilation. It should be emphasized that LVWT
>13 mm and LV dimensions >65 mm are rare in healthy ath-
letes. Analysis of these studies raises some concerns: they
were cross-sectional in design and included mainly white
male athletes; they were performed during competitive sea-
sons, used M-mode or two-dimensional echocardiography,
and controls were age- and gender-matched sedentary indi-
viduals.
Although broadly accepted, the validity of the Morgan-
roth hypothesis is questioned by some authors.38 Spence
et al. prospectively analyzed untrained subjects random-
ized to supervised endurance (n=10) or resistance (n=13)
exercise, with assessments at baseline, after six months
of training and six weeks after detraining.39 LV adaptation,
including increased LV mass and LVWT, were only present in
endurance athletes. Despite the small sample and relatively
short training period, these results cast some doubt on the
importance of remodeling in response to resistance exercise
training.
LA dilation is also a physiological adaptation in trained
athletes. Pelliccia et al. reported a 20% increase in LA
dimensions (M-mode transverse dimension ≥40 mm) among
1777 athletes engaged in 38 disciplines,40 while D’Andrea
et al. showed a 28% increase in indexed LA volume in
615 endurance athletes.41 The increased LA size can be
explained by concomitant LV cavity enlargement and vol-
ume overload. Although not completely understood, LA
remodeling may be one of the mechanisms associated with
supraventricular arrhythmias in athletes.
Due to its unusual shape, which makes it more difficult
to image, the effects of exercise on RV structure have been
neglected. The RV also enlarges in response to continu-
ous exercise training, supporting the concept of balanced
biventricular enlargement.42 Zaidi et al. confirmed greater
RV dimensions in athletes compared to non-athletes, with
smaller dimensions in black athletes.43 MRI studies have con-
firmed RV enlargement, mainly in endurance athletes.44
The association of exercise and aortic root dilation is
inconsistent. The largest study published (n=2317) showed
that dilated aortic root is uncommon among competitive
athletes: ≥40 mm in 1.3% of males and ≥34 mm in 0.9% of
females (99th percentiles).45 Dilatation of the aortic root is
unlikely to represent a physiological adaptation, and is most
likely an expression of pathology. The observation of a 2.5-
fold increase in the aortic root over eight years of follow-up
in male athletes with enlarged aortic root at initial assess-
ment supports this fact. Other small studies report greater
diameters in strength- compared to endurance-trained ath-
letes, but also with a low prevalence of dilated aortic
root.46,47
Functional adaptation
Functional physiological adaptations to exercise training
are incompletely understood. LVEF is generally normal
among athletes. Even extreme and uninterrupted endurance
training over long periods of time appears not to be asso-
ciated with deterioration in LVEF.48 A meta-analysis of
59 studies showed no difference in systolic and diastolic LV
function among trained athletes compared with sedentary
controls.49 However, a transient reduction in LVEF has been
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Table 1 Data of studies reporting left ventricular dimensions in athletes.
Study n Sport Age (y) Male (%) Ethnicity LVEDD LVWT
Pelliccia et al.23 947 Multi (25) 22± 3 78 -- ≥55 mm: 38%
≥60 mm: 4%
Male: 54.2±4.0 mm
(40--66)
Female: 48.4±3.7 mm
(40--61)
>12 mm: 1.7%
Male: 10.1±1.2 mm
(7--16)
Female: 8.4±0.9 mm
(6--11)
Pelliccia et al.36 1309 Multi (39) 24± 6 73 -- ≥55 mm: 45%
≥60 mm: 14%
Male: 55.5±4.3 mm
(43--70)
Female: 48.4±4.2 mm
(38--66)
>12 mm: 1.1%
Mean: 9.3±1.4 mm
(5--15)
Sharma et al.23 720 Multi (13) 16± 1 75 White (98%) Male: 51.6±3.3 mm
(42--60)
Female: 47.7±3.3 mm
(41--55)
≥12 mm: 4%
Mean: 9.5±1.7 mm
(6--14)
Abergel et al.37 286 Cycling 28± 3 100 White >60 mm: 51%
Mean: 60.1±3.9 mm
(49--73)
>13 mm: 8.7%
Mean: 11.1±1.3 mm
(7--15)
Di Paolo et al.29 154 Soccer 16± 1 100 Black >54 mm: 16%
>60 mm: 0.6%
Mean: 51.0±3.6 mm
(42--62)
>12 mm: 2.6%
Mean: 10±1 mm
(6--13)
Basavarajaiah et al.26 300 Multi (6) 21± 6 100 Black Mean: 53±4.4 mm
(44--64)
>12 mm 18%
Mean: 11.3±1.6 mm
(8--16)
LVEDD: left ventricular end-diastolic diameter; LVWT: left ventricular wall thickness; Multi: multiple; y: years.
demonstrated after prolonged strenuous exercise, termed
‘cardiac fatigue’.50 The interpretation of these changes as
physiological is not consensual. Some authors have ques-
tioned the real effects of competitive exercise on LV
dynamics, particularly after prolonged endurance training,
as reported in cyclists.37 The reduction of LVEF in endurance
athletes is secondary to LV dilation, but performance-
enhancing drugs could be involved. Nevertheless it should
be stressed that indices of systolic function are of limited
value in the assessment of ventricular performance at rest
(due to the load dependence of LVEF and the fact that
Doppler indices are only recorded in the systolic phase).
New advances in echocardiography, including strain imag-
ing and speckle tracking, suggest that intense exercise may
lead to changes in LV systolic function that are not detected
by LVEF assessment. These tools are more sensitive in assess-
ing systolic adaptations to exercise, and hence allow early
detection of systolic impairment.42,44,51 Baggish et al. found
unchanged LVEF in 20 rowers after 90 days of training, but
significant changes in all the direct measures of LV systolic
function73: peak systolic tissue velocities increased; radial
strain increased similarly in all segments; longitudinal strain
increased with a base-to-apex gradient; and circumferen-
tial strain increased in the LV free wall but decreased in
regions adjacent to the RV. Reductions in septal circum-
ferential strain were strongly correlated with changes in
RV structure and function. This finding may reflect a novel
form of ventricular interdependence. In 16 ultramarathon
athletes, peak RV strain decreased in the post-race period
and a slight delay in time to peak strain relative to pul-
monary valve closure was identified, while in the LV, peak
circumferential, radial and longitudinal strain, and torsion
decreased significantly after exercise.52 Reductions in these
indices could be a consequence of intrinsic LV impairment or
increased RV afterload. In fact, the RV is not a passive cham-
ber, as previously thought, but plays a crucial role in cardiac
adaptations to exercise. Intense endurance exercise causes
acute RV dysfunction that recovers in the short term, but
chronic structural changes and reduced RV function are evi-
dent in some athletes.19 This hemodynamic imbalance may
promote transient RV injury or incomplete recovery, with
possible long-term structural consequences (Figure 3).
LV diastolic function can be enhanced by prolonged exer-
cise training.53,54 This improvement is essential to preserve
stroke volume, mainly due to the ability of the LV to
relax at high heart rates.55 Sustained endurance training
preserves ventricular compliance with age, potentially pre-
venting heart failure in the elderly.56 In strength sports LV
relaxation appears to remain unchanged or mildly impaired,
although concentric hypertrophy does occur.44
Electrical adaptation
More than 80% of competitive athletes have changes in
resting ECG reflecting physiological adaptation to exercise
training; changes potentially confounded with CV pathol-
ogy are present in 10--14%.28,57,58 Guidelines and consensus
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Table 2 The Seattle criteria for normal ECG findings in athletes (adapted from 61).
1. Sinus bradycardia (≥30 bpm)
2. Sinus arrhythmia
3. Ectopic atrial rhythm
4. Junctional escape rhythm
5. First-degree AV block (PR interval >200 ms)
6. Mobitz type I (Wenckebach) AV block
7. Incomplete RBBB
8. Isolated QRS voltage criteria for LVH
• Except: QRS voltage criteria for LHV occurring with any non-voltage criteria for LVH such as LA enlargement, left axis
deviation, ST segment depression, T-wave inversion or pathological Q waves
9. Early repolarization (ST elevation, J-point elevation, J-waves, or terminal QRS slurring)
10. Convex (‘domed’) ST segment elevation combined with T-wave inversion in leads V1--V4 in black athletes
AV: atrioventricular; bpm: beats per minute; LA: left atrium; LVH: left ventricular hypertrophy: RBBB: right bundle branch block.
documents on ECG interpretation in athletes have been pub-
lished in recent years. The European Society of Cardiology
(ESC) guidelines published in 201059 divide the ECG findings
into two groups:
• Group 1: common and training-related changes;
• Group 2: uncommon and trained-unrelated changes.
Group 1 (normal findings) includes sinus bradycardia,
first-degree atrioventricular (AV) block, incomplete right
bundle branch block and isolated QRS voltage criteria for
LV hypertrophy. The American guidelines, published in 2011,
were in line with the ESC document,60 while in 2013, experts
in sports cardiology and sports medicine defined standards to
distinguish normal from abnormal ECG findings in athletes,
known as the Seattle criteria (Table 2).61--63
Electrical adaptations in athletes result from condition-
ing of the cardiac autonomic nervous system (increased
vagal tone and/or sympathetic withdrawal) and structural
remodeling. Increased vagal tone is responsible for findings
such as bradycardia, sinus arrhythmia, early repolarization
and first-degree Mobitz type I AV block, alterations that dis-
appear with increased heart rate during exercise. Structural
remodeling is responsible for criteria of increased cavity
sizes.61,64
Electrical adaptations include the following:
• Resting bradycardia: present in 60%--80% of highly trained
athletes, especially those engaged in endurance
sports.21,28,29,65 In the absence of symptoms, a heart
rate ≥30 bpm and/or pauses of ≥3 s during sleep hours
should be considered normal.
• Sinus arrhythmia: an exaggerated response is found in
>50% of athletes, resulting from variation during the res-
piratory cycle.21,65
• Ectopic atrial rhythm: P waves with different mor-
phologies compared to the sinus P waves (known as a
‘wandering atrial pacemaker’ if there are more than two
different morphologies) are normal in athletes and are
most easily seen when P waves are negative in the inferior
leads.
• Junctional escape rhythm: resulting from a faster QRS
rate than the resting P wave rate; can be found in athletes
with marked bradycardia.65
• First-degree AV block and Mobitz type I AV block: these
are considered normal findings in athletes. The former is
common (3%--14%) but the second is rare (<1%).21,28,29,64,65
• Incomplete right bundle branch block: present in 30%--40%
of athletes, particularly in endurance disciplines,21,29,65
reflecting prolonged conduction time resulting from
increased RV size secondary to regular training.24,29,65,66
• Isolated QRS voltage criteria for LV hypertrophy: found in
approximately 45% of athletes. In black individuals >80%
may be affected.21,65,66 Association with other markers of
non-voltage criteria for LV hypertrophy (LA enlargement,
left axis deviation, ST-segment depression, T-wave inver-
sions or pathological Q waves) should prompt exclusion of
pathological hypertrophy.60,61
• Early repolarization: present in >50% of highly trained ath-
letes, reaching 80--90% in black athletes.29,65--68 Besides
the strong association with ethnicity, early repolariza-
tion is more common in young male athletes and in those
with increased QRS voltage, interventricular septal thick-
ness and slower heart rate.67 Tikkanen et al. showed
a significant association between early repolarization in
the inferior leads and increased risk of SCD in middle-
aged non-athletic subjects.68 This pattern is also common
among athletes, and probably represents a dynamic pro-
cess related to exercise intensity.67 To date, there is no
evidence to support a relationship between early repolar-
ization and SCD or other cardiac events in athletes. In a
recent retrospective analysis of 118 male soccer players
with early repolarization, no cardiac deaths occurred dur-
ing a mean follow-up of 13.3 years.69 All the patterns of
early repolarization -- ST elevation at QRS end (J-point),
J-wave with or without ST elevation, terminal QRS slurring
with or without J-wave/new J-point -- should be consid-
ered normal variants in athletes.61
• Repolarization in black athletes: more than two-thirds
of black athletes exhibit ST-segment elevation and up
to 25% show T-wave inversions.29,66 Convex (‘domed’)
ST-segment elevation combined with T-wave inversion
in leads V1--V4 is also frequent and in the absence of
symptoms, positive family history or abnormal physi-
cal examination, does not require further assessment
(Figure 4).
• Juvenile pattern: T-wave inversions in the right precordial
leads are a normal ECG finding in athletes aged under
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Table 1 Data of studies reporting left ventricular dimensions in athletes.
Study n Sport Age (y) Male (%) Ethnicity LVEDD LVWT
Pelliccia et al.23 947 Multi (25) 22± 3 78 -- ≥55 mm: 38%
≥60 mm: 4%
Male: 54.2±4.0 mm
(40--66)
Female: 48.4±3.7 mm
(40--61)
>12 mm: 1.7%
Male: 10.1±1.2 mm
(7--16)
Female: 8.4±0.9 mm
(6--11)
Pelliccia et al.36 1309 Multi (39) 24± 6 73 -- ≥55 mm: 45%
≥60 mm: 14%
Male: 55.5±4.3 mm
(43--70)
Female: 48.4±4.2 mm
(38--66)
>12 mm: 1.1%
Mean: 9.3±1.4 mm
(5--15)
Sharma et al.23 720 Multi (13) 16± 1 75 White (98%) Male: 51.6±3.3 mm
(42--60)
Female: 47.7±3.3 mm
(41--55)
≥12 mm: 4%
Mean: 9.5±1.7 mm
(6--14)
Abergel et al.37 286 Cycling 28± 3 100 White >60 mm: 51%
Mean: 60.1±3.9 mm
(49--73)
>13 mm: 8.7%
Mean: 11.1±1.3 mm
(7--15)
Di Paolo et al.29 154 Soccer 16± 1 100 Black >54 mm: 16%
>60 mm: 0.6%
Mean: 51.0±3.6 mm
(42--62)
>12 mm: 2.6%
Mean: 10±1 mm
(6--13)
Basavarajaiah et al.26 300 Multi (6) 21± 6 100 Black Mean: 53±4.4 mm
(44--64)
>12 mm 18%
Mean: 11.3±1.6 mm
(8--16)
LVEDD: left ventricular end-diastolic diameter; LVWT: left ventricular wall thickness; Multi: multiple; y: years.
demonstrated after prolonged strenuous exercise, termed
‘cardiac fatigue’.50 The interpretation of these changes as
physiological is not consensual. Some authors have ques-
tioned the real effects of competitive exercise on LV
dynamics, particularly after prolonged endurance training,
as reported in cyclists.37 The reduction of LVEF in endurance
athletes is secondary to LV dilation, but performance-
enhancing drugs could be involved. Nevertheless it should
be stressed that indices of systolic function are of limited
value in the assessment of ventricular performance at rest
(due to the load dependence of LVEF and the fact that
Doppler indices are only recorded in the systolic phase).
New advances in echocardiography, including strain imag-
ing and speckle tracking, suggest that intense exercise may
lead to changes in LV systolic function that are not detected
by LVEF assessment. These tools are more sensitive in assess-
ing systolic adaptations to exercise, and hence allow early
detection of systolic impairment.42,44,51 Baggish et al. found
unchanged LVEF in 20 rowers after 90 days of training, but
significant changes in all the direct measures of LV systolic
function73: peak systolic tissue velocities increased; radial
strain increased similarly in all segments; longitudinal strain
increased with a base-to-apex gradient; and circumferen-
tial strain increased in the LV free wall but decreased in
regions adjacent to the RV. Reductions in septal circum-
ferential strain were strongly correlated with changes in
RV structure and function. This finding may reflect a novel
form of ventricular interdependence. In 16 ultramarathon
athletes, peak RV strain decreased in the post-race period
and a slight delay in time to peak strain relative to pul-
monary valve closure was identified, while in the LV, peak
circumferential, radial and longitudinal strain, and torsion
decreased significantly after exercise.52 Reductions in these
indices could be a consequence of intrinsic LV impairment or
increased RV afterload. In fact, the RV is not a passive cham-
ber, as previously thought, but plays a crucial role in cardiac
adaptations to exercise. Intense endurance exercise causes
acute RV dysfunction that recovers in the short term, but
chronic structural changes and reduced RV function are evi-
dent in some athletes.19 This hemodynamic imbalance may
promote transient RV injury or incomplete recovery, with
possible long-term structural consequences (Figure 3).
LV diastolic function can be enhanced by prolonged exer-
cise training.53,54 This improvement is essential to preserve
stroke volume, mainly due to the ability of the LV to
relax at high heart rates.55 Sustained endurance training
preserves ventricular compliance with age, potentially pre-
venting heart failure in the elderly.56 In strength sports LV
relaxation appears to remain unchanged or mildly impaired,
although concentric hypertrophy does occur.44
Electrical adaptation
More than 80% of competitive athletes have changes in
resting ECG reflecting physiological adaptation to exercise
training; changes potentially confounded with CV pathol-
ogy are present in 10--14%.28,57,58 Guidelines and consensus
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Table 2 The Seattle criteria for normal ECG findings in athletes (adapted from 61).
1. Sinus bradycardia (≥30 bpm)
2. Sinus arrhythmia
3. Ectopic atrial rhythm
4. Junctional escape rhythm
5. First-degree AV block (PR interval >200 ms)
6. Mobitz type I (Wenckebach) AV block
7. Incomplete RBBB
8. Isolated QRS voltage criteria for LVH
• Except: QRS voltage criteria for LHV occurring with any non-voltage criteria for LVH such as LA enlargement, left axis
deviation, ST segment depression, T-wave inversion or pathological Q waves
9. Early repolarization (ST elevation, J-point elevation, J-waves, or terminal QRS slurring)
10. Convex (‘domed’) ST segment elevation combined with T-wave inversion in leads V1--V4 in black athletes
AV: atrioventricular; bpm: beats per minute; LA: left atrium; LVH: left ventricular hypertrophy: RBBB: right bundle branch block.
documents on ECG interpretation in athletes have been pub-
lished in recent years. The European Society of Cardiology
(ESC) guidelines published in 201059 divide the ECG findings
into two groups:
• Group 1: common and training-related changes;
• Group 2: uncommon and trained-unrelated changes.
Group 1 (normal findings) includes sinus bradycardia,
first-degree atrioventricular (AV) block, incomplete right
bundle branch block and isolated QRS voltage criteria for
LV hypertrophy. The American guidelines, published in 2011,
were in line with the ESC document,60 while in 2013, experts
in sports cardiology and sports medicine defined standards to
distinguish normal from abnormal ECG findings in athletes,
known as the Seattle criteria (Table 2).61--63
Electrical adaptations in athletes result from condition-
ing of the cardiac autonomic nervous system (increased
vagal tone and/or sympathetic withdrawal) and structural
remodeling. Increased vagal tone is responsible for findings
such as bradycardia, sinus arrhythmia, early repolarization
and first-degree Mobitz type I AV block, alterations that dis-
appear with increased heart rate during exercise. Structural
remodeling is responsible for criteria of increased cavity
sizes.61,64
Electrical adaptations include the following:
• Resting bradycardia: present in 60%--80% of highly trained
athletes, especially those engaged in endurance
sports.21,28,29,65 In the absence of symptoms, a heart
rate ≥30 bpm and/or pauses of ≥3 s during sleep hours
should be considered normal.
• Sinus arrhythmia: an exaggerated response is found in
>50% of athletes, resulting from variation during the res-
piratory cycle.21,65
• Ectopic atrial rhythm: P waves with different mor-
phologies compared to the sinus P waves (known as a
‘wandering atrial pacemaker’ if there are more than two
different morphologies) are normal in athletes and are
most easily seen when P waves are negative in the inferior
leads.
• Junctional escape rhythm: resulting from a faster QRS
rate than the resting P wave rate; can be found in athletes
with marked bradycardia.65
• First-degree AV block and Mobitz type I AV block: these
are considered normal findings in athletes. The former is
common (3%--14%) but the second is rare (<1%).21,28,29,64,65
• Incomplete right bundle branch block: present in 30%--40%
of athletes, particularly in endurance disciplines,21,29,65
reflecting prolonged conduction time resulting from
increased RV size secondary to regular training.24,29,65,66
• Isolated QRS voltage criteria for LV hypertrophy: found in
approximately 45% of athletes. In black individuals >80%
may be affected.21,65,66 Association with other markers of
non-voltage criteria for LV hypertrophy (LA enlargement,
left axis deviation, ST-segment depression, T-wave inver-
sions or pathological Q waves) should prompt exclusion of
pathological hypertrophy.60,61
• Early repolarization: present in >50% of highly trained ath-
letes, reaching 80--90% in black athletes.29,65--68 Besides
the strong association with ethnicity, early repolariza-
tion is more common in young male athletes and in those
with increased QRS voltage, interventricular septal thick-
ness and slower heart rate.67 Tikkanen et al. showed
a significant association between early repolarization in
the inferior leads and increased risk of SCD in middle-
aged non-athletic subjects.68 This pattern is also common
among athletes, and probably represents a dynamic pro-
cess related to exercise intensity.67 To date, there is no
evidence to support a relationship between early repolar-
ization and SCD or other cardiac events in athletes. In a
recent retrospective analysis of 118 male soccer players
with early repolarization, no cardiac deaths occurred dur-
ing a mean follow-up of 13.3 years.69 All the patterns of
early repolarization -- ST elevation at QRS end (J-point),
J-wave with or without ST elevation, terminal QRS slurring
with or without J-wave/new J-point -- should be consid-
ered normal variants in athletes.61
• Repolarization in black athletes: more than two-thirds
of black athletes exhibit ST-segment elevation and up
to 25% show T-wave inversions.29,66 Convex (‘domed’)
ST-segment elevation combined with T-wave inversion
in leads V1--V4 is also frequent and in the absence of
symptoms, positive family history or abnormal physi-
cal examination, does not require further assessment
(Figure 4).
• Juvenile pattern: T-wave inversions in the right precordial
leads are a normal ECG finding in athletes aged under
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Figure 4 ECG of healthy male athlete of African origin, showing increased QRS voltage, convex ST-segment elevation and deep
T-wave inversion in V1--V4 (courtesy of Cardiovascular Sciences Research Centre, St. George’s, London University).
16, because of RV dominance and repolarization polarity
directed posteriorly.65
In the interpretation of athletes’ ECG, it should be
stressed that some normal cut-offs differ between the sexes
(e.g. prolonged QT interval according to the Seattle criteria:
female >470 ms; male >480 ms).70
Overlap with cardiomyopathy
It can be challenging to distinguish exercise-related cardiac
adaptations from cardiomyopathies (Figure 5).
Hypertrophic cardiomyopathy
The majority of dilemmas during the assessment of athletes
occur when cardiac remodeling mimics phenotypical findings
of hypertrophic cardiomyopathy (HCM). Almost 2% of adult
male athletes show increased LVWT of 13--15 mm, falling
into the gray zone between extreme expression of athlete’s
heart and a mild HCM phenotype.23 In female and adoles-
cent athletes LVWT >12 mm is extremely rare and should be
investigated further.22 As the phenotypic expression of HCM
Athlete's
heart
HCM
ARVC
Cardiom
yopathy
DCM
LVNC
Figure 5 Overlap between cardiomyopathy and athlete’s
heart. ARVC: arrhythmogenic right ventricular cardiomyopathy;
DCM: dilated cardiomyopathy; HCM: hypertrophic cardiomyopa-
thy; LVNC: left ventricular noncompaction.
is incomplete during periods of rapid growth, younger ath-
letes (prepubertal or pubertal) with suspected HCM should
be closely monitored. The main differences between HCM
and athlete’s heart are depicted in Table 3. Compared to
HCM patients, the hypertrophic pattern in athletes is uni-
form and associated with concomitant LV dilation. Reduction
in LVWT (2--5 mm) after a period of detraining suggests ath-
lete’s heart, but compliance with detraining is difficult and
requires the cooperation of athletes. It should be noted
that in athletes with mild forms of HCM, increased LVWT
could be related to both exercise and HCM and may decrease
after detraining. Absence of response to detraining is sug-
gestive of pathological LV hypertrophy, but regression with
detraining does not necessarily represent only physiolog-
ical hypertrophy. In contrast to physiological remodeling,
in which diastolic function is preserved or even enhanced,
HCM is characterized by abnormal LV relaxation indices and
increased filling pressure; however, a normal diastolic filling
pattern does not exclude pathological hypertrophy.
In cases with some characteristics in the gray zone
additional investigation is necessary. In cardiopulmonary
exercise testing, while athletes achieve peak VO2 that typ-
ically exceed predicted values (usually >120%), in HCM
patients only 1.5% exceed these values. MRI is useful for
morphological characterization, particularly of apical LV
segments, but also due to the additional information it pro-
vides, such as identification of myocardial fibrosis in HCM
located in thicker myocardial segments and in RV insertion
points of the interventricular septum. Although there is a
significant rate of false negative results, genetic tests can
help in difficult cases. A positive result for one of the known
mutations of HCM establishes the diagnosis. Even without
structural changes suggestive of HCM, athletes exhibiting
abnormal and extensive ECG repolarization changes should
be followed, because these changes can precede morpho-
logical features.
Dilated cardiomyopathy
Marked LV dilatation may require a differential diag-
nosis between physiological adaptation and dilated
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Table 3 Differences between hypertrophic cardiomyopathy and athlete’s heart.
Investigation Favors athlete’s heart Favors HCM
Family history Absent Known HCM diagnosis, SCD
Symptoms Asymptomatic and good exertion tolerance Pre-syncope, syncope, palpitations,
breathlessness, chest pain, fatigue out
of proportions to the degree of exertion
Physical examination Unremarkable Loud systolic murmur that increases with
Valsalva maneuver, forceful apical impulse
ECG Normal physiological adaptations (including
isolated LVH criteria)a
High QRS voltage plus unusual findings
Pathological Q waves
ST-segment depression
T-wave inversions in anterolateral leads
LBBB
Echocardiogram Symmetrical increased LVWT (usually
<12 mm in female and junior athletes;
rarely >13 mm in white male athletes)
Normal or improved LV diastolic function
Increased LV dimensions (LVEDD >55 mm)
Balanced RV dilation
Asymmetric increased LVWT (>15 mm) LV
diastolic dysfunction (impaired relaxation,
increased deceleration time and filling
pressures)
Disproportionate LA dilatation
Reduced LV dimension (LVEDD <45 mm)
LVOT obstruction
CPET VO2 max >45 ml/kg/min
VO2 max >120% of predicted
VO2 max lower than predicted
MRIb Absence of late enhancement or
non-specific pattern (ischemic or
non-ischemic, mainly in veteran endurance
athletes)
Typical late enhancement (junction of RV
and interventricular septum and in the
thicker segments)
Detraining Reduction in LVWT (2--5 mm)c Persistence of increased LVWT
Genetic test Negatived Positive for mutation related to HCM
CPET: cardiopulmonary exercise testing; ECG: electrocardiogram; HCM; hypertrophic cardiomyopathy; LBBB: left branch bundle block;
LV: left ventricular; LVEDD: left ventricular end-diastolic diameter; LVH: left ventricular hypertrophy; LVOT: left ventricular outflow
tract; LVWT: left ventricular wall thickness; MRI: magnetic resonance imaging; RV: right ventricle; SCD: sudden cardiac death.
a Depicted in Table 2.
b Morphological findings in MRI are similar to echocardiographic findings but with greater accuracy and beret delineation of apical
ventricular segments.
c Although suggestive, this does not exclude pathology. In athletes with mildly phenotypic HCM, LVWT can also decrease with detraining.
d Negative test does not exclude HCM since only about 50% of the genes responsible for HCM have been identified.
cardiomyopathy (DCM), particularly when LV ejection
fraction is in the lower normal range or depressed. As
previously reported, 14% of athletes have LV diastolic
diameter ≥60 mm, and it can reach 70 mm in men.36 In
extreme endurance sports such as cycling, the prevalence
and degree of LV dilation is greater, with a considerable
proportion of athletes having concomitant decreased LVEF
at rest, fulfilling criteria for a diagnosis of DCM.37 In these
cases of extreme LV dilation, correct assessment of LVEF and
exclusion of wall motion abnormalities are fundamental.
DCM patients have reduced exercise capacity, reflected in
low maximum VO2 and high VE/VCO2 slopes on cardiopul-
monary exercise testing. MRI permits accurate assessment
of LVEF and detection of fibrosis, usually mid-wall.
Arrhythmogenic right ventricular cardiomyopathy
With regard to arrhythmogenic right ventricular cardiomy-
opathy (ARVC), a relationship has been postulated between
ultra-endurance exercise and an ARVC-like phenotype.
Recently 3% black and 0.3% white athletes were found to
meet criteria for ARVC, but further investigation did not
detect any pathological findings.43 Extreme exercise can
cause consecutive bouts of RV dilatation and dysfunction,
which may alter the RV interstitial matrix. In favor of this
hypothesis is the lower than expected prevalence of desmo-
somal gene mutations identified in endurance athletes with
complex ventricular arrhythmias of RV origin.71 This supports
the concept of ARVC being acquired through intense exer-
cise. When ARVC is suspected the combination of findings
from personal and family history, ECG, Holter ECG, transtho-
racic echocardiogram and MRI may establish the diagnosis.
Left ventricular noncompaction
Left ventricular noncompaction (LVNC) is an unclassified
cardiomyopathy for which the optimum diagnostic criteria
are the subject of debate. The current criteria, based on
echocardiography and MRI, reveal low specificity, leading to
overdiagnosis of this entity. Furthermore, the LVNC pheno-
type can overlap with other cardiomyopathies such as HCM
and DCM. Gati et al.58 showed a higher prevalence of LV
trabeculation in athletes compared to controls (18.3% vs.
7.0%), with 8.1% fulfilling criteria for LVNC. Only a small
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Figure 4 ECG of healthy male athlete of African origin, showing increased QRS voltage, convex ST-segment elevation and deep
T-wave inversion in V1--V4 (courtesy of Cardiovascular Sciences Research Centre, St. George’s, London University).
16, because of RV dominance and repolarization polarity
directed posteriorly.65
In the interpretation of athletes’ ECG, it should be
stressed that some normal cut-offs differ between the sexes
(e.g. prolonged QT interval according to the Seattle criteria:
female >470 ms; male >480 ms).70
Overlap with cardiomyopathy
It can be challenging to distinguish exercise-related cardiac
adaptations from cardiomyopathies (Figure 5).
Hypertrophic cardiomyopathy
The majority of dilemmas during the assessment of athletes
occur when cardiac remodeling mimics phenotypical findings
of hypertrophic cardiomyopathy (HCM). Almost 2% of adult
male athletes show increased LVWT of 13--15 mm, falling
into the gray zone between extreme expression of athlete’s
heart and a mild HCM phenotype.23 In female and adoles-
cent athletes LVWT >12 mm is extremely rare and should be
investigated further.22 As the phenotypic expression of HCM
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Figure 5 Overlap between cardiomyopathy and athlete’s
heart. ARVC: arrhythmogenic right ventricular cardiomyopathy;
DCM: dilated cardiomyopathy; HCM: hypertrophic cardiomyopa-
thy; LVNC: left ventricular noncompaction.
is incomplete during periods of rapid growth, younger ath-
letes (prepubertal or pubertal) with suspected HCM should
be closely monitored. The main differences between HCM
and athlete’s heart are depicted in Table 3. Compared to
HCM patients, the hypertrophic pattern in athletes is uni-
form and associated with concomitant LV dilation. Reduction
in LVWT (2--5 mm) after a period of detraining suggests ath-
lete’s heart, but compliance with detraining is difficult and
requires the cooperation of athletes. It should be noted
that in athletes with mild forms of HCM, increased LVWT
could be related to both exercise and HCM and may decrease
after detraining. Absence of response to detraining is sug-
gestive of pathological LV hypertrophy, but regression with
detraining does not necessarily represent only physiolog-
ical hypertrophy. In contrast to physiological remodeling,
in which diastolic function is preserved or even enhanced,
HCM is characterized by abnormal LV relaxation indices and
increased filling pressure; however, a normal diastolic filling
pattern does not exclude pathological hypertrophy.
In cases with some characteristics in the gray zone
additional investigation is necessary. In cardiopulmonary
exercise testing, while athletes achieve peak VO2 that typ-
ically exceed predicted values (usually >120%), in HCM
patients only 1.5% exceed these values. MRI is useful for
morphological characterization, particularly of apical LV
segments, but also due to the additional information it pro-
vides, such as identification of myocardial fibrosis in HCM
located in thicker myocardial segments and in RV insertion
points of the interventricular septum. Although there is a
significant rate of false negative results, genetic tests can
help in difficult cases. A positive result for one of the known
mutations of HCM establishes the diagnosis. Even without
structural changes suggestive of HCM, athletes exhibiting
abnormal and extensive ECG repolarization changes should
be followed, because these changes can precede morpho-
logical features.
Dilated cardiomyopathy
Marked LV dilatation may require a differential diag-
nosis between physiological adaptation and dilated
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Table 3 Differences between hypertrophic cardiomyopathy and athlete’s heart.
Investigation Favors athlete’s heart Favors HCM
Family history Absent Known HCM diagnosis, SCD
Symptoms Asymptomatic and good exertion tolerance Pre-syncope, syncope, palpitations,
breathlessness, chest pain, fatigue out
of proportions to the degree of exertion
Physical examination Unremarkable Loud systolic murmur that increases with
Valsalva maneuver, forceful apical impulse
ECG Normal physiological adaptations (including
isolated LVH criteria)a
High QRS voltage plus unusual findings
Pathological Q waves
ST-segment depression
T-wave inversions in anterolateral leads
LBBB
Echocardiogram Symmetrical increased LVWT (usually
<12 mm in female and junior athletes;
rarely >13 mm in white male athletes)
Normal or improved LV diastolic function
Increased LV dimensions (LVEDD >55 mm)
Balanced RV dilation
Asymmetric increased LVWT (>15 mm) LV
diastolic dysfunction (impaired relaxation,
increased deceleration time and filling
pressures)
Disproportionate LA dilatation
Reduced LV dimension (LVEDD <45 mm)
LVOT obstruction
CPET VO2 max >45 ml/kg/min
VO2 max >120% of predicted
VO2 max lower than predicted
MRIb Absence of late enhancement or
non-specific pattern (ischemic or
non-ischemic, mainly in veteran endurance
athletes)
Typical late enhancement (junction of RV
and interventricular septum and in the
thicker segments)
Detraining Reduction in LVWT (2--5 mm)c Persistence of increased LVWT
Genetic test Negatived Positive for mutation related to HCM
CPET: cardiopulmonary exercise testing; ECG: electrocardiogram; HCM; hypertrophic cardiomyopathy; LBBB: left branch bundle block;
LV: left ventricular; LVEDD: left ventricular end-diastolic diameter; LVH: left ventricular hypertrophy; LVOT: left ventricular outflow
tract; LVWT: left ventricular wall thickness; MRI: magnetic resonance imaging; RV: right ventricle; SCD: sudden cardiac death.
a Depicted in Table 2.
b Morphological findings in MRI are similar to echocardiographic findings but with greater accuracy and beret delineation of apical
ventricular segments.
c Although suggestive, this does not exclude pathology. In athletes with mildly phenotypic HCM, LVWT can also decrease with detraining.
d Negative test does not exclude HCM since only about 50% of the genes responsible for HCM have been identified.
cardiomyopathy (DCM), particularly when LV ejection
fraction is in the lower normal range or depressed. As
previously reported, 14% of athletes have LV diastolic
diameter ≥60 mm, and it can reach 70 mm in men.36 In
extreme endurance sports such as cycling, the prevalence
and degree of LV dilation is greater, with a considerable
proportion of athletes having concomitant decreased LVEF
at rest, fulfilling criteria for a diagnosis of DCM.37 In these
cases of extreme LV dilation, correct assessment of LVEF and
exclusion of wall motion abnormalities are fundamental.
DCM patients have reduced exercise capacity, reflected in
low maximum VO2 and high VE/VCO2 slopes on cardiopul-
monary exercise testing. MRI permits accurate assessment
of LVEF and detection of fibrosis, usually mid-wall.
Arrhythmogenic right ventricular cardiomyopathy
With regard to arrhythmogenic right ventricular cardiomy-
opathy (ARVC), a relationship has been postulated between
ultra-endurance exercise and an ARVC-like phenotype.
Recently 3% black and 0.3% white athletes were found to
meet criteria for ARVC, but further investigation did not
detect any pathological findings.43 Extreme exercise can
cause consecutive bouts of RV dilatation and dysfunction,
which may alter the RV interstitial matrix. In favor of this
hypothesis is the lower than expected prevalence of desmo-
somal gene mutations identified in endurance athletes with
complex ventricular arrhythmias of RV origin.71 This supports
the concept of ARVC being acquired through intense exer-
cise. When ARVC is suspected the combination of findings
from personal and family history, ECG, Holter ECG, transtho-
racic echocardiogram and MRI may establish the diagnosis.
Left ventricular noncompaction
Left ventricular noncompaction (LVNC) is an unclassified
cardiomyopathy for which the optimum diagnostic criteria
are the subject of debate. The current criteria, based on
echocardiography and MRI, reveal low specificity, leading to
overdiagnosis of this entity. Furthermore, the LVNC pheno-
type can overlap with other cardiomyopathies such as HCM
and DCM. Gati et al.58 showed a higher prevalence of LV
trabeculation in athletes compared to controls (18.3% vs.
7.0%), with 8.1% fulfilling criteria for LVNC. Only a small
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Exercise
Time
LVH
↑ LVED
Deep T wave ↓
↓ EF
Left ventricular non-compaction
Athlete’s
LV cavity
LV cavity
Epiphenomenon to ↑ LV preload
Figure 6 Scheme proposed for the significance of left ventric-
ular trabeculation in athletes (adapted from 58). EF: ejection
fraction; LV: left ventricular; LVED: left ventricular end-diastolic
diameter; LVH: left ventricular hypertrophy.
proportion (0.9%) revealed reduced LVEF and marked repo-
larization changes in association with criteria for LVNC,
raising the possibility of an underlying cardiomyopathy. LV
trabeculations without other features of noncompaction or
repolarization changes could be a physiological response to
exercise in highly trained athletes (Figure 6). Changes in
preload imposed by exercise could be the cause of these
morphological changes, since LV trabeculations have been
found in patients with heart failure, thalassemia and in
pregnant women, conditions which are also associated with
increased cardiac preload.
Pre-participation screening of competitive
athletes
Pre-participation screening aims to detect silent CV abnor-
malities associated with risk of SCD. This issue has been the
subject of intense debate, for which there is still no definite
consensus. Few countries have implemented standardized
screening protocols, and even among these, there is consid-
erable heterogeneity. In 2005 the ESC published a consensus
statement for CV pre-participation screening of young com-
petitive athletes.72 This document was mainly based on the
Italian experience, and advocates the inclusion of ECG in the
screening protocol for athletes (Figure 7).
Medical history
Most of the conditions associated with a higher risk of SCD
in athletes are genetically determined with an autosomal
dominant inheritance pattern, and so the family history
is of great importance. Family history should be consid-
ered positive in the presence of SCD, coronary events, or
diagnosis of cardiomyopathies or primary inherited arrhyth-
mias in first-degree relatives (male <55 years; female <65
years). Regarding personal history, care should be taken
in the presence of CV symptoms, particularly if exercise-
related. Chest pain, pre-syncope, syncope, irregular beats,
palpitations, breathlessness or fatigue disproportionate
to exertion are the most commonly reported symptoms.
Family and personal history, physical
examination, 12-lead ECG
Negative findings Positive findings
Young
competitive
athletes
Further examinationsEligible for
competition
Diagnosis of CV disease
Management according to established
protocols
No evidence
of CV disease
Figure 7 Proposed European Society of Cardiology screening
protocol for young competitive athletes (adapted from 72). CV:
cardiovascular; ECG: electrocardiogram.
Syncope is relatively common among highly trained athletes
(up to 6%), most frequently of benign origin due to reflex
mechanisms, and sometimes occurring in the postexertional
period. Although some cases suggest that syncope could
be a manifestation of exaggerated vasodilatation, episodes
during exertion may have a cardiac origin and should be
comprehensively investigated, initially with transthoracic
echocardiogram, Holter ECG and exercise testing, which are
mandatory in the diagnostic workup of these athletes.73 Ath-
letes with syncope or chest pain but normal echocardiogram
and exercise testing should undergo coronary computed
tomography angiography (CCTA) to exclude coronary artery
anomalies. It is important to stress that coronary artery dis-
ease is the most frequent cause of SCD in athletes aged over
35, and it is essential to screen for CV risk factors in this
population.
Physical examination
Beyond the conventional cardiac assessment, physical exam-
ination of athletes should focus on specific factors according
to the suspected diagnosis (e.g. musculoskeletal features
suggestive of systemic manifestations as phenotypic red
flags for cardiomyopathies or Marfan syndrome). Athletes
with positive findings should be referred for additional
investigation, most commonly transthoracic echocardio-
gram, Holter ECG and exercise testing. Cardiac MRI, CCTA
or invasive exams such as electrophysiological study may be
required in specific situations. In the presence of extrac-
ardiac manifestations, collaboration of other specialists is
important, such as neurologists in the case of abnormal neu-
rological findings.
Electrocardiogram
The role of the ECG in athletes’ screening is controver-
sial, with arguments both for and against. Potentially lethal
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conditions with ECG manifestations account for approxi-
mately two-thirds of SCD in young competitive athletes --
HCM, ARVC, DCM, long QT syndrome, Brugada syndrome,
short QT syndrome and pre-excitation syndromes. Some ECG
changes found in cardiomyopathies precede the morpho-
logical phenotype: the condition goes through molecular,
electrical and morphological stages, with risk of life-
threatening arrhythmias at all these stages. However, the
ECG is unable to identify other causes of SCD such as prema-
ture coronary artery disease, congenital coronary anomalies
or aortic root disorders.
Evidence supporting the use of ECG in screening of ath-
letes came from the Veneto region of north Italy, where
after long-term systematic screening the rate of SCD per 100
000 person-years declined from 3.6 to 0.4 in athletes but
remained unchanged in unscreened non-athletes.74 How-
ever, some authors criticize these results, arguing that the
study was not randomized, and countering with a study
performed in Israel in which the mean annual SCD rate
paradoxically increased after ECG screening (from 2.54 to
2.66/100 000).75 These results also should be interpreted
with caution, because the SCD rate was based on media
reports and the number of athletes was estimated.
In the USA pre-participation screening is performed using
personal and family history and physical examination, but
without ECG. This methodology is based on the assumption
that the ECG in not cost-effective for screening of large
populations of athletes due to the high false positive rate.
However, screening without ECG appears to have a lim-
ited ability to detect potentially fatal abnormalities. In a
retrospective analysis of 115 young athletes in the USA suf-
fering SCD and previously screened, only 3% were suspected
of having CV disease based on clinical history and physical
examination and <1% were correctly diagnosed.76
Erroneous interpretation of the ECG may trigger expen-
sive diagnostic tests and lead to unnecessary disqualification
from competitive sports. This is more important for profes-
sional athletes in whom disqualification from competition
has significant financial and psychological consequences.
Conversely, signs of potentially lethal CV disorders may be
misinterpreted as normal variants. It is essential to recog-
nize that false positive ECG rates are strongly influenced by
the criteria used, and so it is critical to improve physicians’
expertise in distinguishing normal adaptations from abnor-
mal changes in athletes. Standardization with the Seattle
criteria has led to improvement in the accuracy of ECG inter-
pretation among several different physician specialties.77
Nevertheless, controversy regarding which ECG changes
should be analyzed in athletes continues. Gati et al.78
recently showed that isolated axis deviation and atrial
enlargement comprise a high burden of the ECG findings,
but do not predict the presence of underlying structural or
functional abnormalities. In this analysis, exclusion of these
characteristics reduced the false positive rate from 13% to
7.5%.
Despite the intense debate concerning its efficacy and
cost-effectiveness, the ECG is recommended by several
organizations, including the International Olympic Com-
mittee, and is invariably performed in real-world clinical
practice. Physicians responsible for assessment of athletes
should therefore be able to identify exercise-induced ECG
adaptations, and in the case of abnormal findings to set in
motion appropriate investigation and management. Table 4
shows some arguments for and against the use of the ECG in
athletes’ pre-participation screening.
Unsolved problems and future directions
Several questions remain unanswered regarding the cardiac
impact of exercise training and the assessment of competi-
tive athletes.
The real prevalence of sudden cardiac death
in athletes
The real prevalence of SCD in athletes remains unknown
and the available data are controversial: values of 1:50 000,
1:100 000, and 1:20 000 have been proposed. Most studies
are based on media reports, with obvious limitations. For
example, a simple search for SCD in athletes in Portugal
on www.google.com and the websites of the most widely
read Portuguese newspapers (sports-related and generalist)
reveals 46 cases in young or veteran athletes, 28 during com-
petition, mainly soccer (n=13). This is unlikely to be the real
number. The first death reported occurred in 1987; there
were eight between 1997 and 2004, followed by the others,
12 occurring in 2004, the year of the case with the highest
media profile in Portugal. This methodology is inaccurate
and skewed. A systematic registry of all SCD cases is war-
ranted and crucial for the epidemiological understanding of
this tragic event.
Causes of sudden cardiac death
Without knowing the causes of death in representative sam-
ples, it will be difficult to establish appropriate preventive
protocols and screening programs. Analysis of SCD victims
should include all the available resources for accurate eti-
ological identification: meticulous post-mortem analysis,
molecular autopsy, genetic tests and direct family history.
Normality and adaptive variants
It is crucial to increase knowledge of normal and adaptive
variant patterns of CV changes induced by exercise train-
ing at clinical, functional and morphological levels. Factors
that should be taken into consideration include the impact of
demographic characteristics such as ethnicity and extreme
ages (from children to veterans), training-related issues,
and the long-term effects of doping and intense exercise
training.
Pre-participation screening programs
It is essential to define a single model for assessment of
athletes that can be used in a sufficiently broad registry to
draw definite conclusions on the specificity, sensitivity and
overall cost-effectiveness of screening programs that would
overcome the historical debate concerning the value of the
ECG.
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Exercise
Time
LVH
↑ LVED
Deep T wave ↓
↓ EF
Left ventricular non-compaction
Athlete’s
LV cavity
LV cavity
Epiphenomenon to ↑ LV preload
Figure 6 Scheme proposed for the significance of left ventric-
ular trabeculation in athletes (adapted from 58). EF: ejection
fraction; LV: left ventricular; LVED: left ventricular end-diastolic
diameter; LVH: left ventricular hypertrophy.
proportion (0.9%) revealed reduced LVEF and marked repo-
larization changes in association with criteria for LVNC,
raising the possibility of an underlying cardiomyopathy. LV
trabeculations without other features of noncompaction or
repolarization changes could be a physiological response to
exercise in highly trained athletes (Figure 6). Changes in
preload imposed by exercise could be the cause of these
morphological changes, since LV trabeculations have been
found in patients with heart failure, thalassemia and in
pregnant women, conditions which are also associated with
increased cardiac preload.
Pre-participation screening of competitive
athletes
Pre-participation screening aims to detect silent CV abnor-
malities associated with risk of SCD. This issue has been the
subject of intense debate, for which there is still no definite
consensus. Few countries have implemented standardized
screening protocols, and even among these, there is consid-
erable heterogeneity. In 2005 the ESC published a consensus
statement for CV pre-participation screening of young com-
petitive athletes.72 This document was mainly based on the
Italian experience, and advocates the inclusion of ECG in the
screening protocol for athletes (Figure 7).
Medical history
Most of the conditions associated with a higher risk of SCD
in athletes are genetically determined with an autosomal
dominant inheritance pattern, and so the family history
is of great importance. Family history should be consid-
ered positive in the presence of SCD, coronary events, or
diagnosis of cardiomyopathies or primary inherited arrhyth-
mias in first-degree relatives (male <55 years; female <65
years). Regarding personal history, care should be taken
in the presence of CV symptoms, particularly if exercise-
related. Chest pain, pre-syncope, syncope, irregular beats,
palpitations, breathlessness or fatigue disproportionate
to exertion are the most commonly reported symptoms.
Family and personal history, physical
examination, 12-lead ECG
Negative findings Positive findings
Young
competitive
athletes
Further examinationsEligible for
competition
Diagnosis of CV disease
Management according to established
protocols
No evidence
of CV disease
Figure 7 Proposed European Society of Cardiology screening
protocol for young competitive athletes (adapted from 72). CV:
cardiovascular; ECG: electrocardiogram.
Syncope is relatively common among highly trained athletes
(up to 6%), most frequently of benign origin due to reflex
mechanisms, and sometimes occurring in the postexertional
period. Although some cases suggest that syncope could
be a manifestation of exaggerated vasodilatation, episodes
during exertion may have a cardiac origin and should be
comprehensively investigated, initially with transthoracic
echocardiogram, Holter ECG and exercise testing, which are
mandatory in the diagnostic workup of these athletes.73 Ath-
letes with syncope or chest pain but normal echocardiogram
and exercise testing should undergo coronary computed
tomography angiography (CCTA) to exclude coronary artery
anomalies. It is important to stress that coronary artery dis-
ease is the most frequent cause of SCD in athletes aged over
35, and it is essential to screen for CV risk factors in this
population.
Physical examination
Beyond the conventional cardiac assessment, physical exam-
ination of athletes should focus on specific factors according
to the suspected diagnosis (e.g. musculoskeletal features
suggestive of systemic manifestations as phenotypic red
flags for cardiomyopathies or Marfan syndrome). Athletes
with positive findings should be referred for additional
investigation, most commonly transthoracic echocardio-
gram, Holter ECG and exercise testing. Cardiac MRI, CCTA
or invasive exams such as electrophysiological study may be
required in specific situations. In the presence of extrac-
ardiac manifestations, collaboration of other specialists is
important, such as neurologists in the case of abnormal neu-
rological findings.
Electrocardiogram
The role of the ECG in athletes’ screening is controver-
sial, with arguments both for and against. Potentially lethal
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conditions with ECG manifestations account for approxi-
mately two-thirds of SCD in young competitive athletes --
HCM, ARVC, DCM, long QT syndrome, Brugada syndrome,
short QT syndrome and pre-excitation syndromes. Some ECG
changes found in cardiomyopathies precede the morpho-
logical phenotype: the condition goes through molecular,
electrical and morphological stages, with risk of life-
threatening arrhythmias at all these stages. However, the
ECG is unable to identify other causes of SCD such as prema-
ture coronary artery disease, congenital coronary anomalies
or aortic root disorders.
Evidence supporting the use of ECG in screening of ath-
letes came from the Veneto region of north Italy, where
after long-term systematic screening the rate of SCD per 100
000 person-years declined from 3.6 to 0.4 in athletes but
remained unchanged in unscreened non-athletes.74 How-
ever, some authors criticize these results, arguing that the
study was not randomized, and countering with a study
performed in Israel in which the mean annual SCD rate
paradoxically increased after ECG screening (from 2.54 to
2.66/100 000).75 These results also should be interpreted
with caution, because the SCD rate was based on media
reports and the number of athletes was estimated.
In the USA pre-participation screening is performed using
personal and family history and physical examination, but
without ECG. This methodology is based on the assumption
that the ECG in not cost-effective for screening of large
populations of athletes due to the high false positive rate.
However, screening without ECG appears to have a lim-
ited ability to detect potentially fatal abnormalities. In a
retrospective analysis of 115 young athletes in the USA suf-
fering SCD and previously screened, only 3% were suspected
of having CV disease based on clinical history and physical
examination and <1% were correctly diagnosed.76
Erroneous interpretation of the ECG may trigger expen-
sive diagnostic tests and lead to unnecessary disqualification
from competitive sports. This is more important for profes-
sional athletes in whom disqualification from competition
has significant financial and psychological consequences.
Conversely, signs of potentially lethal CV disorders may be
misinterpreted as normal variants. It is essential to recog-
nize that false positive ECG rates are strongly influenced by
the criteria used, and so it is critical to improve physicians’
expertise in distinguishing normal adaptations from abnor-
mal changes in athletes. Standardization with the Seattle
criteria has led to improvement in the accuracy of ECG inter-
pretation among several different physician specialties.77
Nevertheless, controversy regarding which ECG changes
should be analyzed in athletes continues. Gati et al.78
recently showed that isolated axis deviation and atrial
enlargement comprise a high burden of the ECG findings,
but do not predict the presence of underlying structural or
functional abnormalities. In this analysis, exclusion of these
characteristics reduced the false positive rate from 13% to
7.5%.
Despite the intense debate concerning its efficacy and
cost-effectiveness, the ECG is recommended by several
organizations, including the International Olympic Com-
mittee, and is invariably performed in real-world clinical
practice. Physicians responsible for assessment of athletes
should therefore be able to identify exercise-induced ECG
adaptations, and in the case of abnormal findings to set in
motion appropriate investigation and management. Table 4
shows some arguments for and against the use of the ECG in
athletes’ pre-participation screening.
Unsolved problems and future directions
Several questions remain unanswered regarding the cardiac
impact of exercise training and the assessment of competi-
tive athletes.
The real prevalence of sudden cardiac death
in athletes
The real prevalence of SCD in athletes remains unknown
and the available data are controversial: values of 1:50 000,
1:100 000, and 1:20 000 have been proposed. Most studies
are based on media reports, with obvious limitations. For
example, a simple search for SCD in athletes in Portugal
on www.google.com and the websites of the most widely
read Portuguese newspapers (sports-related and generalist)
reveals 46 cases in young or veteran athletes, 28 during com-
petition, mainly soccer (n=13). This is unlikely to be the real
number. The first death reported occurred in 1987; there
were eight between 1997 and 2004, followed by the others,
12 occurring in 2004, the year of the case with the highest
media profile in Portugal. This methodology is inaccurate
and skewed. A systematic registry of all SCD cases is war-
ranted and crucial for the epidemiological understanding of
this tragic event.
Causes of sudden cardiac death
Without knowing the causes of death in representative sam-
ples, it will be difficult to establish appropriate preventive
protocols and screening programs. Analysis of SCD victims
should include all the available resources for accurate eti-
ological identification: meticulous post-mortem analysis,
molecular autopsy, genetic tests and direct family history.
Normality and adaptive variants
It is crucial to increase knowledge of normal and adaptive
variant patterns of CV changes induced by exercise train-
ing at clinical, functional and morphological levels. Factors
that should be taken into consideration include the impact of
demographic characteristics such as ethnicity and extreme
ages (from children to veterans), training-related issues,
and the long-term effects of doping and intense exercise
training.
Pre-participation screening programs
It is essential to define a single model for assessment of
athletes that can be used in a sufficiently broad registry to
draw definite conclusions on the specificity, sensitivity and
overall cost-effectiveness of screening programs that would
overcome the historical debate concerning the value of the
ECG.
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Table 4 Arguments for and against the use of the ECG in pre-participation screening of young competitive athletes.
For Against
Availability High false positive rate
The most common causes of SCD have characteristic
findings
Lack of validated standardization criteria to define
normal physiological changes
Higher sensitivity than history and physical examination Not accurate for identifications of some causes of SCD
Italian experience showing a decline of SCD after ECG
screening program implantation
Wide range of normal variants depending on
demographic and sport-related characteristics
Early marker of SCD (frequently the first clinical event) Lack of evidence from prospective studies
Improved diagnostic accuracy with modern standardized
criteria
SCD is rare in young athletes and zero risk is
unattainable
Lacks power and sensitivity of screening based on history
and physical examination is low
Consumes healthcare resources that could be allocated
to other and more common urgent needs
Identification of athletes with high risk for SCD leads to
investigation of family members
Misinterpretation if physicians do not have expertise in
sports cardiology
Cost-effective compared to history and physical
examination
Inappropriate and expensive additional investigation
Interpretation of clinical history and physical examination
are subjective and vary between physicians
Incorrect interpretation can lead to inappropriate
disqualification
Low cost of mass screening (possibility of negotiating cost) Cost-effectiveness remains to be determined
Ethical considerations: equal access should be provided to
all sectors of society, not only to organizations with
greater financial resources such as professional sports
teams
Logistically impractical to implement for assessment of
larger populations
ECG: electrocardiogram; SCD: sudden cardiac death.
Conclusions
Understanding of cardiac physiological adaptation induced
by continued intense exercise training is crucial for accurate
assessment of competitive athletes. The overlap between
these adaptations and cardiomyopathies poses a challenge:
under-diagnosis of a disease may increase the risk of
life-threatening events, and over-diagnosis can result in
improper disqualification from competition. A high level of
suspicion and inclusion of data from clinical history, physical
examination and concomitant investigations are essential.
Standardization of ECG interpretation could decrease the
rate of false positives and allow early detection of poten-
tially fatal CV abnormalities.
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Table 4 Arguments for and against the use of the ECG in pre-participation screening of young competitive athletes.
For Against
Availability High false positive rate
The most common causes of SCD have characteristic
findings
Lack of validated standardization criteria to define
normal physiological changes
Higher sensitivity than history and physical examination Not accurate for identifications of some causes of SCD
Italian experience showing a decline of SCD after ECG
screening program implantation
Wide range of normal variants depending on
demographic and sport-related characteristics
Early marker of SCD (frequently the first clinical event) Lack of evidence from prospective studies
Improved diagnostic accuracy with modern standardized
criteria
SCD is rare in young athletes and zero risk is
unattainable
Lacks power and sensitivity of screening based on history
and physical examination is low
Consumes healthcare resources that could be allocated
to other and more common urgent needs
Identification of athletes with high risk for SCD leads to
investigation of family members
Misinterpretation if physicians do not have expertise in
sports cardiology
Cost-effective compared to history and physical
examination
Inappropriate and expensive additional investigation
Interpretation of clinical history and physical examination
are subjective and vary between physicians
Incorrect interpretation can lead to inappropriate
disqualification
Low cost of mass screening (possibility of negotiating cost) Cost-effectiveness remains to be determined
Ethical considerations: equal access should be provided to
all sectors of society, not only to organizations with
greater financial resources such as professional sports
teams
Logistically impractical to implement for assessment of
larger populations
ECG: electrocardiogram; SCD: sudden cardiac death.
Conclusions
Understanding of cardiac physiological adaptation induced
by continued intense exercise training is crucial for accurate
assessment of competitive athletes. The overlap between
these adaptations and cardiomyopathies poses a challenge:
under-diagnosis of a disease may increase the risk of
life-threatening events, and over-diagnosis can result in
improper disqualification from competition. A high level of
suspicion and inclusion of data from clinical history, physical
examination and concomitant investigations are essential.
Standardization of ECG interpretation could decrease the
rate of false positives and allow early detection of poten-
tially fatal CV abnormalities.
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ABSTRACT
BACKGROUND Anterior T-wave inversion (ATWI) on electrocardiography (ECG) in young white adults raises the pos-
sibility of cardiomyopathy, specifically arrhythmogenic right ventricular cardiomyopathy (ARVC). Whereas the 2010
European consensus recommendations for ECG interpretation in young athletes state that ATWI beyond lead V1 warrants
further investigation, the prevalence and significance of ATWI have never been reported in a large population of
asymptomatic whites.
OBJECTIVES This study investigated the prevalence and significance of ATWI in a large cohort of young, white adults
including athletes.
METHODS Individuals 16 to 35 years of age (n ¼ 14,646), including 4,720 females (32%) and 2,958 athletes (20%),
were evaluated by using a health questionnaire, physical examination, and 12-lead ECG. ATWI was defined as T-wave
inversion in $2 contiguous anterior leads (V1 to V4).
RESULTS ATWI was detected in 338 individuals (2.3%) and was more common in women than in men (4.3% vs. 1.4%,
respectively; p < 0.0001) and more common among athletes than in nonathletes (3.5% vs. 2.0%, respectively;
p < 0.0001). T-wave inversion was predominantly confined to leads V1 to V2 (77%). Only 1.2% of women and 0.2% of
men exhibited ATWI beyond V2. No one with ATWI fulfilled diagnostic criteria for ARVC after further evaluation. During a
mean follow-up of 23.1 � 12.2 months none of the individuals with ATWI experienced an adverse event.
CONCLUSIONS ATWI confined to leads V1 to V2 is a normal variant or physiological phenomenon in asymptomatic
white individuals without a relevant family history. ATWI beyond V2 is rare, particularly in men, and may warrant
investigation. (J Am Coll Cardiol 2017;69:1–9) © 2017 by the American College of Cardiology Foundation.
T here is general agreement that T-waveinversion (TWI) in the inferior or lateralleads in young individuals warrants
further investigation for cardiac disease, particularly
cardiomyopathy (1). It is also well established that
adolescent athletes (2–6) and black adult athletes (7)
frequently exhibit TWI in the anterior leads as part
of the normal physiological or ethnic spectrum
From the aDivision of Cardiovascular Sciences, St. George’s University of London, United Kingdom; and the bDepartment of
Cardiology, Universidade Nova de Lisboa, Hospital das Forças Armadas, Luz Saúde, NOVA Medical School, Lisbon, Portugal. Drs.
Malhotra, Dhutia, Yeo, Steriotis, Finocchiaro, Narain, and Millar were supported by a research grant from the charitable organi-
zation Cardiac Risk in the Young. Dr. Merghani was supported by the British Heart Foundation. All authors have reported that they
have no relationships relevant to the contents of this paper to disclose.
Manuscript received July 13, 2016; revised manuscript received October 1, 2016, accepted October 11, 2016.
Listen to this manuscript’s
audio summary by
JACC Editor-in-Chief
Dr. Valentin Fuster.
J O U R N A L O F T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y VO L . 6 9 , N O . 1 , 2 0 1 7
ª 2 0 1 7 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N
P U B L I S H E D B Y E L S E V I E R
I S S N 0 7 3 5 - 1 0 9 7 / $ 3 6 . 0 0
h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j a c c . 2 0 1 6 . 1 0 . 0 4 4
Tese para obtenção do grau de Doutor em Medicina na Especialidade em Investigação Clínica62
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
58 
MANUSCRIPT 1 
 
 
 
 
 
 
 
 
 
 
64 H. Dores et al.
55. D’Andrea A, Cocchia R, Riegler L, et al. Left ventricular myocar-
dial velocities and deformation indexes in top-level athletes.
J Am Soc Echocardiogr. 2010;23:1281--8.
56. Arbab-Zadeh A, Dijk E, Prasad A, et al. Effect of aging and
physical activity on left ventricular compliance. Circulation.
2004;110:1799--805.
57. Pelliccia A, Culasso F, Di Paolo FM, et al. Prevalence of abnormal
electrocardiograms in a large, unselected population under-
going pre-participation cardiovascular screening. Eur Heart J.
2007;28:2006--10.
58. Gati S, Chandra N, Bennett RL, et al. Increased left ventricu-
lar trabeculation in highly trained athletes: do we need more
stringent criteria for the diagnosis of left ventricular non-
compaction in athletes? Heart. 2013;99:401--8.
59. Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations
for interpretation of 12-lead electrocardiogram in the athlete.
Eur Heart J. 2010;31:243--59.
60. Uberoi A, Stein R, Perez MV, et al. Interpretation of the electro-
cardiogram of young athletes. Circulation. 2011;124:746--57.
61. Drezner JA, Fischbach P, Froelicher V, et al. Normal electro-
cardiographic findings: recognising physiological adaptations in
athletes. Br J Sports Med. 2013;47:125--36.
62. Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardio-
graphic interpretation in athletes: the ‘Seattle Criteria’. Br J
Sports Med. 2013;47:122--4.
63. Drezner JA, Ashley E, Baggish AL, et al. Abnormal electrocar-
diographic findings in athletes: recognising changes suggestive
of cardiomyopathy. Br J Sports Med. 2013;47:137--52.
64. Stein R, Medeiros CM, Rosito GA, et al. Intrinsic sinus and atri-
oventricular node electrophysiologic adaptations in endurance
athletes. J Am Coll Cardiol. 2002;39:1033--8.
65. Papadakis M, Basavarajaiah S, Rawlins J, et al. Prevalence and
significance of T-wave inversions in predominantly Caucasian
adolescent athletes. Eur Heart J. 2009;30:1728--35.
66. Papadakis M, Carre F, Kervio G, et al. The prevalence,
distribution, and clinical outcomes of electrocardiographic
repolarization patterns in male athletes of African/Afro-
Caribbean origin. Eur Heart J. 2011;32:2304--13.
67. Noseworthy PA, Weiner R, Kim J, et al. Early repolariza-
tion pattern in competitive athletes clinical correlates and
the effects of exercise training. Circ Arrhythm Electrophysiol.
2011;4:432--40.
68. Tikkanen JT, Anttonen O, Junttila MJ, et al. Long-term outcome
associated with early repolarization on electrocardiography.
N Engl J Med. 2009;361:2529--37.
69. Biasco L, Cristoforetti Y, Castagno D, et al. Clinical, electro-
cardiographic, echocardiographic characteristics and long term
follow up of elite soccer players with J point elevation. Circ
Arrhythm Electrophysiol. 2013;6:1178--84.
70. Drezner JA, Ackerman MJ, Cannon BC, et al. Abnormal
electrocardiographic findings in athletes: recognising changes
suggestive of primary electrical disease. Br J Sports Med.
2013;47:153--67.
71. La Gerche A, Robberecht C, Kuiperi C, et al. Lower than
expected desmosomal gene mutation prevalence in endurance
athletes with complex ventricular arrhythmia of right ventricu-
lar origin. Heart. 2010;96:1268--74.
72. Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular
pre-participation screening of young competitive athletes
for prevention of sudden death: proposal for a common
European protocol Consensus Statement of the Study
Group of Sport Cardiology of the Working Group of Cardiac
Rehabilitation and Exercise Physiology and the Working Group of
Myocardial and Pericardial Diseases of the European Society
of Cardiology. Eur Heart J. 2005;26:516--24.
73. Baggish AL, Yared KL, Wang F, et al. The impact of
endurance exercise training on left ventricular systolic
mechanics. Am J Physiol Heart Circ Physiol. 2008;295:
H1109--16.
74. Corrado D, Basco C, Pavei A, et al. Trends in sudden cardiovas-
cular death in young competitive athletes after implementation
of preparticipation screening program. JAMA. 2006;296:
1593--601.
75. Steinvil A, Chundadze T, Zeltser D, et al. Mandatory electro-
cardiographic screening of athletes to reduce their risk for
sudden death: proven fact or wishful thinking? J Am Coll Cardiol.
2011;57:1291--6.
76. Van Camp SP, Bloor CM, Mueller FO, et al. Nontraumatic sports
death in high school and college athletes. Med Sci Sports Exerc.
1995;27:641--7.
77. Drezner JA, Asif IM, Owens DS, et al. Accuracy of ECG
interpretation in competitive athletes: the impact of using
standardised ECG criteria. Br J Sports Med. 2012;46:
335--40.
78. Gati S, Sheikh N, Ghani S, et al. Should axis deviation or atrial
enlargement be categorised as abnormal in young athletes? The
athlete’s electrocardiogram: time for re-appraisal of markers
of pathology. Eur Heart J. 2013;34:3641--8.
Document downloaded from http://www.elsevier.pt, day 24/03/2015. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
59 
MANUSCRIPT 2 
 
 
 
 
ORIGINAL INVESTIGATIONS
Anterior T-Wave Inversion in Young
White Athletes and Nonathletes
Prevalence and Significance
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ABSTRACT
BACKGROUND Anterior T-wave inversion (ATWI) on electrocardiography (ECG) in young white adults raises the pos-
sibility of cardiomyopathy, specifically arrhythmogenic right ventricular cardiomyopathy (ARVC). Whereas the 2010
European consensus recommendations for ECG interpretation in young athletes state that ATWI beyond lead V1 warrants
further investigation, the prevalence and significance of ATWI have never been reported in a large population of
asymptomatic whites.
OBJECTIVES This study investigated the prevalence and significance of ATWI in a large cohort of young, white adults
including athletes.
METHODS Individuals 16 to 35 years of age (n ¼ 14,646), including 4,720 females (32%) and 2,958 athletes (20%),
were evaluated by using a health questionnaire, physical examination, and 12-lead ECG. ATWI was defined as T-wave
inversion in $2 contiguous anterior leads (V1 to V4).
RESULTS ATWI was detected in 338 individuals (2.3%) and was more common in women than in men (4.3% vs. 1.4%,
respectively; p < 0.0001) and more common among athletes than in nonathletes (3.5% vs. 2.0%, respectively;
p < 0.0001). T-wave inversion was predominantly confined to leads V1 to V2 (77%). Only 1.2% of women and 0.2% of
men exhibited ATWI beyond V2. No one with ATWI fulfilled diagnostic criteria for ARVC after further evaluation. During a
mean follow-up of 23.1 � 12.2 months none of the individuals with ATWI experienced an adverse event.
CONCLUSIONS ATWI confined to leads V1 to V2 is a normal variant or physiological phenomenon in asymptomatic
white individuals without a relevant family history. ATWI beyond V2 is rare, particularly in men, and may warrant
investigation. (J Am Coll Cardiol 2017;69:1–9) © 2017 by the American College of Cardiology Foundation.
T here is general agreement that T-waveinversion (TWI) in the inferior or lateralleads in young individuals warrants
further investigation for cardiac disease, particularly
cardiomyopathy (1). It is also well established that
adolescent athletes (2–6) and black adult athletes (7)
frequently exhibit TWI in the anterior leads as part
of the normal physiological or ethnic spectrum
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respectively. However, the general
consensus for the significance of anterior
TWI (ATWI), defined as T-wave inversion
in $2 contiguous anterior leads (V1 to V4) in
white adults varies among expert recommen-
dations for the interpretation of the athlete’s
electrocardiogram (ECG). Whereas the Euro-
pean Society of Cardiology recommendations
suggest further evaluation of athletes with
TWI beyond lead V1 (8), more recent recom-
mendations from the Seattle criteria advo-
cate investigation only if TWI extends
beyond V2 (9).
Both of the consensus panels have relied on data
from unselected (10) or small cohorts of athletes (11);
however recent studies reveal that TWI in leads V1 to
V2/V3 is detected in up to 6%of endurance athletes (12).
Conversely, ATWI in V1 to V2/V3 is a recognized repo-
larization abnormality in a significant proportion of
patients with arrhythmogenic right ventricular car-
diomyopathy (ARVC) and a minority of patients with
hypertrophic cardiomyopathy (7), which collectively
accounts for >40% of all sudden cardiac deaths (SCDs)
in young athletes (13). Differentiation of potentially
pathological ATWI from a pattern that represents a
normal variant or physiological remodeling in white
adult athletes is essential to minimize the risk and
consequences of an erroneous diagnosis (6,14).
Because the prevalence of ATWI has been reported
in black athletes, controls of both sexes, and the
adolescent population, the present study focused on
the prevalence and significance of ATWI in a large
cohort of apparently healthy white adults including a
large proportion of athletes.
METHODS
SETTING. The United Kingdom does not support a
nationally sponsored screening program for cardiac
disease in young asymptomatic individuals in the
absence of a family history of inherited cardiac dis-
ease or premature SCD. Several elite sporting orga-
nizations finance the evaluation of their athletes
through the charitable organization CRY (Cardiac Risk
in the Young). These organizations include premier
league football clubs, the Lawn Tennis Association,
and the English Institute of Sport. Up to 1,000 ath-
letes are tested annually at their specific clubs or
national training camps, usually using history, ex-
amination, and ECG. Financially endowed organiza-
tions such as the Football Association and the Lawn
Tennis Association also incorporate echocardiogra-
phy as a standard test.
CRY also offers cardiac screening to all young in-
dividuals (14 to 35 years of age) who wish to be
assessed, even in the absence of symptoms, history
of cardiac disease, or a family history of inherited
cardiac diseases or SCD. Such screenings are con-
ducted at community centers and high schools and are
limited to history, examination, and ECG with referral
for further assessment only in those with abnormal
preliminary findings or if participating as controls for
research studies. Screening events are advertised
through the local media and on the CRY website.
Individuals from the general population, including
those from local high schools, self-present to
screening events whereas competitive athletes attend
specified screening events mandated by their relevant
sporting bodies. The CRY screening program is su-
pervised by our principal investigator (S.S.).
SUBJECTS. Between 2007 and 2013, 14,646 young,
white adults between 16 and 35 years of age under-
went cardiac evaluation through CRY at various
testing centers in England. Ethnicity was self-
reported through the questionnaire that included
terms such as white British, white Irish, white Euro-
pean, and white other.
Athletes . The study included 2,958 athletes (20.2%)
competing at regional, national, or international levels
who performed $8 h of exercise per week. Sporting
disciplines were categorized as predominantly
endurance or strength. Endurance sports were defined
as those typically resulting in >70% maximal oxygen
uptake (VO2max) (15) and included badminton, basket-
ball, canoeing, cycling, hockey, middle- and long-
distance running, rowing, rugby, soccer, squash,
swimming, tennis, and triathlon. All other sports were
deemed strength disciplines, including cricket, diving,
sailing, volley ball, water polo, weight lifting, and
wrestling.
Nonath letes . The nonathlete cohort consisted of
11,688 individuals (79.8%) whose primary inclusion
criterion was a sedentary lifestyle (#2 h organized
physical activity per week). Individuals with symp-
toms suggestive of cardiac disease, history or family
history of cardiac disease or premature cardiac dis-
ease or SCD (<50 years of age) were excluded.
ELECTROCARDIOGRAPHY. A standard 12-lead ECG
was performed while patient were in a supine posi-
tion, using a Marquette Hellige recorder (Marquette-
Hellige Medical Systems, Milwaukee, Wisconsin) at a
paper speed of 25 mm/s. Wave voltages P, Q, R, S, and
T and ST-segments QRS, PR, and QT intervals were
measured in each lead as described elsewhere (16).
SEE PAGE 10
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resonance imaging
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Leads V1 to V4 were classified as anterior precordial
leads. T-wave deflection $0.1 mV in these leads
was regarded as abnormal TWI. Deep TWI was
defined as a T-wave amplitude $0.2 mV. In cases of
biphasic T-waves, we applied the definition to the
negative component of the T-wave. In cases of ATWI,
the ECG was repeated to ensure that the leads were
correctly positioned according to standard recom-
mendations. In women, the ECG electrodes were
placed under the breast tissue according to American
Heart Association recommendations (17). Partial right
bundle branch block was defined as a QRS duration
>0.1 but <0.12 s, with rSR0 morphology in lead V1 and
QRS in V6 (18). Individuals with TWI and complete
right bundle branch block (QRS: $0.12 s) were
excluded from the ATWI group. Additional ECG
markers compatible with ARVC were also sought,
including terminal activation duration of the QRS
complex $55 ms in lead V1, V2, or V3 and the epsilon
wave (19).
The amplitude of the J point (Jt) (20) was measured
at the end of the QRS complex (the onset of the ST-
segment) with reference to the onset of the QRS
complex. The Jt was considered elevated if Jt $0.1 mV
or depressed if Jt #0.1 mV. The morphology of the
ST-segment in the anterior leads was ascertained in
the interval, M (during the 100 ms following Jt) (20).
The ST-segment at the onset of the M interval (i.e., Jt)
was considered elevated if it was above Jt, depressed
if it was below Jt, and isoelectric if it was in line
with Jt. Ascending ST-segments were categorized as
ascending convex or ascending concave (Figure 1).
ECHOCARDIOGRAPHY. Two-dimensional (2D) trans-
thoracic echocardiography was performed in all sub-
jects with ATWI by using Sonos 7500 system (model
CPX50, iE33, Philips, Baltimore, Maryland) and Vivid I
(GE, Tiral, Israel) machines. Standard views were ob-
tained, and dimensions of cavities and wall thickness
measurements and pulsed color and tissue Doppler
measurements were made in accordance with estab-
lished guidelines (21–23). Right ventricular assess-
ment was performed as outlined previously (14). Right
ventricular regional wall-motion abnormalities were
defined as akinetic, dyskinetic, or aneurysmal, in
accordance with diagnostic criteria for ARVC (19).
Echocardiography was also performed as standard
testing in 1,079 athletes and 769 nonathletes without
ATWI of similar age and sex proportion whose exam-
inations had normal results and ECGs. The echocar-
diogram was part of the mandatory pre-participation
cardiac evaluation in athletes, although the echocar-
diogram was conducted as part of research in volun-
teering nonathletes. These cohorts served as
comparative groups for athletes and nonathletes with
ATWI, respectively.
All ECG and echocardiograms were performed by
nationally-accredited cardiac physiologists. Echocar-
diography was conducted by physiologists blinded to
the ECG findings. All ECG and echocardiogram images
FIGURE 1 ST-Segment Morphology
(A) The vertical solid line and the vertical dashed line define the M interval, which has a duration of 100 ms. The horizontal dashed line through the onset of the QRS
complex provides the reference point for the measurement of J point (Jt). Jt is elevated at 0.2 mV with a convex appearance. ST-segment morphologies with anterior
T-wave inversion in chest leads V2 and V3 are shown as the following: (B) ascending convex, (C) isoelectric, (D) ascending concave, and (E) depressed.
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respectively. However, the general
consensus for the significance of anterior
TWI (ATWI), defined as T-wave inversion
in $2 contiguous anterior leads (V1 to V4) in
white adults varies among expert recommen-
dations for the interpretation of the athlete’s
electrocardiogram (ECG). Whereas the Euro-
pean Society of Cardiology recommendations
suggest further evaluation of athletes with
TWI beyond lead V1 (8), more recent recom-
mendations from the Seattle criteria advo-
cate investigation only if TWI extends
beyond V2 (9).
Both of the consensus panels have relied on data
from unselected (10) or small cohorts of athletes (11);
however recent studies reveal that TWI in leads V1 to
V2/V3 is detected in up to 6%of endurance athletes (12).
Conversely, ATWI in V1 to V2/V3 is a recognized repo-
larization abnormality in a significant proportion of
patients with arrhythmogenic right ventricular car-
diomyopathy (ARVC) and a minority of patients with
hypertrophic cardiomyopathy (7), which collectively
accounts for >40% of all sudden cardiac deaths (SCDs)
in young athletes (13). Differentiation of potentially
pathological ATWI from a pattern that represents a
normal variant or physiological remodeling in white
adult athletes is essential to minimize the risk and
consequences of an erroneous diagnosis (6,14).
Because the prevalence of ATWI has been reported
in black athletes, controls of both sexes, and the
adolescent population, the present study focused on
the prevalence and significance of ATWI in a large
cohort of apparently healthy white adults including a
large proportion of athletes.
METHODS
SETTING. The United Kingdom does not support a
nationally sponsored screening program for cardiac
disease in young asymptomatic individuals in the
absence of a family history of inherited cardiac dis-
ease or premature SCD. Several elite sporting orga-
nizations finance the evaluation of their athletes
through the charitable organization CRY (Cardiac Risk
in the Young). These organizations include premier
league football clubs, the Lawn Tennis Association,
and the English Institute of Sport. Up to 1,000 ath-
letes are tested annually at their specific clubs or
national training camps, usually using history, ex-
amination, and ECG. Financially endowed organiza-
tions such as the Football Association and the Lawn
Tennis Association also incorporate echocardiogra-
phy as a standard test.
CRY also offers cardiac screening to all young in-
dividuals (14 to 35 years of age) who wish to be
assessed, even in the absence of symptoms, history
of cardiac disease, or a family history of inherited
cardiac diseases or SCD. Such screenings are con-
ducted at community centers and high schools and are
limited to history, examination, and ECG with referral
for further assessment only in those with abnormal
preliminary findings or if participating as controls for
research studies. Screening events are advertised
through the local media and on the CRY website.
Individuals from the general population, including
those from local high schools, self-present to
screening events whereas competitive athletes attend
specified screening events mandated by their relevant
sporting bodies. The CRY screening program is su-
pervised by our principal investigator (S.S.).
SUBJECTS. Between 2007 and 2013, 14,646 young,
white adults between 16 and 35 years of age under-
went cardiac evaluation through CRY at various
testing centers in England. Ethnicity was self-
reported through the questionnaire that included
terms such as white British, white Irish, white Euro-
pean, and white other.
Athletes . The study included 2,958 athletes (20.2%)
competing at regional, national, or international levels
who performed $8 h of exercise per week. Sporting
disciplines were categorized as predominantly
endurance or strength. Endurance sports were defined
as those typically resulting in >70% maximal oxygen
uptake (VO2max) (15) and included badminton, basket-
ball, canoeing, cycling, hockey, middle- and long-
distance running, rowing, rugby, soccer, squash,
swimming, tennis, and triathlon. All other sports were
deemed strength disciplines, including cricket, diving,
sailing, volley ball, water polo, weight lifting, and
wrestling.
Nonath letes . The nonathlete cohort consisted of
11,688 individuals (79.8%) whose primary inclusion
criterion was a sedentary lifestyle (#2 h organized
physical activity per week). Individuals with symp-
toms suggestive of cardiac disease, history or family
history of cardiac disease or premature cardiac dis-
ease or SCD (<50 years of age) were excluded.
ELECTROCARDIOGRAPHY. A standard 12-lead ECG
was performed while patient were in a supine posi-
tion, using a Marquette Hellige recorder (Marquette-
Hellige Medical Systems, Milwaukee, Wisconsin) at a
paper speed of 25 mm/s. Wave voltages P, Q, R, S, and
T and ST-segments QRS, PR, and QT intervals were
measured in each lead as described elsewhere (16).
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Leads V1 to V4 were classified as anterior precordial
leads. T-wave deflection $0.1 mV in these leads
was regarded as abnormal TWI. Deep TWI was
defined as a T-wave amplitude $0.2 mV. In cases of
biphasic T-waves, we applied the definition to the
negative component of the T-wave. In cases of ATWI,
the ECG was repeated to ensure that the leads were
correctly positioned according to standard recom-
mendations. In women, the ECG electrodes were
placed under the breast tissue according to American
Heart Association recommendations (17). Partial right
bundle branch block was defined as a QRS duration
>0.1 but <0.12 s, with rSR0 morphology in lead V1 and
QRS in V6 (18). Individuals with TWI and complete
right bundle branch block (QRS: $0.12 s) were
excluded from the ATWI group. Additional ECG
markers compatible with ARVC were also sought,
including terminal activation duration of the QRS
complex $55 ms in lead V1, V2, or V3 and the epsilon
wave (19).
The amplitude of the J point (Jt) (20) was measured
at the end of the QRS complex (the onset of the ST-
segment) with reference to the onset of the QRS
complex. The Jt was considered elevated if Jt $0.1 mV
or depressed if Jt #0.1 mV. The morphology of the
ST-segment in the anterior leads was ascertained in
the interval, M (during the 100 ms following Jt) (20).
The ST-segment at the onset of the M interval (i.e., Jt)
was considered elevated if it was above Jt, depressed
if it was below Jt, and isoelectric if it was in line
with Jt. Ascending ST-segments were categorized as
ascending convex or ascending concave (Figure 1).
ECHOCARDIOGRAPHY. Two-dimensional (2D) trans-
thoracic echocardiography was performed in all sub-
jects with ATWI by using Sonos 7500 system (model
CPX50, iE33, Philips, Baltimore, Maryland) and Vivid I
(GE, Tiral, Israel) machines. Standard views were ob-
tained, and dimensions of cavities and wall thickness
measurements and pulsed color and tissue Doppler
measurements were made in accordance with estab-
lished guidelines (21–23). Right ventricular assess-
ment was performed as outlined previously (14). Right
ventricular regional wall-motion abnormalities were
defined as akinetic, dyskinetic, or aneurysmal, in
accordance with diagnostic criteria for ARVC (19).
Echocardiography was also performed as standard
testing in 1,079 athletes and 769 nonathletes without
ATWI of similar age and sex proportion whose exam-
inations had normal results and ECGs. The echocar-
diogram was part of the mandatory pre-participation
cardiac evaluation in athletes, although the echocar-
diogram was conducted as part of research in volun-
teering nonathletes. These cohorts served as
comparative groups for athletes and nonathletes with
ATWI, respectively.
All ECG and echocardiograms were performed by
nationally-accredited cardiac physiologists. Echocar-
diography was conducted by physiologists blinded to
the ECG findings. All ECG and echocardiogram images
FIGURE 1 ST-Segment Morphology
(A) The vertical solid line and the vertical dashed line define the M interval, which has a duration of 100 ms. The horizontal dashed line through the onset of the QRS
complex provides the reference point for the measurement of J point (Jt). Jt is elevated at 0.2 mV with a convex appearance. ST-segment morphologies with anterior
T-wave inversion in chest leads V2 and V3 are shown as the following: (B) ascending convex, (C) isoelectric, (D) ascending concave, and (E) depressed.
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were reviewed by 2 independent cardiologists with
the principal investigator (S.S.) adjudicating any
queries.
FURTHER INVESTIGATIONS. All subjects with
ATWI underwent additional investigations to detect
the broader phenotypic features of a primary
cardiomyopathy, particularly ARVC, hypertrophic
cardiomyopathy and dilated cardiomyopathy. Pre-
determined diagnostic criteria for ARVC were based
on the 2010 Modified Task Force criteria (19). Hyper-
trophic cardiomyopathy was considered in in-
dividuals with left ventricular hypertrophy where
septal or wall thickness measured $15 mm in any
myocardial segment in the absence of another condi-
tion capable of producing left ventricular hypertrophy
of the same magnitude (24,25). Dilated cardiomyopa-
thy was considered in individuals with a dilated LV
(men >59 mm and women >53 mm) when accompa-
nied by a reduced ejection fraction (<52%) (26). The
vast majority of further investigations (n ¼ 1,396; 95%)
were performed at our institution.
Ambulatory ECG moni tor ing . Ambulatory 24-h
ECG recording (Lifecard CF Holters, Spacelabs
Healthcare, Snoqualmie, Washington) was used to
detect ventricular arrhythmias. Subjects were
encouraged to continue day-to-day activities
including exercise during monitoring.
Exerc i se test ing . Exercise testing was performed
upright on a treadmill using the standard Bruce
protocol (27). Subjects were exercised to volitional
exhaustion and assessed for cardiac symptoms,
ischemic changes, attenuated blood pressure
response, or arrhythmias.
S ignal -averaged ECG. Signal-averaged ECG
(SAECG) was acquired according to accepted meth-
odology using the same machines used for standard
ECG, with use of a 40 Hz high-pass bidirectional filter
(28). Late potentials were defined as abnormal values
in 1 or more of the parameters in accordance the
diagnostic criteria for ARVC (19).
Card iac magnet ic resonance imaging . Cardiac
magnetic resonance imaging (CMRI) was performed
using a Philips Achiever 3.0T TX scanner (Philips,
Amsterdam, the Netherlands). Delayed gadolinium
enhancement images were acquired as previously
described (29). Ventricular volumes and function
were measured for both ventricles using standard
techniques and analyzed using semi-automated
software (Extended MR workspace, Philips) (30). All
measures were indexed to body surface area.
ETHICAL APPROVAL. Ethics approval was granted
by the National Research Ethics Service, Essex 2
Research Ethics Committee in the United Kingdom.
Written consent was obtained from all subjects.
STATISTICAL ANALYSIS. Data are mean � SD or
percentages, as appropriate, and were analyzed using
SPSS version 20 software (SPSS, Chicago, Illinois).
Comparisons between groups were performed using
Student t test for continuous variables with adjust-
ment for unequal variance if needed and chi-square
tests or Fisher exact tests for categorical variables.
Univariate analyses were performed to determine
variables (sex, age, athletic status, left ventricular
end diastolic diameter, and right ventricular outflow
tract size [parasternal long- and short-axis measure-
ments]) associated with ATWI. Multivariate logistic
regression analyses were used to determine the in-
dependence of these associations. Significance was
defined as p < 0.05.
RESULTS
DEMOGRAPHICS. The mean age of the cohort was
21.7 � 5.4 years of age. Of the 14,646 subjects, 9,926
were men (67.8%); 2,063 men (20.8%) and 895
women (19.0%) were athletes. Athletes exercised for
TABLE 1 Demographics and ECG Characteristics of Individuals With and
Without ATWI
Population
With ATWI
(n ¼ 338)
Population
Without ATWI
(n ¼ 14,308) p Value
Demographics
Age, yrs 21.1 � 5.4 21.7 � 5.3 0.0398
Female 60.1 31.6 <0.0001
Athlete 30.5 20.0 0.0003
BSA, m2 1.81 � 0.3 1.91 � 0.2 <0.0001
Blood pressure, mm Hg 121/66 � 12/7 123/80 � 10/6 0.0003
ECG parameters
Heart rate, beats/min 64 � 14 66 � 14 <0.0001
PR, ms 150 � 25 151 � 32 <0.0001
QRS, ms 93 � 12 92 � 13 <0.0001
QTc, ms 421 � 28 412 � 20 <0.0001
Incomplete RBBB 17.7 5.5 <0.0001
LBBB 0 0.02 0.77
LVH 17.9 10.1 <0.0001
RVH 1.2 1.1 0.93
ER 15.1 9.7 0.0018
Pathological Q waves 0.5 0.3 <0.0001
LA enlargement 3.3 1.4 0.002
RA enlargement 1.4 0.6 0.1
LAD 1.0 1.2 0.83
RAD 0.7 0.4 0.49
Pre-excitation 0.5 0.5 0.93
Values are mean � SD or % overall population.
ATWI ¼ anterior T-wave inversion; BSA ¼ body surface area; ECG ¼ 12-lead electrocardiogram;
ER ¼ early repolarization; LA ¼ left atrial; LAD ¼ left axis deviation; LBBB ¼ left bundle branch
block; LVH ¼ left ventricular hypertrophy; RA ¼ right atrial; RAD ¼ right axis deviation; RBBB ¼
right bundle branch block; RVH ¼ right ventricular hypertrophy; TWI ¼ T-wave inversion.
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an average of 15.7 � 5.1 h/week compared with non-
athletes, who exercised 1.8 � 0.6 h/week.
PREVALENCE OF ATWI. A total of 338 individuals
(2.3%) exhibited ATWI. Individuals with ATWI were of
similar age and had a similar mean body surface area
compared with those without ATWI (Table 1). ATWI
was more common in women than in men (n ¼ 203
[4.3%] vs. n ¼ 135 [1.4%], respectively; p < 0.0001) and
was more common in athletes than in nonathletes
(n ¼ 103 [3.5%] vs. n ¼ 235 [2%], respectively;
p < 0.0001) in both sexes (women: n ¼ 58 [6.5%] vs.
n ¼ 145 [3.8%]; p ¼ 0.0005, and men: n ¼ 45 [2.1%] vs.
n¼ 90 [1.1%]; p¼ 0.0004) (Central Illustration). Among
athletes, ATWI was more prevalent in those engaging
in endurance sports than in strength sports athletes
(n ¼ 82 [5.6%] vs. n ¼ 41 [2.8%]; respectively;
p < 0.0001). The prevalence of ATWI among those
16 to 21 years of age was similar to that in those 21
years of age and older (2.28% vs. 2.46%, respectively;
p ¼ 0.52).
DISTRIBUTION OF ATWI. A total of 260 individuals
(1.8%) revealed TWI confined to leads V1 to V2. Those
in whom TWI was confined to V1 to V2 constituted
77% of all ATWI cases. Only 78 individuals (0.5%)
demonstrated TWI beyond V2, which was present in
56 women (1.2%) versus 22 men (0.2%) (p < 0.0001).
Among athletes, TWI in leads V1 to V3 was detected in
19 women (2.1%) versus 7 men (0.3%) (p < 0.0001)
(Central Illustration). Four women but none of the
men showed TWI extending to V4, which equated to
2% of all ATWI in females.
Deep ATWI was more common in males than in
females (55.6% vs. 33%, respectively; p ¼ 0.0166) but
did not differ between athletes and nonathletes. Fifty
individuals with ATWI (14.8%) exhibited incomplete
right bundle branch block that never extended
beyond V2.
JT ELEVATION AND ST-SEGMENT MORPHOLOGY
PRECEDING ATWI. Among individuals with ATWI, Jt
elevation was more common in athletes than in
nonathletes (49% vs. 29%, respectively; p ¼ 0.0008)
and more common in men than in women regardless
of athletic status (athletes: 71.1% vs. 31.0%, respec-
tively; p ¼ 0.0004; nonathletes: 58.9% vs. 10.3%,
respectively; p < 0.0001). None of the individuals
with ATWI demonstrated a depressed Jt.
Men frequently showed an elevated ST-segment,
that of ascending convex morphology (42%),
CENTRAL ILLUSTRATION Prevalence of Anterior T-Wave Inversion in the Adult White Population
Malhotra, A. et al. J Am Coll Cardiol. 2017;69(1):1–9.
The overall prevalence of anterior T-wave inversion (ATWI) in adult white individuals (16 to 35 years of age) was 2.3%. ATWI was more common in women and in
athletes. The prevalence of ATWI beyond V2 was rare, falling to 0.2% in male nonathletes.
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were reviewed by 2 independent cardiologists with
the principal investigator (S.S.) adjudicating any
queries.
FURTHER INVESTIGATIONS. All subjects with
ATWI underwent additional investigations to detect
the broader phenotypic features of a primary
cardiomyopathy, particularly ARVC, hypertrophic
cardiomyopathy and dilated cardiomyopathy. Pre-
determined diagnostic criteria for ARVC were based
on the 2010 Modified Task Force criteria (19). Hyper-
trophic cardiomyopathy was considered in in-
dividuals with left ventricular hypertrophy where
septal or wall thickness measured $15 mm in any
myocardial segment in the absence of another condi-
tion capable of producing left ventricular hypertrophy
of the same magnitude (24,25). Dilated cardiomyopa-
thy was considered in individuals with a dilated LV
(men >59 mm and women >53 mm) when accompa-
nied by a reduced ejection fraction (<52%) (26). The
vast majority of further investigations (n ¼ 1,396; 95%)
were performed at our institution.
Ambulatory ECG moni tor ing . Ambulatory 24-h
ECG recording (Lifecard CF Holters, Spacelabs
Healthcare, Snoqualmie, Washington) was used to
detect ventricular arrhythmias. Subjects were
encouraged to continue day-to-day activities
including exercise during monitoring.
Exerc i se test ing . Exercise testing was performed
upright on a treadmill using the standard Bruce
protocol (27). Subjects were exercised to volitional
exhaustion and assessed for cardiac symptoms,
ischemic changes, attenuated blood pressure
response, or arrhythmias.
S ignal -averaged ECG. Signal-averaged ECG
(SAECG) was acquired according to accepted meth-
odology using the same machines used for standard
ECG, with use of a 40 Hz high-pass bidirectional filter
(28). Late potentials were defined as abnormal values
in 1 or more of the parameters in accordance the
diagnostic criteria for ARVC (19).
Card iac magnet ic resonance imaging . Cardiac
magnetic resonance imaging (CMRI) was performed
using a Philips Achiever 3.0T TX scanner (Philips,
Amsterdam, the Netherlands). Delayed gadolinium
enhancement images were acquired as previously
described (29). Ventricular volumes and function
were measured for both ventricles using standard
techniques and analyzed using semi-automated
software (Extended MR workspace, Philips) (30). All
measures were indexed to body surface area.
ETHICAL APPROVAL. Ethics approval was granted
by the National Research Ethics Service, Essex 2
Research Ethics Committee in the United Kingdom.
Written consent was obtained from all subjects.
STATISTICAL ANALYSIS. Data are mean � SD or
percentages, as appropriate, and were analyzed using
SPSS version 20 software (SPSS, Chicago, Illinois).
Comparisons between groups were performed using
Student t test for continuous variables with adjust-
ment for unequal variance if needed and chi-square
tests or Fisher exact tests for categorical variables.
Univariate analyses were performed to determine
variables (sex, age, athletic status, left ventricular
end diastolic diameter, and right ventricular outflow
tract size [parasternal long- and short-axis measure-
ments]) associated with ATWI. Multivariate logistic
regression analyses were used to determine the in-
dependence of these associations. Significance was
defined as p < 0.05.
RESULTS
DEMOGRAPHICS. The mean age of the cohort was
21.7 � 5.4 years of age. Of the 14,646 subjects, 9,926
were men (67.8%); 2,063 men (20.8%) and 895
women (19.0%) were athletes. Athletes exercised for
TABLE 1 Demographics and ECG Characteristics of Individuals With and
Without ATWI
Population
With ATWI
(n ¼ 338)
Population
Without ATWI
(n ¼ 14,308) p Value
Demographics
Age, yrs 21.1 � 5.4 21.7 � 5.3 0.0398
Female 60.1 31.6 <0.0001
Athlete 30.5 20.0 0.0003
BSA, m2 1.81 � 0.3 1.91 � 0.2 <0.0001
Blood pressure, mm Hg 121/66 � 12/7 123/80 � 10/6 0.0003
ECG parameters
Heart rate, beats/min 64 � 14 66 � 14 <0.0001
PR, ms 150 � 25 151 � 32 <0.0001
QRS, ms 93 � 12 92 � 13 <0.0001
QTc, ms 421 � 28 412 � 20 <0.0001
Incomplete RBBB 17.7 5.5 <0.0001
LBBB 0 0.02 0.77
LVH 17.9 10.1 <0.0001
RVH 1.2 1.1 0.93
ER 15.1 9.7 0.0018
Pathological Q waves 0.5 0.3 <0.0001
LA enlargement 3.3 1.4 0.002
RA enlargement 1.4 0.6 0.1
LAD 1.0 1.2 0.83
RAD 0.7 0.4 0.49
Pre-excitation 0.5 0.5 0.93
Values are mean � SD or % overall population.
ATWI ¼ anterior T-wave inversion; BSA ¼ body surface area; ECG ¼ 12-lead electrocardiogram;
ER ¼ early repolarization; LA ¼ left atrial; LAD ¼ left axis deviation; LBBB ¼ left bundle branch
block; LVH ¼ left ventricular hypertrophy; RA ¼ right atrial; RAD ¼ right axis deviation; RBBB ¼
right bundle branch block; RVH ¼ right ventricular hypertrophy; TWI ¼ T-wave inversion.
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an average of 15.7 � 5.1 h/week compared with non-
athletes, who exercised 1.8 � 0.6 h/week.
PREVALENCE OF ATWI. A total of 338 individuals
(2.3%) exhibited ATWI. Individuals with ATWI were of
similar age and had a similar mean body surface area
compared with those without ATWI (Table 1). ATWI
was more common in women than in men (n ¼ 203
[4.3%] vs. n ¼ 135 [1.4%], respectively; p < 0.0001) and
was more common in athletes than in nonathletes
(n ¼ 103 [3.5%] vs. n ¼ 235 [2%], respectively;
p < 0.0001) in both sexes (women: n ¼ 58 [6.5%] vs.
n ¼ 145 [3.8%]; p ¼ 0.0005, and men: n ¼ 45 [2.1%] vs.
n¼ 90 [1.1%]; p¼ 0.0004) (Central Illustration). Among
athletes, ATWI was more prevalent in those engaging
in endurance sports than in strength sports athletes
(n ¼ 82 [5.6%] vs. n ¼ 41 [2.8%]; respectively;
p < 0.0001). The prevalence of ATWI among those
16 to 21 years of age was similar to that in those 21
years of age and older (2.28% vs. 2.46%, respectively;
p ¼ 0.52).
DISTRIBUTION OF ATWI. A total of 260 individuals
(1.8%) revealed TWI confined to leads V1 to V2. Those
in whom TWI was confined to V1 to V2 constituted
77% of all ATWI cases. Only 78 individuals (0.5%)
demonstrated TWI beyond V2, which was present in
56 women (1.2%) versus 22 men (0.2%) (p < 0.0001).
Among athletes, TWI in leads V1 to V3 was detected in
19 women (2.1%) versus 7 men (0.3%) (p < 0.0001)
(Central Illustration). Four women but none of the
men showed TWI extending to V4, which equated to
2% of all ATWI in females.
Deep ATWI was more common in males than in
females (55.6% vs. 33%, respectively; p ¼ 0.0166) but
did not differ between athletes and nonathletes. Fifty
individuals with ATWI (14.8%) exhibited incomplete
right bundle branch block that never extended
beyond V2.
JT ELEVATION AND ST-SEGMENT MORPHOLOGY
PRECEDING ATWI. Among individuals with ATWI, Jt
elevation was more common in athletes than in
nonathletes (49% vs. 29%, respectively; p ¼ 0.0008)
and more common in men than in women regardless
of athletic status (athletes: 71.1% vs. 31.0%, respec-
tively; p ¼ 0.0004; nonathletes: 58.9% vs. 10.3%,
respectively; p < 0.0001). None of the individuals
with ATWI demonstrated a depressed Jt.
Men frequently showed an elevated ST-segment,
that of ascending convex morphology (42%),
CENTRAL ILLUSTRATION Prevalence of Anterior T-Wave Inversion in the Adult White Population
Malhotra, A. et al. J Am Coll Cardiol. 2017;69(1):1–9.
The overall prevalence of anterior T-wave inversion (ATWI) in adult white individuals (16 to 35 years of age) was 2.3%. ATWI was more common in women and in
athletes. The prevalence of ATWI beyond V2 was rare, falling to 0.2% in male nonathletes.
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followed by an ascending concave morphology (33%)
and an isoelectric pattern (25%). In women with
ATWI, the ST segment was most commonly isoelectric
(57%), followed by ascending convex (24%) and
ascending concave (19%) morphologies. Only 1 indi-
vidual with ATWI demonstrated a depressed ST-
segment (Figure 2).
CARDIAC STRUCTURE AND FUNCTION IN
INDIVIDUALS WITH ATWI. The echocardiographic
results of all 338 individuals with ATWI (103 athletes,
235 nonathletes) were compared with the results of
1,848 individuals without ATWI (1,079 athletes, 769
nonathletes). Athletes revealed larger ventricular di-
mensions than nonathletes regardless of ATWI. There
were no differences in left or right ventricular di-
mensions or function in individuals (athletes and
nonathletes) with ATWI compared to those without
AWTI (Table 2).
Cardiac MRI was performed in 250 subjects
(74%) with ATWI. Athletes demonstrated larger left
and right ventricular volumes and masses than
did nonathletes (Table 2). Following gadolinium-
enhanced MRI, there was no evidence of late
enhancement in any subject. None of the individuals
with ATWI showed unequivocal diagnostic features
of ARVC, hypertrophic cardiomyopathy, or dilated
cardiomyopathy.
SAECG. A total of 316 individuals (93%) with ATWI
underwent SAECG, and 21 (7%) showed an abnor-
mality in 1 of the 3 parameters. The most common
abnormality was filtered QRS prolongation (60%), a
phenomenon that has been reported previously in
healthy individuals (31,32).
EXERCISE STRESS TESTING AND AMBULATORY ECG
MONITORING. A total of 274 individuals (81%) with
ATWI underwent an exercise stress test, and 293
(87%) had 24-h ECG monitoring. None of the in-
dividuals with ATWI exhibited arrhythmia during
exercise, other than occasional isolated ventricular
ectopic beats (n ¼ 10; 3%) of right or left ventricular
origin in the early stages of exercise. Similarly, none
showed >500 ventricular ectopic beats or runs of
nonsustained ventricular tachycardia during Holter
monitoring (19).
DETERMINANTS OF ATWI. Univariate predictors of
ATWI were female sex and athletic status. Stepwise
logistic regression identified female sex (odds ratio
[OR]: 3.1; 95% confidence interval [CI]: 1.96 to 4.90;
p < 0.001) and athletic status (OR: 3.3; 95% CI: 1.91
to 5.63; p ¼ 0.001) as being independently associ-
ated with ATWI in the screened adult population,
regardless of age.
DETECTION OF CARDIAC PATHOLOGY. Following
comprehensive clinical evaluation of 274 individuals
(81%) with ATWI (including echocardiography in all
338 individuals and a mean follow-up period of
23.1 � 12.2 months), we could not diagnose ARVC or
any other cardiomyopathy. However, 16 athletes
and 10 nonathletes with ATWI fell into the gray zone
in which structural changes attributed to physiolog-
ical adaptation needed to be differentiated from
primary cardiomyopathies. These subjects included 2
athletes and 3 nonathletes with an indexed para-
sternal right ventricular outflow tract dimension
$19 mm/m2; 1 athlete with a maximal left ventricular
wall thickness of 13 mm; and 6 nonathletes who
initially demonstrated an absolute LVEDD (left ven-
tricular end diastolic diameter) above the upper
limit of normal (>59 mm LVEDD in male nonathletes,
>53 mm in women [3], and LVEDD of >60 mm in
athletes [33]).
IDENTIFICATION OF MINOR CARDIAC PATHOLOGY.
Echocardiography in all 338 subjects with ATWI
failed to show akinetic segments or regional wall
motion abnormalities affecting the right ventricle. A
small proportion revealed minor pathology in 5 sub-
jects (1.5%) including bicuspid aortic valve (n ¼ 2;
0.6%), mitral valve prolapse with moderate mitral
regurgitation (n ¼ 1; 0.3%), atrial septal defect (n ¼1;
0.3%), and patent ductus arteriosus (n ¼ 1; 0.3%).
Seven individuals (2%) had patent foramen ovale
noted, and pectus excavatum was noted in 2 cases
(0.6%).
FIGURE 2 Bar Graph Shows ST-Segment Morphology Type Preceding ATWI in Healthy
Individuals and ATWI According to Sex
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An ascending convex and an ascending concave ST-segment morphology were more
common in men than women. Women more commonly demonstrated an isoelectric
ST-segment. ATWI ¼ anterior T-wave inversion.
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DISCUSSION
Detection of lateral or inferolateral TWI in young
black or white individuals has a relatively high yield
for the diagnosis of cardiomyopathy (1). Although
ATWI is a benign variant in healthy adolescents of all
ethnic origins and in black adolescent and adult ath-
letes, its significance in asymptomatic white adults is
unknown. However, between 50% and 60% of pro-
bands with ARVC show ATWI in leads V1 to V3 (34).
This study of almost 15,000 healthy, white adults,
including 4,720 women and almost 3,000 athletes,
showed that ATWI beyond V1 was present in a small
proportion of individuals (2.3%) and that this preva-
lence fell to just 0.5% beyond V2. ATWI was more
common in women than in men regardless of athletic
status and validates data from much smaller studies
performed 6 to 7 decades ago (35,36). Several postu-
lations for these sex differences have been proposed,
including various levels of sympathetic innervation
and anatomical differences in chest wall structure,
specifically breast tissue. Based on the fact that
the prevalence of ATWI is almost identical in prepu-
bertal boys and girls (3), we suspect that sex differ-
ences in adults are likely to reflect differences in lead
placement as a result of increased breast tissue in
women.
PREVALENCE OF ATWI IN ATHLETES. Athletes
demonstrated a greater prevalence of ATWI than
did nonathletes, particularly those engaging in >15
h/week of exercise. Such intense exercise regimens,
particularly in endurance sports, place a greater he-
modynamic load on the right ventricle that may
manifest on the ECG as ATWI. Our study, however,
was unable to demonstrate any structural differences
between the right ventricles of individuals with ATWI
and those of individuals without.
SIGNIFICANCE OF EXTRAPOLATING DATA FROM
PROBANDS WITH CARDIOMYOPATHY TO LOW-RISK
POPULATIONS. There are justifiable concerns about
the association of ATWI with an underlying cardio-
myopathy such as ARVC or hypertrophic cardiomy-
opathy. While isolated ATWI is rare in hypertrophic
cardiomyopathy (2), ATWI beyond V2 in probands
with ARVC is common and classified as a major
repolarization abnormality in the Revised Task Force
Criteria for ARVC (19). In this study, none of the
athletes with ATWI in leads V2/V3 fulfilled diagnostic
criteria for ARVC based on a combination of health
questionnaire, ECG, and echocardiography in 100% of
cases, signal-averaged ECG in 93%, 24-h ECG in 87%,
exercise testing in 81%, and cardiac magnetic reso-
nance imaging in 74% of subjects. This observation
highlights the fact that data derived from probands
with ARVC for generating diagnostic criteria lack
specificity in low-risk populations (29). However,
TWI beyond V2 was present in just 1 in 200 white
adult athletes and could justify detailed assessment
to exclude ARVC or any other cardiomyopathy.
Our data support the consensus-based Seattle rec-
ommendations, which pragmatically suggest that
only TWI beyond V2 in asymptomatic white athletes
requires further evaluation (9). However, these
TABLE 2 Echocardiographic and CMRI Measurements of Athletes and Nonathletes With
and Without ATWI
Athletes (n ¼ 1,182) Nonathletes (n ¼ 1,004)
With ATWI
(n ¼ 103)
Without ATWI
(n ¼ 1,079) p Value
With ATWI
(n ¼ 235)
Without ATWI
(n ¼ 769) p Value
Ao, mm 28.0 � 4.3 28.6 � 4.5 0.2306 27.1 � 3.6 27.4 � 3.8 0.2839
LA, mm 33.1 � 6.1 33.5 � 4.9 0.4394 31.0 � 4.3 31.3 � 5.5 0.443
LVEDD, mm 50.8 � 5.8 51.5 � 5.6 0.2272 48.1 � 4.5 48.5 � 5.8 0.3315
LVESD, mm 34.0 � 6.1 33.9 � 4.8 0.844 31.1 � 3.9 31.6 � 5.1 0.1666
MLVWT, mm 9.2 � 2.3 8.9 � 2.1 0.1699 8.5 � 2.2 8.3 � 1.5 0.1126
LVMI, g/m2 105 � 15 103 � 16 0.2233 94 � 8 95 � 9 0.1267
% EF 60 � 9 59 � 8 0.231 66 � 8 67 � 9 0.1267
RVOTplax, mm 29.9 � 5.4 29.8 � 4.8 0.8417 26.0 � 3.7 25.4 � 3.6 0.1072
RVOTplax, mm/m
2 16.7 � 2.1 16.8 � 3.7 0.7871 15.2 � 2.5 14.8 � 3.1 0.2041
RVOTpsax, mm 31.6 � 4.9 32.3 � 5.6 0.221 28.2 � 5.8 29.1 � 5.7 0.1266
RVOTpsax, mm/m
2 17.8 � 2.5 17.5 � 2.9 0.3106 16.0 � 2.1 16.1 � 2.5 0.6945
RVOT2, mm 25.8 � 4.8 25.1 � 4.4 0.1263 22.6 � 3.7 23.2 � 4.3 0.0537
RVD1, mm 41.1 � 6.6 40.6 � 5.8 0.4093 35.3 � 4.9 35.6 � 5.5 0.4534
RVD2, mm 34.1 � 6.4 33.3 � 5.5 0.165 28.2 � 4.5 28.7 � 5.7 0.2181
RVD3, mm 84.2 � 10.5 82.0 � 13.2 0.1008 73.5 � 11.4 74.9 � 11.1 0.093
RVWT, mm 4.8 � 1.5 4.6 � 1.3 0.1416 4.2 � 0.8 4.1 � 1.0 0.1613
TAPSE, mm 23.4 � 5.3 23.5 � 4.2 0.8219 22.8 � 4.7 22.9 � 4.5 0.768
PASP, mm Hg 17.6 � 7.7 15.9 � 6.5 0.0128 17.8 � 3.3 18.3 � 4.0 0.0816
TV E/A 1.9 � 0.5 2.0 � 0.4 0.0181 1.9 � 0.6 2.0 � 0.8 0.0771
TV S0, cm/s 14.8 � 2.6 14.9 � 2.5 0.6992 14.6 � 2.8 14.2 � 2.8 0.0556
TV E0, cm/s 13.9 � 3.4 14.1 � 3.1 0.5353 14.9 � 2.9 15.1 � 3.5 0.426
RAA, cm2 19.2 � 3.4 18.8 � 3.7 0.2915 15.2 � 2.8 15.1 � 4.8 0.7613
% RV FAC 38.7 � 4.9 39.6 � 4.8 0.0698 36.2 � 4.1 37.3 � 6.2 0.0108
CMRI
ATWI Athletes
(n ¼ 76)
ATWI Nonathletes
(n ¼ 174)
LVM-I, g/m2 105 � 15 94 � 9 <0.05
LVEDVI, ml/m2 105.8 � 15 94.3 � 14.0 <0.05
% RVEF 52.5 � 5.1 55.5 � 5.9 <0.05
RVEDVI, ml/m2 105.3 � 14.0 94.3 � 14.0 <0.05
% LGE 0 0 –
Values are mean � SD.
Ao ¼ aorta; ATWI ¼ anterior T-wave inversion; CMRI ¼ cardiac magnetic resonance imaging; EF ¼ ejection
fraction according to Simpson’s biplane; FAC ¼ fractional area change; LA ¼ left atrial; LGE ¼ late gadolinium
enhancement; LVEDD ¼ left ventricular end-diastolic diameter; LVEDV ¼ left ventricular end-diastolic volume;
LVEDVI ¼ left ventricular end-diastolic volume index; LVESD ¼ left ventricular end-systolic diameter; LVM-I ¼
left ventricular mass index; MLVWT ¼maximum left ventricular wall thickness; PASP ¼ pulmonary artery systolic
pressure; RAA ¼ right atrial area; RV ¼ right ventricular; RVD1 ¼ right ventricular basal dimension; RVD2 ¼ right
ventricular midventricular dimension; RVD3 ¼ right ventricular longitudinal dimension; RVEDV¼ right ventricular
end-diastolic volume; RVEDVI ¼ right ventricular end-diastolic volume index; RVEF ¼ right ventricular ejection
fraction; RVOT1 ¼ proximal right ventricular outflow tract dimension; RVOT2 ¼ distal right ventricular outflow
tract dimension; RVOTplax ¼ right ventricular outflow tract dimension (parasternal); RVOTsax ¼ right ventricular
outflow tract dimension (short axis); RVWT ¼ right ventricular free wall thickness; S0 ¼ peak systolic velocity;
TAPSE ¼ tricuspid annular plane systolic excursion; TV ¼ tricuspid valve; TV E0 ¼ tricuspid valve early myocardial
relaxation velocity.
J A C C V O L . 6 9 , N O . 1 , 2 0 1 7 Malhotra et al.
J A N U A R Y 3 / 1 0 , 2 0 1 7 : 1 – 9 ATWI in Young White Athletes and Nonathletes
7
Tese para obtenção do grau de Doutor em Medicina na Especialidade em Investigação Clínica68
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
64 
MANUSCRIPT 2 
 
 
 
 
followed by an ascending concave morphology (33%)
and an isoelectric pattern (25%). In women with
ATWI, the ST segment was most commonly isoelectric
(57%), followed by ascending convex (24%) and
ascending concave (19%) morphologies. Only 1 indi-
vidual with ATWI demonstrated a depressed ST-
segment (Figure 2).
CARDIAC STRUCTURE AND FUNCTION IN
INDIVIDUALS WITH ATWI. The echocardiographic
results of all 338 individuals with ATWI (103 athletes,
235 nonathletes) were compared with the results of
1,848 individuals without ATWI (1,079 athletes, 769
nonathletes). Athletes revealed larger ventricular di-
mensions than nonathletes regardless of ATWI. There
were no differences in left or right ventricular di-
mensions or function in individuals (athletes and
nonathletes) with ATWI compared to those without
AWTI (Table 2).
Cardiac MRI was performed in 250 subjects
(74%) with ATWI. Athletes demonstrated larger left
and right ventricular volumes and masses than
did nonathletes (Table 2). Following gadolinium-
enhanced MRI, there was no evidence of late
enhancement in any subject. None of the individuals
with ATWI showed unequivocal diagnostic features
of ARVC, hypertrophic cardiomyopathy, or dilated
cardiomyopathy.
SAECG. A total of 316 individuals (93%) with ATWI
underwent SAECG, and 21 (7%) showed an abnor-
mality in 1 of the 3 parameters. The most common
abnormality was filtered QRS prolongation (60%), a
phenomenon that has been reported previously in
healthy individuals (31,32).
EXERCISE STRESS TESTING AND AMBULATORY ECG
MONITORING. A total of 274 individuals (81%) with
ATWI underwent an exercise stress test, and 293
(87%) had 24-h ECG monitoring. None of the in-
dividuals with ATWI exhibited arrhythmia during
exercise, other than occasional isolated ventricular
ectopic beats (n ¼ 10; 3%) of right or left ventricular
origin in the early stages of exercise. Similarly, none
showed >500 ventricular ectopic beats or runs of
nonsustained ventricular tachycardia during Holter
monitoring (19).
DETERMINANTS OF ATWI. Univariate predictors of
ATWI were female sex and athletic status. Stepwise
logistic regression identified female sex (odds ratio
[OR]: 3.1; 95% confidence interval [CI]: 1.96 to 4.90;
p < 0.001) and athletic status (OR: 3.3; 95% CI: 1.91
to 5.63; p ¼ 0.001) as being independently associ-
ated with ATWI in the screened adult population,
regardless of age.
DETECTION OF CARDIAC PATHOLOGY. Following
comprehensive clinical evaluation of 274 individuals
(81%) with ATWI (including echocardiography in all
338 individuals and a mean follow-up period of
23.1 � 12.2 months), we could not diagnose ARVC or
any other cardiomyopathy. However, 16 athletes
and 10 nonathletes with ATWI fell into the gray zone
in which structural changes attributed to physiolog-
ical adaptation needed to be differentiated from
primary cardiomyopathies. These subjects included 2
athletes and 3 nonathletes with an indexed para-
sternal right ventricular outflow tract dimension
$19 mm/m2; 1 athlete with a maximal left ventricular
wall thickness of 13 mm; and 6 nonathletes who
initially demonstrated an absolute LVEDD (left ven-
tricular end diastolic diameter) above the upper
limit of normal (>59 mm LVEDD in male nonathletes,
>53 mm in women [3], and LVEDD of >60 mm in
athletes [33]).
IDENTIFICATION OF MINOR CARDIAC PATHOLOGY.
Echocardiography in all 338 subjects with ATWI
failed to show akinetic segments or regional wall
motion abnormalities affecting the right ventricle. A
small proportion revealed minor pathology in 5 sub-
jects (1.5%) including bicuspid aortic valve (n ¼ 2;
0.6%), mitral valve prolapse with moderate mitral
regurgitation (n ¼ 1; 0.3%), atrial septal defect (n ¼1;
0.3%), and patent ductus arteriosus (n ¼ 1; 0.3%).
Seven individuals (2%) had patent foramen ovale
noted, and pectus excavatum was noted in 2 cases
(0.6%).
FIGURE 2 Bar Graph Shows ST-Segment Morphology Type Preceding ATWI in Healthy
Individuals and ATWI According to Sex
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An ascending convex and an ascending concave ST-segment morphology were more
common in men than women. Women more commonly demonstrated an isoelectric
ST-segment. ATWI ¼ anterior T-wave inversion.
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DISCUSSION
Detection of lateral or inferolateral TWI in young
black or white individuals has a relatively high yield
for the diagnosis of cardiomyopathy (1). Although
ATWI is a benign variant in healthy adolescents of all
ethnic origins and in black adolescent and adult ath-
letes, its significance in asymptomatic white adults is
unknown. However, between 50% and 60% of pro-
bands with ARVC show ATWI in leads V1 to V3 (34).
This study of almost 15,000 healthy, white adults,
including 4,720 women and almost 3,000 athletes,
showed that ATWI beyond V1 was present in a small
proportion of individuals (2.3%) and that this preva-
lence fell to just 0.5% beyond V2. ATWI was more
common in women than in men regardless of athletic
status and validates data from much smaller studies
performed 6 to 7 decades ago (35,36). Several postu-
lations for these sex differences have been proposed,
including various levels of sympathetic innervation
and anatomical differences in chest wall structure,
specifically breast tissue. Based on the fact that
the prevalence of ATWI is almost identical in prepu-
bertal boys and girls (3), we suspect that sex differ-
ences in adults are likely to reflect differences in lead
placement as a result of increased breast tissue in
women.
PREVALENCE OF ATWI IN ATHLETES. Athletes
demonstrated a greater prevalence of ATWI than
did nonathletes, particularly those engaging in >15
h/week of exercise. Such intense exercise regimens,
particularly in endurance sports, place a greater he-
modynamic load on the right ventricle that may
manifest on the ECG as ATWI. Our study, however,
was unable to demonstrate any structural differences
between the right ventricles of individuals with ATWI
and those of individuals without.
SIGNIFICANCE OF EXTRAPOLATING DATA FROM
PROBANDS WITH CARDIOMYOPATHY TO LOW-RISK
POPULATIONS. There are justifiable concerns about
the association of ATWI with an underlying cardio-
myopathy such as ARVC or hypertrophic cardiomy-
opathy. While isolated ATWI is rare in hypertrophic
cardiomyopathy (2), ATWI beyond V2 in probands
with ARVC is common and classified as a major
repolarization abnormality in the Revised Task Force
Criteria for ARVC (19). In this study, none of the
athletes with ATWI in leads V2/V3 fulfilled diagnostic
criteria for ARVC based on a combination of health
questionnaire, ECG, and echocardiography in 100% of
cases, signal-averaged ECG in 93%, 24-h ECG in 87%,
exercise testing in 81%, and cardiac magnetic reso-
nance imaging in 74% of subjects. This observation
highlights the fact that data derived from probands
with ARVC for generating diagnostic criteria lack
specificity in low-risk populations (29). However,
TWI beyond V2 was present in just 1 in 200 white
adult athletes and could justify detailed assessment
to exclude ARVC or any other cardiomyopathy.
Our data support the consensus-based Seattle rec-
ommendations, which pragmatically suggest that
only TWI beyond V2 in asymptomatic white athletes
requires further evaluation (9). However, these
TABLE 2 Echocardiographic and CMRI Measurements of Athletes and Nonathletes With
and Without ATWI
Athletes (n ¼ 1,182) Nonathletes (n ¼ 1,004)
With ATWI
(n ¼ 103)
Without ATWI
(n ¼ 1,079) p Value
With ATWI
(n ¼ 235)
Without ATWI
(n ¼ 769) p Value
Ao, mm 28.0 � 4.3 28.6 � 4.5 0.2306 27.1 � 3.6 27.4 � 3.8 0.2839
LA, mm 33.1 � 6.1 33.5 � 4.9 0.4394 31.0 � 4.3 31.3 � 5.5 0.443
LVEDD, mm 50.8 � 5.8 51.5 � 5.6 0.2272 48.1 � 4.5 48.5 � 5.8 0.3315
LVESD, mm 34.0 � 6.1 33.9 � 4.8 0.844 31.1 � 3.9 31.6 � 5.1 0.1666
MLVWT, mm 9.2 � 2.3 8.9 � 2.1 0.1699 8.5 � 2.2 8.3 � 1.5 0.1126
LVMI, g/m2 105 � 15 103 � 16 0.2233 94 � 8 95 � 9 0.1267
% EF 60 � 9 59 � 8 0.231 66 � 8 67 � 9 0.1267
RVOTplax, mm 29.9 � 5.4 29.8 � 4.8 0.8417 26.0 � 3.7 25.4 � 3.6 0.1072
RVOTplax, mm/m
2 16.7 � 2.1 16.8 � 3.7 0.7871 15.2 � 2.5 14.8 � 3.1 0.2041
RVOTpsax, mm 31.6 � 4.9 32.3 � 5.6 0.221 28.2 � 5.8 29.1 � 5.7 0.1266
RVOTpsax, mm/m
2 17.8 � 2.5 17.5 � 2.9 0.3106 16.0 � 2.1 16.1 � 2.5 0.6945
RVOT2, mm 25.8 � 4.8 25.1 � 4.4 0.1263 22.6 � 3.7 23.2 � 4.3 0.0537
RVD1, mm 41.1 � 6.6 40.6 � 5.8 0.4093 35.3 � 4.9 35.6 � 5.5 0.4534
RVD2, mm 34.1 � 6.4 33.3 � 5.5 0.165 28.2 � 4.5 28.7 � 5.7 0.2181
RVD3, mm 84.2 � 10.5 82.0 � 13.2 0.1008 73.5 � 11.4 74.9 � 11.1 0.093
RVWT, mm 4.8 � 1.5 4.6 � 1.3 0.1416 4.2 � 0.8 4.1 � 1.0 0.1613
TAPSE, mm 23.4 � 5.3 23.5 � 4.2 0.8219 22.8 � 4.7 22.9 � 4.5 0.768
PASP, mm Hg 17.6 � 7.7 15.9 � 6.5 0.0128 17.8 � 3.3 18.3 � 4.0 0.0816
TV E/A 1.9 � 0.5 2.0 � 0.4 0.0181 1.9 � 0.6 2.0 � 0.8 0.0771
TV S0, cm/s 14.8 � 2.6 14.9 � 2.5 0.6992 14.6 � 2.8 14.2 � 2.8 0.0556
TV E0, cm/s 13.9 � 3.4 14.1 � 3.1 0.5353 14.9 � 2.9 15.1 � 3.5 0.426
RAA, cm2 19.2 � 3.4 18.8 � 3.7 0.2915 15.2 � 2.8 15.1 � 4.8 0.7613
% RV FAC 38.7 � 4.9 39.6 � 4.8 0.0698 36.2 � 4.1 37.3 � 6.2 0.0108
CMRI
ATWI Athletes
(n ¼ 76)
ATWI Nonathletes
(n ¼ 174)
LVM-I, g/m2 105 � 15 94 � 9 <0.05
LVEDVI, ml/m2 105.8 � 15 94.3 � 14.0 <0.05
% RVEF 52.5 � 5.1 55.5 � 5.9 <0.05
RVEDVI, ml/m2 105.3 � 14.0 94.3 � 14.0 <0.05
% LGE 0 0 –
Values are mean � SD.
Ao ¼ aorta; ATWI ¼ anterior T-wave inversion; CMRI ¼ cardiac magnetic resonance imaging; EF ¼ ejection
fraction according to Simpson’s biplane; FAC ¼ fractional area change; LA ¼ left atrial; LGE ¼ late gadolinium
enhancement; LVEDD ¼ left ventricular end-diastolic diameter; LVEDV ¼ left ventricular end-diastolic volume;
LVEDVI ¼ left ventricular end-diastolic volume index; LVESD ¼ left ventricular end-systolic diameter; LVM-I ¼
left ventricular mass index; MLVWT ¼maximum left ventricular wall thickness; PASP ¼ pulmonary artery systolic
pressure; RAA ¼ right atrial area; RV ¼ right ventricular; RVD1 ¼ right ventricular basal dimension; RVD2 ¼ right
ventricular midventricular dimension; RVD3 ¼ right ventricular longitudinal dimension; RVEDV¼ right ventricular
end-diastolic volume; RVEDVI ¼ right ventricular end-diastolic volume index; RVEF ¼ right ventricular ejection
fraction; RVOT1 ¼ proximal right ventricular outflow tract dimension; RVOT2 ¼ distal right ventricular outflow
tract dimension; RVOTplax ¼ right ventricular outflow tract dimension (parasternal); RVOTsax ¼ right ventricular
outflow tract dimension (short axis); RVWT ¼ right ventricular free wall thickness; S0 ¼ peak systolic velocity;
TAPSE ¼ tricuspid annular plane systolic excursion; TV ¼ tricuspid valve; TV E0 ¼ tricuspid valve early myocardial
relaxation velocity.
J A C C V O L . 6 9 , N O . 1 , 2 0 1 7 Malhotra et al.
J A N U A R Y 3 / 1 0 , 2 0 1 7 : 1 – 9 ATWI in Young White Athletes and Nonathletes
7
Hélder Dores 69
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
66 
MANUSCRIPT 2 
 
 
 
 
recommendations are at odds with recommendations
from the European Society of Cardiology and the
recently published refined criteria (8,37). Given the
potentially sinister ramifications of false negative
tests with regard to ARVC in particular, more robust
data are necessary before such criteria can be adopted
with more certainly in future updates for ECG inter-
pretation in athletes. This comprehensive study of a
large population of athletes with ATWI provides
support for the Seattle consensus.
POTENTIAL MARKERS OF DISEASE IN INDIVIDUALS
WITH ATWI. In athletes with TWI beyond V1, infor-
mation from the preceding Jt or ST-segment may
provide valuable diagnostic information when
considering ARVC. Based on comparisons between 45
athletes with ATWI and 35 patients with ARVC, we
have previously reported that a Jt and ST-segment in
line with the onset of the QRS complex or a depressed
ST-segment preceding ATWI is a powerful discrimi-
nator between the 2 entities (29). Moreover, a recent
study examining ATWI as a marker of cardiomyopa-
thy in a small cohort of athletes of black and
white ethnicity showed that Jt elevation ($0.1 mV)
preceding the TWI excluded ARVC (34). Our large
study of almost 15,000 white individuals provides
validation for these concepts in males but reveals
that Jt may be in line with the onset of the QRS
complex in as many as 50% of healthy females with
ATWI. Importantly, only 1 athlete demonstrated
ATWI with preceding ST-segment depression and
none of the individuals with ATWI showed Jt
depression suggesting that the presence of such
electrical markers may be pointers for cardiac
pathology.
There remains the possibility that ATWI confined
to V1 to V2 may be a manifestation of ARVC. We have
examined our own cohort of 35 probands with ARVC
and identified ATWI in V1 to V2 alone in 6%. All of
these patients either expressed symptoms or other
electrical features diagnostic of ARVC (29).
STUDY LIMITATIONS. This study was cross-sectional
in nature, and although there were no adverse clin-
ical events in the ATWI group during a follow-up of
nearly 2 years, we cannot be certain whether ATWI
may precede the development of ARVC by several
years. Familial evaluation was not performed in any
of the individuals with ATWI because none fulfilled
overt criteria for a cardiomyopathy. However, we
concede that such practice may have highlighted
some individuals with incomplete expression of dis-
ease. A small proportion of ATWI individuals were
lost to follow-up due to logistical difficulties that
could not be overcome (e.g., emigration). CMRI is the
recognized gold standard for the investigation of
primary cardiomyopathies but was only performed in
250 (74%) individuals with ATWI. However, 81% of all
individuals with ATWI had all of ECG, echocardiog-
raphy, SAECG, Holter, and exercise stress test, which
are sufficient to diagnose ARVC according to modified
task force criteria (19). Voluntary cardiac screening
programs of nonathletes in the community conducted
through organizations such as CRY do have a poten-
tial for inherent selection bias though given the large
numbers included in this study of nearly 15,000 par-
ticipants, the potential of any such bias is signifi-
cantly mitigated.
CONCLUSIONS
ATWI is present in 2.3% of the young white popula-
tion and is more common in women and in athletes.
Almost 80% of ATWI is confined to leads V1 to V2 and
has a poor diagnostic yield for cardiac pathology,
implying that this ECG pattern could be considered a
normal phenomenon in asymptomatic individuals
without a family history of cardiomyopathy or pre-
mature SCD. In contrast, TWI extending beyond V2 is
present in only 1% of females and 0.2% in men and
may justify further evaluation in white individuals,
particularly when preceded by Jt depression or ST-
segment depression.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: ATWI
confined to leads V1 and V2 may be a normal variant or
physiological phenomenon in asymptomatic white
individuals without a family history of relevant heart
disease.
TRANSLATIONAL OUTLOOK: Further research is
needed to understand the clinical significance of TWI
beyond lead V2, which occurs in approximately 1 in
200 young, white athletes and in an unknown pro-
portion of nonathletes.
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recommendations are at odds with recommendations
from the European Society of Cardiology and the
recently published refined criteria (8,37). Given the
potentially sinister ramifications of false negative
tests with regard to ARVC in particular, more robust
data are necessary before such criteria can be adopted
with more certainly in future updates for ECG inter-
pretation in athletes. This comprehensive study of a
large population of athletes with ATWI provides
support for the Seattle consensus.
POTENTIAL MARKERS OF DISEASE IN INDIVIDUALS
WITH ATWI. In athletes with TWI beyond V1, infor-
mation from the preceding Jt or ST-segment may
provide valuable diagnostic information when
considering ARVC. Based on comparisons between 45
athletes with ATWI and 35 patients with ARVC, we
have previously reported that a Jt and ST-segment in
line with the onset of the QRS complex or a depressed
ST-segment preceding ATWI is a powerful discrimi-
nator between the 2 entities (29). Moreover, a recent
study examining ATWI as a marker of cardiomyopa-
thy in a small cohort of athletes of black and
white ethnicity showed that Jt elevation ($0.1 mV)
preceding the TWI excluded ARVC (34). Our large
study of almost 15,000 white individuals provides
validation for these concepts in males but reveals
that Jt may be in line with the onset of the QRS
complex in as many as 50% of healthy females with
ATWI. Importantly, only 1 athlete demonstrated
ATWI with preceding ST-segment depression and
none of the individuals with ATWI showed Jt
depression suggesting that the presence of such
electrical markers may be pointers for cardiac
pathology.
There remains the possibility that ATWI confined
to V1 to V2 may be a manifestation of ARVC. We have
examined our own cohort of 35 probands with ARVC
and identified ATWI in V1 to V2 alone in 6%. All of
these patients either expressed symptoms or other
electrical features diagnostic of ARVC (29).
STUDY LIMITATIONS. This study was cross-sectional
in nature, and although there were no adverse clin-
ical events in the ATWI group during a follow-up of
nearly 2 years, we cannot be certain whether ATWI
may precede the development of ARVC by several
years. Familial evaluation was not performed in any
of the individuals with ATWI because none fulfilled
overt criteria for a cardiomyopathy. However, we
concede that such practice may have highlighted
some individuals with incomplete expression of dis-
ease. A small proportion of ATWI individuals were
lost to follow-up due to logistical difficulties that
could not be overcome (e.g., emigration). CMRI is the
recognized gold standard for the investigation of
primary cardiomyopathies but was only performed in
250 (74%) individuals with ATWI. However, 81% of all
individuals with ATWI had all of ECG, echocardiog-
raphy, SAECG, Holter, and exercise stress test, which
are sufficient to diagnose ARVC according to modified
task force criteria (19). Voluntary cardiac screening
programs of nonathletes in the community conducted
through organizations such as CRY do have a poten-
tial for inherent selection bias though given the large
numbers included in this study of nearly 15,000 par-
ticipants, the potential of any such bias is signifi-
cantly mitigated.
CONCLUSIONS
ATWI is present in 2.3% of the young white popula-
tion and is more common in women and in athletes.
Almost 80% of ATWI is confined to leads V1 to V2 and
has a poor diagnostic yield for cardiac pathology,
implying that this ECG pattern could be considered a
normal phenomenon in asymptomatic individuals
without a family history of cardiomyopathy or pre-
mature SCD. In contrast, TWI extending beyond V2 is
present in only 1% of females and 0.2% in men and
may justify further evaluation in white individuals,
particularly when preceded by Jt depression or ST-
segment depression.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: ATWI
confined to leads V1 and V2 may be a normal variant or
physiological phenomenon in asymptomatic white
individuals without a family history of relevant heart
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TRANSLATIONAL OUTLOOK: Further research is
needed to understand the clinical significance of TWI
beyond lead V2, which occurs in approximately 1 in
200 young, white athletes and in an unknown pro-
portion of nonathletes.
Malhotra et al. J A C C V O L . 6 9 , N O . 1 , 2 0 1 7
ATWI in Young White Athletes and Nonathletes J A N U A R Y 3 / 1 0 , 2 0 1 7 : 1 – 9
8
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
67 
MANUSCRIPT 2 
 
 
 
 
  
RE F E RENCE S
1. Schnell F, Riding N, O’Hanlon R, et al.
Recognition and significance of pathological
T-wave inversions in athletes. Circulation 2015;
131:165–73.
2. Papadakis M, Basavarajaiah S, Rawlins J, et al.
Prevalence and significance of T-wave inversions
in predominantly Caucasian adolescent athletes.
Eur Heart J 2009;30:1728–35.
3. Migliore F, Zorzi A, Michieli P, et al. Prevalence
of cardiomyopathy in Italian asymptomatic chil-
dren with electrocardiographic T-wave inversion
at preparticipation screening. Circulation 2012;
125:529–38.
4. Sharma S, Whyte G, Elliott P, et al. Electrocar-
diographic changes in 1,000 highly trained junior
elite athletes. Br J Sports Med 1999;33:319–24.
5. Rawlins J, Carre F, Kervio G, et al. Ethnic dif-
ferences in physiological cardiac adaptation to
intense physical exercise in highly trained female
athletes. Circulation 2010;121:1078–85.
6. Sheikh N, Papadakis M, Carre F, et al. Cardiac
adaptation to exercise in adolescent athletes of
African ethnicity: an emergent elite athletic pop-
ulation. Br J Sports Med 2013;47:585–92.
7. Papadakis M, Carre F, Kervio G, et al. The
prevalence, distribution, and clinical outcomes of
electrocardiographic repolarization patterns in
male athletes of African/Afro-Caribbean origin.
Eur Heart J 2011;32:2304–13.
8. Corrado D, Pelliccia A, Heidbuchel H, et al.
Recommendations for interpretation of 12-lead
electrocardiogram in the athlete. Eur Heart J
2010;31:243–59.
9. Drezner J, Ackerman MJ, Anderson J, et al.
Electrocardiographic interpretation in athletes: the
“Seattle criteria.” Br J Sports Med 2013;47:122–4.
10. Pelliccia A, Culasso F, Di Paolo F, et al. Prev-
alence of abnormal electrocardiograms in a large,
unselected population undergoing pre-
participation cardiovascular screening. Eur Heart
J 2007;28:2006–10.
11. Uberoi A, Stein R, Perez M, et al. Interpretation
of the electrocardiogram of young athletes.
Circulation 2011;124:746–57.
12. Brosnan M, La Gerche A, Kalman J, et al.
Comparison of frequency of significant electro-
cardiographic abnormalities in endurance versus
nonendurance athletes. Am J Cardiol 2014;113:
1567–73.
13. Corrado D, Basso C, Rizzoli G, Schiavon M,
Thiene G. Does sports activity enhance the risk of
sudden death in adolescents and young adults?
J Am Coll Cardiol 2003;42:1959–63.
14. Zaidi A, Ghani S, Sharma R, et al. Physiological
right ventricular adaptation in elite athletes of
African and Afro-Caribbean origin. Circulation
2013;127:1783–92.
15. Mitchell JH, Haskell W, Snell P, Van Camp SP.
Task Force 8: classification of sports. J Am Coll
Cardiol 2005;45:1364–7.
16. Friedmann H. Diagnostic Electrocardiography
and Vectorcardiography. New York, NY: McGraw-
Hill, 1971.
17. Kligfield P, Gettes LS, Bailey JJ, et al. Recom-
mendations for the standardization and interpretation
of the electrocardiogram: part I: The electrocardio-
gram and its technology: a scientific statement from
the American Heart Association Electrocardiography
and Arrhythmias Committee, Council on Clinical Car-
diology. Circulation 2007;115:1306–24.
18. Surawicz B, Knilans TK. Right bundle
branch block. In: Andjelkovic N, editor. Chou’s
Electrocardiography in Clinical Practice. 6th ed.
Philadelphia, PA: Elsevier Saunders, 2008:95–107.
19. Marcus FI, McKenna WJ, Sherrill D, et al. Diag-
nosis of arrhythmogenic right ventricular cardio-
myopathy/dysplasia: proposed modification of the
task force criteria. Circulation 2010;121:1533–41.
20. Macfarlane PW, Antzelevitch C, HaissaguerreM,
et al. The early repolarization pattern: a consensus
paper. J Am Coll Cardiol 2015;66:470–7.
21. Lang RM, Bierig M, Devereux RB, et al. Rec-
ommendations for chamber quantification: a
report from the American Society of Echo-
cardiography’s Guidelines and Standards Commit-
tee and the Chamber Quantification Writing Group,
developed in conjunction with the European As-
sociation of Echocardiograph. J Am Soc Echo-
cardiogr 2005;18:1440–63.
22. Quiñones M, Otto CM, Stoddard M, et al. Recom-
mendations for quantification of Doppler echocardi-
ography:A report fromtheDopplerquantification task
forceof thenomenclatureandstandards committeeof
the American Society of Echocardiography. J Am Soc
Echocardiogr 2002;15:167–84.
23. Nagueh SF, Appleton CP, Gillebert TC, et al.
Recommendations for the evaluation of left ven-
tricular diastolic function by echocardiography.
J Am Soc Echocardiogr 2009;22:107–33.
24. Elliott PM, Anastasakis A, Borger M, et al. 2014
ESC Guidelines on diagnosis and management of
hypertrophic cardiomyopathy: the Task Force for
the Diagnosis and Management of Hypertrophic
Cardiomyopathy of the European Society of Cardi-
ology (ESC). Eur Heart J 2014;35:2733–79.
25. Gersh BJ, Maron BJ, Bonow RO, et al.
2011 ACCF/AHA guideline for the diagnosis and
treatment of hypertrophic cardiomyopathy: a
report of the American College of Cardiology
Foundation/American Heart Association Task
Force on Practice Guidelines. J Am Coll Cardiol
2011;58:e212–60.
26. Lang RM, Badano LP, Mor-Avi V, et al. Rec-
ommendations for cardiac chamber quantification
by echocardiography in adults: an update from the
American Society of Echocardiography and the
European Association of Cardiovascular Imaging.
J Am Soc Echocardiogr 2015;28:1–39.e14.
27. Bruce RA. Exercise testing of patients with
coronary heart disease. Principles and normal
standards for evaluation. Ann Clin Res 1971;3:
323–32.
28. Cain M, Anderson J, Arnsdorf M, et al. Signal-
averaged electrocardiography. ACC expert
consensus document. J Am Coll Cardiol 1996;27:
238–49.
29. Zaidi A, Sheikh N, Jongman JK, et al. Clinical
differentiation between physiological remodeling
and arrhythmogenic right ventricular cardiomy-
opathy in athletes with marked electrocardio-
graphic repolarization anomalies. J Am Coll Cardiol
2015;65:2702–11.
30. Grothues F, Moon JC, Bellenger N, Smith GS,
Klein HU, Pennell DJ. Interstudy reproducibility of
right ventricular volumes, function, and mass with
cardiovascular magnetic resonance. Am Heart J
2004;147:218–23.
31. Bauce B, Frigo G, Benini G, et al. Differences
and similarities between arrhythmogenic right
ventricular cardiomyopathy and athlete’s heart
adaptations. Br J Sports Med 2010;44:148–54.
32. Biffi A, Verdile L, Ansalone G, et al. Lack of
correlation between ventricular late potentials
and left ventricular mass in top-level male ath-
letes. Med Sci Sports Exerc 1999;31:359–61.
33. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ.
Physiologic left ventricular cavity dilatation in elite
athletes. Ann Intern Med 1999;130:23–31.
34. Calore C, Zorzi A, Sheikh N, et al. Electrocar-
diographic anterior T-wave inversion in athletes of
different ethnicities: differential diagnosis be-
tween athlete’s heart and cardiomyopathy. Eur
Heart J 2016;37:2515–27.
35. Suarez RM, Suarez RM Jr. The T-wave of the
precordial electrocardiogram at different age
levels. Am Hear J 1946;32:480–93.
36. Gottschalk C, Craige E. A comparison of the
precordial S-T and T waves in the electrocardio-
grams of 600 healthy young Negro and white
adults. South Med J 1956;49:453–7.
37. Sheikh N, Papadakis M, Ghani S, et al. Com-
parison of ECG criteria for the detection of cardiac
abnormalities in elite black and white athletes.
Circulation 2014;129:1637–49.
KEY WORDS anterior T-wave inversion,
arrhythmogenic right ventricular
cardiomyopathy, ECG screening, ethnicity
J A C C V O L . 6 9 , N O . 1 , 2 0 1 7 Malhotra et al.
J A N U A R Y 3 / 1 0 , 2 0 1 7 : 1 – 9 ATWI in Young White Athletes and Nonathletes
9
Hélder Dores 71
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
68 
  
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
69 
MANUSCRIPT 3 
 
 
  
Ann Noninvasive Electrocardiol. 2017;e12438. wileyonlinelibrary.com/journal/anec  | 1 of 1
https://doi.org/10.1111/anec.12438
© 2017 Wiley Periodicals, Inc.
Received:20October2016  |  Accepted:10January2017
DOI:10.1111/anec.12438
L E T T E R  T O  T H E  E D I T O R
ECG in athlete: “Normal or pathologic variant?”
DearEditor,
We read with interest the case reported by Noyes and Schulman
titled “Normal variant T- wave changes in an athlete with structurally 
­normal­cardiac­anatomy­and­function”(NoyesandSchulman2016).The
authorsdescribeachallengingcase,showingacommoncontroversy—
interpretation of athlete’s electrocardiogram (ECG). They described
a26-year-oldblackcompetitiveathletewithoccasionalepisodesof
very fast heartbeat unrelated to exertion, associatedwithmild diz-
ziness, andECGchanges (deepT-wave inversions in inferior-lateral
leads).Further investigationsdidnotdetectpathologyandtheECG
findingswereclassifiedasa“normalvariant.”
Wehavesomecommentsregardingthemanagementofthiscase.
Independentlyof thecriteriaused, theECG is clearlyabnormaland
althoughunremarkableresultsinimagingtests,wethinkthatitisabu-
sivetoclassifythesefindingsasa“normalvariant” (Papadakisetal.,
2011; Pelliccia etal., 2008). This expressionmaymislead the read-
ers, leading towrong interpretationswith potential adverse clinical
impact.Ascitedinthediscussion,abnormalECGsmayrepresentthe
initial expression of underlying cardiomyopathies, point that should
havebeendeeplydiscussed.Ifthesechangeswerea“normalvariant”
or an extreme expression of physiological adaptations, amore pro-
nounced structural remodelingwould be expected. In the brief de-
scriptionofechocardiogramandcardiacmagneticresonance,itseems
tonotoccur,butthedescriptionof“minimalincreaseinleftventricular
wall thicknesswith slightlygreater thickness in theapical region” is
intriguing(earlymanifestationofapicalhypertrophiccardiomyopathy,
commonly presented with similar ECGs?). Furthermore, the global
shapeandgeometryof the leftventricledonot suggest adaptation
toexercise.Otherfundamentalpointisthefactthattheathletewas
symptomatic. Although not exercise-related and unspecific, those
symptoms can be present in disorders as arrhythmias, and exercise
testingand24-hrHoltercouldhelptheinvestigation.Inthesecasesit
ismandatoryacloserfollow-up,butnodataweregivenhowtheECG
andimagingtestsbehaveinthefollowing3years.
Controversialcasesinsportscardiologyarecommonandsharing
experiencesaddvaluetoabestapproach.ThisECGpatternismark-
edly abnormal and suggestive of pathology until proven otherwise,
beingimportanttorememberthatimagingphenotypemayariselater
andobscureunderlying cardiomyopathy.On theotherhand ithave
been referredwarning symptoms and family history “thatwas con-
cerningforaninheritedcardiomyopathy.”Wemustbeverycautious
in assessing this type of ECG changes, because its classification as
“normalvariant”maybeawrongmessage.
HelderDoresMD1,2,3
AntónioFreitasMD4
1Cardiology, Hospital das Forças Armadas, Lisbon, Portugal
2Cardiology, Hospital da Luz, Lisbon, Portugal
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Abstract
Introduction: Athletes can exhibit abnormal electrocardiogram (ECG) phenotypes that require
further evaluation prior to competition. These are apparently more prevalent in high-intensity
endurance sports. The purpose of this study was to assess the association between ECG findings
in athletes and intensity of sport and level of competition.
Methods: A cohort of 3423 competitive athletes had their ECGs assessed according to the
Seattle criteria (SC). The presence of abnormal ECGs was correlated with: (1) intensity of
sport (low/moderate vs. at least one high static or dynamic component); (2) competitive level
(regional vs. national/international); (3) training volume (≤20 vs. >20 hours/week); (4) type of
sport (high dynamic vs. high static component). The same endpoints were studied according to
the ‘Refined Criteria’ (RC).
Results: Abnormal ECGs according to the SC were present in 225 (6.6%) athletes, more fre-
quently in those involved in high-intensity sports (8.0% vs. 5.4%; p=0.002), particularly in
dynamic sports, and competing at national/international level (7.1% vs. 4.9%; p=0.028). Training
volume was not significantly associated with abnormal ECGs. By multivariate analysis, high-
intensity sport (OR 1.55, 1.18-2.03; p=0.002) and national/international level (OR 1.50, 95%
CI 1.04-2.14; p=0.027) were independent predictors of abnormal ECGs, and these variables,
when combined, doubled the prevalence of this finding. According to the RC, abnormal ECGs
decreased to 103 (3.0%), but were also more frequent in high-intensity sports (4.2% vs. 2.0%;
p<0.001).
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Conclusions: There is a positive correlation between higher intensity of sports and increased
prevalence of ECG abnormalities. This relationship persists with the use of more restrictive
criteria for ECG interpretation, although the number of abnormal ECGs is lower.
© 2016 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan˜a, S.L.U. All rights
reserved.
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Alterac¸ões eletrocardiográficas em atletas: correlac¸ão com a intensidade de desporto
e o nível de competic¸ão
Resumo
Introduc¸ão: O eletrocardiograma (ECG) do atleta pode apresentar alterac¸ões que requerem
avaliac¸ões adicionais, aparentemente mais frequentes nos desportos de endurance. O objetivo
deste trabalho foi avaliar a associac¸ão entre a presenc¸a de alterac¸ões no ECG do atleta com a
intensidade de desporto e nível competitivo.
Métodos: Uma coorte de 3423 atletas de nível competitivo realizaram ECG que foi interpre-
tado pelos critérios de Seattle (CS). A presenc¸a de alterac¸ões anormais foi correlacionada com:
1) intensidade de desporto (baixo/moderado versus pelo menos um componente elevado,
estático ou dinâmico); 2) nível competitivo (regional versus nacional/internacional); 3) volu-
me de treino (≤20 versus >20 horas/semana); 4) tipo de desporto (elevados componentes
dinâmico versus estático). Os mesmos endpoints foram estudados pelos Refined Criteria (RC).
Resultados: De acordo com os SC, 225 (6,6%) atletas tinham alterac¸ões patológicas, mais
frequentes nos envolvidos em desportos de elevada intensidade (8,0 versus 5,4%; p=0,002),
sobretudo dinâmica, e em nível nacional/internacional (7,1 versus 4,9%; p=0,028). O volume
de treino não esteve significativamente associado a estas alterac¸ões. Em análise multi-
variada, desporto de elevada intensidade (OR 1,55, IC 95% 1,18-2,03; p=0,002) e o nível
nacional/internacional (OR 1,50, IC 95% 1,04-2,14; p=0,027) foram preditores independentes
de ECG anormais, variáveis que combinadas duplicaram a prevalência. Com os RC o número de
ECG patológicos decresceu para 103 (3,0%), também mais frequentes nos desportos de elevada
intensidade (4,2 versus 2,0%; p<0,001).
Conclusões: Verificou-se uma correlac¸ão positiva entre desporto de elevada intensidade e nível
competitivo com alterac¸ões ECG consideradas patológicas. Apesar do menor número destas
alterac¸ões, esta relac¸ão persiste com o uso de critérios mais restritivos na sua interpretac¸ão.
© 2016 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier Espan˜a, S.L.U. Todos os
direitos reservados.
Introduction
Repeated exercise training induces various cardiovascular
adaptations that can manifest as changes in the resting
12-lead electrocardiogram (ECG). These changes can be
classified as pathological in non-athletic individuals but
considered physiological and training-related in athletes.1
However, evaluation of the athlete’s ECG is challenging
because various physiological adaptations can overlap with
conditions associated with an increased risk of sudden car-
diac death.
The prevalence, pattern and degree of ECG changes are
not uniform among athletes and are dependent on various
factors including age,2,3 gender4--6 and ethnicity.7,8 Although
a higher prevalence of marked ECG changes has been
reported in athletes engaged in high-intensity endurance
sports, the association between the type of sport and the
occurrence of abnormal ECG findings in athletes is not well
established. The majority of existing studies reporting ECG
changes according to the type of sport were performed in
small populations, mainly covering endurance disciplines,
and did not include sports characterized by different loading
conditions.2,9,10
The conventional dual division between endurance/
dynamic and static/strength sports seems rather simplistic.
Many sporting disciplines combine elements of both types
of exercise, and it can therefore be difficult to establish
which is predominant. Additionally, factors such as duration
of training and emotional stress related to competition are
not taken into consideration.11
The purpose of the study was to assess the association
between intensity of sport and level of competition with
the presence of abnormal ECG findings in athletes.
Methods
Athletes
Between September 2006 and July 2012, 15 175 young indi-
viduals (aged between 14 and 35 years) underwent cardiac
evaluation in the UK, as part of a pre-participation screening
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program established by the charitable organization Cardiac
Risk in the Young. For the purpose of this study selected
athletes were defined as individuals involved in regular
competition (regional, national or international) and train-
ing more than four hours per week. The final population
comprised 3423 athletes. Cardiac evaluation consisted of a
self-report health questionnaire, physical examination and
a 12-lead ECG. On an individual basis, when indicated for
clinical reasons, ECG abnormalities or research, transtho-
racic echocardiography was also performed. All the athletes
included in this analysis were asymptomatic and normoten-
sive at rest (<140/90 mmHg). Ethnicity, number of hours of
exercise-training/week and level of competition were self-
assigned.
12-lead electrocardiogram
A 12-lead ECG was performed using GE® Marquette Hellige
(Milwaukee, WI, USA) or Philips® Pagewriter Trim III (Both-
ell, WA, USA) electrocardiographs, with a paper speed of
25 mm/s and amplification of 0.1 mV/mm, as previously
described.12 Heart rate and QRS axis were calculated; inter-
vals, durations, and voltages were measured in each lead.
The ECGs were analyzed by the cardiologist responsible for
each screening session and later read independently by two
cardiologists, highly experienced in sports cardiology, car-
diomyopathies and primary electrical cardiac diseases. All
ECGs were interpreted and categorized as normal (without
changes or with training-related changes) or abnormal (with
changes that justified additional investigations for exclusion
of cardiac pathology) in accordance with the Seattle criteria
(SC) and the Refined Criteria (RC).13--16
Transthoracic echocardiogram
Transthoracic echocardiography was performed by a car-
diologist or a senior cardiac physiologist, using a Philips®
Sonos 7500, Philips® iE33, or Philips® CPX50 (Bothell, WA,
USA) and Acuson Computed Sono-graph® 128XP/10c (San
Jose, CA, USA). Standard views and chamber measurements
were performed as previously suggested.17 Left ventricu-
lar wall thickness was measured in two-dimensional (2D)
parasternal short axis, at the level of the mitral valve and
papillary muscles, and right ventricular dimensions were
measured in apical 4-chamber view and right ventricular
outflow in parasternal short-axis view at the aortic valve
level. Color tissue Doppler and 2D continuous and pulsed
Doppler were performed using standard parasternal and api-
cal views. Assessment of diastolic function included pulsed
Doppler across the mitral valve and tissue Doppler velocity
imaging of the septal and lateral mitral valve annulus and
free wall tricuspid valve annulus. An experienced cardiac
physiologist independently repeated all cardiac measure-
ments.
Classification of sports
The sporting disciplines of all the athletes included in the
study were categorized according to the classification pro-
posed by Mitchel et al. in the 36th Bethesda Conference
guidelines.11 This classification is based on the peak of static
and dynamic components achieved during exercise, eval-
uated by maximal oxygen uptake and maximal voluntary
contraction.
The volume of training was analyzed according to the
number of hours performed per week and the competitive
level was stratified according to the nature of the competi-
tion -- regional, national or international.
The following categories were formulated, according to
which the distribution of abnormal ECG changes was ana-
lyzed:
• Intensity of sport: low/moderate vs. at least one high
static or dynamic component (categories III and/or C of
the Mitchell et al. classification)11
• Competitive level: regional vs. national/international
• Training volume: ≤20 vs. >20 hours/week
• Type of sport: high static vs. high dynamic component.
Ethical approval and consent
Written consent was obtained from individuals aged 16 years
or over and from a parent for those aged less than 16 years.
The National Research Ethics Service, Essex 2 Research
Ethics Committee, granted ethical approval in the UK.
Statistical analysis
Continuous variables with normal distribution were
expressed as means and standard deviations. Normality
was tested with the Kolmogorov-Smirnov test. Categorical
variables were expressed as frequencies and percentages.
Statistical comparison of baseline characteristics was
performed using the chi-square test or Fisher’s exact
test, when appropriate, and the Student’s t test or the
Mann-Whitney test for continuous variables. To identify
independent predictors of abnormal SC, multivariate
analysis using a binary logistic regression model (enter
method) was performed. Two-tailed tests of significance
are reported. For all comparisons, a p value of <0.05 was
considered statistically significant. When appropriate, 95%
confidence intervals (CI) were calculated. The statistical
analysis was performed with SPSS version 21.0 (SPSS® Inc.,
Chicago, IL, USA).
Results
Baseline characteristics
Of the 3423 athletes included in the final analysis, mean
age was 20.1±5.0 years, 2468 (72.1%) were male and the
majority were Caucasian (90.1%). Athletes were engaged in
43 sporting disciplines, with rugby (35.0%), football (9.7%),
swimming (6.3%) and rowing/canoeing (4.6%) being the
most popular sports. Almost half of the overall population
(46.3%) were engaged in sports with a high static and/or
high dynamic component (category III and/or C). Regarding
the competitive level, 795 (23.2%) athletes were involved
in regional, 1277 (37.3%) in national and 1352 (39.5%) in
international competitions. The mean number of training
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Conclusions: There is a positive correlation between higher intensity of sports and increased
prevalence of ECG abnormalities. This relationship persists with the use of more restrictive
criteria for ECG interpretation, although the number of abnormal ECGs is lower.
© 2016 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan˜a, S.L.U. All rights
reserved.
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Alterac¸ões eletrocardiográficas em atletas: correlac¸ão com a intensidade de desporto
e o nível de competic¸ão
Resumo
Introduc¸ão: O eletrocardiograma (ECG) do atleta pode apresentar alterac¸ões que requerem
avaliac¸ões adicionais, aparentemente mais frequentes nos desportos de endurance. O objetivo
deste trabalho foi avaliar a associac¸ão entre a presenc¸a de alterac¸ões no ECG do atleta com a
intensidade de desporto e nível competitivo.
Métodos: Uma coorte de 3423 atletas de nível competitivo realizaram ECG que foi interpre-
tado pelos critérios de Seattle (CS). A presenc¸a de alterac¸ões anormais foi correlacionada com:
1) intensidade de desporto (baixo/moderado versus pelo menos um componente elevado,
estático ou dinâmico); 2) nível competitivo (regional versus nacional/internacional); 3) volu-
me de treino (≤20 versus >20 horas/semana); 4) tipo de desporto (elevados componentes
dinâmico versus estático). Os mesmos endpoints foram estudados pelos Refined Criteria (RC).
Resultados: De acordo com os SC, 225 (6,6%) atletas tinham alterac¸ões patológicas, mais
frequentes nos envolvidos em desportos de elevada intensidade (8,0 versus 5,4%; p=0,002),
sobretudo dinâmica, e em nível nacional/internacional (7,1 versus 4,9%; p=0,028). O volume
de treino não esteve significativamente associado a estas alterac¸ões. Em análise multi-
variada, desporto de elevada intensidade (OR 1,55, IC 95% 1,18-2,03; p=0,002) e o nível
nacional/internacional (OR 1,50, IC 95% 1,04-2,14; p=0,027) foram preditores independentes
de ECG anormais, variáveis que combinadas duplicaram a prevalência. Com os RC o número de
ECG patológicos decresceu para 103 (3,0%), também mais frequentes nos desportos de elevada
intensidade (4,2 versus 2,0%; p<0,001).
Conclusões: Verificou-se uma correlac¸ão positiva entre desporto de elevada intensidade e nível
competitivo com alterac¸ões ECG consideradas patológicas. Apesar do menor número destas
alterac¸ões, esta relac¸ão persiste com o uso de critérios mais restritivos na sua interpretac¸ão.
© 2016 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier Espan˜a, S.L.U. Todos os
direitos reservados.
Introduction
Repeated exercise training induces various cardiovascular
adaptations that can manifest as changes in the resting
12-lead electrocardiogram (ECG). These changes can be
classified as pathological in non-athletic individuals but
considered physiological and training-related in athletes.1
However, evaluation of the athlete’s ECG is challenging
because various physiological adaptations can overlap with
conditions associated with an increased risk of sudden car-
diac death.
The prevalence, pattern and degree of ECG changes are
not uniform among athletes and are dependent on various
factors including age,2,3 gender4--6 and ethnicity.7,8 Although
a higher prevalence of marked ECG changes has been
reported in athletes engaged in high-intensity endurance
sports, the association between the type of sport and the
occurrence of abnormal ECG findings in athletes is not well
established. The majority of existing studies reporting ECG
changes according to the type of sport were performed in
small populations, mainly covering endurance disciplines,
and did not include sports characterized by different loading
conditions.2,9,10
The conventional dual division between endurance/
dynamic and static/strength sports seems rather simplistic.
Many sporting disciplines combine elements of both types
of exercise, and it can therefore be difficult to establish
which is predominant. Additionally, factors such as duration
of training and emotional stress related to competition are
not taken into consideration.11
The purpose of the study was to assess the association
between intensity of sport and level of competition with
the presence of abnormal ECG findings in athletes.
Methods
Athletes
Between September 2006 and July 2012, 15 175 young indi-
viduals (aged between 14 and 35 years) underwent cardiac
evaluation in the UK, as part of a pre-participation screening
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program established by the charitable organization Cardiac
Risk in the Young. For the purpose of this study selected
athletes were defined as individuals involved in regular
competition (regional, national or international) and train-
ing more than four hours per week. The final population
comprised 3423 athletes. Cardiac evaluation consisted of a
self-report health questionnaire, physical examination and
a 12-lead ECG. On an individual basis, when indicated for
clinical reasons, ECG abnormalities or research, transtho-
racic echocardiography was also performed. All the athletes
included in this analysis were asymptomatic and normoten-
sive at rest (<140/90 mmHg). Ethnicity, number of hours of
exercise-training/week and level of competition were self-
assigned.
12-lead electrocardiogram
A 12-lead ECG was performed using GE® Marquette Hellige
(Milwaukee, WI, USA) or Philips® Pagewriter Trim III (Both-
ell, WA, USA) electrocardiographs, with a paper speed of
25 mm/s and amplification of 0.1 mV/mm, as previously
described.12 Heart rate and QRS axis were calculated; inter-
vals, durations, and voltages were measured in each lead.
The ECGs were analyzed by the cardiologist responsible for
each screening session and later read independently by two
cardiologists, highly experienced in sports cardiology, car-
diomyopathies and primary electrical cardiac diseases. All
ECGs were interpreted and categorized as normal (without
changes or with training-related changes) or abnormal (with
changes that justified additional investigations for exclusion
of cardiac pathology) in accordance with the Seattle criteria
(SC) and the Refined Criteria (RC).13--16
Transthoracic echocardiogram
Transthoracic echocardiography was performed by a car-
diologist or a senior cardiac physiologist, using a Philips®
Sonos 7500, Philips® iE33, or Philips® CPX50 (Bothell, WA,
USA) and Acuson Computed Sono-graph® 128XP/10c (San
Jose, CA, USA). Standard views and chamber measurements
were performed as previously suggested.17 Left ventricu-
lar wall thickness was measured in two-dimensional (2D)
parasternal short axis, at the level of the mitral valve and
papillary muscles, and right ventricular dimensions were
measured in apical 4-chamber view and right ventricular
outflow in parasternal short-axis view at the aortic valve
level. Color tissue Doppler and 2D continuous and pulsed
Doppler were performed using standard parasternal and api-
cal views. Assessment of diastolic function included pulsed
Doppler across the mitral valve and tissue Doppler velocity
imaging of the septal and lateral mitral valve annulus and
free wall tricuspid valve annulus. An experienced cardiac
physiologist independently repeated all cardiac measure-
ments.
Classification of sports
The sporting disciplines of all the athletes included in the
study were categorized according to the classification pro-
posed by Mitchel et al. in the 36th Bethesda Conference
guidelines.11 This classification is based on the peak of static
and dynamic components achieved during exercise, eval-
uated by maximal oxygen uptake and maximal voluntary
contraction.
The volume of training was analyzed according to the
number of hours performed per week and the competitive
level was stratified according to the nature of the competi-
tion -- regional, national or international.
The following categories were formulated, according to
which the distribution of abnormal ECG changes was ana-
lyzed:
• Intensity of sport: low/moderate vs. at least one high
static or dynamic component (categories III and/or C of
the Mitchell et al. classification)11
• Competitive level: regional vs. national/international
• Training volume: ≤20 vs. >20 hours/week
• Type of sport: high static vs. high dynamic component.
Ethical approval and consent
Written consent was obtained from individuals aged 16 years
or over and from a parent for those aged less than 16 years.
The National Research Ethics Service, Essex 2 Research
Ethics Committee, granted ethical approval in the UK.
Statistical analysis
Continuous variables with normal distribution were
expressed as means and standard deviations. Normality
was tested with the Kolmogorov-Smirnov test. Categorical
variables were expressed as frequencies and percentages.
Statistical comparison of baseline characteristics was
performed using the chi-square test or Fisher’s exact
test, when appropriate, and the Student’s t test or the
Mann-Whitney test for continuous variables. To identify
independent predictors of abnormal SC, multivariate
analysis using a binary logistic regression model (enter
method) was performed. Two-tailed tests of significance
are reported. For all comparisons, a p value of <0.05 was
considered statistically significant. When appropriate, 95%
confidence intervals (CI) were calculated. The statistical
analysis was performed with SPSS version 21.0 (SPSS® Inc.,
Chicago, IL, USA).
Results
Baseline characteristics
Of the 3423 athletes included in the final analysis, mean
age was 20.1±5.0 years, 2468 (72.1%) were male and the
majority were Caucasian (90.1%). Athletes were engaged in
43 sporting disciplines, with rugby (35.0%), football (9.7%),
swimming (6.3%) and rowing/canoeing (4.6%) being the
most popular sports. Almost half of the overall population
(46.3%) were engaged in sports with a high static and/or
high dynamic component (category III and/or C). Regarding
the competitive level, 795 (23.2%) athletes were involved
in regional, 1277 (37.3%) in national and 1352 (39.5%) in
international competitions. The mean number of training
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Table 1 Abnormal electrocardiographic changes.
Characteristics n (%)
Left atrial enlargement 76 (2.1)
Left axis deviation 47 (1.4)
T-wave inversion (excluding aVR, III and V1) 42 (1.2)
Wolff-Parkinson-White pattern 28 (0.01)
Right axis deviation 23 (0.01)
Long QT interval 13 (<0.01)
ST-segment depression 3 (<0.01)
Complete left bundle branch block 1 (<0.01)
Intraventricular conduction delay (QRS >140
ms)
1 (<0.01)
Pathological Q waves 1 (<0.01)
Brugada type 2 pattern 1 (<0.01)
hours/week was 16.2±7.7 (5-50 hours), with 714 (20.9%) of
athletes training for >20 hours/week.
Electrocardiographic findings
Based on the SC, approximately 80% of the overall
population (n=2731) had alterations in the 12-lead
ECG: normal/training-related in 2482 (72.5%) and
abnormal/training-unrelated in 225 (6.6%) athletes.
Among the abnormal ECG changes, the most prevalent
were left atrial enlargement in 76 athletes (2.1%), left axis
deviation in 47 (1.4%), T-wave inversions in 42 (1.2%) and
Wolff-Parkinson White pattern in 28 (0.01) (Table 1). These
abnormal ECG findings were more frequent in athletes
involved in high-intensity sports (8.0% vs. 5.4%; p=0.002)
(Figure 1A). Athletes with abnormal SC were more likely to
be of Black/Caribbean descendent (8.0% vs. 5.0%; p=0.047)
and to compete at national/international level (82.7% vs.
76.3%; p=0.028) in sports with a high static or dynamic
component (56.0% vs. 45.6%; p=0.002). Athletes involved
in disciplines with predominantly high dynamic intensity
(classes C--I/II) had a higher rate of abnormal ECG changes
(9.1% vs. 5.5%; p<0.001), but there was no significant
difference in sports with high static intensity (III-A/B) (4.5%
vs. 6.7%; p=0.153). Comparing only athletes involved in
disciplines with isolated high dynamic intensity (classes
C-I/II) with those in high static intensity (classes III-A/B),
the former had a higher rate of abnormal ECG changes
(9.1% vs. 4.5%; p=0.014). Exercising >20 hours/week was
not significantly associated with the presence of abnormal
ECG changes (Table 2).
By multivariate analysis, national/international level
(odds ratio [OR] 1.50, 95% confidence interval [CI] 1.04-
2.14; p=0.027) and high-intensity sport (OR 1.55, 1.18-2.03;
p=0.002) were independent predictors of abnormal ECG
changes, with a trend for Black/Caribbean ethnicity (OR
1.58, 95% CI 0.95-2.62; p=0.078) (Table 3). The combination
of the two independent variables revealed a significan-
tly higher frequency of abnormal ECG findings in athletes
competing in high-intensity sports at national/international
level (8.7% vs. 5.5%; p<0.001) (Figure 2A).
Interpretation of ECGs with the RC led to a decrease
of more than half in the number of abnormal/training-
unrelated ECG changes, to 103 (3.0%) athletes, including
among those involved in high-intensity sports (4.2% vs. 2.0%;
p<0.001) (Figure 1B). These athletes with abnormal RC were
Table 2 Prevalence of baseline characteristics according to the presence or absence of abnormal Seattle criteria.13--15
Variables n (%) Overall population With abnormal SC Without abnormal SC p*
Demographic
Age (mean ± D) 20.1±5.0 19.8±5.0 20.1±5.0 0.316
Male 2468 (72.1) 156 (69.3) 2312 (72.3) 0.338
Caucasian 3085 (90.1) 197 (87.6) 2888 (90.3) 0.181
Black/Caribbean 177 (5.2) 18 (8.0) 159 (5.0) 0.047
Asian 43 (1.3) 4 (1.8) 39 (1.2) 0.467
Other ethnicity 118 (3.4) 6 (2.7) 112 (3.5) 0.507
Competitive level and training volume
National/international 2625 (76.7) 186 (82.7) 2439 (76.3) 0.028
No. hours/week (mean ± D) 16.2±7.7 16.0±7.2 17.7±7.7 0.734
>20 hours/week 714 (20.9) 48 (21.3) 666 (20.8) 0.856
Intensity of sports (Mitchell classification)11
Class A 540 (15.8) 36 (16.0) 504 (15.8) 0.924
Class B 1566 (45.7) 75 (33.3) 1491 (46.6) <0.001
Class C 1317 (38.5) 114 (50.7) 1203 (37.6) <0.001
Class I 933 (27.3) 67 (29.2%) 866 (27.1) 0.380
Class II 1938 (56.6) 126 (56.0) 1813 (56.7) 0.840
Class III 552 (16.1) 32 (14.2) 520 (16.3) 0.422
High intensity (at least one of III/C) 1584 (46.3) 126 (56.0) 1458 (45.6) 0.002
Greater dynamic intensity (C-I/II) 1033 (30.2) 94 (41.8) 939 (29.4) <0.001
Greater static intensity (III-A/B) 267 (7.8) 12 (5.3) 255 (8.0) 0.153
D: deviation; SC: Seattle criteria.
* p value for comparisons: athletes with abnormal SC vs. athletes without abnormal SC.
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Figure 1 Distribution of abnormal (training-unrelated) ECG findings (A: Seattle criteria; B: Refined Criteria) according to intensity
of sport -- low-moderate vs. high (categories III and/or C). Max O2: maximal oxygen uptake; MVC: maximal voluntary contraction.
Adapted from Mitchell et al.11
Table 3 Independent predictors of abnormal changes
according to the Seattle criteria by multivariate analysis
(binary logistic regression).
Variables OR 95% CI p
Black/Caribbean ethnicity 1.58 0.95-2.63 0.078
National/international level 1.50 1.04-2.14 0.027
High-intensity sports 1.55 1.18-2.03 0.002
CI: confidence interval; OR: odds ratio.
more likely to be female (47.6% vs. 27.3%; <0.001) and to
be involved in disciplines with predominantly high dynamic
intensity (classes C-I/II) (4.7% vs. 2.3%; p<0.001), but there
was no significant difference in disciplines with predomi-
nantly high static intensity (III-A/B) (2.6% vs. 3.0%; p=0.700).
Comparing only athletes involved in disciplines with isolated
high dynamic intensity (classes C-I/II) with those in high
static intensity (classes III-A/B), there was no significant dif-
ference in prevalence of abnormal ECG changes (4.7% vs.
2.6%; p=0.127). Competing at national/international level
(82.5% vs. 76.6%; p=0.161) and training >20 hours/week
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Table 1 Abnormal electrocardiographic changes.
Characteristics n (%)
Left atrial enlargement 76 (2.1)
Left axis deviation 47 (1.4)
T-wave inversion (excluding aVR, III and V1) 42 (1.2)
Wolff-Parkinson-White pattern 28 (0.01)
Right axis deviation 23 (0.01)
Long QT interval 13 (<0.01)
ST-segment depression 3 (<0.01)
Complete left bundle branch block 1 (<0.01)
Intraventricular conduction delay (QRS >140
ms)
1 (<0.01)
Pathological Q waves 1 (<0.01)
Brugada type 2 pattern 1 (<0.01)
hours/week was 16.2±7.7 (5-50 hours), with 714 (20.9%) of
athletes training for >20 hours/week.
Electrocardiographic findings
Based on the SC, approximately 80% of the overall
population (n=2731) had alterations in the 12-lead
ECG: normal/training-related in 2482 (72.5%) and
abnormal/training-unrelated in 225 (6.6%) athletes.
Among the abnormal ECG changes, the most prevalent
were left atrial enlargement in 76 athletes (2.1%), left axis
deviation in 47 (1.4%), T-wave inversions in 42 (1.2%) and
Wolff-Parkinson White pattern in 28 (0.01) (Table 1). These
abnormal ECG findings were more frequent in athletes
involved in high-intensity sports (8.0% vs. 5.4%; p=0.002)
(Figure 1A). Athletes with abnormal SC were more likely to
be of Black/Caribbean descendent (8.0% vs. 5.0%; p=0.047)
and to compete at national/international level (82.7% vs.
76.3%; p=0.028) in sports with a high static or dynamic
component (56.0% vs. 45.6%; p=0.002). Athletes involved
in disciplines with predominantly high dynamic intensity
(classes C--I/II) had a higher rate of abnormal ECG changes
(9.1% vs. 5.5%; p<0.001), but there was no significant
difference in sports with high static intensity (III-A/B) (4.5%
vs. 6.7%; p=0.153). Comparing only athletes involved in
disciplines with isolated high dynamic intensity (classes
C-I/II) with those in high static intensity (classes III-A/B),
the former had a higher rate of abnormal ECG changes
(9.1% vs. 4.5%; p=0.014). Exercising >20 hours/week was
not significantly associated with the presence of abnormal
ECG changes (Table 2).
By multivariate analysis, national/international level
(odds ratio [OR] 1.50, 95% confidence interval [CI] 1.04-
2.14; p=0.027) and high-intensity sport (OR 1.55, 1.18-2.03;
p=0.002) were independent predictors of abnormal ECG
changes, with a trend for Black/Caribbean ethnicity (OR
1.58, 95% CI 0.95-2.62; p=0.078) (Table 3). The combination
of the two independent variables revealed a significan-
tly higher frequency of abnormal ECG findings in athletes
competing in high-intensity sports at national/international
level (8.7% vs. 5.5%; p<0.001) (Figure 2A).
Interpretation of ECGs with the RC led to a decrease
of more than half in the number of abnormal/training-
unrelated ECG changes, to 103 (3.0%) athletes, including
among those involved in high-intensity sports (4.2% vs. 2.0%;
p<0.001) (Figure 1B). These athletes with abnormal RC were
Table 2 Prevalence of baseline characteristics according to the presence or absence of abnormal Seattle criteria.13--15
Variables n (%) Overall population With abnormal SC Without abnormal SC p*
Demographic
Age (mean ± D) 20.1±5.0 19.8±5.0 20.1±5.0 0.316
Male 2468 (72.1) 156 (69.3) 2312 (72.3) 0.338
Caucasian 3085 (90.1) 197 (87.6) 2888 (90.3) 0.181
Black/Caribbean 177 (5.2) 18 (8.0) 159 (5.0) 0.047
Asian 43 (1.3) 4 (1.8) 39 (1.2) 0.467
Other ethnicity 118 (3.4) 6 (2.7) 112 (3.5) 0.507
Competitive level and training volume
National/international 2625 (76.7) 186 (82.7) 2439 (76.3) 0.028
No. hours/week (mean ± D) 16.2±7.7 16.0±7.2 17.7±7.7 0.734
>20 hours/week 714 (20.9) 48 (21.3) 666 (20.8) 0.856
Intensity of sports (Mitchell classification)11
Class A 540 (15.8) 36 (16.0) 504 (15.8) 0.924
Class B 1566 (45.7) 75 (33.3) 1491 (46.6) <0.001
Class C 1317 (38.5) 114 (50.7) 1203 (37.6) <0.001
Class I 933 (27.3) 67 (29.2%) 866 (27.1) 0.380
Class II 1938 (56.6) 126 (56.0) 1813 (56.7) 0.840
Class III 552 (16.1) 32 (14.2) 520 (16.3) 0.422
High intensity (at least one of III/C) 1584 (46.3) 126 (56.0) 1458 (45.6) 0.002
Greater dynamic intensity (C-I/II) 1033 (30.2) 94 (41.8) 939 (29.4) <0.001
Greater static intensity (III-A/B) 267 (7.8) 12 (5.3) 255 (8.0) 0.153
D: deviation; SC: Seattle criteria.
* p value for comparisons: athletes with abnormal SC vs. athletes without abnormal SC.
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Figure 1 Distribution of abnormal (training-unrelated) ECG findings (A: Seattle criteria; B: Refined Criteria) according to intensity
of sport -- low-moderate vs. high (categories III and/or C). Max O2: maximal oxygen uptake; MVC: maximal voluntary contraction.
Adapted from Mitchell et al.11
Table 3 Independent predictors of abnormal changes
according to the Seattle criteria by multivariate analysis
(binary logistic regression).
Variables OR 95% CI p
Black/Caribbean ethnicity 1.58 0.95-2.63 0.078
National/international level 1.50 1.04-2.14 0.027
High-intensity sports 1.55 1.18-2.03 0.002
CI: confidence interval; OR: odds ratio.
more likely to be female (47.6% vs. 27.3%; <0.001) and to
be involved in disciplines with predominantly high dynamic
intensity (classes C-I/II) (4.7% vs. 2.3%; p<0.001), but there
was no significant difference in disciplines with predomi-
nantly high static intensity (III-A/B) (2.6% vs. 3.0%; p=0.700).
Comparing only athletes involved in disciplines with isolated
high dynamic intensity (classes C-I/II) with those in high
static intensity (classes III-A/B), there was no significant dif-
ference in prevalence of abnormal ECG changes (4.7% vs.
2.6%; p=0.127). Competing at national/international level
(82.5% vs. 76.6%; p=0.161) and training >20 hours/week
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Figure 2 Distribution of abnormal ECG changes (A: Seattle
criteria; B: Refined Criteria) according to the combination of
type/intensity of sport and competitive level. Int.: interna-
tional; Nat.: national.
(19.4% vs. 20.9%; p=0.715) were not significantly associated
with abnormal RC. However, the combination of intensity of
sport and competitive level revealed significant abnormal
ECG changes in athletes involved in high-intensity sports
at national/international level (4.7% vs. 2.1%; p<0.001)
(Figure 2B).
Transthoracic echocardiography
Of the overall population, 1345 (39.3%) athletes under-
went transthoracic echocardiography. Structural findings
were interpreted as abnormal in 26 (0.8%) athletes. The
echocardiographic findings classified as abnormal were aor-
tic bicuspid valve (n=7), isolated right ventricular changes
(e.g. hypertrabeculation) (n=5), mitral valve prolapse (n=4),
anomalous coronary origin (n=2), dilated aortic root (n=2),
left ventricular hypertrophy with interventricular septum
≥15 mm (n=1), large patent foramen ovale (n=1), tricus-
pid valve prolapse (n=1), pulmonary valve stenosis (n=1),
atrial septal defect (n=1) and cor triatriatum (n=1). These
structural alterations were more frequent in athletes with
both abnormal SC (2.7% vs. 0.6%; p=0.010) and abnormal RC
(3.9% vs. 0.7%; p<0.001). A higher frequency of echocardio-
graphic changes classified as abnormal was also evident in
athletes engaged in high-intensity sports and competing at
national/international level (1.3% vs. 0.5%; p=0.012).
Discussion
In the large cohort of competitive athletes under analysis,
the rate of abnormal ECG changes suggestive of cardiovascu-
lar abnormalities decreased with the use of more restrictive
criteria. Independently of the criteria used (SC or RC), ECG
abnormalities were more common among athletes involved
in sports characterized by a high dynamic and/or static
component, mainly elite athletes competing at national or
international level. Otherwise, there was no significant asso-
ciation between the number of hours of training/week and
abnormal ECG changes. Abnormal structural changes identi-
fied by transthoracic echocardiography were more common
in athletes with concomitant abnormal changes on the ECG,
as well as in those involved in high-intensity sports and at
the national/international level.
The rate of abnormal ECGs was lower than has previously
been reported (10-14%), which is related to the use of more
restrictive criteria (the SC and particularly the RC).1,8,16,18--20
In a recent study,20 use of the SC compared to the European
Society of Cardiology (ESC) recommendations21 significan-
tly reduced the rate of false-positive ECG screening results,
while still identifying athletes with cardiac conditions. The
RC16 showed an additional improvement compared to the SC,
with a significant decrease in false positives in both black
and white athletes, without compromising the sensitivity of
the ECG in detecting pathological conditions. In fact, some
ECG findings, including isolated axis deviation and atrial
enlargement, which account for a large number of changes
in athletes’ ECGs, do not predict structural cardiac disease
when assessed by transthoracic echocardiography.19
Intensity and type of sport
Few studies have reported the association of type of sport
with ECG findings in athletes, and these were mainly
performed before the publication of guidelines for ECG
interpretation in athletes, in which the sporting disciplines
were analyzed individually and not according to the inten-
sity of the dynamic and static components of exercise.20,21
A higher prevalence of ECG changes in athletes has been
mainly reported in endurance disciplines. Pelliccia et al.,9
in 1005 athletes performing at national or international
level in 38 different sporting disciplines, showed that abnor-
mal ECG changes were more common in endurance sports
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such as cycling, canoeing/rowing and cross-country skiing.
Athletes engaged in endurance sports exhibit more pro-
nounced physiological structural remodeling, which may
also manifest with marked ECG alterations. The present
study revealed that this relationship between intensity of
sport and ECG changes is also evident for non-physiological
changes. However, these results should be interpreted with
caution. Despite the differences in cardiac loading con-
ditions induced by different types of exercise, some ECG
abnormalities are found in athletes engaged in predomi-
nantly dynamic as well as in those in predominantly static
sports. Although the association is more evident in sports
with high dynamic levels, sporting disciplines in this study
are typically characterized by a combination of both types
of exercise (at least one type with moderate intensity), as
in rugby, swimming and basketball.
Competitive level
The impact of competitive level on electrical remodeling
is also not well established and has not been considered
in previous classifications of sports. The majority of previ-
ous studies were performed in athletes with similar levels
of competition, mostly at national or international level.
Nonetheless, given the large number of individuals involved
in regular sports training at low levels of competition (club
or regional) or even not competing, it is important to analyze
cardiovascular adaptations in a broad spectrum of competi-
tive levels as well as the other factors that play a part.22
Although this idea is controversial, it has been proposed
that the emotional stress of competition can induce sympa-
thetic activation, which is a potential trigger for arrhythmias
or myocardial ischemia.10 It might be assumed that sports
played at higher levels of competition (national or interna-
tional), independently of the intensity of physical exercise,
would be associated with greater psychological stress. Nev-
ertheless, no relation between emotional stress induced by
highly competitive sport and ECG abnormalities has been
reported.
Training volume
Although there is an empirical assumption that the cause-
effect relationship between the volume of training and
electrical remodeling is obvious, there is little evidence of
abnormal ECG findings and the idea is controversial. In a
study by Papadakis et al.23 in adolescent Caucasian athletes,
the duration of training was not an independent predictor
for T-wave inversion in the precordial leads, one of the most
frequent abnormalities seen in the ECGs of competitive ath-
letes. Comparing athletes training for fewer hours a week
with those training more, the latter more frequently have
ECG changes, as shown by Gati et al.19 with respect to left
axis deviation and left atrial enlargement.
Our results offer new insights regarding the association
of intensity and level of competition with the presence of
abnormal ECG findings, and highlight characteristics that
should be considered together when interpreting an ath-
lete’s ECG.
Limitations
The present study has some limitations that should be
highlighted. The analysis was retrospective. Some of the
characteristics, such as the volume of training, were self-
reported by the athletes. Although this was a large cohort
compared to previous studies, larger populations should be
analyzed, bearing in mind the low rate of the endpoints
studied. The low representation of some groups, such as
females and non-Caucasians, limits the generalization of
these results. Athletes at the extreme end of the spectrum
(those with the highest sporting intensity and competitive
level) may be more prone to develop abnormal ECG changes.
For those with intermediate levels of intensity and competi-
tion, correlation with the presence of abnormal ECG findings
is difficult to establish due to the dichotomized criteria used
in this study. The categorization of sports into nine groups,
as in the classification of Mitchell et al.,11 makes this less
easy to implement and further subdividing sports may hin-
der reliable comparisons between the different categories.
Although this was not the aim of the study, it is difficult
to establish associations between echocardiographic abnor-
malities and ECG findings; transthoracic echocardiography
was not systematically performed and the main purpose of
the study was research.
Conclusions
The present study shows a positive correlation between
greater intensity of sport and increased prevalence of ECG
abnormalities. This relationship persists with the use of
more restrictive criteria for ECG interpretation (the ‘Refined
Criteria’), although the number of abnormal ECGs is lower.
The characteristics of specific sports should be taken into
account when evaluating elite athletes, to help with early
identification of those who may be more prone to develop
ECG abnormalities and to prevent unnecessary subsequent
evaluation and unwarranted disqualification from competi-
tive sport.
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Figure 2 Distribution of abnormal ECG changes (A: Seattle
criteria; B: Refined Criteria) according to the combination of
type/intensity of sport and competitive level. Int.: interna-
tional; Nat.: national.
(19.4% vs. 20.9%; p=0.715) were not significantly associated
with abnormal RC. However, the combination of intensity of
sport and competitive level revealed significant abnormal
ECG changes in athletes involved in high-intensity sports
at national/international level (4.7% vs. 2.1%; p<0.001)
(Figure 2B).
Transthoracic echocardiography
Of the overall population, 1345 (39.3%) athletes under-
went transthoracic echocardiography. Structural findings
were interpreted as abnormal in 26 (0.8%) athletes. The
echocardiographic findings classified as abnormal were aor-
tic bicuspid valve (n=7), isolated right ventricular changes
(e.g. hypertrabeculation) (n=5), mitral valve prolapse (n=4),
anomalous coronary origin (n=2), dilated aortic root (n=2),
left ventricular hypertrophy with interventricular septum
≥15 mm (n=1), large patent foramen ovale (n=1), tricus-
pid valve prolapse (n=1), pulmonary valve stenosis (n=1),
atrial septal defect (n=1) and cor triatriatum (n=1). These
structural alterations were more frequent in athletes with
both abnormal SC (2.7% vs. 0.6%; p=0.010) and abnormal RC
(3.9% vs. 0.7%; p<0.001). A higher frequency of echocardio-
graphic changes classified as abnormal was also evident in
athletes engaged in high-intensity sports and competing at
national/international level (1.3% vs. 0.5%; p=0.012).
Discussion
In the large cohort of competitive athletes under analysis,
the rate of abnormal ECG changes suggestive of cardiovascu-
lar abnormalities decreased with the use of more restrictive
criteria. Independently of the criteria used (SC or RC), ECG
abnormalities were more common among athletes involved
in sports characterized by a high dynamic and/or static
component, mainly elite athletes competing at national or
international level. Otherwise, there was no significant asso-
ciation between the number of hours of training/week and
abnormal ECG changes. Abnormal structural changes identi-
fied by transthoracic echocardiography were more common
in athletes with concomitant abnormal changes on the ECG,
as well as in those involved in high-intensity sports and at
the national/international level.
The rate of abnormal ECGs was lower than has previously
been reported (10-14%), which is related to the use of more
restrictive criteria (the SC and particularly the RC).1,8,16,18--20
In a recent study,20 use of the SC compared to the European
Society of Cardiology (ESC) recommendations21 significan-
tly reduced the rate of false-positive ECG screening results,
while still identifying athletes with cardiac conditions. The
RC16 showed an additional improvement compared to the SC,
with a significant decrease in false positives in both black
and white athletes, without compromising the sensitivity of
the ECG in detecting pathological conditions. In fact, some
ECG findings, including isolated axis deviation and atrial
enlargement, which account for a large number of changes
in athletes’ ECGs, do not predict structural cardiac disease
when assessed by transthoracic echocardiography.19
Intensity and type of sport
Few studies have reported the association of type of sport
with ECG findings in athletes, and these were mainly
performed before the publication of guidelines for ECG
interpretation in athletes, in which the sporting disciplines
were analyzed individually and not according to the inten-
sity of the dynamic and static components of exercise.20,21
A higher prevalence of ECG changes in athletes has been
mainly reported in endurance disciplines. Pelliccia et al.,9
in 1005 athletes performing at national or international
level in 38 different sporting disciplines, showed that abnor-
mal ECG changes were more common in endurance sports
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such as cycling, canoeing/rowing and cross-country skiing.
Athletes engaged in endurance sports exhibit more pro-
nounced physiological structural remodeling, which may
also manifest with marked ECG alterations. The present
study revealed that this relationship between intensity of
sport and ECG changes is also evident for non-physiological
changes. However, these results should be interpreted with
caution. Despite the differences in cardiac loading con-
ditions induced by different types of exercise, some ECG
abnormalities are found in athletes engaged in predomi-
nantly dynamic as well as in those in predominantly static
sports. Although the association is more evident in sports
with high dynamic levels, sporting disciplines in this study
are typically characterized by a combination of both types
of exercise (at least one type with moderate intensity), as
in rugby, swimming and basketball.
Competitive level
The impact of competitive level on electrical remodeling
is also not well established and has not been considered
in previous classifications of sports. The majority of previ-
ous studies were performed in athletes with similar levels
of competition, mostly at national or international level.
Nonetheless, given the large number of individuals involved
in regular sports training at low levels of competition (club
or regional) or even not competing, it is important to analyze
cardiovascular adaptations in a broad spectrum of competi-
tive levels as well as the other factors that play a part.22
Although this idea is controversial, it has been proposed
that the emotional stress of competition can induce sympa-
thetic activation, which is a potential trigger for arrhythmias
or myocardial ischemia.10 It might be assumed that sports
played at higher levels of competition (national or interna-
tional), independently of the intensity of physical exercise,
would be associated with greater psychological stress. Nev-
ertheless, no relation between emotional stress induced by
highly competitive sport and ECG abnormalities has been
reported.
Training volume
Although there is an empirical assumption that the cause-
effect relationship between the volume of training and
electrical remodeling is obvious, there is little evidence of
abnormal ECG findings and the idea is controversial. In a
study by Papadakis et al.23 in adolescent Caucasian athletes,
the duration of training was not an independent predictor
for T-wave inversion in the precordial leads, one of the most
frequent abnormalities seen in the ECGs of competitive ath-
letes. Comparing athletes training for fewer hours a week
with those training more, the latter more frequently have
ECG changes, as shown by Gati et al.19 with respect to left
axis deviation and left atrial enlargement.
Our results offer new insights regarding the association
of intensity and level of competition with the presence of
abnormal ECG findings, and highlight characteristics that
should be considered together when interpreting an ath-
lete’s ECG.
Limitations
The present study has some limitations that should be
highlighted. The analysis was retrospective. Some of the
characteristics, such as the volume of training, were self-
reported by the athletes. Although this was a large cohort
compared to previous studies, larger populations should be
analyzed, bearing in mind the low rate of the endpoints
studied. The low representation of some groups, such as
females and non-Caucasians, limits the generalization of
these results. Athletes at the extreme end of the spectrum
(those with the highest sporting intensity and competitive
level) may be more prone to develop abnormal ECG changes.
For those with intermediate levels of intensity and competi-
tion, correlation with the presence of abnormal ECG findings
is difficult to establish due to the dichotomized criteria used
in this study. The categorization of sports into nine groups,
as in the classification of Mitchell et al.,11 makes this less
easy to implement and further subdividing sports may hin-
der reliable comparisons between the different categories.
Although this was not the aim of the study, it is difficult
to establish associations between echocardiographic abnor-
malities and ECG findings; transthoracic echocardiography
was not systematically performed and the main purpose of
the study was research.
Conclusions
The present study shows a positive correlation between
greater intensity of sport and increased prevalence of ECG
abnormalities. This relationship persists with the use of
more restrictive criteria for ECG interpretation (the ‘Refined
Criteria’), although the number of abnormal ECGs is lower.
The characteristics of specific sports should be taken into
account when evaluating elite athletes, to help with early
identification of those who may be more prone to develop
ECG abnormalities and to prevent unnecessary subsequent
evaluation and unwarranted disqualification from competi-
tive sport.
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Abstract
Introduction: Assessment of the electrocardiogram (ECG) in athletes remains controversial,
with lack of standardization and difficulty in applying specific criteria in its interpretation. The
purpose of this study was to assess variability in the interpretation of the ECG in athletes.
Methods: Twenty ECGs of competitive athletes were assessed by cardiologists and cardiology
residents, 11 of them normal or with isolated physiological changes and nine pathological. Each
ECG was classified as normal/physiological or pathological, with or without the use of specific
interpretation criteria.
Results: The study presents responses from 58 physicians, 42 (72.4%) of them cardiologists.
Sixteen (27.6%) physicians reported that they regularly assessed athletes and 32 (55.2%) did
not use specific ECG interpretation criteria, of which the Seattle criteria were the most com-
monly used (n=13). Each physician interpreted 15±2 ECGs correctly, corresponding to 74% of
the total number of ECGs (variation: 45%-100%). Interpretation of pathological ECGs was correct
in 68% (variation: 22%-100%) and of normal/physiological in 79% (variation: 55%-100%). There
was no significant difference in interpretation between cardiologists and residents (74±10% vs.
75±10%; p=0.724) or between those who regularly assessed athletes and those who did not
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Introduction: Assessment of the electrocardiogram (ECG) in athletes remains controversial,
with lack of standardization and difficulty in applying specific criteria in its interpretation. The
purpose of this study was to assess variability in the interpretation of the ECG in athletes.
Methods: Twenty ECGs of competitive athletes were assessed by cardiologists and cardiology
residents, 11 of them normal or with isolated physiological changes and nine pathological. Each
ECG was classified as normal/physiological or pathological, with or without the use of specific
interpretation criteria.
Results: The study presents responses from 58 physicians, 42 (72.4%) of them cardiologists.
Sixteen (27.6%) physicians reported that they regularly assessed athletes and 32 (55.2%) did
not use specific ECG interpretation criteria, of which the Seattle criteria were the most com-
monly used (n=13). Each physician interpreted 15±2 ECGs correctly, corresponding to 74% of
the total number of ECGs (variation: 45%-100%). Interpretation of pathological ECGs was correct
in 68% (variation: 22%-100%) and of normal/physiological in 79% (variation: 55%-100%). There
was no significant difference in interpretation between cardiologists and residents (74±10% vs.
75±10%; p=0.724) or between those who regularly assessed athletes and those who did not
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(77±12% vs. 73±9%; p=0.286), but there was a trend for a higher rate of correct interpretation
using specific criteria (77±10% vs. 72±10%; p=0.092). The reproducibility of the study was
excellent (intraclass correlation coefficient=0.972; p<0.001).
Conclusions: A quarter of the ECGs were not correctly assessed and variability in interpretation
was high. The use of specific criteria can improve the accuracy of interpretation of athletes’
ECGs, which is an important part of pre-competitive screening, but one that is underused.
© 2017 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan˜a, S.L.U. All rights
reserved.
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Variabilidade na interpretac¸ão do eletrocardiograma do atleta: mais uma limitac¸ão na
avaliac¸ão pré-competitiva
Resumo
Introduc¸ão: A interpretac¸ão do eletrocardiograma (ECG) do atleta permanece controversa,
com ausência de estandardizac¸ão e dificuldade na aplicac¸ão de critérios específicos na sua
interpretac¸ão. O objetivo deste trabalho é avaliar a variabilidade na interpretac¸ão do ECG de
atletas.
Metodologia: Vinte ECG de atletas foram avaliados por cardiologistas e internos de cardiologia,
11 normais ou apenas com alterac¸ões fisiológicas e nove patológicos. Cada ECG foi classificado
pelos inquiridos em normal/com alterac¸ões fisiológicas ou patológico, usando ou não critérios
específicos na sua interpretac¸ão.
Resultados: Foram incluídas as respostas de 58 médicos, 42 (72,4%) cardiologistas. Dezasseis
(27,6%) afirmaram avaliar frequentemente atletas e 32 (55,2%) não usar critérios específicos
na interpretac¸ão do ECG, sendo os mais usados os critérios de Seattle (n=13). Em média, cada
médico interpretou corretamente 15±2 ECG, correspondendo a 74% dos trac¸ados (variac¸ão:
45-100%). A interpretac¸ão dos ECG foi correta em 68% (variac¸ão: 22-100%) dos patológicos
e em 79% (variac¸ão: 55-100%) dos normais/com alterac¸ões fisiológicas. Não houve diferenc¸a
significativa na interpretac¸ão entre cardiologistas e internos (74±10% versus 75±10%; p=0,724),
nem entre os que avaliam frequentemente ou não atletas (77±12% versus 73±9%; p=0,286),
verificando-se uma tendência para interpretac¸ão mais correta com critérios específicos (77±10%
versus 72±10%; p=0,092). A reprodutibilidade do estudo foi excelente (intraclass correlation
coefficient=0,972; p<0,001).
Conclusão: Na amostra estudada, cerca de um quarto dos ECG foram incorretamente avaliados,
havendo uma elevada variabilidade na sua interpretac¸ão. O uso de critérios específicos na
interpretac¸ão do ECG do atleta pode melhorar a acuidade deste exame no screening de atletas,
mas são ainda subutilizados.
© 2017 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier Espan˜a, S.L.U. Todos os
direitos reservados.
Introduction
The main purpose of pre-competitive screening of athletes
is to enable early (pre-clinical) identification of patholog-
ical conditions associated with increased risk of serious
clinical events, including sudden death. Data from Italy
show an 89% reduction in the incidence of sudden death
in competitive athletes following the inclusion of the elec-
trocardiogram (ECG) in pre-competitive screening.1 In view
of this, most European countries currently recommend that
pre-competitive screening should include personal and fam-
ily history, physical examination, and a resting 12-lead ECG.2
Despite this evidence and the many arguments in sup-
port of ECG assessment, the inclusion of this exam in
pre-competitive screening remains controversial, basically
because of disagreement between Europe and the US, where
it is not formally recommended.3,4 Of the arguments put for-
ward against ECGs in athletes, the most frequent is the high
false-positive rate, which can lead to unnecessary additional
diagnostic exams and inappropriate exclusion of healthy
individuals from competition. Most false positives result
from incorrect interpretation of the ECG, mainly because
alterations caused by exercise-induced physiological adap-
tations of the heart are wrongly classified as pathological.5--7
Thus, the central issue in this controversy is not whether the
ECG should be included in pre-participation screening, but
rather how the exam should be interpreted.
Various increasingly restrictive criteria have been pub-
lished with the aim of standardizing interpretation of the
ECG in athletes, notably those of the European Society of
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Table 1 Main characteristics of the athletes and electrocardiograms under analysis.
ECG Athlete Interpretation Main alterations
1 Male, Caucasian, age 35 years; running Pathological (Brugada
syndrome)
Type 1 Brugada
2 Male, Caucasian, age 24 years; judo Pathological (ARVD) Voltage criteria for RVH; right axis deviation
(>120◦)
3 Female, black, age 22 years; handball Pathological (HCM) Negative T waves in inferior leads and
V5-V6
4 Male, Caucasian, age 23 years;
gymnastics
Physiological Sinus bradycardia; incomplete right bundle
branch block
5 Male, Caucasian, age 30 years; 11-a-side
soccer
Pathological (anomalous
coronary artery origin)
ST-segment depression in lateral leads,
negative T waves in inferior leads
6 Male, Caucasian, age 23 years; running Pathological (HCM) Pathological Q waves in inferior and lateral
leads
7 Male, Caucasian, age 31 years; running Physiological Sinus bradycardia; early repolarization
8 Male, Caucasian, age 35 years; running Physiological Sinus bradycardia; voltage criteria for LVH
9 Male, Caucasian, age 22 years; running Physiological Sinus bradycardia; early repolarization;
voltage criteria for LVH
10 Male, black, age 24 years; boxing Physiological Sinus bradycardia; negative T waves in
V1-V4; voltage criteria for LVH
11 Female, Caucasian, age 24 years;
running
Physiological Sinus bradycardia
12 Male, Caucasian, age 18 years;
kickboxing
Physiological Sinus arrhythmia; early repolarization;
voltage criteria for LVH
13 Male, Caucasian, age 31 years; tennis Pathological (WPW) Short PR interval (<120 ms), delta wave
14 Male, Caucasian, age 30 years; cycling Physiological Sinus bradycardia
15 Male, Caucasian, age 19 years; 11-a-side
soccer
Physiological Sinus bradycardia; early repolarization;
voltage criteria for LVH
16 Male, Caucasian, age 22 years; running Physiological Type 1 2nd-degree atrioventricular block
17 Male, black, age 25 years; 11-a-side
soccer
Pathological (HCM) Negative T waves in inferior leads and
V3-V6
18 Female, Caucasian, age 30 years; cycling Pathological (ARVD) Isolated PVCs with LBBB pattern and
negative T waves in inferior leads
19 Male, Caucasian, age 15 years; swimming Pathological (LQTS) Long QT interval (QTc >480 ms)
20 Male, Caucasian, age 16 years; rugby Physiological Sinus bradycardia; juvenile pattern
(negative T waves in V1-V3)
ARVD: arrhythmogenic right ventricular dysplasia; HCM: hypertrophic cardiomyopathy; LBBB: left bundle branch block; LQTS: long QT
syndrome; LVH: left ventricular hypertrophy; PVCs: premature ventricular contractions; QTc: corrected QT interval; RVH: right ventricular
hypertrophy; WPW: Wolff-Parkinson-White syndrome.
Cardiology (ESC), the Seattle criteria, and the ‘refined’
criteria.8--11 However, although the application of these
criteria has led to a significantly lower number of false
positives, they are still underused, and variability in the
interpretation of the ECG in athletes remains high.12,13
The purpose of this study was to assess variability in the
interpretation of the ECG in competitive athletes, with or
without the use of specific criteria, in a sample of cardiolo-
gists and cardiology residents in Portugal.
Methods
Study population and selection of
electrocardiograms
Twenty ECGs of competitive athletes from pre-competitive
screening assessments were selected. Most athletes were
male (n=18) and Caucasian (n=17); median age was
24 (22-31) years. They performed at least eight hours of
training a week and participated in various sports, most
involving high-intensity dynamic exercise: medium- or long-
distance running (n=7), soccer (n=4), cycling (n=2), rugby
(n=1), swimming (n=1), gymnastics (n=1), tennis (n=1), box-
ing (n=1), judo (n=1) and kickboxing (n=1).
Of the selected ECGs, 11 were normal or with iso-
lated physiological changes, and nine were pathological.
The traces were selected after a validation and classifi-
cation process agreed unanimously by three cardiologists
experienced in sports medicine, particularly in interpreting
athletes’ ECGs. For the pathological ECGs, the diagnosis
of heart disease (cardiomyopathy or primary arrhythmia)
was established on the basis of additional diagnostic exams.
Table 1 presents the main characteristics of the athletes and
ECGs under analysis.
Figure 1 shows two examples of the ECGs included in this
study, one non-pathological (Figure 1A), with only physio-
logical alterations irrespective of the criteria used for its
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(77±12% vs. 73±9%; p=0.286), but there was a trend for a higher rate of correct interpretation
using specific criteria (77±10% vs. 72±10%; p=0.092). The reproducibility of the study was
excellent (intraclass correlation coefficient=0.972; p<0.001).
Conclusions: A quarter of the ECGs were not correctly assessed and variability in interpretation
was high. The use of specific criteria can improve the accuracy of interpretation of athletes’
ECGs, which is an important part of pre-competitive screening, but one that is underused.
© 2017 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan˜a, S.L.U. All rights
reserved.
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Introduc¸ão: A interpretac¸ão do eletrocardiograma (ECG) do atleta permanece controversa,
com ausência de estandardizac¸ão e dificuldade na aplicac¸ão de critérios específicos na sua
interpretac¸ão. O objetivo deste trabalho é avaliar a variabilidade na interpretac¸ão do ECG de
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11 normais ou apenas com alterac¸ões fisiológicas e nove patológicos. Cada ECG foi classificado
pelos inquiridos em normal/com alterac¸ões fisiológicas ou patológico, usando ou não critérios
específicos na sua interpretac¸ão.
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(27,6%) afirmaram avaliar frequentemente atletas e 32 (55,2%) não usar critérios específicos
na interpretac¸ão do ECG, sendo os mais usados os critérios de Seattle (n=13). Em média, cada
médico interpretou corretamente 15±2 ECG, correspondendo a 74% dos trac¸ados (variac¸ão:
45-100%). A interpretac¸ão dos ECG foi correta em 68% (variac¸ão: 22-100%) dos patológicos
e em 79% (variac¸ão: 55-100%) dos normais/com alterac¸ões fisiológicas. Não houve diferenc¸a
significativa na interpretac¸ão entre cardiologistas e internos (74±10% versus 75±10%; p=0,724),
nem entre os que avaliam frequentemente ou não atletas (77±12% versus 73±9%; p=0,286),
verificando-se uma tendência para interpretac¸ão mais correta com critérios específicos (77±10%
versus 72±10%; p=0,092). A reprodutibilidade do estudo foi excelente (intraclass correlation
coefficient=0,972; p<0,001).
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interpretac¸ão do ECG do atleta pode melhorar a acuidade deste exame no screening de atletas,
mas são ainda subutilizados.
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The main purpose of pre-competitive screening of athletes
is to enable early (pre-clinical) identification of patholog-
ical conditions associated with increased risk of serious
clinical events, including sudden death. Data from Italy
show an 89% reduction in the incidence of sudden death
in competitive athletes following the inclusion of the elec-
trocardiogram (ECG) in pre-competitive screening.1 In view
of this, most European countries currently recommend that
pre-competitive screening should include personal and fam-
ily history, physical examination, and a resting 12-lead ECG.2
Despite this evidence and the many arguments in sup-
port of ECG assessment, the inclusion of this exam in
pre-competitive screening remains controversial, basically
because of disagreement between Europe and the US, where
it is not formally recommended.3,4 Of the arguments put for-
ward against ECGs in athletes, the most frequent is the high
false-positive rate, which can lead to unnecessary additional
diagnostic exams and inappropriate exclusion of healthy
individuals from competition. Most false positives result
from incorrect interpretation of the ECG, mainly because
alterations caused by exercise-induced physiological adap-
tations of the heart are wrongly classified as pathological.5--7
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rather how the exam should be interpreted.
Various increasingly restrictive criteria have been pub-
lished with the aim of standardizing interpretation of the
ECG in athletes, notably those of the European Society of
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Table 1 Main characteristics of the athletes and electrocardiograms under analysis.
ECG Athlete Interpretation Main alterations
1 Male, Caucasian, age 35 years; running Pathological (Brugada
syndrome)
Type 1 Brugada
2 Male, Caucasian, age 24 years; judo Pathological (ARVD) Voltage criteria for RVH; right axis deviation
(>120◦)
3 Female, black, age 22 years; handball Pathological (HCM) Negative T waves in inferior leads and
V5-V6
4 Male, Caucasian, age 23 years;
gymnastics
Physiological Sinus bradycardia; incomplete right bundle
branch block
5 Male, Caucasian, age 30 years; 11-a-side
soccer
Pathological (anomalous
coronary artery origin)
ST-segment depression in lateral leads,
negative T waves in inferior leads
6 Male, Caucasian, age 23 years; running Pathological (HCM) Pathological Q waves in inferior and lateral
leads
7 Male, Caucasian, age 31 years; running Physiological Sinus bradycardia; early repolarization
8 Male, Caucasian, age 35 years; running Physiological Sinus bradycardia; voltage criteria for LVH
9 Male, Caucasian, age 22 years; running Physiological Sinus bradycardia; early repolarization;
voltage criteria for LVH
10 Male, black, age 24 years; boxing Physiological Sinus bradycardia; negative T waves in
V1-V4; voltage criteria for LVH
11 Female, Caucasian, age 24 years;
running
Physiological Sinus bradycardia
12 Male, Caucasian, age 18 years;
kickboxing
Physiological Sinus arrhythmia; early repolarization;
voltage criteria for LVH
13 Male, Caucasian, age 31 years; tennis Pathological (WPW) Short PR interval (<120 ms), delta wave
14 Male, Caucasian, age 30 years; cycling Physiological Sinus bradycardia
15 Male, Caucasian, age 19 years; 11-a-side
soccer
Physiological Sinus bradycardia; early repolarization;
voltage criteria for LVH
16 Male, Caucasian, age 22 years; running Physiological Type 1 2nd-degree atrioventricular block
17 Male, black, age 25 years; 11-a-side
soccer
Pathological (HCM) Negative T waves in inferior leads and
V3-V6
18 Female, Caucasian, age 30 years; cycling Pathological (ARVD) Isolated PVCs with LBBB pattern and
negative T waves in inferior leads
19 Male, Caucasian, age 15 years; swimming Pathological (LQTS) Long QT interval (QTc >480 ms)
20 Male, Caucasian, age 16 years; rugby Physiological Sinus bradycardia; juvenile pattern
(negative T waves in V1-V3)
ARVD: arrhythmogenic right ventricular dysplasia; HCM: hypertrophic cardiomyopathy; LBBB: left bundle branch block; LQTS: long QT
syndrome; LVH: left ventricular hypertrophy; PVCs: premature ventricular contractions; QTc: corrected QT interval; RVH: right ventricular
hypertrophy; WPW: Wolff-Parkinson-White syndrome.
Cardiology (ESC), the Seattle criteria, and the ‘refined’
criteria.8--11 However, although the application of these
criteria has led to a significantly lower number of false
positives, they are still underused, and variability in the
interpretation of the ECG in athletes remains high.12,13
The purpose of this study was to assess variability in the
interpretation of the ECG in competitive athletes, with or
without the use of specific criteria, in a sample of cardiolo-
gists and cardiology residents in Portugal.
Methods
Study population and selection of
electrocardiograms
Twenty ECGs of competitive athletes from pre-competitive
screening assessments were selected. Most athletes were
male (n=18) and Caucasian (n=17); median age was
24 (22-31) years. They performed at least eight hours of
training a week and participated in various sports, most
involving high-intensity dynamic exercise: medium- or long-
distance running (n=7), soccer (n=4), cycling (n=2), rugby
(n=1), swimming (n=1), gymnastics (n=1), tennis (n=1), box-
ing (n=1), judo (n=1) and kickboxing (n=1).
Of the selected ECGs, 11 were normal or with iso-
lated physiological changes, and nine were pathological.
The traces were selected after a validation and classifi-
cation process agreed unanimously by three cardiologists
experienced in sports medicine, particularly in interpreting
athletes’ ECGs. For the pathological ECGs, the diagnosis
of heart disease (cardiomyopathy or primary arrhythmia)
was established on the basis of additional diagnostic exams.
Table 1 presents the main characteristics of the athletes and
ECGs under analysis.
Figure 1 shows two examples of the ECGs included in this
study, one non-pathological (Figure 1A), with only physio-
logical alterations irrespective of the criteria used for its
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Female, black, age 22 years; running
aVRI V1 V4
V5
V6
V2
V3
aVL
aVF
46bpm
16mm
35mm
II
aVRI V1 V4
V5
V6
V2
V3
aVL
aVF
II
III
III
Figure 1 Two of the electrocardiograms (ECGs) in the study questionnaire. (A) ECG showing physiological alterations (sinus brady-
cardia, isolated voltage criteria for left ventricular hypertrophy and early repolarization); (B) ECG showing pathological alterations
(negative T waves in all inferior leads and V5-V6), in an athlete diagnosed with hypertrophic cardiomyopathy.
interpretation, and the other pathological (Figure 1B), that
of an athlete with hypertrophic cardiomyopathy.
Interpretation of electrocardiograms
The ECGs selected for this analysis were included in a form
developed on the Google Forms platform (https://docs.
google.com/forms/d/1vpVaTKSSlp2TfjiIkGtvX4qZBmkiNnn
KnSKHKUYJSR4/viewform). The form was emailed to cardio-
logists and cardiology residents working in representative
cardiology departments throughout Portugal (a total of
186 physicians). After an introductory text explaining the
study’s background and aims, the physicians were asked
to identify themselves as a cardiologist or a cardiology
resident and to state the main area of their clinical practice
(specifically whether they worked within a subspecialty
of cardiology), whether they regularly assessed athletes’
ECGs and whether they used specific criteria to do so, and
if so, which. Each ECG was accompanied by information
on the athlete’s demographic characteristics (age, gender
and race) and sport. For each ECG, the respondent was
asked whether they considered the trace pathological or
non-pathological. Only questionnaires with responses to
all questions were considered valid, and only one could be
submitted by each physician. Data collection took place
over a period of one month (November 2015). All records
were kept confidential and only the lead investigator had
access to the results.
Statistical analysis
The data were analyzed using SPSS for Windows, version
22.0. Categorical variables were expressed as absolute val-
ues and percentages and compared with the chi-square
test, while continuous variables were expressed as means ±
standard deviation and were compared with the Student’s t
test under conditions of normality and homoscedasticity or
as medians and interquartile range (25th-75th percentile)
for non-normal distributions. The reproducibility of the
study was assessed by calculating the intraclass correlation
coefficient. Results with p<0.05 were considered statisti-
cally significant.
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Table 2 Interpretation of electrocardiograms according to the characteristics of the physicians surveyed and the methods
used.
n (%) Total Mean percentage of correctly interpreted ECGs
Total Non-pathological Pathological
Main area of clinical practice
Cardiologist 42 (72.4) 74 79 67
Cardiology resident 16 (27.6) 75 79 70
Clinical cardiology 41 (70.7) 75 80 70
Other areas of cardiology 17 (29.3) 72 78 64
Regular assessment of athletes 16 (27.6) 77 84 68
Interpretation of ECG
Based on clinical experience 32 (55.2) 72 80 73
Based on specific criteria 26 (44.8) 77 78 75
ESC criteria 8 (13.8) 72 74 69
Seattle criteria 13 (22.4) 77 80 74
Refined criteria 4 (6.9) 86 86 86
Other criteria 1 (1.9) 70 55 89
ECG: electrocardiogram; ESC: European Society of Cardiology.
100%
80%
26 21 32
68
7974
All ECGs
Correct interpretation Incorrect interpretation
Non-pathological ECGs Pathological ECGs
60%
40%
20%
0%
Figure 2 Proportions of correct and incorrect interpretations
of electrocardiograms. ECG: electrocardiograms.
Results
The study included responses from 58 physicians (response
rate 31%), 42 (72.4%) of them cardiologists and the remain-
der cardiology residents; 16 (27.6%) of the physicians stated
that they regularly assessed athletes. More than half (32;
55.2%) did not use specific criteria for assessing athletes’
ECGs, and of those who did, the most commonly used were
the Seattle criteria (n=13), followed by the ESC criteria
(n=8). Table 2 presents the characteristics of the physicians
surveyed and the percentages of correctly interpreted ECGs.
Each physician correctly interpreted a mean of 15±2
traces, corresponding to 74% of the ECGs analyzed, ranging
between 45% and 100%. For pathological ECGs, the interpre-
tation was correct in 68% of cases, ranging between 22% and
100%, while for non-pathological traces it was correct in 79%
of cases (55%-100%) (Figures 2 and 3).
There were no statistically significant differences
between cardiologists and residents concerning correctness
100
80
60
40
20
All ECGs
%
Non-pathological ECGs Pathological ECGs
Figure 3 Variability in proportions of correctly interpreted
electrocardiograms. ECG: electrocardiograms.
of interpretation (74±10% vs. 75±10%; p=0.724), or between
physicians who regularly assessed athletes’ ECGs and those
who did not (77±12% vs. 73±9%; p=0.286). There was a
trend for a higher rate of correct interpretation using spe-
cific criteria (77±10% vs. 72±10%; p=0.092). The intraclass
correlation coefficient was 0.972 (95% confidence interval
0.951-0.987; p<0.001), showing that the reproducibility of
the study was excellent.
Discussion
This study demonstrates that assessment of the ECG in ath-
letes remains less than optimal, since around a quarter of
the ECGs analyzed were not correctly assessed and vari-
ability in interpretation was high. Although most of the
physicians surveyed (cardiologists and residents) stated that
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Figure 1 Two of the electrocardiograms (ECGs) in the study questionnaire. (A) ECG showing physiological alterations (sinus brady-
cardia, isolated voltage criteria for left ventricular hypertrophy and early repolarization); (B) ECG showing pathological alterations
(negative T waves in all inferior leads and V5-V6), in an athlete diagnosed with hypertrophic cardiomyopathy.
interpretation, and the other pathological (Figure 1B), that
of an athlete with hypertrophic cardiomyopathy.
Interpretation of electrocardiograms
The ECGs selected for this analysis were included in a form
developed on the Google Forms platform (https://docs.
google.com/forms/d/1vpVaTKSSlp2TfjiIkGtvX4qZBmkiNnn
KnSKHKUYJSR4/viewform). The form was emailed to cardio-
logists and cardiology residents working in representative
cardiology departments throughout Portugal (a total of
186 physicians). After an introductory text explaining the
study’s background and aims, the physicians were asked
to identify themselves as a cardiologist or a cardiology
resident and to state the main area of their clinical practice
(specifically whether they worked within a subspecialty
of cardiology), whether they regularly assessed athletes’
ECGs and whether they used specific criteria to do so, and
if so, which. Each ECG was accompanied by information
on the athlete’s demographic characteristics (age, gender
and race) and sport. For each ECG, the respondent was
asked whether they considered the trace pathological or
non-pathological. Only questionnaires with responses to
all questions were considered valid, and only one could be
submitted by each physician. Data collection took place
over a period of one month (November 2015). All records
were kept confidential and only the lead investigator had
access to the results.
Statistical analysis
The data were analyzed using SPSS for Windows, version
22.0. Categorical variables were expressed as absolute val-
ues and percentages and compared with the chi-square
test, while continuous variables were expressed as means ±
standard deviation and were compared with the Student’s t
test under conditions of normality and homoscedasticity or
as medians and interquartile range (25th-75th percentile)
for non-normal distributions. The reproducibility of the
study was assessed by calculating the intraclass correlation
coefficient. Results with p<0.05 were considered statisti-
cally significant.
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Table 2 Interpretation of electrocardiograms according to the characteristics of the physicians surveyed and the methods
used.
n (%) Total Mean percentage of correctly interpreted ECGs
Total Non-pathological Pathological
Main area of clinical practice
Cardiologist 42 (72.4) 74 79 67
Cardiology resident 16 (27.6) 75 79 70
Clinical cardiology 41 (70.7) 75 80 70
Other areas of cardiology 17 (29.3) 72 78 64
Regular assessment of athletes 16 (27.6) 77 84 68
Interpretation of ECG
Based on clinical experience 32 (55.2) 72 80 73
Based on specific criteria 26 (44.8) 77 78 75
ESC criteria 8 (13.8) 72 74 69
Seattle criteria 13 (22.4) 77 80 74
Refined criteria 4 (6.9) 86 86 86
Other criteria 1 (1.9) 70 55 89
ECG: electrocardiogram; ESC: European Society of Cardiology.
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Figure 2 Proportions of correct and incorrect interpretations
of electrocardiograms. ECG: electrocardiograms.
Results
The study included responses from 58 physicians (response
rate 31%), 42 (72.4%) of them cardiologists and the remain-
der cardiology residents; 16 (27.6%) of the physicians stated
that they regularly assessed athletes. More than half (32;
55.2%) did not use specific criteria for assessing athletes’
ECGs, and of those who did, the most commonly used were
the Seattle criteria (n=13), followed by the ESC criteria
(n=8). Table 2 presents the characteristics of the physicians
surveyed and the percentages of correctly interpreted ECGs.
Each physician correctly interpreted a mean of 15±2
traces, corresponding to 74% of the ECGs analyzed, ranging
between 45% and 100%. For pathological ECGs, the interpre-
tation was correct in 68% of cases, ranging between 22% and
100%, while for non-pathological traces it was correct in 79%
of cases (55%-100%) (Figures 2 and 3).
There were no statistically significant differences
between cardiologists and residents concerning correctness
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Figure 3 Variability in proportions of correctly interpreted
electrocardiograms. ECG: electrocardiograms.
of interpretation (74±10% vs. 75±10%; p=0.724), or between
physicians who regularly assessed athletes’ ECGs and those
who did not (77±12% vs. 73±9%; p=0.286). There was a
trend for a higher rate of correct interpretation using spe-
cific criteria (77±10% vs. 72±10%; p=0.092). The intraclass
correlation coefficient was 0.972 (95% confidence interval
0.951-0.987; p<0.001), showing that the reproducibility of
the study was excellent.
Discussion
This study demonstrates that assessment of the ECG in ath-
letes remains less than optimal, since around a quarter of
the ECGs analyzed were not correctly assessed and vari-
ability in interpretation was high. Although most of the
physicians surveyed (cardiologists and residents) stated that
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they did not use specific criteria for ECG interpretations,
there was a trend for a higher rate of correct interpretation
using such criteria.
These results are consistent with previously published
findings, and empirically there is a perception that variabil-
ity (intra- and inter-observer) in interpretation of the ECG in
athletes is high. However, there have been few recent stud-
ies on the subject. Berte et al.12 carried out a similar study,
using a larger number of ECGs (138) and a smaller number of
physicians (seven cardiologists and seven sports physicians),
in which the ECGs were interpreted according to established
criteria; variability was high, with disagreement on 35% of
the ECGs overall. In a study by Hill et al.14 using a similar
sample to the present work (18 ECGs analyzed by 53 pedi-
atric cardiologists), the rate of incorrect interpretation was
31%. Analyzing 40 ECGs of athletes interpreted by physicians
of various specialties, Drezner et al.15 showed that accuracy
improved significantly after participants were provided with
and asked to adopt the Seattle criteria; among cardiologists,
the proportion of ECGs interpreted incorrectly fell from 15%
to 4%.15
Although the difference was not statistically significant,
in our study the rate of correct interpretation was lower
for pathological ECGs, i.e. the proportion of false nega-
tives was higher than that of false positives. Since the main
problem with interpreting athletes’ ECGs is the high false-
positive rate, the opposite would be expected. Irrespective
of the characteristics analyzed, the proportion of patho-
logical ECGs interpreted correctly was low except with the
refined criteria,11 which were only used by a small number
of physicians. Since these are the most recent criteria, they
are probably more familiar to physicians with more experi-
ence and/or more interest in the area, who are thus more
likely to interpret the ECG correctly. In previous studies the
false-positive rate was similar, with more accurate inter-
pretation seen after the adoption of specific criteria.14--16
For example, an assessment of the diagnostic accuracy of
the Seattle criteria showed that the false-positive rate fell
from 30% to 9% after they were applied.15 It is thus essential
to raise awareness of specific criteria for the interpreta-
tion of the ECG in athletes and ensure they are correctly
applied.
Variability in interpretation means that many athletes
undergo unnecessary additional diagnostic exams, which
have a considerable socioeconomic impact. There is also the
question of the psychological stress caused by an incorrect
reading, as well as the fact that these exams do not iden-
tify all causes of sudden death or ensure that athletes have
been inappropriately barred from competing. Furthermore,
the low prevalence of pathological ECGs in athletes means
that they are more difficult to identify, increasing the vari-
ability of interpretation (the prevalence effect).15 Another
important aspect is the influence of exercise-induced (phys-
iological) electrical adaptations in the heart, which are
affected by the athlete’s demographic characteristics and
the type of sport.5
There aremany arguments in favor of including the ECG in
pre-competitive screening of athletes, but it is still essential
to optimize their interpretation. Possible ways to achieve
this include training, standardization of methods, and cen-
tralized screening in specialized units. It is also important
to raise awareness of the specific criteria for interpreting
athletes’ ECGs and of their advantages and disadvantages,
ideally through the publication of consensus documents and
protocols indicating which criteria to adopt, in order to
encourage standardization. However, the current criteria
are the product of expert opinion and retrospective stud-
ies, and there have been few prospective analyses that can
identify the ECG alterations that correlate most closely with
clinical events, especially sudden death. Despite the short-
comings of the currently available criteria, their limitations
cannot be evaluated, let alone overcome, until they have
been applied in clinical practice.
Limitations
This study has certain limitations that should be pointed
out. The sample size was small, which limits the applica-
bility of its results, and fewer than one third of surveyed
physicians responded to the questionnaire. However, even
so, the final study population was larger than in some
previous studies on this subject. The characteristics of
the selected athletes were very similar, with few non-
Caucasians, females, or older athletes included. Although
the questionnaire responses were confidential, physicians
who were more interested and experienced in this area
may have been more motivated to respond, and this also
may have skewed the results. Some of the participants
may have consulted the criteria when analyzing the ECGs,
which hampers assessment of their existing knowledge; how-
ever, this does not affect the main purpose of the study
and is in fact to be recommended in clinical practice,
particularly for physicians who do not regularly assess
athletes.
Conclusions
In the study population, a quarter of athletes’ ECGs were
not correctly assessed and variability in interpretation was
high. Standardization of ECG interpretation in athletes with
the use of specific criteria can improve the accuracy of this
exam in pre-competitive screening. However, these criteria
are still underused, a situation that could be changed by
improvements in medical training in this area.
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they did not use specific criteria for ECG interpretations,
there was a trend for a higher rate of correct interpretation
using such criteria.
These results are consistent with previously published
findings, and empirically there is a perception that variabil-
ity (intra- and inter-observer) in interpretation of the ECG in
athletes is high. However, there have been few recent stud-
ies on the subject. Berte et al.12 carried out a similar study,
using a larger number of ECGs (138) and a smaller number of
physicians (seven cardiologists and seven sports physicians),
in which the ECGs were interpreted according to established
criteria; variability was high, with disagreement on 35% of
the ECGs overall. In a study by Hill et al.14 using a similar
sample to the present work (18 ECGs analyzed by 53 pedi-
atric cardiologists), the rate of incorrect interpretation was
31%. Analyzing 40 ECGs of athletes interpreted by physicians
of various specialties, Drezner et al.15 showed that accuracy
improved significantly after participants were provided with
and asked to adopt the Seattle criteria; among cardiologists,
the proportion of ECGs interpreted incorrectly fell from 15%
to 4%.15
Although the difference was not statistically significant,
in our study the rate of correct interpretation was lower
for pathological ECGs, i.e. the proportion of false nega-
tives was higher than that of false positives. Since the main
problem with interpreting athletes’ ECGs is the high false-
positive rate, the opposite would be expected. Irrespective
of the characteristics analyzed, the proportion of patho-
logical ECGs interpreted correctly was low except with the
refined criteria,11 which were only used by a small number
of physicians. Since these are the most recent criteria, they
are probably more familiar to physicians with more experi-
ence and/or more interest in the area, who are thus more
likely to interpret the ECG correctly. In previous studies the
false-positive rate was similar, with more accurate inter-
pretation seen after the adoption of specific criteria.14--16
For example, an assessment of the diagnostic accuracy of
the Seattle criteria showed that the false-positive rate fell
from 30% to 9% after they were applied.15 It is thus essential
to raise awareness of specific criteria for the interpreta-
tion of the ECG in athletes and ensure they are correctly
applied.
Variability in interpretation means that many athletes
undergo unnecessary additional diagnostic exams, which
have a considerable socioeconomic impact. There is also the
question of the psychological stress caused by an incorrect
reading, as well as the fact that these exams do not iden-
tify all causes of sudden death or ensure that athletes have
been inappropriately barred from competing. Furthermore,
the low prevalence of pathological ECGs in athletes means
that they are more difficult to identify, increasing the vari-
ability of interpretation (the prevalence effect).15 Another
important aspect is the influence of exercise-induced (phys-
iological) electrical adaptations in the heart, which are
affected by the athlete’s demographic characteristics and
the type of sport.5
There aremany arguments in favor of including the ECG in
pre-competitive screening of athletes, but it is still essential
to optimize their interpretation. Possible ways to achieve
this include training, standardization of methods, and cen-
tralized screening in specialized units. It is also important
to raise awareness of the specific criteria for interpreting
athletes’ ECGs and of their advantages and disadvantages,
ideally through the publication of consensus documents and
protocols indicating which criteria to adopt, in order to
encourage standardization. However, the current criteria
are the product of expert opinion and retrospective stud-
ies, and there have been few prospective analyses that can
identify the ECG alterations that correlate most closely with
clinical events, especially sudden death. Despite the short-
comings of the currently available criteria, their limitations
cannot be evaluated, let alone overcome, until they have
been applied in clinical practice.
Limitations
This study has certain limitations that should be pointed
out. The sample size was small, which limits the applica-
bility of its results, and fewer than one third of surveyed
physicians responded to the questionnaire. However, even
so, the final study population was larger than in some
previous studies on this subject. The characteristics of
the selected athletes were very similar, with few non-
Caucasians, females, or older athletes included. Although
the questionnaire responses were confidential, physicians
who were more interested and experienced in this area
may have been more motivated to respond, and this also
may have skewed the results. Some of the participants
may have consulted the criteria when analyzing the ECGs,
which hampers assessment of their existing knowledge; how-
ever, this does not affect the main purpose of the study
and is in fact to be recommended in clinical practice,
particularly for physicians who do not regularly assess
athletes.
Conclusions
In the study population, a quarter of athletes’ ECGs were
not correctly assessed and variability in interpretation was
high. Standardization of ECG interpretation in athletes with
the use of specific criteria can improve the accuracy of this
exam in pre-competitive screening. However, these criteria
are still underused, a situation that could be changed by
improvements in medical training in this area.
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1
Preparticipation cardiovascular screening of young ath-letes with electrocardiography (ECG) is effective for 
detecting potentially serious cardiac disease and is endorsed 
by the European Society of Cardiology (ESC) and several 
international sporting bodies.1–3 However, the accuracy of the 
ECG is dependent on the individual interpretation of the test, 
which may vary considerably among cardiologists of differing 
experience.4,5
See Editorial by Prutkin and Drezner
Background—Preparticipation screening for cardiovascular disease in young athletes with electrocardiography is endorsed 
by the European Society of Cardiology and several major sporting organizations. One of the concerns of the ECG as 
a screening test in young athletes relates to the potential for variation in interpretation. We investigated the degree of 
variation in ECG interpretation in athletes and its financial impact among cardiologists of differing experience.
Methods and Results—Eight cardiologists (4 with experience in screening athletes) each reported 400 ECGs of consecutively 
screened young athletes according to the 2010 European Society of Cardiology recommendations, Seattle criteria, and 
refined criteria. Cohen κ coefficient was used to calculate interobserver reliability. Cardiologists proposed secondary 
investigations after ECG interpretation, the costs of which were based on the UK National Health Service tariffs. 
Inexperienced cardiologists were more likely to classify an ECG as abnormal compared with experienced cardiologists 
(odds ratio, 1.44; 95% confidence interval, 1.03–2.02). Modification of ECG interpretation criteria improved interobserver 
reliability for categorizing an ECG as abnormal from poor (2010 European Society of Cardiology recommendations; 
κ=0.15) to moderate (refined criteria; κ=0.41) among inexperienced cardiologists; however, interobserver reliability 
was moderate for all 3 criteria among experienced cardiologists (κ=0.40–0.53). Inexperienced cardiologists were more 
likely to refer athletes for further evaluation compared with experienced cardiologists (odds ratio, 4.74; 95% confidence 
interval, 3.50–6.43) with poorer interobserver reliability (κ=0.22 versus κ=0.47). Interobserver reliability for secondary 
investigations after ECG interpretation ranged from poor to fair among inexperienced cardiologists (κ=0.15–0.30) and 
fair to moderate among experienced cardiologists (κ=0.21–0.46). The cost of cardiovascular evaluation per athlete was 
$175 (95% confidence interval, $142–$228) and $101 (95% confidence interval, $83–$131) for inexperienced and 
experienced cardiologists, respectively.
Conclusions—Interpretation of the ECG in athletes and the resultant cascade of investigations are highly physician 
dependent even in experienced hands with important downstream financial implications, emphasizing the need for formal 
training and standardized diagnostic pathways.  (Circ Cardiovasc Qual Outcomes. 2017;10:e003306. DOI: 10.1161/
CIRCOUTCOMES.116.003306.)
Key Words: athletes ◼ cardiologists ◼ death, sudden, cardiac ◼ heart disease ◼ sports
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Recent modification of ECG interpretation recommen-
dations has improved the efficacy of the ECG as a screen-
ing tool by reducing the false-positive rate and cost of 
screening.3,6–8 Whether such modification has an impact 
on the variation of ECG interpretation in young athletes 
is unknown. Furthermore, whether experience of report-
ing ECGs in athletes affects variability of interpretation 
and recommended secondary testing among cardiolo-
gists is also unknown. This study evaluated the variation 
of interpretation of the athlete’s ECG and its financial 
impact between experienced and inexperienced cardiolo-
gists using 3 internationally recognized ECG interpretation 
recommendations.3,6,7
Methods
Study Population
The charitable organization Cardiac Risk in the Young has an estab-
lished cardiac screening program for young individuals aged 14 to 
35 years, which serves many professional sporting organizations in 
the United Kingdom (www.c-r-y.org.uk). The Cardiac Risk in the 
Young screening protocol consists of a health questionnaire pertain-
ing to symptoms suggestive of cardiac disease or a family history 
of cardiac disease, a physical examination, and a 12-lead ECG. The 
first 400 consecutively assessed athlete’s ECGs from the program in 
2014 were used for the primary analysis of interobserver agreement. 
These athletes have been presented previously as part of a nationwide 
ECG screening cost analysis.8 None of the athletes were considered 
to have symptoms suggestive of cardiovascular disease, and none had 
a significant family history of cardiovascular disease. All had a nor-
mal physical examination. These athletes were evaluated by different 
experienced sports cardiologists. Purely as a reference, 24 (6.0%) of 
the athletes were referred for further evaluation, 23 (5.8%) underwent 
echocardiography, 6 (1.5%) exercise stress testing, 8 (2.0%) Holter, 
and 5 (1.3%) cardiac magnetic resonance imaging.
Participants
Eight cardiologists independently participated in the interpretation 
of the ECGs, of whom 4 were experienced in evaluating the ECG 
in athletes. For the purposes of the study, we defined cardiologists 
with experience as those who were working in a specialist sports car-
diology unit for >2 years and had independently conducted prepar-
ticipation ECG screening with ECG in ≥1000 athletes. Conversely, 
inexperienced cardiologists were defined as those who did not rou-
tinely report on athlete’s ECG. Both groups consisted of 3 general 
cardiologists and 1 electrophysiologist.
ECG Interpretation
All cardiologists were provided with the 400 anonymized ECGs in 
random order and in a digital printable format, which included the 
age, sex, and ethnicity of the athlete. The cardiologists were informed 
that all athletes had normal history and physical examination find-
ings. Digital measurements of heart rate, QRS duration, PR interval, 
and QT interval were omitted.
The cardiologists were provided with a copy of published docu-
ments detailing the 2010 ESC recommendations, the Seattle crite-
ria, and the refined criteria 1 month before commencement of ECG 
interpretation (Table 1).3,6,7 Each cardiologist was instructed to as-
sign the ECGs as normal or abnormal per criterion and specify the 
abnormities.
All cardiologists calculated the QT interval manually. Instructions 
were provided on measuring the QT interval using the tangent meth-
od.9 Cardiologists were advised to report the longest QT interval value 
as the absolute QT and to correct the QT interval for heart rate using 
the Bazett formula, where the corrected QT interval (QTc)=QT/√RR 
interval.10
Secondary Investigations and Financial Analysis
The initial preparticipation screening tests (history, physical exami-
nation, and ECG) were performed at a subsidized cost of $53 per 
athlete screened.
In the event of an abnormal ECG, the cardiologists were instruct-
ed to propose specific secondary investigations based on their usual 
clinical practice. The cost of secondary investigations was calculated 
based on the 2014/2015 UK National Health Service tariff payment 
system (Table I in the Data Supplement). Genetic testing was not in-
cluded in the cost analysis because it is usually reserved for individu-
als with disease phenotype for the purposes of cascade screening.
Statistics
The data were graphically explored and summarized accordingly, that 
is, means, SDs, median interquartile range, and range for continuous 
data and proportions for categorical or binary independent data.
Raw indices of interobserver agreement are presented as the 
overall and specific proportions of agreement among the groups of 
cardiologists. Cohen κ coefficient was used to calculate the over-
all interobserver reliability in ECG interpretation between groups 
of cardiologists (experienced and inexperienced) with κ<0.20 rep-
resenting poor interobserver reliability, 0.20 to 0.40 representing 
fair reliability, 0.40 to 0.60 representing moderate reliability, 0.60 
to 0.80 representing good agreement, and 0.80 to 1.00 representing 
very good reliability. To disentangle the potential heterogeneities in 
the κ values across age, sex, and ethnicity, 2 novel binary variables 
were constructed for each group of clinical experts in a similar fash-
ion: 1 if all 4 clinicians perfectly agreed, 0 otherwise. Then, a bivari-
ate logistic regression was applied to the joined binary outcome for 
a simultaneous flavor of the odds of perfect agreement within the 2 
clinical groups. As this is not an indication of agreement because 
some information is lost, the Cohen agreement coefficient was re-
calculated across heterogeneous groups in the population indicated 
by this analysis and subsequently presented. Further referrals com-
prised 5 destinations (echocardiography, exercise stress test, Holter, 
cardiac magnetic resonance imaging, and family screening) with the 
possibility that a patient required >1. Given the binary nature of this 
WHAT IS KNOWN
• The inclusion of the ECG to a health questionnaire 
and physical examination screening protocol in 
young athletes improves sensitivity to detect serious 
cardiac disease; however, a concern of the ECG as 
a screening tool relates to the potential for variation 
in interpretation especially in inexperienced hands.
WHAT THE STUDY ADDS
• There is only moderate interobserver reliability for 
ECG interpretation even among cardiologists with 
experience in the cardiovascular evaluation of young 
athletes.
• Modification of ECG interpretation criteria improves 
reliability among inexperienced cardiologists.
• The decision to propose secondary investigations 
after ECG interpretation varies among inexperienced 
and experienced cardiologists, respectively, with sig-
nificant downstream financial implications.
• The findings of this study highlight that formal train-
ing and development of standardized diagnostic path-
ways are essential to support cardiologists involved 
in cardiovascular screening of young athletes.
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multivariate response, we adopted a simpler yet easily interpretable 
approach. Each destination was considered a separate binary out-
come, and a 2-level logistic regression applied to account for the in-
herent dependencies in the data arising from multiple measurements 
for the same athlete.
P values <0.05 were considered statistically significant, and the 
uncertainty of the estimates is expressed as their 95% confidence in-
tervals (CI). Marginal predictions, that is, predicted proportions sum-
marized according to the clinical relevance, are also presented. The 
analyses were performed in Stata (StataCorp 2015, Stata Statistical 
Software).
Ethics
Ethical approval was granted by the Essex 2 Research Ethics 
Committee. Written consent was obtained from individuals ≥16 years 
of age and from a parent/guardian for those <16 years of age.
Results
Demographics
Athletes were aged 20.5±4.8 years. Two hundred and 
eighty-five (71%) were male. Three hundred and eighteen 
(79%) athletes were white and 43 (11%) were of African/
Afro-Caribbean origin (black). Thirty-nine (10%) athletes 
consisted of other ethnicities including mixed race, Asian 
or Polynesian. Athletes competed in a total of 18 different 
sporting disciplines—predominantly soccer (29%), rugby 
(16%), and cycling (15%)—and exercised for 16.6±6.0 
hours per week.
Identification of ECGs Suggestive of Cardiac 
Disease
One (0.3%) athlete was diagnosed with potentially serious 
cardiac disease, notably long-QT syndrome (QTc 520 ms). 
The ECG of this athlete was classified as requiring further 
evaluation by all 8 cardiologists.
Categorization of ECG Abnormalities in 
Accordance to ECG Interpretation Criteria
Frequency of ECG Abnormalities
Inexperienced cardiologists more frequently categorized an 
ECG as abnormal compared with experienced cardiologists 
for all 3 criteria (Figure 1). Compared with both the 2010 ESC 
recommendations and the Seattle criteria, the refined criteria 
reduced the proportion of ECGs categorized as abnormal 
among all cardiologists.
Interobserver Reliability
Interobserver reliability for categorizing an ECG as abnormal 
among inexperienced cardiologists was poor for the 2010 ESC 
recommendations (κ=0.15; 95% CI, 0.12–0.20), fair for the 
Seattle criteria (κ=0.25; 95% CI, 0.16–0.32), and moderate 
for the refined criteria (κ=0.41; 95% CI, 0.24–0.50; Figure 2). 
Among experienced cardiologists, there was moderate reli-
ability for categorizing an ECG as abnormal for all 3 criteria 
(2010 ESC recommendations: κ=0.40; 95% CI, 0.37–0.45; 
Seattle criteria: κ=0.53; 95% CI, 0.39–0.64; and refined crite-
ria: κ=0.43; 95% CI, 0.21–0.51).
Interobserver reliability for the presence of a long-QT 
interval was only fair to moderate (κ=0.21–0.44) among inex-
perienced cardiologists (Table II in the Data Supplement). 
Conversely, interobserver reliability for the presence of a 
long-QT interval among experienced cardiologists improved 
from fair (κ=0.31) with the 2010 ESC recommendations to 
good (κ=0.60) with the Seattle and refined criteria. There was 
Table 1. Summary of Definition of ECG Abnormalities in 
Athletes According to the 2010 ESC Recommendations, Seattle 
Criteria, and Refined Criteria3,6,7
All 3 criteria ST-segment depression
 Pathological Q waves
 Complete left bundle branch block
 Ventricular pre-excitation
 Brugada-like early repolarization pattern
 Premature ventricular contractions
 Atrial or ventricular arrhythmia
2010 ESC 
recommendations
T-wave inversion
 Long-QT interval >440 ms (male) or >460 ms 
(female)
 Short-QT interval <380 ms
 Right ventricular hypertrophy
 Right- or left-axis deviation
 Right or left atrial enlargement
 Complete right bundle branch block
 Nonspecific intraventricular delay (QRS >120 
ms)
Seattle criteria T-wave inversion beyond V2 in white athletes
 T-wave inversion beyond V4 in black athletes
 Long-QT interval ≥470 ms (male) or ≥480 ms 
(female)
 Short-QT interval ≤320 ms
 Right ventricular hypertrophy (in presence of 
right-axis deviation)
 Left-axis deviation
 Right or left atrial enlargement
 Nonspecific intraventricular delay (QRS ≥140 
ms)
Refined criteria T-wave inversion beyond V1 in white athletes
 T-wave inversion beyond V4 in black athletes
 Long-QT interval ≥470 ms (male) or ≥480 ms 
(female)
 Short-QT interval ≤320 ms
 Complete right bundle branch block
 Borderline variants (requiring investigation if 
>1 present)
 T-wave inversion up to V4 in black athletes
 Right ventricular hypertrophy
 Right- or left-axis deviation
 Right or left atrial enlargement
ESC indicates European Society of Cardiology.
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These athletes have been presented previously as part of a nationwide 
ECG screening cost analysis.8 None of the athletes were considered 
to have symptoms suggestive of cardiovascular disease, and none had 
a significant family history of cardiovascular disease. All had a nor-
mal physical examination. These athletes were evaluated by different 
experienced sports cardiologists. Purely as a reference, 24 (6.0%) of 
the athletes were referred for further evaluation, 23 (5.8%) underwent 
echocardiography, 6 (1.5%) exercise stress testing, 8 (2.0%) Holter, 
and 5 (1.3%) cardiac magnetic resonance imaging.
Participants
Eight cardiologists independently participated in the interpretation 
of the ECGs, of whom 4 were experienced in evaluating the ECG 
in athletes. For the purposes of the study, we defined cardiologists 
with experience as those who were working in a specialist sports car-
diology unit for >2 years and had independently conducted prepar-
ticipation ECG screening with ECG in ≥1000 athletes. Conversely, 
inexperienced cardiologists were defined as those who did not rou-
tinely report on athlete’s ECG. Both groups consisted of 3 general 
cardiologists and 1 electrophysiologist.
ECG Interpretation
All cardiologists were provided with the 400 anonymized ECGs in 
random order and in a digital printable format, which included the 
age, sex, and ethnicity of the athlete. The cardiologists were informed 
that all athletes had normal history and physical examination find-
ings. Digital measurements of heart rate, QRS duration, PR interval, 
and QT interval were omitted.
The cardiologists were provided with a copy of published docu-
ments detailing the 2010 ESC recommendations, the Seattle crite-
ria, and the refined criteria 1 month before commencement of ECG 
interpretation (Table 1).3,6,7 Each cardiologist was instructed to as-
sign the ECGs as normal or abnormal per criterion and specify the 
abnormities.
All cardiologists calculated the QT interval manually. Instructions 
were provided on measuring the QT interval using the tangent meth-
od.9 Cardiologists were advised to report the longest QT interval value 
as the absolute QT and to correct the QT interval for heart rate using 
the Bazett formula, where the corrected QT interval (QTc)=QT/√RR 
interval.10
Secondary Investigations and Financial Analysis
The initial preparticipation screening tests (history, physical exami-
nation, and ECG) were performed at a subsidized cost of $53 per 
athlete screened.
In the event of an abnormal ECG, the cardiologists were instruct-
ed to propose specific secondary investigations based on their usual 
clinical practice. The cost of secondary investigations was calculated 
based on the 2014/2015 UK National Health Service tariff payment 
system (Table I in the Data Supplement). Genetic testing was not in-
cluded in the cost analysis because it is usually reserved for individu-
als with disease phenotype for the purposes of cascade screening.
Statistics
The data were graphically explored and summarized accordingly, that 
is, means, SDs, median interquartile range, and range for continuous 
data and proportions for categorical or binary independent data.
Raw indices of interobserver agreement are presented as the 
overall and specific proportions of agreement among the groups of 
cardiologists. Cohen κ coefficient was used to calculate the over-
all interobserver reliability in ECG interpretation between groups 
of cardiologists (experienced and inexperienced) with κ<0.20 rep-
resenting poor interobserver reliability, 0.20 to 0.40 representing 
fair reliability, 0.40 to 0.60 representing moderate reliability, 0.60 
to 0.80 representing good agreement, and 0.80 to 1.00 representing 
very good reliability. To disentangle the potential heterogeneities in 
the κ values across age, sex, and ethnicity, 2 novel binary variables 
were constructed for each group of clinical experts in a similar fash-
ion: 1 if all 4 clinicians perfectly agreed, 0 otherwise. Then, a bivari-
ate logistic regression was applied to the joined binary outcome for 
a simultaneous flavor of the odds of perfect agreement within the 2 
clinical groups. As this is not an indication of agreement because 
some information is lost, the Cohen agreement coefficient was re-
calculated across heterogeneous groups in the population indicated 
by this analysis and subsequently presented. Further referrals com-
prised 5 destinations (echocardiography, exercise stress test, Holter, 
cardiac magnetic resonance imaging, and family screening) with the 
possibility that a patient required >1. Given the binary nature of this 
WHAT IS KNOWN
• The inclusion of the ECG to a health questionnaire 
and physical examination screening protocol in 
young athletes improves sensitivity to detect serious 
cardiac disease; however, a concern of the ECG as 
a screening tool relates to the potential for variation 
in interpretation especially in inexperienced hands.
WHAT THE STUDY ADDS
• There is only moderate interobserver reliability for 
ECG interpretation even among cardiologists with 
experience in the cardiovascular evaluation of young 
athletes.
• Modification of ECG interpretation criteria improves 
reliability among inexperienced cardiologists.
• The decision to propose secondary investigations 
after ECG interpretation varies among inexperienced 
and experienced cardiologists, respectively, with sig-
nificant downstream financial implications.
• The findings of this study highlight that formal train-
ing and development of standardized diagnostic path-
ways are essential to support cardiologists involved 
in cardiovascular screening of young athletes.
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multivariate response, we adopted a simpler yet easily interpretable 
approach. Each destination was considered a separate binary out-
come, and a 2-level logistic regression applied to account for the in-
herent dependencies in the data arising from multiple measurements 
for the same athlete.
P values <0.05 were considered statistically significant, and the 
uncertainty of the estimates is expressed as their 95% confidence in-
tervals (CI). Marginal predictions, that is, predicted proportions sum-
marized according to the clinical relevance, are also presented. The 
analyses were performed in Stata (StataCorp 2015, Stata Statistical 
Software).
Ethics
Ethical approval was granted by the Essex 2 Research Ethics 
Committee. Written consent was obtained from individuals ≥16 years 
of age and from a parent/guardian for those <16 years of age.
Results
Demographics
Athletes were aged 20.5±4.8 years. Two hundred and 
eighty-five (71%) were male. Three hundred and eighteen 
(79%) athletes were white and 43 (11%) were of African/
Afro-Caribbean origin (black). Thirty-nine (10%) athletes 
consisted of other ethnicities including mixed race, Asian 
or Polynesian. Athletes competed in a total of 18 different 
sporting disciplines—predominantly soccer (29%), rugby 
(16%), and cycling (15%)—and exercised for 16.6±6.0 
hours per week.
Identification of ECGs Suggestive of Cardiac 
Disease
One (0.3%) athlete was diagnosed with potentially serious 
cardiac disease, notably long-QT syndrome (QTc 520 ms). 
The ECG of this athlete was classified as requiring further 
evaluation by all 8 cardiologists.
Categorization of ECG Abnormalities in 
Accordance to ECG Interpretation Criteria
Frequency of ECG Abnormalities
Inexperienced cardiologists more frequently categorized an 
ECG as abnormal compared with experienced cardiologists 
for all 3 criteria (Figure 1). Compared with both the 2010 ESC 
recommendations and the Seattle criteria, the refined criteria 
reduced the proportion of ECGs categorized as abnormal 
among all cardiologists.
Interobserver Reliability
Interobserver reliability for categorizing an ECG as abnormal 
among inexperienced cardiologists was poor for the 2010 ESC 
recommendations (κ=0.15; 95% CI, 0.12–0.20), fair for the 
Seattle criteria (κ=0.25; 95% CI, 0.16–0.32), and moderate 
for the refined criteria (κ=0.41; 95% CI, 0.24–0.50; Figure 2). 
Among experienced cardiologists, there was moderate reli-
ability for categorizing an ECG as abnormal for all 3 criteria 
(2010 ESC recommendations: κ=0.40; 95% CI, 0.37–0.45; 
Seattle criteria: κ=0.53; 95% CI, 0.39–0.64; and refined crite-
ria: κ=0.43; 95% CI, 0.21–0.51).
Interobserver reliability for the presence of a long-QT 
interval was only fair to moderate (κ=0.21–0.44) among inex-
perienced cardiologists (Table II in the Data Supplement). 
Conversely, interobserver reliability for the presence of a 
long-QT interval among experienced cardiologists improved 
from fair (κ=0.31) with the 2010 ESC recommendations to 
good (κ=0.60) with the Seattle and refined criteria. There was 
Table 1. Summary of Definition of ECG Abnormalities in 
Athletes According to the 2010 ESC Recommendations, Seattle 
Criteria, and Refined Criteria3,6,7
All 3 criteria ST-segment depression
 Pathological Q waves
 Complete left bundle branch block
 Ventricular pre-excitation
 Brugada-like early repolarization pattern
 Premature ventricular contractions
 Atrial or ventricular arrhythmia
2010 ESC 
recommendations
T-wave inversion
 Long-QT interval >440 ms (male) or >460 ms 
(female)
 Short-QT interval <380 ms
 Right ventricular hypertrophy
 Right- or left-axis deviation
 Right or left atrial enlargement
 Complete right bundle branch block
 Nonspecific intraventricular delay (QRS >120 
ms)
Seattle criteria T-wave inversion beyond V2 in white athletes
 T-wave inversion beyond V4 in black athletes
 Long-QT interval ≥470 ms (male) or ≥480 ms 
(female)
 Short-QT interval ≤320 ms
 Right ventricular hypertrophy (in presence of 
right-axis deviation)
 Left-axis deviation
 Right or left atrial enlargement
 Nonspecific intraventricular delay (QRS ≥140 
ms)
Refined criteria T-wave inversion beyond V1 in white athletes
 T-wave inversion beyond V4 in black athletes
 Long-QT interval ≥470 ms (male) or ≥480 ms 
(female)
 Short-QT interval ≤320 ms
 Complete right bundle branch block
 Borderline variants (requiring investigation if 
>1 present)
 T-wave inversion up to V4 in black athletes
 Right ventricular hypertrophy
 Right- or left-axis deviation
 Right or left atrial enlargement
ESC indicates European Society of Cardiology.
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moderate and good reliability for the presence of abnormal 
T-wave inversion among inexperienced (κ=0.43–0.54) and 
experienced cardiologists (κ=0.54–0.64), respectively. The 
degree of reliability for the presence for other ECG abnormal-
ities ranged from poor to moderate among the cardiologists 
(Table II in the Data Supplement).
Proportion of Overall and Specific Interobserver Agreement
Proportion of overall interobserver agreement was higher 
among experienced cardiologists compared with inexperi-
enced cardiologists for all 3 criteria (Table 2). Among both 
groups, overall agreement was driven specifically by agree-
ment in ECGs categorized as normal. Modification of ECG 
interpretation criteria improved the overall proportion of 
interobserver agreement for both inexperienced and experi-
enced cardiologists.
Bivariate Binary Outcome Model
On the basis of the 2010 ESC recommendations, sex (male 
athletes) and ethnicity (black athletes) proved to be the stron-
gest predictors of disagreement among inexperienced cardi-
ologists as suggested by the bivariate binary mode, whereas 
sex (male athletes) was the main source of difference in agree-
ment among experienced cardiologists (Table III in the Data 
Supplement).
Figure 1. ECGs categorized as abnormal 
by each cardiologist. Inexperienced 
cardiologists are more likely to categorize 
an ECG as abnormal compared with 
experienced cardiologists irrespective 
of criteria used. CI indicates confidence 
interval; and OR, odds ratio.
Figure 2. The estimated interobserver reliability among cardiologists for categorizing an ECG as abnormal. Interobserver reliability for 
an abnormal ECG among experienced cardiologists was moderate for all 3 criteria. Among inexperienced cardiologists, modification of 
ECG criteria improved interobserver reliability from poor to moderate. CI indicates confidence interval; and ESC, European Society of 
Cardiology.
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Further Evaluation and Secondary Investigations
Frequency of Investigations and Interobserver Reliability
Inexperienced cardiologists recommended further evalu-
ation in 17.7% (95% CI, 15.0%–20.0%) of the 400 ECGs 
and showed fair interobserver reliability with respect to 
which ECGs required further evaluation (κ=0.23; 95% CI, 
0.14–0.30). Experienced cardiologists recommended further 
evaluation in 7.0% (95% CI, 5.3%–8.8%) of the 400 ECGs, 
with moderate interobserver reliability (κ=0.40; 95% CI, 
0.31–0.53).
Inexperienced cardiologists were likely to recommend a 
higher proportion of secondary investigations compared with 
experienced cardiologists, with poor to fair interobserver reli-
ability (Table 3; Figure 3). Interobserver reliability for sec-
ondary investigations ranged from fair to moderate among 
experienced cardiologists.
Proportion of Overall and Specific Interobserver Agreement
Proportion of overall and specific agreement for recommend-
ing further evaluation and secondary investigations after ECG 
interpretation was higher among experienced cardiologists 
(Table 4). Agreement for familial evaluation was compa-
rable among both groups. In both groups, overall agreement 
was specifically driven by agreement in not recommending 
investigations.
Costs Generated by Secondary Investigation
On the basis of the predicted proportions for each group, the 
cost of secondary investigation among inexperienced cardi-
ologists amounted to $48 697 (95% CI, $35 583–$69 896) and 
equated to $122 (95% CI, $89–$175) per athlete screened. For 
experienced cardiologists, the total cost of secondary investi-
gation amounted to $19 123 (95% CI, $11 878–$30 726) and 
equated to $48 (95% CI, $30–$78) per athlete screened.
Accounting for the initial preparticipation screening costs, 
the overall cost per athlete equated to $175 (95% CI, $142–
$228) and $101 (95% CI, $83–$131) for inexperienced and 
experienced cardiologists, respectively.
Discussion
The ECG is a relatively cheap investigation that improves the 
sensitivity for detecting potentially serious cardiac disease 
in athletes compared with history and examination alone.11 
Recent modification of ECG interpretation recommendations 
in athletes has significantly reduced false-positive rates with-
out compromising sensitivity.7,12,13 However, as with any sub-
jective investigation, the effectiveness of the ECG is dependent 
on the individual interpretation of the test. This study conveys 
important data pertaining to variation in interpretation of the 
ECG in a relatively large cohort of highly trained athletes and 
reveals that there is only moderate reliability in ECG interpre-
tation in athletes among experienced cardiologists. Intuitively, 
such variation will have significant financial implications on 
downstream costs of systematic evaluation of athletes.
Impact of Experience in Interpretation of the ECG 
in Athletes
An important concern about the ECG as a screening tool is the 
potential for erroneous diagnosis in inexperienced hands. This 
study reveals that inexperienced cardiologists were at least 
Table 2. Proportion of Overall and Specific Agreement for ECG Interpretation Among Cardiologists
 Cardiologists Overall Agreement (+95% CI)
Agreement for Abnormal 
(+95% CI)
Agreement for 
Normal (+95% CI)
2010 ESC recommendations Inexperienced 0.60 (0.58–0.63) 0.46 (0.44–0.52) 0.68 (0.65–0.71)
 Experienced 0.75 (0.72–0.77) 0.58 (0.53–0.63) 0.82 (0.79–0.82)
Seattle criteria Inexperienced 0.80 (0.78–0.83) 0.44 (0.29–0.48) 0.88 (0.87–0.90)
 Experienced 0.93 (0.92–0.95) 0.57 (0.45–0.67) 0.96 (0.95–0.97)
Refined criteria Inexperienced 0.92 (0.90–0.95) 0.46 (0.35–0.56) 0.96 (0.95–0.97)
 Experienced 0.94 (0.92–0.95) 0.46 (0.32–0.58) 0.97 (0.96–0.98)
Table 3. Estimated Proportions of Further Evaluation and Secondary Investigations Proposed After 
ECG Interpretation
Proportion of ECGs Requiring Further Evaluation and Secondary 
Investigations (n=400) (Marginal Proportions [95% CI])
Odds Ratio 
(95% CI) P Value Inexperienced Cardiologists, % Experienced Cardiologists, %
Further evaluation after 
screening
17.7 (15.0–20.0) 7.0 (5.5–8.8) 4.7 (3.5–6.4) P<0.001
Echocardiography 16.4 (13.8–19.1) 6.5 (4.9–8.1) 4.7 (3.4–6.5) P<0.001
Exercise stress test 6.9 (5.3–8.6) 1.7 (0.9–2.5) 5.9 (3.6–9.6) P<0.001
Holter 6.1 (4.4–7.7) 1.7 (0.9–2.6) 5.5 (3.2–9.2) P<0.001
Cardiac MRI 5.5 (3.8–7.1) 0.9 (0.2–1.5) 12.2 (6.1–24.6) P<0.001
Family screening 0.8 (0.4–1.4) 0.9 (0.4–1.5) 0.9 (0.4–2.0) P=0.84
CI indicates confidence interval; and MRI, magnetic resonance imaging.
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moderate and good reliability for the presence of abnormal 
T-wave inversion among inexperienced (κ=0.43–0.54) and 
experienced cardiologists (κ=0.54–0.64), respectively. The 
degree of reliability for the presence for other ECG abnormal-
ities ranged from poor to moderate among the cardiologists 
(Table II in the Data Supplement).
Proportion of Overall and Specific Interobserver Agreement
Proportion of overall interobserver agreement was higher 
among experienced cardiologists compared with inexperi-
enced cardiologists for all 3 criteria (Table 2). Among both 
groups, overall agreement was driven specifically by agree-
ment in ECGs categorized as normal. Modification of ECG 
interpretation criteria improved the overall proportion of 
interobserver agreement for both inexperienced and experi-
enced cardiologists.
Bivariate Binary Outcome Model
On the basis of the 2010 ESC recommendations, sex (male 
athletes) and ethnicity (black athletes) proved to be the stron-
gest predictors of disagreement among inexperienced cardi-
ologists as suggested by the bivariate binary mode, whereas 
sex (male athletes) was the main source of difference in agree-
ment among experienced cardiologists (Table III in the Data 
Supplement).
Figure 1. ECGs categorized as abnormal 
by each cardiologist. Inexperienced 
cardiologists are more likely to categorize 
an ECG as abnormal compared with 
experienced cardiologists irrespective 
of criteria used. CI indicates confidence 
interval; and OR, odds ratio.
Figure 2. The estimated interobserver reliability among cardiologists for categorizing an ECG as abnormal. Interobserver reliability for 
an abnormal ECG among experienced cardiologists was moderate for all 3 criteria. Among inexperienced cardiologists, modification of 
ECG criteria improved interobserver reliability from poor to moderate. CI indicates confidence interval; and ESC, European Society of 
Cardiology.
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Further Evaluation and Secondary Investigations
Frequency of Investigations and Interobserver Reliability
Inexperienced cardiologists recommended further evalu-
ation in 17.7% (95% CI, 15.0%–20.0%) of the 400 ECGs 
and showed fair interobserver reliability with respect to 
which ECGs required further evaluation (κ=0.23; 95% CI, 
0.14–0.30). Experienced cardiologists recommended further 
evaluation in 7.0% (95% CI, 5.3%–8.8%) of the 400 ECGs, 
with moderate interobserver reliability (κ=0.40; 95% CI, 
0.31–0.53).
Inexperienced cardiologists were likely to recommend a 
higher proportion of secondary investigations compared with 
experienced cardiologists, with poor to fair interobserver reli-
ability (Table 3; Figure 3). Interobserver reliability for sec-
ondary investigations ranged from fair to moderate among 
experienced cardiologists.
Proportion of Overall and Specific Interobserver Agreement
Proportion of overall and specific agreement for recommend-
ing further evaluation and secondary investigations after ECG 
interpretation was higher among experienced cardiologists 
(Table 4). Agreement for familial evaluation was compa-
rable among both groups. In both groups, overall agreement 
was specifically driven by agreement in not recommending 
investigations.
Costs Generated by Secondary Investigation
On the basis of the predicted proportions for each group, the 
cost of secondary investigation among inexperienced cardi-
ologists amounted to $48 697 (95% CI, $35 583–$69 896) and 
equated to $122 (95% CI, $89–$175) per athlete screened. For 
experienced cardiologists, the total cost of secondary investi-
gation amounted to $19 123 (95% CI, $11 878–$30 726) and 
equated to $48 (95% CI, $30–$78) per athlete screened.
Accounting for the initial preparticipation screening costs, 
the overall cost per athlete equated to $175 (95% CI, $142–
$228) and $101 (95% CI, $83–$131) for inexperienced and 
experienced cardiologists, respectively.
Discussion
The ECG is a relatively cheap investigation that improves the 
sensitivity for detecting potentially serious cardiac disease 
in athletes compared with history and examination alone.11 
Recent modification of ECG interpretation recommendations 
in athletes has significantly reduced false-positive rates with-
out compromising sensitivity.7,12,13 However, as with any sub-
jective investigation, the effectiveness of the ECG is dependent 
on the individual interpretation of the test. This study conveys 
important data pertaining to variation in interpretation of the 
ECG in a relatively large cohort of highly trained athletes and 
reveals that there is only moderate reliability in ECG interpre-
tation in athletes among experienced cardiologists. Intuitively, 
such variation will have significant financial implications on 
downstream costs of systematic evaluation of athletes.
Impact of Experience in Interpretation of the ECG 
in Athletes
An important concern about the ECG as a screening tool is the 
potential for erroneous diagnosis in inexperienced hands. This 
study reveals that inexperienced cardiologists were at least 
Table 2. Proportion of Overall and Specific Agreement for ECG Interpretation Among Cardiologists
 Cardiologists Overall Agreement (+95% CI)
Agreement for Abnormal 
(+95% CI)
Agreement for 
Normal (+95% CI)
2010 ESC recommendations Inexperienced 0.60 (0.58–0.63) 0.46 (0.44–0.52) 0.68 (0.65–0.71)
 Experienced 0.75 (0.72–0.77) 0.58 (0.53–0.63) 0.82 (0.79–0.82)
Seattle criteria Inexperienced 0.80 (0.78–0.83) 0.44 (0.29–0.48) 0.88 (0.87–0.90)
 Experienced 0.93 (0.92–0.95) 0.57 (0.45–0.67) 0.96 (0.95–0.97)
Refined criteria Inexperienced 0.92 (0.90–0.95) 0.46 (0.35–0.56) 0.96 (0.95–0.97)
 Experienced 0.94 (0.92–0.95) 0.46 (0.32–0.58) 0.97 (0.96–0.98)
Table 3. Estimated Proportions of Further Evaluation and Secondary Investigations Proposed After 
ECG Interpretation
Proportion of ECGs Requiring Further Evaluation and Secondary 
Investigations (n=400) (Marginal Proportions [95% CI])
Odds Ratio 
(95% CI) P Value Inexperienced Cardiologists, % Experienced Cardiologists, %
Further evaluation after 
screening
17.7 (15.0–20.0) 7.0 (5.5–8.8) 4.7 (3.5–6.4) P<0.001
Echocardiography 16.4 (13.8–19.1) 6.5 (4.9–8.1) 4.7 (3.4–6.5) P<0.001
Exercise stress test 6.9 (5.3–8.6) 1.7 (0.9–2.5) 5.9 (3.6–9.6) P<0.001
Holter 6.1 (4.4–7.7) 1.7 (0.9–2.6) 5.5 (3.2–9.2) P<0.001
Cardiac MRI 5.5 (3.8–7.1) 0.9 (0.2–1.5) 12.2 (6.1–24.6) P<0.001
Family screening 0.8 (0.4–1.4) 0.9 (0.4–1.5) 0.9 (0.4–2.0) P=0.84
CI indicates confidence interval; and MRI, magnetic resonance imaging.
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44% more likely to categorize an ECG as abnormal compared 
with experienced cardiologists (Figure 1). Furthermore, inex-
perience was associated with poorer interobserver reliability 
for categorizing an ECG as abnormal.
Reassuringly, the ECG of the athlete harboring potentially 
serious cardiac disease was identified by all 8 cardiologists. 
From the clinical point of view, it is arguable that this is cer-
tainly the most important aspect of the ECG as a screening 
tool.
Impact of Modification of Standardized ECG 
Interpretation Criteria
The impact of recent modification of ECG interpretation cri-
teria on variation in interpretation in highly trained athletes 
has not been ascertained in a large cohort of highly trained 
young adult athletes although Berte et al4 reported a higher 
overall agreement with the Seattle criteria compared with the 
2010 ESC recommendations in a small cohort of adolescent 
male soccer players. We observed that contemporary ECG 
interpretation guidelines (Seattle and refined criteria) improve 
the proportion of overall interobserver agreement by ≤35% 
and 20% among inexperienced and experienced cardiologists, 
respectively (Table 2), and reduce the interobserver reliabil-
ity gap between experienced and inexperienced cardiologists 
when categorizing an ECG as abnormal (Figure 2).
Impact of ECG Interpretation Variation on 
Workload and Costs
The workload and cost of secondary investigations required 
to confirm or refute the diagnosis of cardiac disease after an 
ECG abnormality are cited as important obstacles to screening 
young athletes with ECG.14 We observed that inexperienced 
cardiologists were 5 times more likely to refer an athlete for 
further evaluation compared with experienced cardiologists 
based on ECG interpretation. Specifically, screening by inex-
perienced cardiologists resulted in a 5-fold increase in num-
ber of echocardiograms requested, 6-fold increase in exercise 
stress tests and Holter monitors, and a 12-fold increase in car-
diac magnetic resonance imaging scans compared with expe-
rienced cardiologists (Table 3). In addition to the increased 
Figure 3. The estimated interobserver 
reliability among cardiologists for 
secondary investigations after ECG 
interpretation. Inexperienced cardiologists 
demonstrated poorer interobserver 
reliability for secondary investigations 
compared with experienced cardiologists. 
CI indicates confidence interval.
Table 4. Proportions of Overall and Specific Agreement Among Cardiologists for Recommending 
Further Evaluation and Secondary Investigations After ECG Interpretation
 Cardiologists
Overall Agreement 
(+95% CI)
Agreement to 
Recommend (+95% CI)
Agreement Not to 
Recommend (+95% CI)
Further evaluation 
after screening
Inexperienced 0.77 (0.74–0.79) 0.38 (0.31–0.44) 0.86 (0.83–0.87)
 Experienced 0.92 (0.89–0.93) 0.45 (0.35–0.55) 0.95 (0.94–0.96)
Echocardiography Inexperienced 0.81 (0.78–0.84) 0.40 (0.32–0.47) 0.89 (0.87–0.90)
 Experienced 0.94 (0.92–0.95) 0.50 (0.37–0.61) 0.97 (0.96–0.98)
Exercise stress test Inexperienced 0.89 (0.87–0.91) 0.19 (0.10–0.29) 0.94 (0.93–0.95)
 Experienced 0.98 (0.96–0.99) 0.33 (0.11–0.53) 0.99 (0.98–0.99)
Holter Inexperienced 0.91 (0.89–0.92) 0.20 (0.12–0.29) 0.95 (0.94–0.96)
 Experienced 0.98 (0.97–0.99) 0.38 (0.07–0.63) 0.99 (0.98–0.99)
Cardiac MRI Inexperienced 0.92 (0.90–0.94) 0.27 (0.17–0.37) 0.96 (0.95–0.97)
 Experienced 0.99 (0.98–0.99) 0.24 (0.11–0.41) 0.99 (0.98–0.99)
Family screening Inexperienced 0.99 (0.98–0.99) 0.31 (0.00–0.67) 0.99 (0.99–0.99)
 Experienced 0.98 (0.97–0.99) 0.12 (0.00–0.35) 0.99 (0.99–0.99)
CI indicates confidence interval; and MRI, magnetic resonance imaging.
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number of investigations requested, interobserver reliability 
among inexperienced cardiologists for these secondary inves-
tigations ranged from poor to fair (Figure 3). Consequently, 
ECG-based preparticipation screening conducted by inexpe-
rienced cardiologists resulted in an ≈2-fold increase in cost 
compared with experienced cardiologists.
Experience was associated with a lower frequency of sec-
ondary investigations and improvement in proportion of over-
all agreement (Tables 3 and 4); nevertheless, interobserver 
reliability among experienced cardiologists for these investiga-
tions was only fair to moderate (Figure 3). In real-life practice, 
cardiovascular screening in athletes is conducted by physi-
cians of varying experience, ranging from general cardiolo-
gists, electrophysiologists, and sports physicians. Therefore, 
the variation in interpretation is likely to fall between the 2 
ranges above and will have significant implications on health 
resources that may preclude financial planning and sustain-
ability of nationwide ECG screening of young athletes.
Despite demonstrating a reduction in the number of posi-
tive ECGs with contemporary ECG criteria, inexperienced 
cardiologists proposed further investigations in 17.7% of the 
cohort, which is considerably higher than expected based on 
the authors’ experience and existing publications. This finding 
indicate that modification of ECG interpretation criteria may 
be associated with a lower positive ECG rate but may still not 
influence the personal practice among inexperienced cardiolo-
gists without further expert guidance.
Strategies to Reduce Variation in ECG 
Interpretation and Clinical Practice
Despite the success of the Italian athletic screening program 
in reducing sudden cardiac death, preparticipation screening 
with ECG remains a contentious issue given the absence of 
randomized control study evidence demonstrating that early 
detection of disease translates to lives saved, and conse-
quently, ECG screening is not universally practiced. Never-
theless, ECG screening is endorsed by several major sporting 
organizations including Fédération Internationale de Football 
Association and the International Olympic Committee.2,15 
Although our study has shown only moderate reliability for 
interpretation of the athlete’s ECG among experienced cardi-
ologists, we do not aim to deter sporting organizations from 
screening athletes with ECG. Indeed, the ECG is associated 
with interobserver reliability rates that are comparable to 
well-established and generally accepted screening tests such 
as Papanicolaou smear testing for cervical carcinoma and 
mammography for carcinoma of the breast.16–19 Furthermore, 
the only serious condition conferring increased risk of sudden 
cardiac death was identified on the basis of an abnormal ECG. 
By acknowledging the degree and impact of variation in ECG 
interpretation in athletes, our findings should herald the devel-
opment of effective educational approaches aimed at reducing 
this variation. Modification of guidelines for the interpretation 
of the ECG in athletes from the 2010 ESC recommendations to 
the Seattle and refined criteria seem to be useful in improving 
agreement and reliability in ECG interpretation especially in 
inexperienced cardiologists; however, a better understanding 
of physiological versus pathological ECG patterns requires 
appropriate training and education of physicians including 
cardiologists to potentially minimize variation regardless of 
whether ECG analysis is being conducted for screening pur-
poses or for diagnostic purposes. Recent small studies have 
demonstrated significant improvement in ECG interpretation 
in athletes after online training among inexperienced physi-
cians and hold promise for the future.20,21
In comparison to other established and endorsed screen-
ing programs in the UK National Health Service (www.gov.
uk/topic/population-screening-programmes) with similar 
rates of positive screening tests, there were no standardized 
diagnostic pathways for asymptomatic young athletes exhibit-
ing ECG anomalies.7,8,13,22–28 In this regard, the recently pub-
lished international recommendations for ECG screening in 
athletes are unique as they provide guidance to physicians 
on the minimal set of investigations for each electric abnor-
mality.29,30 Such guidance will hopefully reduce variation in 
clinical practice among screening cardiologists, which may 
improve efficiency.
Limitations
This study has several limitations warranting mention. The 
definition of experience in interpreting the ECG in athletes 
was arbitrary, but there is currently no formal accreditation 
available to quantify this more accurately. We only included 
adult cardiologists for this study, and hence, the findings may 
not be readily applicable to organizations whose athletes are 
screened by pediatric cardiologists, sports physicians, and 
other healthcare providers. Only 400 athlete ECGs were 
included to make the study feasible. All 400 athletes were not 
assessed with echocardiography, and consequently there is no 
gold-standard reference on which to calculate the interpreter’s 
accuracy for detecting of structural heart disease; however, 
our study aimed to investigate the level of interobserver vari-
ability in ECG interpretation and clinical practice rather than 
detection of disease. Although all cardiologists were supplied 
with published documents for all 3 ECG interpretation crite-
ria, we cannot exclude that some may not have strictly adhered 
to them and reported ECGs based on their own experience. 
Machine-generated intervals were removed to aptly test the 
knowledge of the cardiologists in this study, but the impact 
they present on variation is not known.
Conclusions
Interpretation of the ECG in young athletes and the resul-
tant cascade of downstream investigations is highly physi-
cian dependent even in experienced hands, which markedly 
impacts on the workload and cost of ECG screening. Formal 
training and development of a standardized diagnostic path-
way is essential to support cardiologists involved in cardiovas-
cular screening of young athletes.
Sources of Funding
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grants from the Cardiac Risk in the Young organization.
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44% more likely to categorize an ECG as abnormal compared 
with experienced cardiologists (Figure 1). Furthermore, inex-
perience was associated with poorer interobserver reliability 
for categorizing an ECG as abnormal.
Reassuringly, the ECG of the athlete harboring potentially 
serious cardiac disease was identified by all 8 cardiologists. 
From the clinical point of view, it is arguable that this is cer-
tainly the most important aspect of the ECG as a screening 
tool.
Impact of Modification of Standardized ECG 
Interpretation Criteria
The impact of recent modification of ECG interpretation cri-
teria on variation in interpretation in highly trained athletes 
has not been ascertained in a large cohort of highly trained 
young adult athletes although Berte et al4 reported a higher 
overall agreement with the Seattle criteria compared with the 
2010 ESC recommendations in a small cohort of adolescent 
male soccer players. We observed that contemporary ECG 
interpretation guidelines (Seattle and refined criteria) improve 
the proportion of overall interobserver agreement by ≤35% 
and 20% among inexperienced and experienced cardiologists, 
respectively (Table 2), and reduce the interobserver reliabil-
ity gap between experienced and inexperienced cardiologists 
when categorizing an ECG as abnormal (Figure 2).
Impact of ECG Interpretation Variation on 
Workload and Costs
The workload and cost of secondary investigations required 
to confirm or refute the diagnosis of cardiac disease after an 
ECG abnormality are cited as important obstacles to screening 
young athletes with ECG.14 We observed that inexperienced 
cardiologists were 5 times more likely to refer an athlete for 
further evaluation compared with experienced cardiologists 
based on ECG interpretation. Specifically, screening by inex-
perienced cardiologists resulted in a 5-fold increase in num-
ber of echocardiograms requested, 6-fold increase in exercise 
stress tests and Holter monitors, and a 12-fold increase in car-
diac magnetic resonance imaging scans compared with expe-
rienced cardiologists (Table 3). In addition to the increased 
Figure 3. The estimated interobserver 
reliability among cardiologists for 
secondary investigations after ECG 
interpretation. Inexperienced cardiologists 
demonstrated poorer interobserver 
reliability for secondary investigations 
compared with experienced cardiologists. 
CI indicates confidence interval.
Table 4. Proportions of Overall and Specific Agreement Among Cardiologists for Recommending 
Further Evaluation and Secondary Investigations After ECG Interpretation
 Cardiologists
Overall Agreement 
(+95% CI)
Agreement to 
Recommend (+95% CI)
Agreement Not to 
Recommend (+95% CI)
Further evaluation 
after screening
Inexperienced 0.77 (0.74–0.79) 0.38 (0.31–0.44) 0.86 (0.83–0.87)
 Experienced 0.92 (0.89–0.93) 0.45 (0.35–0.55) 0.95 (0.94–0.96)
Echocardiography Inexperienced 0.81 (0.78–0.84) 0.40 (0.32–0.47) 0.89 (0.87–0.90)
 Experienced 0.94 (0.92–0.95) 0.50 (0.37–0.61) 0.97 (0.96–0.98)
Exercise stress test Inexperienced 0.89 (0.87–0.91) 0.19 (0.10–0.29) 0.94 (0.93–0.95)
 Experienced 0.98 (0.96–0.99) 0.33 (0.11–0.53) 0.99 (0.98–0.99)
Holter Inexperienced 0.91 (0.89–0.92) 0.20 (0.12–0.29) 0.95 (0.94–0.96)
 Experienced 0.98 (0.97–0.99) 0.38 (0.07–0.63) 0.99 (0.98–0.99)
Cardiac MRI Inexperienced 0.92 (0.90–0.94) 0.27 (0.17–0.37) 0.96 (0.95–0.97)
 Experienced 0.99 (0.98–0.99) 0.24 (0.11–0.41) 0.99 (0.98–0.99)
Family screening Inexperienced 0.99 (0.98–0.99) 0.31 (0.00–0.67) 0.99 (0.99–0.99)
 Experienced 0.98 (0.97–0.99) 0.12 (0.00–0.35) 0.99 (0.99–0.99)
CI indicates confidence interval; and MRI, magnetic resonance imaging.
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number of investigations requested, interobserver reliability 
among inexperienced cardiologists for these secondary inves-
tigations ranged from poor to fair (Figure 3). Consequently, 
ECG-based preparticipation screening conducted by inexpe-
rienced cardiologists resulted in an ≈2-fold increase in cost 
compared with experienced cardiologists.
Experience was associated with a lower frequency of sec-
ondary investigations and improvement in proportion of over-
all agreement (Tables 3 and 4); nevertheless, interobserver 
reliability among experienced cardiologists for these investiga-
tions was only fair to moderate (Figure 3). In real-life practice, 
cardiovascular screening in athletes is conducted by physi-
cians of varying experience, ranging from general cardiolo-
gists, electrophysiologists, and sports physicians. Therefore, 
the variation in interpretation is likely to fall between the 2 
ranges above and will have significant implications on health 
resources that may preclude financial planning and sustain-
ability of nationwide ECG screening of young athletes.
Despite demonstrating a reduction in the number of posi-
tive ECGs with contemporary ECG criteria, inexperienced 
cardiologists proposed further investigations in 17.7% of the 
cohort, which is considerably higher than expected based on 
the authors’ experience and existing publications. This finding 
indicate that modification of ECG interpretation criteria may 
be associated with a lower positive ECG rate but may still not 
influence the personal practice among inexperienced cardiolo-
gists without further expert guidance.
Strategies to Reduce Variation in ECG 
Interpretation and Clinical Practice
Despite the success of the Italian athletic screening program 
in reducing sudden cardiac death, preparticipation screening 
with ECG remains a contentious issue given the absence of 
randomized control study evidence demonstrating that early 
detection of disease translates to lives saved, and conse-
quently, ECG screening is not universally practiced. Never-
theless, ECG screening is endorsed by several major sporting 
organizations including Fédération Internationale de Football 
Association and the International Olympic Committee.2,15 
Although our study has shown only moderate reliability for 
interpretation of the athlete’s ECG among experienced cardi-
ologists, we do not aim to deter sporting organizations from 
screening athletes with ECG. Indeed, the ECG is associated 
with interobserver reliability rates that are comparable to 
well-established and generally accepted screening tests such 
as Papanicolaou smear testing for cervical carcinoma and 
mammography for carcinoma of the breast.16–19 Furthermore, 
the only serious condition conferring increased risk of sudden 
cardiac death was identified on the basis of an abnormal ECG. 
By acknowledging the degree and impact of variation in ECG 
interpretation in athletes, our findings should herald the devel-
opment of effective educational approaches aimed at reducing 
this variation. Modification of guidelines for the interpretation 
of the ECG in athletes from the 2010 ESC recommendations to 
the Seattle and refined criteria seem to be useful in improving 
agreement and reliability in ECG interpretation especially in 
inexperienced cardiologists; however, a better understanding 
of physiological versus pathological ECG patterns requires 
appropriate training and education of physicians including 
cardiologists to potentially minimize variation regardless of 
whether ECG analysis is being conducted for screening pur-
poses or for diagnostic purposes. Recent small studies have 
demonstrated significant improvement in ECG interpretation 
in athletes after online training among inexperienced physi-
cians and hold promise for the future.20,21
In comparison to other established and endorsed screen-
ing programs in the UK National Health Service (www.gov.
uk/topic/population-screening-programmes) with similar 
rates of positive screening tests, there were no standardized 
diagnostic pathways for asymptomatic young athletes exhibit-
ing ECG anomalies.7,8,13,22–28 In this regard, the recently pub-
lished international recommendations for ECG screening in 
athletes are unique as they provide guidance to physicians 
on the minimal set of investigations for each electric abnor-
mality.29,30 Such guidance will hopefully reduce variation in 
clinical practice among screening cardiologists, which may 
improve efficiency.
Limitations
This study has several limitations warranting mention. The 
definition of experience in interpreting the ECG in athletes 
was arbitrary, but there is currently no formal accreditation 
available to quantify this more accurately. We only included 
adult cardiologists for this study, and hence, the findings may 
not be readily applicable to organizations whose athletes are 
screened by pediatric cardiologists, sports physicians, and 
other healthcare providers. Only 400 athlete ECGs were 
included to make the study feasible. All 400 athletes were not 
assessed with echocardiography, and consequently there is no 
gold-standard reference on which to calculate the interpreter’s 
accuracy for detecting of structural heart disease; however, 
our study aimed to investigate the level of interobserver vari-
ability in ECG interpretation and clinical practice rather than 
detection of disease. Although all cardiologists were supplied 
with published documents for all 3 ECG interpretation crite-
ria, we cannot exclude that some may not have strictly adhered 
to them and reported ECGs based on their own experience. 
Machine-generated intervals were removed to aptly test the 
knowledge of the cardiologists in this study, but the impact 
they present on variation is not known.
Conclusions
Interpretation of the ECG in young athletes and the resul-
tant cascade of downstream investigations is highly physi-
cian dependent even in experienced hands, which markedly 
impacts on the workload and cost of ECG screening. Formal 
training and development of a standardized diagnostic path-
way is essential to support cardiologists involved in cardiovas-
cular screening of young athletes.
Sources of Funding
H. Dhutia, A. Malhotra, and Dr Finocchiaro were funded by research 
grants from the Cardiac Risk in the Young organization.
Disclosures
Dr Sharma has been an applicant on previous grants from Cardiac 
Risk in the Young and British Heart Foundation to study athletes. The 
other authors report no conflicts.
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ABSTRACT Background: Screening of competitive athletes and other individuals exposed to regular and intense
physical exercise, such as military personnel, can lead to an early and preclinical identification of cardiac conditions
associated with a higher risk for sudden cardiac death. The electrocardiogram (ECG) has been recommended for
the precompetitive screening, but its interpretation remains controversial. The aim of this study was to compare three
different standardized criteria for interpretation of athletes’ ECG applied in military. Methods: Prospective study of
1,380 consecutive healthy military, 249 (18%) also involved in competitive sport, screened with clinical history, physi-
cal examination, and ECG. The ECG was interpreted according to the European Society of Cardiology (ESC) recom-
mendations, the Seattle Criteria (SC), and the Refined Criteria (RC). Findings: Independently of the criteria used, the
majority of the individuals included had ECG changes, mainly physiological: ESC 55.1%, SC 63.6%, and RC 64.4%.
The rate of pathological ECGs was significantly higher with the ESC criteria when compared to SC and RC (ESC
14.8%, SC 5.0% and RC 4.5%; p < 0.001). A significant cardiac abnormality was diagnosed with additional investiga-
tions in 4 patients (Brugada syndrome Type 1, mitral valve prolapse, bicuspid aortic valve, and Wolff–Parkinson–
White pattern). Discussion: Electrical cardiac adaptations are frequent in military personnel, similar to competitive
athletes. Some ECG changes, previously considered pathological, could in fact correspond to physiological adapta-
tions. The refinement of the ECG interpretation in this athletic population seems to reduce the rate of false-positive
cases. This may have a favorable socioeconomic impact, especially by reducing the health cost burden and number of
disability days.
INTRODUCTION
Screening of competitive athletes and other individuals
exposed to regular and intense physical exercise, such as
military personnel, can lead to an early and preclinical iden-
tification of cardiac conditions associated with a higher risk
for sudden cardiac death (SCD). Italian data have shown an
89% reduction in the incidence of SCD in competitive ath-
letes after the inclusion of the electrocardiogram (ECG) in
screening programs.1 Despite this, the methodology adopted
for precompetitive athlete evaluations remains somewhat
controversial. Despite the agreement for the inclusion of
clinical history (personal and family) and physical examina-
tion in these screening programs, the same is not true for
the ECG, emphasizing the dichotomy between European
countries and the United States of America, where it is not
formally recommended.2,3
Among the arguments against the inclusion of the ECG
in the evaluation of competitive athletes stands the higher
rate of false-positive cases, which lead to unnecessary addi-
tional investigations and inappropriate disqualification of
healthy individuals from competition. The majority of these
false positive cases are related to the higher variability and
the absence of standardization in ECG interpretation, with
classification of physiological adaptations induced by exer-
cise as pathological changes.4 Recently, specific criteria
were published aiming to standardize and improve the inter-
pretation of athletes’ ECG.5–8
The active duty military, especially those in Special
Forces, is characterized by intense physical exercise, similar
to competitive sport, but with some specificities that can
increase the risk of complications and clinical events. In this
setting, as recommended for the evaluation of competitive
athletes, military are frequently evaluated, with clinical his-
tory (personal and family), physical examination and 12-lead
resting ECG.9
The aim of this study was to compare three different spe-
cific criteria for the interpretation of athletes’ ECG applied
in a military population and assess which one associates
with higher accuracy and lower rate of false-positive cases.
METHODOLOGY
Population Studied
Prospective cross-sectional study of 1,380 Portuguese Armed
Forces military (Army, Navy, and Air Force) consecutively
evaluated in the yearly routine clinical evaluation, regularly
involved in physical exercise, training at least 4 hours per
*Armed Forces Hospital, Paço do Lumiar, 1690-020 Lisbon, Portugal.
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week. Individuals with cardiovascular (CV) symptoms and an
established diagnosis of cardiac disease were excluded from
this analysis. All the individuals included have given the
informed consent for the participation in the study.
Clinical and Sports History
The following baseline data were collected for all individ-
uals: demographics (age, gender, and ethnicity), anthropo-
metric data (weight and height), medical history with focus
on the clinical CV risk factors (hypertension, dyslipidemia,
smoking, diabetes, and family history of CV disease), medi-
cation, exercise-related characteristics, and sports history.
Dyslipidemia and diabetes were defined by the presence of
an abnormal lipid profile (total cholesterol ≥ 200 mg/dL,
low-density lipoprotein ≥ 100 mg/dL, and/or triglyceride
≥ 150 mg/dL), and fasting plasma glucose ≥ 126 mg/dL
(annually mandatory in military), respectively, and/or by
regular therapy for these conditions. History of smoking was
defined as active smoking or cessation in the last year. Fam-
ily history of CV disease was defined as the occurrence of
fatal or nonfatal CV events (sudden death, acute myocardial
infarction, or stroke) in first-degree relatives (men <55 years
and women <65 years).
Regarding sports history, we assessed the following char-
acteristics: number of training hours per week, type of sport,
sportive modalities, intensity of sport, and the number of
years at the competitive level. The type of sports were catego-
rized according to the classification proposed by Mitchell.10
Electrocardiogram
The 12-lead resting ECG was interpreted according to the
following criteria: European Society of Cardiology Criteria6
(ESC) recommendations, Seattle Criteria7 (SC), and Refined
Criteria8 (RC) (Fig. 1). The ECGs were assessed by two
cardiologists with experience in sports cardiology and classi-
fied into three categories: (1) normal, (2) with physiological
changes, and (3) with abnormal changes. In the case of
doubt or disagreement among the observers, a third cardiolo-
gist revised the traces. The individuals with ECGs classified
as abnormal by any of the criteria used were referred for
evaluation in a sports cardiology clinic, when appropriate
with the realization of additional investigations.
Statistical Analysis
Continuous variables with normal distribution were expressed
as means and standard deviations. Normality was tested with
the Kolmogorov–Smrinov test. Categorical variables were
expressed as frequencies and percentages. Statistical compari-
son of the baseline characteristics was performed using the χ 2
test or Fisher’s exact test, when appropriate, and Student t or
Mann–Whitney tests for continuous variables. To identify inde-
pendent predictors of abnormal ECG changes, a multivariate
analysis using a binary logistic regression model (enter method)
was performed. Two-tailed tests of significance are reported.
For all comparisons, a p value of <0.05 was considered statis-
tically significant. When appropriate, 95% confidence inter-
vals (CIs) were calculated. Statistical analysis was performed
with SPSS, version 21.0 (SPSS Inc., Chicago, Illinois).
RESULTS
Baseline Characteristics
Baseline characteristics are depicted in Table I. Briefly, of the
1,380 consecutive military analyzed, the majority were male
(88.8%), white (94.8%), and with a mean age of 30.1 ±
8.3 years old (23% veteran athletes). Regarding clinical CV
risk factors, smoking was present in almost a quarter of the
entire population (24.0%), whereas 6.7% had a family history
of CV disease and 3.0% a history of dyslipidemia (3.0%).
Concomitant clinical conditions were rare (asthma seen in
0.2% and hypothyroidism in 0.3%). Thirty individuals (2.2%)
were on regular pharmacological therapy, mainly statins.
Physical Exercise and Sports History
Data related to exercise habits and sport practice are presented
in Table II. The mean number of training hours per week was
6 ± 4 hours and 15.7% of the participants trained at least
10 hours per week. Beyond the exercise performed in the
context of military activity, approximately a fifth of the indi-
viduals (18.0%) were also involved in competitive sport,
whereas 18.7% had been competitive athletes in the past.
The large majority of the participants (1,030, 74.6%) were
involved in modalities characterized by high dynamic exercise
(class C of the Mitchell classification). Among the sports
modalities, the most frequent were long distance running
(45.0%) and soccer (15.9%).
Electrocardiogram
The most frequent ECG changes were sinus bradycardia
(44.0%), isolated QRS voltage for left ventricular hypertrophy
(28.0%) and early repolarization (24.7%). Among the poten-
tially abnormal changes, the most frequent were T wave
inversion (7.0% in two contiguous leads except III/V1/aVR),FIGURE 1. ECG classification according to the different criteria.
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axis deviation (5.6%), pathological Q wave (0.5%), Brugada
pattern (Type ½, seen in 3 cases), and ventricular pre-excitation
(1 case) (Table III). Independently of the criteria used, the
majority of individuals had ECG changes, mainly physiolog-
ical: ESC 55.1%, SC 63.6%, and RC 64.4%. In contrast, the
rate of pathological ECGs was significantly higher using
ESC when compared to SC and RC (ESC 14.8%, SC 5.0%,
and RC 4.5%; p < 0.001). Table IV presents ECG findings
according to the criteria used for its interpretation.
Predictors of Pathological ECG changes According
to the ESC Recommendations
Independently of the applied criteria, pathological ECG
changes were more frequent in younger and Black individ-
uals, training at least 10 hours per week and mainly in those
involved in competitive sport. According to the ESC recom-
mendations: age (28 ± 8 vs. 31 ± 8 years; p < 0.001), Black
ethnicity (32.8% vs. 14.0%; p < 0.001), training ≥ 10 hours
per week (19.8% vs. 14.3%; p = 0.040), and competitive
level (19.7% vs. 14.1%; p = 0.030); according to the SC:
age (27 ± 8 vs. 30 ± 8 years; p = 0.002), Black ethnicity
(13.8% vs. 4.6%; p = 0.002), training ≥ 10 hours per week
(9.7% vs. 4.3%; p = 0.001), and competitive level (19.7%
vs. 14.1%; p = 0.030); according to the RC: age (27 ± 8 vs.
30 ± 8 years; p = 0.002), Black ethnicity (15.5% vs. 4.0%;
p < 0.001), training ≥ 10 hours per week (7.4% vs. 4.2%;
p = 0.042), and competitive level (8.4% vs. 3.8%; p = 0.002).
By multivariate analysis, age (odds ratio [OR] 0.97, 95%
CI 0.95–0.99; p = 0.003) and Black ethnicity (OR 2.71,
95% CI 1.48–4.98; p = 0.001) remained independent predic-
tors of pathological ECG changes.
Additional Investigations
Approximately 7% of the population (N = 97) was evaluated
in a sports cardiology clinic: 83 were submitted to a trans-
thoracic echocardiogram, 77 had a treadmill stress test,
11 had 24-hour Holters, 7 had a cardiac magnetic resonance,
and 5 had a computed tomography angiography. One
TABLE I. Baseline Characteristics
Characteristics (N = 1,380) N (%)
Male Gender 1,226 (88.8)
Age (Years) 30 ± 8
BMI (kg/m2) 24.4 ± 2.9
Ethnicity
White 1,308 (94.8)
Black 58 (4.2)
Other 14 (1.0)
CV Risk Factors
>1 Risk Factor 222 (16.1)
Smoking 331 (24.0)
Dyslipidemia (TC ≥ 200 mg/dL or
LDL ≥ 100 mg/dL or TG ≥ 150 mg/dL)
42 (3.0)
Diabetes Mellitus (FPG ≥ 126 mg/dL or
HbA1c ≥ 6.5%)
11 (0.8)
Family History of CV 93 (6.7)
Obesity (BMI ≥ 30.0 kg/m2) 46 (3.3)
BMI, body mass index; FPG, fasting plasma glucose; LDL, low-density
lipoprotein; TC, total cholesterol; TG, triglyceride.
TABLE II. Sport History
Characteristics (N = 1,380) N (%)
Training Hours/Week 6 ± 4
≥ 10 h/Week 217 (15.7)
Competitive Sport 249 (18.0)
Competitive Sport in the Past 258 (18.7)
Sports Activity
High Dynamic Sport (Mitchell Class C) 1,030 (74.6)
Multimodality 604 (43.8)
Long Distance Running (>10 km) 621 (45.0)
Soccer 219 (15.9)
Weightlifting 130 (9.4)
Cycling 99 (7.2)
Swimming 44 (3.2)
TABLE III. Main Electrocardiographic Changes
ECG Findings (N = 1,380) N (%)
Sinus Bradycardia 607 (44.0)
Isolated QRS Voltage for Left Ventricular Hypertrophy 386 (28.0)
Early Repolarization 341 (24.7)
T Waves Inversiona 97 (7.0)
Incomplete Right Bundle Branch Block 72 (5.2)
First-Degree Atrioventricular Block 47 (3.4)
Right Axis Deviation 47 (3.4)
Left Axis Deviation 31 (2.2)
QTc > 440 Milliseconds in Males or
>460 Milliseconds in Females
17 (1.2)
Intraventricular Conduction Delay
(QRS >120 Milliseconds)b
8 (0.6)
Pathological Q Waves 7 (0.5)
Right Ventricular Hypertrophy 7 (0.5)
QTc < 380 Milliseconds 6 (0.4)
Second-Degree Atrioventricular Block Mobitz I 3 (0.2)
Premature Ventricular Contractionsc 3 (0.2)
Brugada Pattern (Type 1/2) 3 (0.2)
Ventricular Pre-Excitation 1 (0.1)
aExcept III/V1/aVR. b3 left bundle branch block and one right bundle
branch block. cIsolated in all the cases.
TABLE IV. Predictors of Pathological ECG Changes According
to the ESC Recommendations
Univariate Analysis
Characteristics
With
Pathological
Changes
Without
Pathological
Changes
Age 20.8 ± 8.3 31.0 ± 8.0 <0.001
Black Ethnicity 14 (8.1) 35 (3.4) 0.011
Competitive Sport 39 (24.4) 167 (18.0) 0.057
Multivariate Analysis
Characteristics OR CI 95% p Value
Age 0.97 0.95–0.99 0.003
Black Ethnicity 2.71 1.5–5.0 0.001
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week. Individuals with cardiovascular (CV) symptoms and an
established diagnosis of cardiac disease were excluded from
this analysis. All the individuals included have given the
informed consent for the participation in the study.
Clinical and Sports History
The following baseline data were collected for all individ-
uals: demographics (age, gender, and ethnicity), anthropo-
metric data (weight and height), medical history with focus
on the clinical CV risk factors (hypertension, dyslipidemia,
smoking, diabetes, and family history of CV disease), medi-
cation, exercise-related characteristics, and sports history.
Dyslipidemia and diabetes were defined by the presence of
an abnormal lipid profile (total cholesterol ≥ 200 mg/dL,
low-density lipoprotein ≥ 100 mg/dL, and/or triglyceride
≥ 150 mg/dL), and fasting plasma glucose ≥ 126 mg/dL
(annually mandatory in military), respectively, and/or by
regular therapy for these conditions. History of smoking was
defined as active smoking or cessation in the last year. Fam-
ily history of CV disease was defined as the occurrence of
fatal or nonfatal CV events (sudden death, acute myocardial
infarction, or stroke) in first-degree relatives (men <55 years
and women <65 years).
Regarding sports history, we assessed the following char-
acteristics: number of training hours per week, type of sport,
sportive modalities, intensity of sport, and the number of
years at the competitive level. The type of sports were catego-
rized according to the classification proposed by Mitchell.10
Electrocardiogram
The 12-lead resting ECG was interpreted according to the
following criteria: European Society of Cardiology Criteria6
(ESC) recommendations, Seattle Criteria7 (SC), and Refined
Criteria8 (RC) (Fig. 1). The ECGs were assessed by two
cardiologists with experience in sports cardiology and classi-
fied into three categories: (1) normal, (2) with physiological
changes, and (3) with abnormal changes. In the case of
doubt or disagreement among the observers, a third cardiolo-
gist revised the traces. The individuals with ECGs classified
as abnormal by any of the criteria used were referred for
evaluation in a sports cardiology clinic, when appropriate
with the realization of additional investigations.
Statistical Analysis
Continuous variables with normal distribution were expressed
as means and standard deviations. Normality was tested with
the Kolmogorov–Smrinov test. Categorical variables were
expressed as frequencies and percentages. Statistical compari-
son of the baseline characteristics was performed using the χ 2
test or Fisher’s exact test, when appropriate, and Student t or
Mann–Whitney tests for continuous variables. To identify inde-
pendent predictors of abnormal ECG changes, a multivariate
analysis using a binary logistic regression model (enter method)
was performed. Two-tailed tests of significance are reported.
For all comparisons, a p value of <0.05 was considered statis-
tically significant. When appropriate, 95% confidence inter-
vals (CIs) were calculated. Statistical analysis was performed
with SPSS, version 21.0 (SPSS Inc., Chicago, Illinois).
RESULTS
Baseline Characteristics
Baseline characteristics are depicted in Table I. Briefly, of the
1,380 consecutive military analyzed, the majority were male
(88.8%), white (94.8%), and with a mean age of 30.1 ±
8.3 years old (23% veteran athletes). Regarding clinical CV
risk factors, smoking was present in almost a quarter of the
entire population (24.0%), whereas 6.7% had a family history
of CV disease and 3.0% a history of dyslipidemia (3.0%).
Concomitant clinical conditions were rare (asthma seen in
0.2% and hypothyroidism in 0.3%). Thirty individuals (2.2%)
were on regular pharmacological therapy, mainly statins.
Physical Exercise and Sports History
Data related to exercise habits and sport practice are presented
in Table II. The mean number of training hours per week was
6 ± 4 hours and 15.7% of the participants trained at least
10 hours per week. Beyond the exercise performed in the
context of military activity, approximately a fifth of the indi-
viduals (18.0%) were also involved in competitive sport,
whereas 18.7% had been competitive athletes in the past.
The large majority of the participants (1,030, 74.6%) were
involved in modalities characterized by high dynamic exercise
(class C of the Mitchell classification). Among the sports
modalities, the most frequent were long distance running
(45.0%) and soccer (15.9%).
Electrocardiogram
The most frequent ECG changes were sinus bradycardia
(44.0%), isolated QRS voltage for left ventricular hypertrophy
(28.0%) and early repolarization (24.7%). Among the poten-
tially abnormal changes, the most frequent were T wave
inversion (7.0% in two contiguous leads except III/V1/aVR),FIGURE 1. ECG classification according to the different criteria.
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axis deviation (5.6%), pathological Q wave (0.5%), Brugada
pattern (Type ½, seen in 3 cases), and ventricular pre-excitation
(1 case) (Table III). Independently of the criteria used, the
majority of individuals had ECG changes, mainly physiolog-
ical: ESC 55.1%, SC 63.6%, and RC 64.4%. In contrast, the
rate of pathological ECGs was significantly higher using
ESC when compared to SC and RC (ESC 14.8%, SC 5.0%,
and RC 4.5%; p < 0.001). Table IV presents ECG findings
according to the criteria used for its interpretation.
Predictors of Pathological ECG changes According
to the ESC Recommendations
Independently of the applied criteria, pathological ECG
changes were more frequent in younger and Black individ-
uals, training at least 10 hours per week and mainly in those
involved in competitive sport. According to the ESC recom-
mendations: age (28 ± 8 vs. 31 ± 8 years; p < 0.001), Black
ethnicity (32.8% vs. 14.0%; p < 0.001), training ≥ 10 hours
per week (19.8% vs. 14.3%; p = 0.040), and competitive
level (19.7% vs. 14.1%; p = 0.030); according to the SC:
age (27 ± 8 vs. 30 ± 8 years; p = 0.002), Black ethnicity
(13.8% vs. 4.6%; p = 0.002), training ≥ 10 hours per week
(9.7% vs. 4.3%; p = 0.001), and competitive level (19.7%
vs. 14.1%; p = 0.030); according to the RC: age (27 ± 8 vs.
30 ± 8 years; p = 0.002), Black ethnicity (15.5% vs. 4.0%;
p < 0.001), training ≥ 10 hours per week (7.4% vs. 4.2%;
p = 0.042), and competitive level (8.4% vs. 3.8%; p = 0.002).
By multivariate analysis, age (odds ratio [OR] 0.97, 95%
CI 0.95–0.99; p = 0.003) and Black ethnicity (OR 2.71,
95% CI 1.48–4.98; p = 0.001) remained independent predic-
tors of pathological ECG changes.
Additional Investigations
Approximately 7% of the population (N = 97) was evaluated
in a sports cardiology clinic: 83 were submitted to a trans-
thoracic echocardiogram, 77 had a treadmill stress test,
11 had 24-hour Holters, 7 had a cardiac magnetic resonance,
and 5 had a computed tomography angiography. One
TABLE I. Baseline Characteristics
Characteristics (N = 1,380) N (%)
Male Gender 1,226 (88.8)
Age (Years) 30 ± 8
BMI (kg/m2) 24.4 ± 2.9
Ethnicity
White 1,308 (94.8)
Black 58 (4.2)
Other 14 (1.0)
CV Risk Factors
>1 Risk Factor 222 (16.1)
Smoking 331 (24.0)
Dyslipidemia (TC ≥ 200 mg/dL or
LDL ≥ 100 mg/dL or TG ≥ 150 mg/dL)
42 (3.0)
Diabetes Mellitus (FPG ≥ 126 mg/dL or
HbA1c ≥ 6.5%)
11 (0.8)
Family History of CV 93 (6.7)
Obesity (BMI ≥ 30.0 kg/m2) 46 (3.3)
BMI, body mass index; FPG, fasting plasma glucose; LDL, low-density
lipoprotein; TC, total cholesterol; TG, triglyceride.
TABLE II. Sport History
Characteristics (N = 1,380) N (%)
Training Hours/Week 6 ± 4
≥ 10 h/Week 217 (15.7)
Competitive Sport 249 (18.0)
Competitive Sport in the Past 258 (18.7)
Sports Activity
High Dynamic Sport (Mitchell Class C) 1,030 (74.6)
Multimodality 604 (43.8)
Long Distance Running (>10 km) 621 (45.0)
Soccer 219 (15.9)
Weightlifting 130 (9.4)
Cycling 99 (7.2)
Swimming 44 (3.2)
TABLE III. Main Electrocardiographic Changes
ECG Findings (N = 1,380) N (%)
Sinus Bradycardia 607 (44.0)
Isolated QRS Voltage for Left Ventricular Hypertrophy 386 (28.0)
Early Repolarization 341 (24.7)
T Waves Inversiona 97 (7.0)
Incomplete Right Bundle Branch Block 72 (5.2)
First-Degree Atrioventricular Block 47 (3.4)
Right Axis Deviation 47 (3.4)
Left Axis Deviation 31 (2.2)
QTc > 440 Milliseconds in Males or
>460 Milliseconds in Females
17 (1.2)
Intraventricular Conduction Delay
(QRS >120 Milliseconds)b
8 (0.6)
Pathological Q Waves 7 (0.5)
Right Ventricular Hypertrophy 7 (0.5)
QTc < 380 Milliseconds 6 (0.4)
Second-Degree Atrioventricular Block Mobitz I 3 (0.2)
Premature Ventricular Contractionsc 3 (0.2)
Brugada Pattern (Type 1/2) 3 (0.2)
Ventricular Pre-Excitation 1 (0.1)
aExcept III/V1/aVR. b3 left bundle branch block and one right bundle
branch block. cIsolated in all the cases.
TABLE IV. Predictors of Pathological ECG Changes According
to the ESC Recommendations
Univariate Analysis
Characteristics
With
Pathological
Changes
Without
Pathological
Changes
Age 20.8 ± 8.3 31.0 ± 8.0 <0.001
Black Ethnicity 14 (8.1) 35 (3.4) 0.011
Competitive Sport 39 (24.4) 167 (18.0) 0.057
Multivariate Analysis
Characteristics OR CI 95% p Value
Age 0.97 0.95–0.99 0.003
Black Ethnicity 2.71 1.5–5.0 0.001
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individual was also submitted to a flecainide drug challenge
test because of a baseline Type 2 Brugada pattern, which
was negative. After these evaluations, we confirmed cardiac
disease in 2 cases—1 patient with Brugada syndrome and 1
with the Wolff–Parkinson–White syndrome. These individ-
uals were excluded from exercise practice, the former perma-
nently and the last temporarily until percutaneous ablation.
Other relevant findings evidenced in the additional investiga-
tions included 1 case of mitral valve prolapse and 1 bicuspid
aortic valve, both without significant functional repercussion.
DISCUSSION
The application of more restrictive criteria for the interpreta-
tion of athletes’ ECG (SC and RC) was associated with a
significant reduction in the rate of false-positive cases
(approximately two-thirds) when compared to the ESC rec-
ommendations. The majority of the young military included
in this study had physiological ECG changes and only two
individuals were diagnosed with a relevant cardiac disease
(primary arrhythmic diseases).
Precompetitive Evaluation
The diagnosis of cardiac conditions associated with an
increased risk of SCD represents the main objective of
precompetitive screening of athletes and other individuals
under intense exercise training, as the case of military. In
this setting, the evaluation should focus on the preclinical
identification of CV disease, the main cause of SCD in these
populations. Although the inclusion of the clinical history
and physical examination in these screening programs seems
relatively straightforward, the inclusion of the ECG remains
controversial, mainly as a result of the dichotomy between
European countries and the United States of America, where
it is not formally recommended.9,11 There are several argu-
ments pro-ECG inclusion in precompetitive evaluation, such
as its accessibility and the fact that approximately two-thirds
of SCD in young athletes are caused by conditions
manifested with ECG changes.4 Otherwise, the main con for
the ECG in the context of athletes evaluation is the higher
rate of false-positive cases.
Exercise-Induced Cardiac Adaptations
Exercise training is responsible for several physiological
cardiac adaptations: structural, functional, and electrical. The
differentiation of these physiological adaptations with patho-
logical changes is often challenging because of the overlap
with common findings in cardiac conditions, as cardio-
myopathies and primary arrhythmic diseases.4 Nevertheless,
physiological changes should be well differentiated from
pathological abnormalities to reduce the risk of unnecessary
investigations and disqualification of healthy individuals
from competition. However, ECG changes in athletes or
individuals that exercise regularly are more frequent and
exuberant in the presence of specific demographic and
exercise-related characteristics.12–14 As previously reported,
our study showed more pathological ECG changes in youn-
ger and black individuals.
Interpretation of Athletes’ ECG
Recent investigations have showed that some ECG changes
which were previously considered pathological could in fact
correspond to physiological adaptations. In a study per-
formed by Gati et al15 in competitive athletes, 43% of the
ECGs changes were axis deviation or voltage criteria for
atria dilation, findings that were not associated with cardio-
myopathies and contributed to the higher rate of false-
positive cases. In this context, the reclassification of some
changes, as proposed in SC and RC, improves specify in the
interpretation of athletes’ ECG. The evaluation of T wave
inversion, long QT interval, axis deviation, and isolated volt-
age criteria for ventricle hypertrophy (left or right) are exam-
ples of these changes.16
Our study reveals that ESC recommendations are respon-
sible for an unacceptable higher rate of false-positive cases
when compared with the more recent criteria for ECG inter-
pretation in athletes. This has been reported in several stud-
ies since the publication of the SC. Brosnan et al16 showed
a similar reduction in the false-positive rate using SC vs.
ESC recommendations (4.5% vs. 17.3%; p < 0.001). The
RC, proposed by Sheikh et al,8 also associated with a sig-
nificant reduction of false-positive rate, including when
compared with the SC. It should be highlighted that this
study included a significant number of Black athletes in
whom the RC were shown to be more accurate. Additionally,
it was shown that, independently of the criteria used, when
applied in a population of young patients with hypertrophic
cardiomyopathy, the sensitivity to detect cardiac abnormalities
did not decrease.8
Particularities of the Military Activity
Military activity is characterized by a high intensity and vol-
ume of exercise, similar to that performed by some competi-
tive athletes. However, the evidence resultant from specific
studies in military population is scarce when compared with
the large number of studies in athletes. Still, studies have
shown similar incidence and causes of SCD in both
populations. A landmark study by Eckart et al17 analyzed
cases of SCD in 6.3 millions of military recruited in United
States of America during approximately 25 years (1977–
2001). This study showed that nontraumatic SCD was a rare
event (N = 126), mainly occurring as the result of a CV
cause (more frequently resulting from a coronary anomaly,
followed by myocarditis and hypertrophic cardiomyopathy),
in male and during exertion. However, it is important to
highlight that military activity has specificities that increase
the risk of exercise-related injuries.18 Military personnel
are exposed to extreme meteorological and geographic
conditions that can give rise to complications such as
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hypothermia, heat shock, or rhabdomyolysis with subse-
quent dehydration and hydroelectrolyte disturbances that can
precipitate malignant arrhythmias.18 The life-threatening
conditions in military operations, nuclear, biological, chemi-
cal, and radiological threat, the contact with explosives,
weapons used, type of equipment, isolation, and emotional
stress are factors that exponentially increase the risk—“con-
tinuum of operational stress.”19 On the other hand, military
training, in which resistance, mobility, strength, and flexibil-
ity are essential components, has simultaneously characteris-
tics of isotonic and isometric exercise. This may increase the
difficulty in differentiating physiological vs. pathological
changes. In this setting, the military should be periodically
evaluated as thoroughly as competitive athletes, focusing on
the preclinical identification of conditions potentially associ-
ated with an increased risk of SCD.
Limitations
This study presents some limitations. First, military are sub-
mitted to frequent medical examinations, including at admis-
sion in Armed Forces, before entry in specific courses and
periodically (at least annually). It follows that the majority
of the individuals included in this analysis had been assessed
multiple times and therefore our study represents a healthier
cohort which is not necessarily representative of a hypotheti-
cal population of individuals being initially considered for
military training. Second, the Portuguese Armed Forces rep-
resentativity in the sample is reduced, mostly because of the
lower number of female military or non-whites, limiting the
extension of the results. Third, as a result of the broad spec-
trum of the military, from members of Special Forces to
occupations which are considered sedentary, it would have
been nice to include a control group, to directly compare the
ECG results of the studied population, to ascertain whether
the rate of the observed ECG anomalies was truly different
compared with a civilian population. Fourth, this sort of
mass screening is not practical in military clinical settings
because of limitations of staffing and equipment, but it
would be possible in larger hospitals.
Fifth, as further investigations were only performed in
individuals with abnormal ECGs, it was not possible to
assess the false-negative rate. Finally, although the sample
size is not negligible, given the lower frequency of patholog-
ical changes detected in this population a larger sample size
may be necessary for stronger conclusions.
CONCLUSIONS
Electrical cardiac adaptations are frequent in military person-
nel. As in competitive athletes, the refinement of the ECG
interpretation in this athletic population seems to reduce the
rate of false-positive cases. This result may have a favorable
socioeconomic impact by reducing the health cost burden
and the number of disability days.
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individual was also submitted to a flecainide drug challenge
test because of a baseline Type 2 Brugada pattern, which
was negative. After these evaluations, we confirmed cardiac
disease in 2 cases—1 patient with Brugada syndrome and 1
with the Wolff–Parkinson–White syndrome. These individ-
uals were excluded from exercise practice, the former perma-
nently and the last temporarily until percutaneous ablation.
Other relevant findings evidenced in the additional investiga-
tions included 1 case of mitral valve prolapse and 1 bicuspid
aortic valve, both without significant functional repercussion.
DISCUSSION
The application of more restrictive criteria for the interpreta-
tion of athletes’ ECG (SC and RC) was associated with a
significant reduction in the rate of false-positive cases
(approximately two-thirds) when compared to the ESC rec-
ommendations. The majority of the young military included
in this study had physiological ECG changes and only two
individuals were diagnosed with a relevant cardiac disease
(primary arrhythmic diseases).
Precompetitive Evaluation
The diagnosis of cardiac conditions associated with an
increased risk of SCD represents the main objective of
precompetitive screening of athletes and other individuals
under intense exercise training, as the case of military. In
this setting, the evaluation should focus on the preclinical
identification of CV disease, the main cause of SCD in these
populations. Although the inclusion of the clinical history
and physical examination in these screening programs seems
relatively straightforward, the inclusion of the ECG remains
controversial, mainly as a result of the dichotomy between
European countries and the United States of America, where
it is not formally recommended.9,11 There are several argu-
ments pro-ECG inclusion in precompetitive evaluation, such
as its accessibility and the fact that approximately two-thirds
of SCD in young athletes are caused by conditions
manifested with ECG changes.4 Otherwise, the main con for
the ECG in the context of athletes evaluation is the higher
rate of false-positive cases.
Exercise-Induced Cardiac Adaptations
Exercise training is responsible for several physiological
cardiac adaptations: structural, functional, and electrical. The
differentiation of these physiological adaptations with patho-
logical changes is often challenging because of the overlap
with common findings in cardiac conditions, as cardio-
myopathies and primary arrhythmic diseases.4 Nevertheless,
physiological changes should be well differentiated from
pathological abnormalities to reduce the risk of unnecessary
investigations and disqualification of healthy individuals
from competition. However, ECG changes in athletes or
individuals that exercise regularly are more frequent and
exuberant in the presence of specific demographic and
exercise-related characteristics.12–14 As previously reported,
our study showed more pathological ECG changes in youn-
ger and black individuals.
Interpretation of Athletes’ ECG
Recent investigations have showed that some ECG changes
which were previously considered pathological could in fact
correspond to physiological adaptations. In a study per-
formed by Gati et al15 in competitive athletes, 43% of the
ECGs changes were axis deviation or voltage criteria for
atria dilation, findings that were not associated with cardio-
myopathies and contributed to the higher rate of false-
positive cases. In this context, the reclassification of some
changes, as proposed in SC and RC, improves specify in the
interpretation of athletes’ ECG. The evaluation of T wave
inversion, long QT interval, axis deviation, and isolated volt-
age criteria for ventricle hypertrophy (left or right) are exam-
ples of these changes.16
Our study reveals that ESC recommendations are respon-
sible for an unacceptable higher rate of false-positive cases
when compared with the more recent criteria for ECG inter-
pretation in athletes. This has been reported in several stud-
ies since the publication of the SC. Brosnan et al16 showed
a similar reduction in the false-positive rate using SC vs.
ESC recommendations (4.5% vs. 17.3%; p < 0.001). The
RC, proposed by Sheikh et al,8 also associated with a sig-
nificant reduction of false-positive rate, including when
compared with the SC. It should be highlighted that this
study included a significant number of Black athletes in
whom the RC were shown to be more accurate. Additionally,
it was shown that, independently of the criteria used, when
applied in a population of young patients with hypertrophic
cardiomyopathy, the sensitivity to detect cardiac abnormalities
did not decrease.8
Particularities of the Military Activity
Military activity is characterized by a high intensity and vol-
ume of exercise, similar to that performed by some competi-
tive athletes. However, the evidence resultant from specific
studies in military population is scarce when compared with
the large number of studies in athletes. Still, studies have
shown similar incidence and causes of SCD in both
populations. A landmark study by Eckart et al17 analyzed
cases of SCD in 6.3 millions of military recruited in United
States of America during approximately 25 years (1977–
2001). This study showed that nontraumatic SCD was a rare
event (N = 126), mainly occurring as the result of a CV
cause (more frequently resulting from a coronary anomaly,
followed by myocarditis and hypertrophic cardiomyopathy),
in male and during exertion. However, it is important to
highlight that military activity has specificities that increase
the risk of exercise-related injuries.18 Military personnel
are exposed to extreme meteorological and geographic
conditions that can give rise to complications such as
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hypothermia, heat shock, or rhabdomyolysis with subse-
quent dehydration and hydroelectrolyte disturbances that can
precipitate malignant arrhythmias.18 The life-threatening
conditions in military operations, nuclear, biological, chemi-
cal, and radiological threat, the contact with explosives,
weapons used, type of equipment, isolation, and emotional
stress are factors that exponentially increase the risk—“con-
tinuum of operational stress.”19 On the other hand, military
training, in which resistance, mobility, strength, and flexibil-
ity are essential components, has simultaneously characteris-
tics of isotonic and isometric exercise. This may increase the
difficulty in differentiating physiological vs. pathological
changes. In this setting, the military should be periodically
evaluated as thoroughly as competitive athletes, focusing on
the preclinical identification of conditions potentially associ-
ated with an increased risk of SCD.
Limitations
This study presents some limitations. First, military are sub-
mitted to frequent medical examinations, including at admis-
sion in Armed Forces, before entry in specific courses and
periodically (at least annually). It follows that the majority
of the individuals included in this analysis had been assessed
multiple times and therefore our study represents a healthier
cohort which is not necessarily representative of a hypotheti-
cal population of individuals being initially considered for
military training. Second, the Portuguese Armed Forces rep-
resentativity in the sample is reduced, mostly because of the
lower number of female military or non-whites, limiting the
extension of the results. Third, as a result of the broad spec-
trum of the military, from members of Special Forces to
occupations which are considered sedentary, it would have
been nice to include a control group, to directly compare the
ECG results of the studied population, to ascertain whether
the rate of the observed ECG anomalies was truly different
compared with a civilian population. Fourth, this sort of
mass screening is not practical in military clinical settings
because of limitations of staffing and equipment, but it
would be possible in larger hospitals.
Fifth, as further investigations were only performed in
individuals with abnormal ECGs, it was not possible to
assess the false-negative rate. Finally, although the sample
size is not negligible, given the lower frequency of patholog-
ical changes detected in this population a larger sample size
may be necessary for stronger conclusions.
CONCLUSIONS
Electrical cardiac adaptations are frequent in military person-
nel. As in competitive athletes, the refinement of the ECG
interpretation in this athletic population seems to reduce the
rate of false-positive cases. This result may have a favorable
socioeconomic impact by reducing the health cost burden
and the number of disability days.
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Case Report
Symptomatic Exercise-induced Intraventricular Gradient in 
Competitive Athlete
Helder Dores,1,2,3,4 Lígia Mendes,1,2 António Ferreira,2 Jose Ferreira Santos1
Hospital da Luz Setúbal,1 Setúbal; Hospital da Luz Lisboa;2 Hospital das Forças Armadas;3 NOVA Medical School,4 Lisboa - Portugal
Case Report
We describe the case of a 17-year-old caucasian male 
tennis player, training a mean of 20-24h/week, refereed for 
evaluation in Sport’s Cardiology clinic due to symptoms of 
dizziness on strenuous exercise, relieving soon after decubitus. 
The athlete denied other concomitant complaints, namely 
thoracic pain, palpitations, syncope or decrease in physical 
performance. Although this is the most symptomatic episode, 
he revealed other prior episodes with similar presentation, 
but less intense and occurring in environments with high 
temperatures. Personal/family history was unremarkable and 
all pre-competitive evaluations were normal and without 
restrictions for competitive sport. Physical examination 
did not show significant findings – cardiac evaluation was 
normal, heart rate and blood pressure at rest were 52 bpm 
121/64mmHg respectively. 
The 12-lead electrocardiogram and transthoracic 
echocardiogram did not show pathological findings, only 
cardiac physiological adaptations to exercise (Figure 1). 
Subsequently the athlete underwent a treadmill exercise 
stress echocardiogram revealing an excellent functional 
capacity (19’09’’ of Bruce protocol, 19.3METs), but with 
reproduction of symptoms (dizziness) in the peak of exercise 
with simultaneous decrease in systolic blood pressure (185
?90mmHg) and detection of intraventricular gradient (IVG) 
– at least 69mmHg (Figure 2). In the first minute of recovery 
the symptoms disappeared and blood pressure normalized.
The athlete was advertised to stop the sportive practice. 
An ambulatory 24h-Holter monitoring and cardiac magnetic 
resonance were subsequently performed, not showing 
pathological changes, namely arrhythmias or structural 
cardiac abnormalities. 
After these investigations the case was discussed with 
involvement of the athlete, parents and coach. It was decided 
to reinitiate exercise with a gradual increase in intensity and 
volume of training, with the special advertising to increase 
hydration (apparently suboptimal according to the coach 
report) and to begin beta-blocker therapy if the symptoms 
persist. After 18 months of follow-up the athlete remain 
asymptomatic, with excellent performance and without need 
of pharmacologic therapy.
Discussion
The development of significant exercise-induced IVG 
(>30mmHg at rest or >50mmHg with exercise) is uncommon, 
but can lead to several and unspecific symptoms such as 
dizziness, thoracic pain, or even ventricular repolarization 
changes and arrhythmias during exercise test.1,2 This condition 
is usually associated to global or segmental left ventricular 
hypertrophy or an abnormal implantation of the papillary 
muscles, but the pathophysiological mechanisms are not well 
established. Three potential mechanisms are purposed for the 
development of IVG:
a) Increase of physiological non-obstructive IVGs;
b) End-systolic obstruction secondary to ventricular 
cavity obliteration;
c) Mid-systolic obstruction due to systolic anterior motion 
of the mitral valve with restriction of ejection flow.3,4
In a study performed by Zywca et al.5 the independent 
predictors of dynamic left ventricular outflow tract obstruction in 
individuals without hypertrophic cardiomyopathy were: chordal 
systolic anterior motion, smaller left ventricle at end-systole, 
higher systolic blood pressure at peak, younger individuals and 
increased septal wall thickness.5 However, as in the case reported, 
IVG can occur without structural cardiac changes, namely of 
the mitral valve apparatus, and eventually justified by extreme 
myocardial deformation in response to load conditions.3 In 
this context, IVG is more frequently described in athletes or in 
situations with increased inotropic stimuli as during dobutamine 
stress echocardiogram.6,7 Exercise stress echocardiogram plays 
a relevant role in the evaluation of symptomatic athletes, with 
reproduction of symptoms and the potential detection of 
significant IVGs.1,8
The clinical significance of IVG remains unknown – it could 
be one extreme physiological adaptation to exercise, one isolated 
pathological entity or in the other hand corresponds to a pre-
phenotypic finding of cardiomyopathy.
Regarding the preventive/therapeutic measures to adopt in 
the presence of an athlete with IVG, maintenance adequate 
hydration during exercise is crucial, often sufficient for the 
remission of symptoms. Exercising under higher temperatures 
without adequate hydration can increase the gradient secondary 
to left ventricle cavity obliteration. Among the pharmacological 
therapy, the evidence indicates a significant effectiveness of beta-
blocker therapy, both in the remission of symptoms and in the 
remission/disappearance of IVG.1,9
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capacity (19’09’’ of Bruce protocol, 19.3METs), but with 
reproduction of symptoms (dizziness) in the peak of exercise 
with simultaneous decrease in systolic blood pressure (185
?90mmHg) and detection of intraventricular gradient (IVG) 
– at least 69mmHg (Figure 2). In the first minute of recovery 
the symptoms disappeared and blood pressure normalized.
The athlete was advertised to stop the sportive practice. 
An ambulatory 24h-Holter monitoring and cardiac magnetic 
resonance were subsequently performed, not showing 
pathological changes, namely arrhythmias or structural 
cardiac abnormalities. 
After these investigations the case was discussed with 
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The development of significant exercise-induced IVG 
(>30mmHg at rest or >50mmHg with exercise) is uncommon, 
but can lead to several and unspecific symptoms such as 
dizziness, thoracic pain, or even ventricular repolarization 
changes and arrhythmias during exercise test.1,2 This condition 
is usually associated to global or segmental left ventricular 
hypertrophy or an abnormal implantation of the papillary 
muscles, but the pathophysiological mechanisms are not well 
established. Three potential mechanisms are purposed for the 
development of IVG:
a) Increase of physiological non-obstructive IVGs;
b) End-systolic obstruction secondary to ventricular 
cavity obliteration;
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In a study performed by Zywca et al.5 the independent 
predictors of dynamic left ventricular outflow tract obstruction in 
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IVG can occur without structural cardiac changes, namely of 
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this context, IVG is more frequently described in athletes or in 
situations with increased inotropic stimuli as during dobutamine 
stress echocardiogram.6,7 Exercise stress echocardiogram plays 
a relevant role in the evaluation of symptomatic athletes, with 
reproduction of symptoms and the potential detection of 
significant IVGs.1,8
The clinical significance of IVG remains unknown – it could 
be one extreme physiological adaptation to exercise, one isolated 
pathological entity or in the other hand corresponds to a pre-
phenotypic finding of cardiomyopathy.
Regarding the preventive/therapeutic measures to adopt in 
the presence of an athlete with IVG, maintenance adequate 
hydration during exercise is crucial, often sufficient for the 
remission of symptoms. Exercising under higher temperatures 
without adequate hydration can increase the gradient secondary 
to left ventricle cavity obliteration. Among the pharmacological 
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Athlete with intraventricular gradient
Arq Bras Cardiol. 2017; 109(1):87-89
Figure 1 - Transthoracic echocardiogram at rest without evidence of significant morfo-functional abnormalities – left ventricle dimensions (LV) by M Mode (A), 
volumes and LV ejection fraction (B), tissular Doppler at mitral ring (C) and global longitudinal strain (D).
Figure 2 - Exercise stress echocardiogram performed in treadmill with Bruce protocol, revealing a significant decrease in systolic blood pressure (185 ? 90mmHg) 
in peak of exercise, with concomitant detection of IVG (bottom picture).
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The small published data and the short follow-up of athletes 
with IVG did not permit definite conclusions regarding the 
prognostic impact, but there are not described fatal clinical 
events in athletes with IVG without structural cardiac changes. In 
this setting there are not specific recommendations relatively to 
competitive sport in athletes with IVG.10,11 In general, if an athlete 
is still symptomatic despite the stressed preventive/therapeutic 
measures, it is not advised to maintain sportive practice, especially 
with the intensity of exercise that precipitates the symptoms, and 
this should be regularly evaluated during follow-up.
Shortly, in the presence of an athlete with exercise-induced 
symptoms, IVG should be taken in consideration. The exclusion 
of potential pathologies associated to an increased risk for sudden 
cardiac death is fundamental in the reproduction of symptoms, 
in which exercise stress echocardiogram plays an important role. 
IVG remains poorly clarified and some questions unanswered:
- Which is the etiology/pathophysiology of IVG (physiologic 
versus pathologic)?
- Which is the clinical impact at long-term of IVG?
- Which should be the recommendations regarding the 
eligibility for competitive sport of athletes with IVG?
- Which should be the surveillance/follow-up of athletes 
with IVG?
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Figure 1 - Transthoracic echocardiogram at rest without evidence of significant morfo-functional abnormalities – left ventricle dimensions (LV) by M Mode (A), 
volumes and LV ejection fraction (B), tissular Doppler at mitral ring (C) and global longitudinal strain (D).
Figure 2 - Exercise stress echocardiogram performed in treadmill with Bruce protocol, revealing a significant decrease in systolic blood pressure (185 ? 90mmHg) 
in peak of exercise, with concomitant detection of IVG (bottom picture).
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Abstract (1) To study the prevalence and severity of
coronary artery disease (CAD) in diabetic patients. (2) To
provide a detailed characterization of the coronary ath-
erosclerotic burden, including the localization, degree of
stenosis and plaque composition by coronary computed
tomography angiography (CCTA). Single center prospec-
tive registry including a total of 581 consecutive stable
patients (April 2011–March 2012) undergoing CCTA
(Dual-source CT) for the evaluation of suspected CAD
without previous myocardial infarction or revascularization
procedures. Different coronary plaque burden indexes and
plaque type and distribution patterns were compared
between patients with (n = 85) and without diabetes
(n = 496). The prevalence of CAD (any plaque; 74.1 vs.
56 %; p = 0.002) and obstructive CAD (C50 % stenosis;
31.8 vs. 10.3 %; p\ 0.001) were significantly higher in
diabetic patients. The remaining coronary atherosclerotic
burden indexes evaluated (plaque in LM-3v-2v with prox.
LAD; SIS; SSS; CT-LeSc) were also significantly higher in
diabetic patients. In the per segment analysis, diabetics had
a higher percentage of segments with plaque in every
vessel (2.6/13.1/7.5/10.5 % for diabetics vs. 1.4/7.1/3.3/
4.4 % for nondiabetics for LM, LAD, LCx, RCA respec-
tively; p\ 0.001 for all) and of both calcified (19.3 vs.
9.2 %, p\ 0.001) and noncalcified or mixed types (14.4
vs. 7.0 %; p\ 0.001); the ratio of proximal-to-distal rela-
tive plaque distribution (calculated as LM/proximal vs.
mid/distal/branches) was lower for diabetics (0.75 vs. 1.04;
p = 0.009). Diabetes was an independent predictor of
CAD and was also associated with more advanced CAD,
evaluated by indexes of coronary atherosclerotic burden.
Diabetics had a significantly higher prevalence of plaques
in every anatomical subset and for the different plaque
composition. In this report, the relative geographic distri-
bution of the plaques within each subgroup, favored a more
mid-to-distal localization in the diabetic patients.
Keywords Diabetes  Coronary artery disease 
Atherosclerotic burden  Coronary CT angiography
Introduction
Patients with diabetes are considered to be at an increased
risk of cardiovascular events and therefore it has been
recommended by many guidelines a more aggressive
management of this subset of patients, especially for those
with established cardiovascular disease [1, 2].
By contrast, on a primary prevention unselected popu-
lation level, some of the preventive measures for diabetic
patients, like the use of antiplatelets, have failed to dem-
onstrate a clear clinical benefit [3] and are no longer rec-
ommended in the absence of clinical evidence of
atherosclerotic disease [4]. The reason for the lack of
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benefit of aspirin in diabetic patients is likely related to the
fact that diabetic patients represents an heterogeneous
subset in what concerns the prevalence and severity of
atherosclerotic coronary burden.
This illustrates the need for risk stratification of diabetic
patients to identify the ones that can benefit from a more
aggressive management at earlier stages. This is an
opportunity for noninvasive imaging modalities, such as
coronary computed tomography angiography (CCTA),
which provides a detailed and comprehensive evaluation of
the presence and extent of coronary artery disease (CAD),
and can play an important role identifying the diabetic
patients that could benefit from a more aggressive pre-
vention of cardiovascular events.
Since CCTA is used mainly as a gatekeeper for the
exclusion of significant CAD [5], most of the referred
patients are at low to intermediate risk, this provides a good
setting to study atherosclerotic disease at an earlier stage.
Therefore the aim of this study is two-folded:
1. To study the prevalence and severity of CAD in
diabetic patients at earlier stages of CAD, to further
evaluate the concept of CAD equivalent.
2. To provide a detailed characterization of the coronary
atherosclerotic burden in diabetic patients, using
the comprehensive information derived from CCTA
on the localization, degree of stenosis and plaque
composition.
Methods
Population
Single center prospective registry, including a total of 772
consecutive patients undergoing CCTA (with Dual source
CT), from April 2011 to March 2012.
Patients were excluded if: (1) previous history of myo-
cardial infarction and/or revascularization procedures
(n = 70); (2) referred for Cardiac CT for other indications
than the evaluation of possible CAD (cardiac CT for atrial
fibrillation ablation or transcatheter aortic valve implanta-
tion procedures; n = 88); (3) referred for suspected acute
coronary syndromes (n = 24); (4) with atrial fibrillation or
other significant arrhythmias during scan acquisition that
compromised image quality (n = 9). This resulted in a
24.7 % of the total population being excluded.
For the purpose of this study, 581 stable patients refer-
red for suspected CAD were included in the context of: (1)
Previous equivocal or inconclusive stress tests or discor-
dant with the clinical evaluation (n = 417, 71.8 %); (2)
Cardiac CT as 1st line investigation of possible CAD
(n = 136, 23.4; %); 3) Preoperative CAD assessment
prior to noncoronary valvular or aortic surgery (n = 17;
2.9 %); (4) Evaluation of possible CAD in cardiomyopa-
thies (Dilated or Hypertrophic) (n = 11; 1.9 %) (Fig. 1:
Patient selection and study design).
The study was approved by the local ethics committee
and all patients gave a written informed consent.
A detailed medical history by means of a risk factors
questionnaire was obtained from the patients to assess for
the presence of: (1) Diabetes mellitus (defined as a fasting
glucose level of ‡7 mmol/l or the need for insulin or oral
hypoglycemic agents) [6]; (2) Dyslipidemia (defined as a
total cholesterol level ‡5 mmol/l or treatment with lipid-
lowering drugs) [7]; (3) Hypertension (defined as blood
pressure ‡140/90 mm Hg or the use of antihypertensive
medication) [8]; (4) Obesity (body mass index ‡30 kg/m2);
(5) positive family history of premature CAD [defined as
the presence of CAD in first-degree relatives younger than
55 (male) or 65 (female) years of age] [9]; (6) smoking
(defined as previous\1 year) or current smoker.
Pre-test probability of CAD was determined using both
the Diamond and Forrester extended CAD consortium
method (DF–CAD consortium model) [10] and the Morise
score [11]. The cardiovascular risk was assessed with the
HeartScore [4]. For the DF–CAD consortium probability
model, as the CAD probability and CV risk of our popu-
lation was shifted to lower probability (less that 2 % had a
‡70 % DF probability), the DF–CAD consortium model
categories ‡30–70 % and ‡70 % were gathered in a
intermediate to high (C30 %) probability group. For the
Morise, the original described cut-off points (for low,
intermediate and high probability) were used, and for the
HeartScore the established high risk cut-off of ‡5 % was
used.
Scan protocol and image reconstruction
All scans were performed with a dual-source scanner
(Somatom Definition, Siemens Medical, Germany), with
the patient in dorsal decubitus and in deep inspiration
breath-hold. Sublingual nitroglycerin was administered to
all patients except when contraindicated and intravenous
metoprolol (5 mg, with a titration dose up to 20 mg) was
administered in patients with heart rate[65 beats/min.
During the scan acquisition, a bolus of iodinated con-
trast (Visipaque, GE Healthcare, USA) was injected at a
6 ml/s infusion rate, followed by a 50-ml saline flush. The
dose of contrast was calculated according to the following
formula: (acquisition time ? 6 s delay) x flow (6 ml/s).
Contrast timing was performed to optimize uniform con-
trast enhancement of the coronary arteries.
Dose reduction strategies—including electrocardio-
gram-gated tube current modulation, reduced tube voltage,
and prospective axial triggering—were used whenever
1106 Int J Cardiovasc Imaging (2013) 29:1105–1114
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feasible. Mean estimated radiation dose was 4.6 ±
3.7 mSv, contrast dose was 98.9 ± 14.4 ml and heart rate
was 65.6 ± 10.6 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75 mm with
0.4 mm increments.
Post-processing was carried out using Circulation
software, with multiplanar reconstructions, maximum
intensity projection and volume rendering technique.
Coronary artery analysis
All scans were analyzed in the same session by both a
cardiologist and a radiologist with Level III—equivalent
experience. The Society of Cardiovascular Computed
Tomography (SCCT) recommended classification was used
regarding segmentation (16 segments), stenosis severity
(\25; 25–49; 50–69; 70–99; 100 %) and plaque composi-
tion (calcified, noncalcified, mixed plaque) [12]. In each
coronary artery segment, coronary atherosclerosis was
defined as tissue structures [1 mm2 that existed either
within the coronary artery lumen or adjacent to the coro-
nary artery lumen that could be discriminated from sur-
rounding pericardial tissue, epicardial fat, or the vessel
lumen itself. [13] Coronary atherosclerotic lesions were
quantified for stenosis by visual estimation. Percent
obstruction of coronary artery lumen was based on a
comparison of the luminal diameter of the segment
exhibiting obstruction to the luminal diameter of the most
normal-appearing site immediately proximal to the plaque.
In the detailed per segment analysis, for the distribution
of plaque on the 3 main coronary vessels, this rules were
applied: plaques in the diagonal branches were counted as
belonging to the left anterior descending (LAD); plaques in
the obtuse marginal an intermediate branch were counted
as belonging to the LCx; plaques in the posterior
descending and right postero-lateral were counted as
belonging to the right coronary artery (RCA). For the last
two, coronary dominance was taking into account. The
ratio of ‘‘proximal-to-distal relative plaque distribution’’
was calculated as the proportion of plaques between these
two subgroups: (1) Left main and proximal segments of the
LAD, LCx and RCA; (2) Mid and distal segments of LAD
and RCA, distal LCx and all evaluable coronary branches.
Definition of the coronary atherosclerotic burden
indexes
The following coronary atherosclerotic burden indexes
were evaluated and compared between patients with and
Fig. 1 Patient selection and
study design. CAD coronary
artery disease, TAVI
transcatheter aortic valve
implantation, aFib atrial
fibrillation, MI myocardial
infarction, CABG coronary
artery bypass grafting, PCI
percutaneous coronary
intervention, ACS acute
coronary syndromes
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For the purpose of this study, 581 stable patients refer-
red for suspected CAD were included in the context of: (1)
Previous equivocal or inconclusive stress tests or discor-
dant with the clinical evaluation (n = 417, 71.8 %); (2)
Cardiac CT as 1st line investigation of possible CAD
(n = 136, 23.4; %); 3) Preoperative CAD assessment
prior to noncoronary valvular or aortic surgery (n = 17;
2.9 %); (4) Evaluation of possible CAD in cardiomyopa-
thies (Dilated or Hypertrophic) (n = 11; 1.9 %) (Fig. 1:
Patient selection and study design).
The study was approved by the local ethics committee
and all patients gave a written informed consent.
A detailed medical history by means of a risk factors
questionnaire was obtained from the patients to assess for
the presence of: (1) Diabetes mellitus (defined as a fasting
glucose level of ‡7 mmol/l or the need for insulin or oral
hypoglycemic agents) [6]; (2) Dyslipidemia (defined as a
total cholesterol level ‡5 mmol/l or treatment with lipid-
lowering drugs) [7]; (3) Hypertension (defined as blood
pressure ‡140/90 mm Hg or the use of antihypertensive
medication) [8]; (4) Obesity (body mass index ‡30 kg/m2);
(5) positive family history of premature CAD [defined as
the presence of CAD in first-degree relatives younger than
55 (male) or 65 (female) years of age] [9]; (6) smoking
(defined as previous\1 year) or current smoker.
Pre-test probability of CAD was determined using both
the Diamond and Forrester extended CAD consortium
method (DF–CAD consortium model) [10] and the Morise
score [11]. The cardiovascular risk was assessed with the
HeartScore [4]. For the DF–CAD consortium probability
model, as the CAD probability and CV risk of our popu-
lation was shifted to lower probability (less that 2 % had a
‡70 % DF probability), the DF–CAD consortium model
categories ‡30–70 % and ‡70 % were gathered in a
intermediate to high (C30 %) probability group. For the
Morise, the original described cut-off points (for low,
intermediate and high probability) were used, and for the
HeartScore the established high risk cut-off of ‡5 % was
used.
Scan protocol and image reconstruction
All scans were performed with a dual-source scanner
(Somatom Definition, Siemens Medical, Germany), with
the patient in dorsal decubitus and in deep inspiration
breath-hold. Sublingual nitroglycerin was administered to
all patients except when contraindicated and intravenous
metoprolol (5 mg, with a titration dose up to 20 mg) was
administered in patients with heart rate[65 beats/min.
During the scan acquisition, a bolus of iodinated con-
trast (Visipaque, GE Healthcare, USA) was injected at a
6 ml/s infusion rate, followed by a 50-ml saline flush. The
dose of contrast was calculated according to the following
formula: (acquisition time ? 6 s delay) x flow (6 ml/s).
Contrast timing was performed to optimize uniform con-
trast enhancement of the coronary arteries.
Dose reduction strategies—including electrocardio-
gram-gated tube current modulation, reduced tube voltage,
and prospective axial triggering—were used whenever
1106 Int J Cardiovasc Imaging (2013) 29:1105–1114
123
Author's personal copy
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
125 
MANUSCRIPT 11 
 
 
 
 
feasible. Mean estimated radiation dose was 4.6 ±
3.7 mSv, contrast dose was 98.9 ± 14.4 ml and heart rate
was 65.6 ± 10.6 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75 mm with
0.4 mm increments.
Post-processing was carried out using Circulation
software, with multiplanar reconstructions, maximum
intensity projection and volume rendering technique.
Coronary artery analysis
All scans were analyzed in the same session by both a
cardiologist and a radiologist with Level III—equivalent
experience. The Society of Cardiovascular Computed
Tomography (SCCT) recommended classification was used
regarding segmentation (16 segments), stenosis severity
(\25; 25–49; 50–69; 70–99; 100 %) and plaque composi-
tion (calcified, noncalcified, mixed plaque) [12]. In each
coronary artery segment, coronary atherosclerosis was
defined as tissue structures [1 mm2 that existed either
within the coronary artery lumen or adjacent to the coro-
nary artery lumen that could be discriminated from sur-
rounding pericardial tissue, epicardial fat, or the vessel
lumen itself. [13] Coronary atherosclerotic lesions were
quantified for stenosis by visual estimation. Percent
obstruction of coronary artery lumen was based on a
comparison of the luminal diameter of the segment
exhibiting obstruction to the luminal diameter of the most
normal-appearing site immediately proximal to the plaque.
In the detailed per segment analysis, for the distribution
of plaque on the 3 main coronary vessels, this rules were
applied: plaques in the diagonal branches were counted as
belonging to the left anterior descending (LAD); plaques in
the obtuse marginal an intermediate branch were counted
as belonging to the LCx; plaques in the posterior
descending and right postero-lateral were counted as
belonging to the right coronary artery (RCA). For the last
two, coronary dominance was taking into account. The
ratio of ‘‘proximal-to-distal relative plaque distribution’’
was calculated as the proportion of plaques between these
two subgroups: (1) Left main and proximal segments of the
LAD, LCx and RCA; (2) Mid and distal segments of LAD
and RCA, distal LCx and all evaluable coronary branches.
Definition of the coronary atherosclerotic burden
indexes
The following coronary atherosclerotic burden indexes
were evaluated and compared between patients with and
Fig. 1 Patient selection and
study design. CAD coronary
artery disease, TAVI
transcatheter aortic valve
implantation, aFib atrial
fibrillation, MI myocardial
infarction, CABG coronary
artery bypass grafting, PCI
percutaneous coronary
intervention, ACS acute
coronary syndromes
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without diabetes: (1) Coronary artery disease (CAD)—
presence of any plaque in the coronary tree; (2)
‘‘Obstructive CAD’’—presence of at least one plaque with
‡50 % stenosis; (3) ‘‘LM-3v-2v with proximal LAD’’—
Plaque in the left main or in the 3 main epicardial vessels
or in 2 main epicardial vessels including the proximal
left anterior descending (LAD); (4) ‘‘SIS’’—segment
involvement score, obtained as the total number of seg-
ments with plaque; (5) ‘‘SSS’’—segment stenosis score,
obtained by grading the stenosis severity of each segment
with plaque, as was previously described [13]. For these
last two, the prognostically validated cut-offs ([5) were
used [13]
(6) ‘‘Calcium score (CaSc) ‡100’’; (7) ‘‘CaSc ‡75th
percentile’’ (according to published nomograms [14]; (8)
CCTA-adapted Leaman score (CT-LeSc)—this score was
calculated taking in account 3 weighting factors (locali-
zation, plaque composition and stenosis severity) according
to previously described methodology and the same cut-off
for high plaque burden (C8.3) was used (provided as
additional information to the reviewers, since the manu-
script, where it is originally described, is under consider-
ation elsewhere). In Fig. 2, two case examples of diabetic
patients with nonobstructive CAD are shown, with the
different plaque burden indexes.
Statistical analysis
Continuous variables are presented as mean ± SD or
medians (interquartile range) and categorical variables as
frequencies with percentages.
The non-parametric Mann–Whitney or Kruskal–Wallis
tests were used to compare continuous variables. Chi
square test was used to evaluate differences in frequencies.
Differences were regarded significant when p\ 0.05 (two-
tailed).
Multivariate analyses (binary logistic regression
model—enter method) were performed to identify inde-
pendent predictors of CAD (any plaque and obstructive)
using the demographic and clinical variables presented in
Table 1, that were significant in univariate analysis
(p\ 0.05). A second multivariable analyses was per-
formed to identify independent predictors among the clin-
ical scores of CAD probability (Diamond-Forrester CAD
consortium model and Morise score) and the CV risk score
HeartScore. For the detailed per segment analysis, the unit
of measure was each segment and there were no adjust-
ments or corrections made for the serial correlation
between segments.
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) was
used for all statistical analyses.
Fig. 2 Two case examples of diabetic patients with nonobstructive
CAD. The different plaque burden indexes are shown. CAD coronary
artery disease, SIS segment involvement score, SSS segment stenosis
score, CT-LeSc CT Leaman score, LM left main, LAD left anterior
descending, LCx left circunflex, RCA right coronary artery, LM-3 V-
2VproxLAD plaque in left main or 3 vessels or 2 vessels with
proximal LAD
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Results
Study population
In the final study population (n = 581), 85 patients were
diabetics (14.6 %).
Regarding the demographic and clinical variables, dia-
betic patients were older (mean age 61.4 ± 8.7 vs.
56.9 ± 11.3) and had a higher prevalence of obesity (28.6 %
vs. 17.4 %) and hypertension (84.7 vs. 58.9 %). This was
predominantly a population with low to intermediate CAD
probability, more so in the nondiabetic population since
61.7 % had a DF–CAD consortium\30 and 90.7 % had a
Morise score\16. The cardiovascular risk, as estimatedwith
the HeartScore (C5 %), was significantly higher in the
patients with diabetes (42.4 vs. 22.6 %) (Table 1).
Independent predictors of CAD
Diabetes was an independent predictor of both the presence
of plaque (OR 1.81; 95 % CI 1.02–3.21; p = 0.041) and of
obstructive CAD (OR 3.69; 95 % CI 2.08–6.53; p\ 0.001).
The other independent predictors of the presence of plaque
were age ‡65 years (OR 3.42; 95 % CI 2.15–5.45;
p\ 0.001), male sex (OR 2.72; 95 % CI 1.85–4.01;
p\ 0.001), hypertension (OR 1.82; 95 % CI 1.23–2.67;
p = 0.002), dyslipidemia (OR1.89; 95 %CI 1.29–2.77; p =
0.001), chest pain (OR 0.62; 95 %CI 0.42–0.91; p = 0.014)
an DF–CAD consortium ‡30 % (OR 2.62; 95 % CI
1.70–4.05; p\ 0.001), a Morise score ‡16 (OR 2.55; 95 %
CI 1.57–4.14; p\ 0.001), and an HeartScore ‡5 % (OR
3.90; 95 %CI 2.19–6.94; p\ 0.001). The other independent
predictors of obstructive CADwere age ‡65 years (OR 1.98;
95 %CI 1.16–3.37; p = 0.012),male sex (OR2.94; 95 %CI
1.68–5.15; p\ 0.001), an DF–CAD consortium ‡30 % (OR
1.88; 95 % CI 1.04–3.42; p = 0.038), a Morise score ‡16
(OR 1.84; 95 % CI 1.06–3.20; p = 0.031), and an Heart-
Score ‡5 % (OR 2.71; 95 % CI 1.50–4.88; p = 0.001).
Coronary artery disease prevalence, severity
and coronary atherosclerotic burden indexes—per
patient analysis
The prevalence of plaques in the coronary arteries was high
in the overall study population, but this was significantly
higher for diabetic patients, as almost 3 out of 4 diabetic
patients (74.1 %) had plaques in the coronary arteries.
Table 1 Demographic and clinical characteristics of the study
population
No diabetes
(n = 496)
Diabetes
(n = 85)
p
Demographic
Age 56.9 ± 11.3 61.4 ± 8.7 \0.001
Male sex 277 (55.8) 47 (55.3) 1.000
Risk factors
Obesity (BMI ‡30) 85 (17.4) 24 (28.6) 0.023
Hypertension 292 (58.9) 72 (84.7) \0.001
Dyslipidemia 301 (60.7) 59 (69.4) 0.147
Smoking 118 (23.8) 20 (23.5) 1.000
Family history of premature
CAD
168 (33.9) 26 (30.6) 0.619
Chest pain 265 (54.3) 46 (54.1) 1.000
CAD probability
DF–CAD consortium ‡30 % 189 (38.1) 42 (49.4) 0.049
DF–CAD consortium\30 % 307 (61.9) 43 (50.6)
Morise score ‡16 46 (9.3) 26 (30.6) \0.001
Morise score 9–15 316 (63.7) 53 (62.4)
Morise score 0–8 134 (27.0) 6 (7.1)
CV risk
HeartScore ‡5 % 112 (22.6) 36 (42.4) \0.001
Values are mean ± SD or n (%)
CAD coronary artery disease, BMI body mass index, DF–CAD con-
sortium diamond-forrester CAD consortium model, CV cardiovascular
Table 2 Calcium score and CCTA characteristics of the study
population
No diabetes
(n = 496)
Diabetes
(n = 85)
p
Calcium score
Median 0 (0-67) 68 (0-311) \0.001
CaSc ‡100 96 (19.4) 40 (47.1) \0.001
CaSc ‡75th percentile 60 (12.1) 23 (27.1) 0.001
CCTA
Normal/No plaque 217 (43.8) 22 (25.9) \0.001
Nonobstructive CAD 228 (46.0) 36 (42.4)
Obstructive CAD 51 (10.3) 27 (31.8)
Coronary atherosclerotic burden indexes
Plaque in LM-3v-2v with
prox. LAD
178 (35.9) 53 (62.4) \0.001
Segment involvement score
[5
66 (13.3) 31 (36.5) \0.001
Segment stenosis score[5 25 (5.0) 21 (24.7) \0.001
CT-Leaman Score ‡8.3 79 (15.9) 35 (41.2) \0.001
Technical data
Heart rate (bpm) 65.3 ± 10.6 67.0 ± 10.2 0.172
Contrast dose (ml) 99.3 ± 14.7 96.7 ± 12.3 0.119
Radiation dose (mSv) 4.7 ± 4.9 5.7 ± 3.8 0.069
Values are mean ± SD, median (IQR) or n (%)
CaSc calcium score, CCTA coronary computed tomography angiog-
raphy, CAD coronary artery disease, LM-3v-2v left main, 3 vessel, 2
vessel, LAD left anterior descending, bpm beats per minute, mSv
milisievert
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without diabetes: (1) Coronary artery disease (CAD)—
presence of any plaque in the coronary tree; (2)
‘‘Obstructive CAD’’—presence of at least one plaque with
‡50 % stenosis; (3) ‘‘LM-3v-2v with proximal LAD’’—
Plaque in the left main or in the 3 main epicardial vessels
or in 2 main epicardial vessels including the proximal
left anterior descending (LAD); (4) ‘‘SIS’’—segment
involvement score, obtained as the total number of seg-
ments with plaque; (5) ‘‘SSS’’—segment stenosis score,
obtained by grading the stenosis severity of each segment
with plaque, as was previously described [13]. For these
last two, the prognostically validated cut-offs ([5) were
used [13]
(6) ‘‘Calcium score (CaSc) ‡100’’; (7) ‘‘CaSc ‡75th
percentile’’ (according to published nomograms [14]; (8)
CCTA-adapted Leaman score (CT-LeSc)—this score was
calculated taking in account 3 weighting factors (locali-
zation, plaque composition and stenosis severity) according
to previously described methodology and the same cut-off
for high plaque burden (C8.3) was used (provided as
additional information to the reviewers, since the manu-
script, where it is originally described, is under consider-
ation elsewhere). In Fig. 2, two case examples of diabetic
patients with nonobstructive CAD are shown, with the
different plaque burden indexes.
Statistical analysis
Continuous variables are presented as mean ± SD or
medians (interquartile range) and categorical variables as
frequencies with percentages.
The non-parametric Mann–Whitney or Kruskal–Wallis
tests were used to compare continuous variables. Chi
square test was used to evaluate differences in frequencies.
Differences were regarded significant when p\ 0.05 (two-
tailed).
Multivariate analyses (binary logistic regression
model—enter method) were performed to identify inde-
pendent predictors of CAD (any plaque and obstructive)
using the demographic and clinical variables presented in
Table 1, that were significant in univariate analysis
(p\ 0.05). A second multivariable analyses was per-
formed to identify independent predictors among the clin-
ical scores of CAD probability (Diamond-Forrester CAD
consortium model and Morise score) and the CV risk score
HeartScore. For the detailed per segment analysis, the unit
of measure was each segment and there were no adjust-
ments or corrections made for the serial correlation
between segments.
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) was
used for all statistical analyses.
Fig. 2 Two case examples of diabetic patients with nonobstructive
CAD. The different plaque burden indexes are shown. CAD coronary
artery disease, SIS segment involvement score, SSS segment stenosis
score, CT-LeSc CT Leaman score, LM left main, LAD left anterior
descending, LCx left circunflex, RCA right coronary artery, LM-3 V-
2VproxLAD plaque in left main or 3 vessels or 2 vessels with
proximal LAD
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Results
Study population
In the final study population (n = 581), 85 patients were
diabetics (14.6 %).
Regarding the demographic and clinical variables, dia-
betic patients were older (mean age 61.4 ± 8.7 vs.
56.9 ± 11.3) and had a higher prevalence of obesity (28.6 %
vs. 17.4 %) and hypertension (84.7 vs. 58.9 %). This was
predominantly a population with low to intermediate CAD
probability, more so in the nondiabetic population since
61.7 % had a DF–CAD consortium\30 and 90.7 % had a
Morise score\16. The cardiovascular risk, as estimatedwith
the HeartScore (C5 %), was significantly higher in the
patients with diabetes (42.4 vs. 22.6 %) (Table 1).
Independent predictors of CAD
Diabetes was an independent predictor of both the presence
of plaque (OR 1.81; 95 % CI 1.02–3.21; p = 0.041) and of
obstructive CAD (OR 3.69; 95 % CI 2.08–6.53; p\ 0.001).
The other independent predictors of the presence of plaque
were age ‡65 years (OR 3.42; 95 % CI 2.15–5.45;
p\ 0.001), male sex (OR 2.72; 95 % CI 1.85–4.01;
p\ 0.001), hypertension (OR 1.82; 95 % CI 1.23–2.67;
p = 0.002), dyslipidemia (OR1.89; 95 %CI 1.29–2.77; p =
0.001), chest pain (OR 0.62; 95 %CI 0.42–0.91; p = 0.014)
an DF–CAD consortium ‡30 % (OR 2.62; 95 % CI
1.70–4.05; p\ 0.001), a Morise score ‡16 (OR 2.55; 95 %
CI 1.57–4.14; p\ 0.001), and an HeartScore ‡5 % (OR
3.90; 95 %CI 2.19–6.94; p\ 0.001). The other independent
predictors of obstructive CADwere age ‡65 years (OR 1.98;
95 %CI 1.16–3.37; p = 0.012),male sex (OR2.94; 95 %CI
1.68–5.15; p\ 0.001), an DF–CAD consortium ‡30 % (OR
1.88; 95 % CI 1.04–3.42; p = 0.038), a Morise score ‡16
(OR 1.84; 95 % CI 1.06–3.20; p = 0.031), and an Heart-
Score ‡5 % (OR 2.71; 95 % CI 1.50–4.88; p = 0.001).
Coronary artery disease prevalence, severity
and coronary atherosclerotic burden indexes—per
patient analysis
The prevalence of plaques in the coronary arteries was high
in the overall study population, but this was significantly
higher for diabetic patients, as almost 3 out of 4 diabetic
patients (74.1 %) had plaques in the coronary arteries.
Table 1 Demographic and clinical characteristics of the study
population
No diabetes
(n = 496)
Diabetes
(n = 85)
p
Demographic
Age 56.9 ± 11.3 61.4 ± 8.7 \0.001
Male sex 277 (55.8) 47 (55.3) 1.000
Risk factors
Obesity (BMI ‡30) 85 (17.4) 24 (28.6) 0.023
Hypertension 292 (58.9) 72 (84.7) \0.001
Dyslipidemia 301 (60.7) 59 (69.4) 0.147
Smoking 118 (23.8) 20 (23.5) 1.000
Family history of premature
CAD
168 (33.9) 26 (30.6) 0.619
Chest pain 265 (54.3) 46 (54.1) 1.000
CAD probability
DF–CAD consortium ‡30 % 189 (38.1) 42 (49.4) 0.049
DF–CAD consortium\30 % 307 (61.9) 43 (50.6)
Morise score ‡16 46 (9.3) 26 (30.6) \0.001
Morise score 9–15 316 (63.7) 53 (62.4)
Morise score 0–8 134 (27.0) 6 (7.1)
CV risk
HeartScore ‡5 % 112 (22.6) 36 (42.4) \0.001
Values are mean ± SD or n (%)
CAD coronary artery disease, BMI body mass index, DF–CAD con-
sortium diamond-forrester CAD consortium model, CV cardiovascular
Table 2 Calcium score and CCTA characteristics of the study
population
No diabetes
(n = 496)
Diabetes
(n = 85)
p
Calcium score
Median 0 (0-67) 68 (0-311) \0.001
CaSc ‡100 96 (19.4) 40 (47.1) \0.001
CaSc ‡75th percentile 60 (12.1) 23 (27.1) 0.001
CCTA
Normal/No plaque 217 (43.8) 22 (25.9) \0.001
Nonobstructive CAD 228 (46.0) 36 (42.4)
Obstructive CAD 51 (10.3) 27 (31.8)
Coronary atherosclerotic burden indexes
Plaque in LM-3v-2v with
prox. LAD
178 (35.9) 53 (62.4) \0.001
Segment involvement score
[5
66 (13.3) 31 (36.5) \0.001
Segment stenosis score[5 25 (5.0) 21 (24.7) \0.001
CT-Leaman Score ‡8.3 79 (15.9) 35 (41.2) \0.001
Technical data
Heart rate (bpm) 65.3 ± 10.6 67.0 ± 10.2 0.172
Contrast dose (ml) 99.3 ± 14.7 96.7 ± 12.3 0.119
Radiation dose (mSv) 4.7 ± 4.9 5.7 ± 3.8 0.069
Values are mean ± SD, median (IQR) or n (%)
CaSc calcium score, CCTA coronary computed tomography angiog-
raphy, CAD coronary artery disease, LM-3v-2v left main, 3 vessel, 2
vessel, LAD left anterior descending, bpm beats per minute, mSv
milisievert
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All the indexes of coronary atherosclerotic burden were
significantly higher in diabetics as compared to nondia-
betics (Table 2; Fig. 3).
For some of these indexes, like the presence of
obstructive disease, and the SSS, the prevalence was 3–5
times higher in diabetics.
By gender, male diabetics had more often coronary
artery disease (any plaque and obstructive), as compared to
their counterparts (Fig. 4).
Prevalence, localization and type of plaques—per
segment analysis
For the analysis of the atherosclerotic burden indexes,
8,136 coronary segments were evaluated for the presence
of plaque, degree of stenosis and type of plaque. Because
of small size (\2 mm) or insufficient image quality related
to artifacts or severe calcification, 866 (10.6 %) segments
were excluded (n = 723–10.4 % in nondiabetics;
n = 143–12.0 % in diabetics).
On a ‘‘per evaluable segment’’ analysis, diabetics had
significantly more segments with plaque and this was
observed in the left main as well as in the other 3 coronary
territories and in both more proximal and more distal
locations (Table 3; Fig. 5). The prevalence of obstructive
plaque was also significantly higher in patients with, as
compared to patients without diabetes (11.6 vs. 6.9 %,
p\ 0.001).
On a ‘‘per segment with plaque’’ analysis, nondiabetics
had an almost equal distribution of plaques between more
proximal (LM/proximal segments) and more mid-to-distal
(Mid/distal/branches) localization (ratio of 1.04), but the
opposite was seen in patients with diabetes, in whom more
plaques were found in the more mid-to-distal segments, as
reflected by a ratio of ‘‘proximal-to-distal relative plaque
distribution’’ of 0.75 (Table 3).
Regarding plaque composition, diabetics had also a
higher percentage of all types of plaques (both calcified and
noncalcified or mixed plaques) per evaluable segment
(Table 4).
Discussion
The main findings of this study are:
1. Although diabetic patients had a higher prevalence of
coronary artery disease, coronary atherosclerotic
plaques were commonly observed in both patients
with and without diabetes.
Fig. 3 Diabetes and indexes of
coronary atherosclerotic burden.
CAD coronary artery disease,
LM left main, LAD left anterior
descending, LCx left circunflex,
LM-3 V-2VproxLAD plaque in
left main or 3 vessels or 2
vessels with proximal LAD, SIS
segment involvement score, SSS
segment stenosis score, CT-
LeSc CT Leaman score
Fig. 4 Prevalence of coronary artery disease (any plaque and
obstructive) across the different diabetes and sex subgroups. CAD
coronary artery disease
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2. Several different coronary atherosclerotic burden indexes
were more prevalent in diabetics, indicating more diffuse
and severe CAD, and this was especially true for males.
3. In the detailed per segment analysis, diabetics had a
higher percentage of segments with plaque in every
vessel and of both calcified and noncalcified or mixed
types; ratio of proximal-to-distal relative plaque distri-
bution suggested an anatomical gradient in the geo-
graphic distribution, with higher proportion of disease
involvement in the mid/distal/branches segments in
diabetic patients.
Diabetes as an heterogeneous group—not all diabetics
have the same CV risk
For many years, diabetic patients have been considered as a
subset at higher risk of cardiovascular events. Nevertheless,
Table 3 Prevalence, and localization of plaques—per segment analysis
No diabetes (n = 496;
6,957 segments)
Diabetes (n = 85;
1,187 segments)
p
All evaluable segments 6,234 (89.6) 1,044 (88.0) 0.093
Segments with any plaque 1,008 (16.2) 352 (33.7) \0.001
Coronary artery distribution
Any plaque in the LM 87 (1.4) 27 (2.6) 0.007
Any plaque in the RCA 276 (4.4) 110 (10.5) \0.001
Any plaque in the LAD 441 (7.1) 137 (13.1) \0.001
Any plaque in the LCx/Ramus 204 (3.3) 78 (7.5) \0.001
Proximal versus distal distribution
Any plaque in LM/Proximal 514 (8.2) 151 (14.5) \0.001
Any plaque in Mid/Distal/Branches 494 (7.9) 201 (19.3) \0.001
‘‘Ratio of proximal-to-distal relative plaque distribution’’ 1.04 (514/494) 0.75 (151/201) 0.009
‘‘Ratio of proximal-to-distal relative plaque distribution’’—proportion of plaques in the ‘‘LM/Proximal’’ versus ‘‘Mid/Distal/branches’’
LM left main, RCA right coronary artery, LAD left anterior descending, LCx left circunflex, Ramus intermediate branch, ‘‘LM/Prox’’ left main or
proximal segments of the LAD, LCx or RCA, ‘‘Mid/Distal/Branches’’ mid or distal segments of the LAD and RCA, distal segment of the LCx,
and branches
Fig. 5 Prevalence and localization of plaques (any plaque) on a per
segment analysis. LM left main, LAD left anterior descending, LCx
left circunflex, RCA right coronary artery
Table 4 Type of plaques—per
segment analysis
LM left main, RCA right
coronary artery, LAD left
anterior descending, LCx left
circunflex, Ramus intermediate
branch, ‘‘LM/Proximal’’ left
main or proximal segments of
the LAD, LCx or RCA, ‘‘Mid/
Distal/Branches’’ Mid or distal
segments of the LAD and RCA,
distal segment of the LCx, and
branches
No diabetes (n = 496;
6,957 segments)
Diabetes (n = 85;
1,187 segments)
p
All evaluable segments 6,234 (89.6) 1,044 (88.0) 0.093
Segments with any plaque 1,008 (16.2) 352 (33.7) \0.001
Calcified plaque
All segments 571 (9.2) 202 (19.3) \0.001
LM/Proximal 291 (4.7) 83 (8.0) \0.001
Mid/Distal/Branches 280 (4.5) 119 (11.4) \0.001
Noncalcified or mixed plaques
All segments 437 (7.0) 150 (14.4) \0.001
LM/Proximal 223 (3.6) 68 (6.5) \0.001
Mid/Distal/Branches 214 (3.4) 82 (7.9) \0.001
Int J Cardiovasc Imaging (2013) 29:1105–1114 1111
123
Author's personal copy
Tese para obtenção do grau de Doutor em Medicina na Especialidade em Investigação Clínica132
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
128 
MANUSCRIPT 11 
 
 
 
 
 
All the indexes of coronary atherosclerotic burden were
significantly higher in diabetics as compared to nondia-
betics (Table 2; Fig. 3).
For some of these indexes, like the presence of
obstructive disease, and the SSS, the prevalence was 3–5
times higher in diabetics.
By gender, male diabetics had more often coronary
artery disease (any plaque and obstructive), as compared to
their counterparts (Fig. 4).
Prevalence, localization and type of plaques—per
segment analysis
For the analysis of the atherosclerotic burden indexes,
8,136 coronary segments were evaluated for the presence
of plaque, degree of stenosis and type of plaque. Because
of small size (\2 mm) or insufficient image quality related
to artifacts or severe calcification, 866 (10.6 %) segments
were excluded (n = 723–10.4 % in nondiabetics;
n = 143–12.0 % in diabetics).
On a ‘‘per evaluable segment’’ analysis, diabetics had
significantly more segments with plaque and this was
observed in the left main as well as in the other 3 coronary
territories and in both more proximal and more distal
locations (Table 3; Fig. 5). The prevalence of obstructive
plaque was also significantly higher in patients with, as
compared to patients without diabetes (11.6 vs. 6.9 %,
p\ 0.001).
On a ‘‘per segment with plaque’’ analysis, nondiabetics
had an almost equal distribution of plaques between more
proximal (LM/proximal segments) and more mid-to-distal
(Mid/distal/branches) localization (ratio of 1.04), but the
opposite was seen in patients with diabetes, in whom more
plaques were found in the more mid-to-distal segments, as
reflected by a ratio of ‘‘proximal-to-distal relative plaque
distribution’’ of 0.75 (Table 3).
Regarding plaque composition, diabetics had also a
higher percentage of all types of plaques (both calcified and
noncalcified or mixed plaques) per evaluable segment
(Table 4).
Discussion
The main findings of this study are:
1. Although diabetic patients had a higher prevalence of
coronary artery disease, coronary atherosclerotic
plaques were commonly observed in both patients
with and without diabetes.
Fig. 3 Diabetes and indexes of
coronary atherosclerotic burden.
CAD coronary artery disease,
LM left main, LAD left anterior
descending, LCx left circunflex,
LM-3 V-2VproxLAD plaque in
left main or 3 vessels or 2
vessels with proximal LAD, SIS
segment involvement score, SSS
segment stenosis score, CT-
LeSc CT Leaman score
Fig. 4 Prevalence of coronary artery disease (any plaque and
obstructive) across the different diabetes and sex subgroups. CAD
coronary artery disease
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2. Several different coronary atherosclerotic burden indexes
were more prevalent in diabetics, indicating more diffuse
and severe CAD, and this was especially true for males.
3. In the detailed per segment analysis, diabetics had a
higher percentage of segments with plaque in every
vessel and of both calcified and noncalcified or mixed
types; ratio of proximal-to-distal relative plaque distri-
bution suggested an anatomical gradient in the geo-
graphic distribution, with higher proportion of disease
involvement in the mid/distal/branches segments in
diabetic patients.
Diabetes as an heterogeneous group—not all diabetics
have the same CV risk
For many years, diabetic patients have been considered as a
subset at higher risk of cardiovascular events. Nevertheless,
Table 3 Prevalence, and localization of plaques—per segment analysis
No diabetes (n = 496;
6,957 segments)
Diabetes (n = 85;
1,187 segments)
p
All evaluable segments 6,234 (89.6) 1,044 (88.0) 0.093
Segments with any plaque 1,008 (16.2) 352 (33.7) \0.001
Coronary artery distribution
Any plaque in the LM 87 (1.4) 27 (2.6) 0.007
Any plaque in the RCA 276 (4.4) 110 (10.5) \0.001
Any plaque in the LAD 441 (7.1) 137 (13.1) \0.001
Any plaque in the LCx/Ramus 204 (3.3) 78 (7.5) \0.001
Proximal versus distal distribution
Any plaque in LM/Proximal 514 (8.2) 151 (14.5) \0.001
Any plaque in Mid/Distal/Branches 494 (7.9) 201 (19.3) \0.001
‘‘Ratio of proximal-to-distal relative plaque distribution’’ 1.04 (514/494) 0.75 (151/201) 0.009
‘‘Ratio of proximal-to-distal relative plaque distribution’’—proportion of plaques in the ‘‘LM/Proximal’’ versus ‘‘Mid/Distal/branches’’
LM left main, RCA right coronary artery, LAD left anterior descending, LCx left circunflex, Ramus intermediate branch, ‘‘LM/Prox’’ left main or
proximal segments of the LAD, LCx or RCA, ‘‘Mid/Distal/Branches’’ mid or distal segments of the LAD and RCA, distal segment of the LCx,
and branches
Fig. 5 Prevalence and localization of plaques (any plaque) on a per
segment analysis. LM left main, LAD left anterior descending, LCx
left circunflex, RCA right coronary artery
Table 4 Type of plaques—per
segment analysis
LM left main, RCA right
coronary artery, LAD left
anterior descending, LCx left
circunflex, Ramus intermediate
branch, ‘‘LM/Proximal’’ left
main or proximal segments of
the LAD, LCx or RCA, ‘‘Mid/
Distal/Branches’’ Mid or distal
segments of the LAD and RCA,
distal segment of the LCx, and
branches
No diabetes (n = 496;
6,957 segments)
Diabetes (n = 85;
1,187 segments)
p
All evaluable segments 6,234 (89.6) 1,044 (88.0) 0.093
Segments with any plaque 1,008 (16.2) 352 (33.7) \0.001
Calcified plaque
All segments 571 (9.2) 202 (19.3) \0.001
LM/Proximal 291 (4.7) 83 (8.0) \0.001
Mid/Distal/Branches 280 (4.5) 119 (11.4) \0.001
Noncalcified or mixed plaques
All segments 437 (7.0) 150 (14.4) \0.001
LM/Proximal 223 (3.6) 68 (6.5) \0.001
Mid/Distal/Branches 214 (3.4) 82 (7.9) \0.001
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it has been difficult to prove a clear benefit of some primary
prevention measures, like is the case of aspirin in the pri-
mary prevention of cardiovascular events. This inconsistent
benefit of aspirin in the absence of clinical manifestations
of cardiovascular disease, can be related to the fact that it is
less effective in these patients [15] or more likely that
diabetic patients are an heterogeneous group in terms of
cardiovascular disease presence and extent. This way,
without risk stratification, we could be overtreating some
low risk diabetic patients, exposing them to the risk of side
effects that could offset the reduction in expected athero-
thrombotic events rate.
Of note, there has been a more consistent beneficial
effect of aspirin as primary preventive measure in males,
for reducing the risk of myocardial infarction [3] and this is
in line with our findings of higher prevalence of coronary
plaques and obstructive CAD in this subgroup, as com-
pared to females.
Recently, Saely et al. [16] revisited the concept of dia-
betes as a CAD equivalent in a study comparing the vas-
cular event rate of patients according to the presence of
diabetes and/or CAD. In this study, diabetes was not per se
a CAD risk equivalent, since diabetic patients without
significant CAD had a lower event rate than nondiabetic
patients with significant CAD.
CCTA derived coronary atherosclerotic burden indexes
Scores derived from invasive angiography have previously
demonstrated to further stratify diabetic patients with more
advanced CAD [17].We hypothesized that this could also be
the case for diabetics with less severe CAD, using the com-
prehensive information derived fromCCTAon the presence,
localization, degree of stenosis and plaque composition.
Several different aspects of coronary disease are
reflected in these scores: prevalence and severity (any
plaque and obstructive CAD), number of plaques (SIS),
number and distribution (plaque in LM-3v-2v with prox.
LAD), number and stenosis severity (SSS), absolute and
relative amount of calcified plaque (CaSc ‡100 and ‡75th
percentile) and localization, stenosis severity and type of
plaque (CT-Le score). All the coronary atherosclerotic
burden indexes were significantly higher in diabetics as
compared to nondiabetics, reflecting the higher prevalence
as well as the more severe coronary disease of this subset
of patients and they can be useful as noninvasive imaging
tools for risk stratification. Some of these indexes have
already been prognostically validated and demonstrated a
good correlation with major cardiovascular events [13, 18,
19]. In our view, since the prevalence of plaque is very
high, even in this predominantly low-to-intermediate CAD
probability population, these coronary atherosclerotic bur-
den indexes can help risk stratify patients and should
ideally be included in the CCTA report. However, since
they convey information on different aspects of CAD, with
some overlap in the information they provide and, in
clinical practice, reporting on all of them is not suitable,
ideally we should be able to decide in the future which
one(s) should be routinely used, based on their prognostic
performance.
Anatomical distribution and plaque composition
In this report, the higher prevalence of plaques in diabetic
patients was seen in the left main as well as in the other 3
coronary territories and in both proximal and distal locations.
Regarding the left main and the other proximal locations, we
observed a higher percentage of plaques in diabetics as
compared to nondiabetics. This is in line with previous
studies linking the geographic distribution of myocardial
infarction culprit lesions to more proximal locations in the
coronary tree [20] and could explain the higher incidence of
coronary events experienced by diabetic patients.
One interesting finding in our study is related to the
relative geographic localization of plaques in diabetics as
compared to patients without diabetes.
Although in prevalence of evaluable segments, diabetics
had more plaques in every location (both proximal and dis-
tal) compared to nondiabetics, the relative geographic plaque
distribution was different in the two subgroups of patients,
since diabetics had a ratio of ‘‘proximal-to-distal relative
plaque distribution’’ of 0.75 (vs. 1.04 for nondiabetics),
suggesting a higher predisposition to disease involvement of
the more distal segments. This finding, on a per segment
analysis, together with the higher prevalence of a SIS[5 on
the per patient analysis reflects the more diffuse nature of
coronary atherosclerotic burden of diabetic patients.
As diabetic patients are considered to be a model of
more advanced CAD, this could suggest that as the coro-
nary atherosclerosis progresses, distal segments become
more involved by disease, although serial measurements in
time would be the ideal setting to evaluate this hypothesis.
The per segment analysis allowed also the evaluation of
the plaque composition. Diabetic patients had a signifi-
cantly higher prevalence of segments with both calcified
and noncalcified or mixed plaques, in both more proximal
or more distal locations. The proportion of calcified to
noncalcified or mixed plaques was the same for both sub-
groups of patients.
Limitations
There are a number of limitations related to this report:
1. This is a single center data with medium size cohort;
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2. The population included in our study was mainly
composed of patients with low to intermediate CAD
probability and CV risk, as this reflects daily practice
of CCTA being used as a gatekeeper to exclude
obstructive CAD and are in line with the recommen-
dations. Since coronary plaques were present in nearly
60 % of the patients, this was an opportunity to
evaluate the coronary atherosclerotic burden pattern of
DM patients at earlier stages.
3. There were some differences in the baseline charac-
teristics of the two subgroups of patients, that could
have contributed to the higher disease extent observed
in diabetic patients. Nevertheless, after adjusting for
those differences, diabetes remained an independent
predictor of both the presence and severity of CAD.
4. Since patients were referred for CCTA because of
symptoms and/or the results of stress tests, some
referral bias has to be acknowledged.
Conclusions
Diabetes was an independent predictor of CAD and was
also associated with more advanced CAD, evaluated by
indexes of coronary atherosclerotic burden.
The comprehensive information regarding the presence,
severity and type of plaque noninvasively provided by
CCTA, has made possible a detailed characterization of the
coronary disease pattern of diabetic patients at an earlier
stage of disease.
Diabetics had a significantly higher prevalence of pla-
ques in every anatomical subset (type of vessel and both
proximal or distal localizations) and for the different pla-
que composition (both calcified and noncalcified or mixed).
In this report, the relative geographic distribution of the
plaques within each subgroup, favored a more mid-to-distal
localization in the diabetic patients.
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it has been difficult to prove a clear benefit of some primary
prevention measures, like is the case of aspirin in the pri-
mary prevention of cardiovascular events. This inconsistent
benefit of aspirin in the absence of clinical manifestations
of cardiovascular disease, can be related to the fact that it is
less effective in these patients [15] or more likely that
diabetic patients are an heterogeneous group in terms of
cardiovascular disease presence and extent. This way,
without risk stratification, we could be overtreating some
low risk diabetic patients, exposing them to the risk of side
effects that could offset the reduction in expected athero-
thrombotic events rate.
Of note, there has been a more consistent beneficial
effect of aspirin as primary preventive measure in males,
for reducing the risk of myocardial infarction [3] and this is
in line with our findings of higher prevalence of coronary
plaques and obstructive CAD in this subgroup, as com-
pared to females.
Recently, Saely et al. [16] revisited the concept of dia-
betes as a CAD equivalent in a study comparing the vas-
cular event rate of patients according to the presence of
diabetes and/or CAD. In this study, diabetes was not per se
a CAD risk equivalent, since diabetic patients without
significant CAD had a lower event rate than nondiabetic
patients with significant CAD.
CCTA derived coronary atherosclerotic burden indexes
Scores derived from invasive angiography have previously
demonstrated to further stratify diabetic patients with more
advanced CAD [17].We hypothesized that this could also be
the case for diabetics with less severe CAD, using the com-
prehensive information derived fromCCTAon the presence,
localization, degree of stenosis and plaque composition.
Several different aspects of coronary disease are
reflected in these scores: prevalence and severity (any
plaque and obstructive CAD), number of plaques (SIS),
number and distribution (plaque in LM-3v-2v with prox.
LAD), number and stenosis severity (SSS), absolute and
relative amount of calcified plaque (CaSc ‡100 and ‡75th
percentile) and localization, stenosis severity and type of
plaque (CT-Le score). All the coronary atherosclerotic
burden indexes were significantly higher in diabetics as
compared to nondiabetics, reflecting the higher prevalence
as well as the more severe coronary disease of this subset
of patients and they can be useful as noninvasive imaging
tools for risk stratification. Some of these indexes have
already been prognostically validated and demonstrated a
good correlation with major cardiovascular events [13, 18,
19]. In our view, since the prevalence of plaque is very
high, even in this predominantly low-to-intermediate CAD
probability population, these coronary atherosclerotic bur-
den indexes can help risk stratify patients and should
ideally be included in the CCTA report. However, since
they convey information on different aspects of CAD, with
some overlap in the information they provide and, in
clinical practice, reporting on all of them is not suitable,
ideally we should be able to decide in the future which
one(s) should be routinely used, based on their prognostic
performance.
Anatomical distribution and plaque composition
In this report, the higher prevalence of plaques in diabetic
patients was seen in the left main as well as in the other 3
coronary territories and in both proximal and distal locations.
Regarding the left main and the other proximal locations, we
observed a higher percentage of plaques in diabetics as
compared to nondiabetics. This is in line with previous
studies linking the geographic distribution of myocardial
infarction culprit lesions to more proximal locations in the
coronary tree [20] and could explain the higher incidence of
coronary events experienced by diabetic patients.
One interesting finding in our study is related to the
relative geographic localization of plaques in diabetics as
compared to patients without diabetes.
Although in prevalence of evaluable segments, diabetics
had more plaques in every location (both proximal and dis-
tal) compared to nondiabetics, the relative geographic plaque
distribution was different in the two subgroups of patients,
since diabetics had a ratio of ‘‘proximal-to-distal relative
plaque distribution’’ of 0.75 (vs. 1.04 for nondiabetics),
suggesting a higher predisposition to disease involvement of
the more distal segments. This finding, on a per segment
analysis, together with the higher prevalence of a SIS[5 on
the per patient analysis reflects the more diffuse nature of
coronary atherosclerotic burden of diabetic patients.
As diabetic patients are considered to be a model of
more advanced CAD, this could suggest that as the coro-
nary atherosclerosis progresses, distal segments become
more involved by disease, although serial measurements in
time would be the ideal setting to evaluate this hypothesis.
The per segment analysis allowed also the evaluation of
the plaque composition. Diabetic patients had a signifi-
cantly higher prevalence of segments with both calcified
and noncalcified or mixed plaques, in both more proximal
or more distal locations. The proportion of calcified to
noncalcified or mixed plaques was the same for both sub-
groups of patients.
Limitations
There are a number of limitations related to this report:
1. This is a single center data with medium size cohort;
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2. The population included in our study was mainly
composed of patients with low to intermediate CAD
probability and CV risk, as this reflects daily practice
of CCTA being used as a gatekeeper to exclude
obstructive CAD and are in line with the recommen-
dations. Since coronary plaques were present in nearly
60 % of the patients, this was an opportunity to
evaluate the coronary atherosclerotic burden pattern of
DM patients at earlier stages.
3. There were some differences in the baseline charac-
teristics of the two subgroups of patients, that could
have contributed to the higher disease extent observed
in diabetic patients. Nevertheless, after adjusting for
those differences, diabetes remained an independent
predictor of both the presence and severity of CAD.
4. Since patients were referred for CCTA because of
symptoms and/or the results of stress tests, some
referral bias has to be acknowledged.
Conclusions
Diabetes was an independent predictor of CAD and was
also associated with more advanced CAD, evaluated by
indexes of coronary atherosclerotic burden.
The comprehensive information regarding the presence,
severity and type of plaque noninvasively provided by
CCTA, has made possible a detailed characterization of the
coronary disease pattern of diabetic patients at an earlier
stage of disease.
Diabetics had a significantly higher prevalence of pla-
ques in every anatomical subset (type of vessel and both
proximal or distal localizations) and for the different pla-
que composition (both calcified and noncalcified or mixed).
In this report, the relative geographic distribution of the
plaques within each subgroup, favored a more mid-to-distal
localization in the diabetic patients.
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Abstract
Background: The relation between body mass index (BMI) and coronary artery disease (CAD) extension remains
controversial. The aim of this study was to evaluate the correlation between BMI and CAD extension documented by
coronary computed tomography angiography (CCTA).
Methods and results: Prospective registry including 1706 consecutive stable patients that performed CCTA (dual
source scanner) for the evaluation of CAD. The population was stratified by BMI: normal 530 (31.1%), overweight 802
(47.0%) and obesity 374 (21.9%). BMI was significantly higher in patients with CAD (27.7� 4.3 vs 26.8� 4.3 kg/m2,
p< 0.001); these patients were also older, more often male and had higher prevalence of diabetes, hypertension and
dyslipidemia. By multivariate analysis (logistic regression) BMI remains an independent predictor of CAD (odds ratio
(OR) 1.03, 95% confidence interval (CI) 1.01–1.06; p¼ 0.012). Regarding the severity of CAD, BMI was not significantly
different among patients with and without obstructive CAD (27.7� 4.3 vs 27.2� 4.3 kg/m2, p¼ 0.120). In 319 patients
(4516 segments; 4077 evaluable), a detailed atherosclerotic burden was evaluated and compared among BMI classes,
defined according to the presence of plaque and the degree of stenosis. Obstructive CAD was identified in 16.9% of the
patients and 45.1% had non-obstructive CAD. The discriminative threshold for high burden, established by the segment
involvement score (SIS), was >5 segments with plaque (15.4% patients). The prevalence of SIS >5 among the BMI classes
was: 18.7%, 13.7% and 13.6% for normal, overweight and obesity respectively (p values for the specific classes versus all
other patients: 0.241, 0.450 and 0.663).
Conclusions: In this population of stable patients undergoing CCTA for suspected CAD, BMI was an independent
predictor of its presence, but was not correlated with the coronary disease severity.
Keywords
Cardiac computed tomography, body mass index, coronary artery disease
Received 7 January 2013; accepted 29 May 2013
Introduction
In recent years, obesity has reached epidemic propor-
tions, and is currently a highly prevalent chronic con-
dition associated with significant morbidity and
mortality.1 In the general population, overweight and
obesity are associated with an increased risk of cardio-
vascular disease and all-cause mortality.2,3 However,
among patients with known coronary artery disease
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Abstract
Background: The relation between body mass index (BMI) and coronary artery disease (CAD) extension remains
controversial. The aim of this study was to evaluate the correlation between BMI and CAD extension documented by
coronary computed tomography angiography (CCTA).
Methods and results: Prospective registry including 1706 consecutive stable patients that performed CCTA (dual
source scanner) for the evaluation of CAD. The population was stratified by BMI: normal 530 (31.1%), overweight 802
(47.0%) and obesity 374 (21.9%). BMI was significantly higher in patients with CAD (27.7� 4.3 vs 26.8� 4.3 kg/m2,
p< 0.001); these patients were also older, more often male and had higher prevalence of diabetes, hypertension and
dyslipidemia. By multivariate analysis (logistic regression) BMI remains an independent predictor of CAD (odds ratio
(OR) 1.03, 95% confidence interval (CI) 1.01–1.06; p¼ 0.012). Regarding the severity of CAD, BMI was not significantly
different among patients with and without obstructive CAD (27.7� 4.3 vs 27.2� 4.3 kg/m2, p¼ 0.120). In 319 patients
(4516 segments; 4077 evaluable), a detailed atherosclerotic burden was evaluated and compared among BMI classes,
defined according to the presence of plaque and the degree of stenosis. Obstructive CAD was identified in 16.9% of the
patients and 45.1% had non-obstructive CAD. The discriminative threshold for high burden, established by the segment
involvement score (SIS), was >5 segments with plaque (15.4% patients). The prevalence of SIS >5 among the BMI classes
was: 18.7%, 13.7% and 13.6% for normal, overweight and obesity respectively (p values for the specific classes versus all
other patients: 0.241, 0.450 and 0.663).
Conclusions: In this population of stable patients undergoing CCTA for suspected CAD, BMI was an independent
predictor of its presence, but was not correlated with the coronary disease severity.
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In recent years, obesity has reached epidemic propor-
tions, and is currently a highly prevalent chronic con-
dition associated with significant morbidity and
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(CAD), the evidence is contradictory. Several studies
have suggested an ’obesity paradox’ due to a protective
effect of obesity against adverse outcomes, and the cor-
relation between body mass index (BMI) and survival
has been described as having a U-shaped curve.4,5
Additionally, the relationship between obesity and
CAD extension remains controversial. Several authors
suggest that, paradoxically, obese patients have a lower
CAD burden (Duke myocardial jeopardy scores) and
lower prevalence of high-risk coronary anatomy (sig-
nificant left main or triple vessel disease) compared to
non-obese patients.6,7
Recently, coronary computed tomography angiog-
raphy (CCTA) has become widely available and
adopted in the clinical practice, mainly due to the
high negative predictive value to rule out obstructive
CAD.8,9 In addition, CCTA allows also the identifica-
tion of non-obstructive CAD, providing in this way a
noninvasive quantification of the total coronary athero-
sclerotic burden. As showed in the large CONFIRM
Registry,10 both non-obstructive and obstructive
CAD, identified by CCTA, were associated with
worse cardiovascular outcomes, while the absence of
CAD was associated with a favorable prognosis. To
the best of our knowledge, there are no previous pub-
lished studies evaluating the relationship of BMI with
both the presence and extension of CAD, documented
by CCTA, and this was the aim of the present study.
Methods
Population
From February 2007 to October 2011 all consecutive
stable patients undergoing CCTA (dual source scanner)
for the evaluation of possible CAD were included in a
single centre prospective registry. Figure 1 shows
patient selection and study design. Patients referred
from the emergency department (possible acute coron-
ary syndrome) or indications other than evaluation for
possible CAD were excluded from this analysis. For the
purpose of this study, 1706 patients were included in
the context of: previous equivocal or inconclusive stress
tests or discordant with the clinical evaluation
(n¼ 1253; 73.5%), CCTA as first line investigation of
possible CAD (n¼ 294; 17.2%), preoperative CAD
assessment prior to non-coronary valvular or aortic
surgery (n¼ 34, 2.0%), evaluation of possible CAD in
cardiomyopathies (n¼ 125, 7.3%).
A detailed medical history with a risk factors ques-
tionnaire was obtained from the patients to assess for
the presence of: (a) diabetes mellitus (defined as a fast-
ing glucose level of �7.0mmol/l or the need for insulin
or oral hypoglycemic agents); (b) dyslipidemia (defined
as a total cholesterol level �5mmol/l or treatment with
lipid-lowering drugs); (c) hypertension (defined as
blood pressure �140/90mm Hg or the use of antihy-
pertensive medication); (d) Positive family history of
premature CAD (defined as the presence of CAD in
first-degree relatives younger than 55 (male) or 65
(female) years old); (e) smoking (defined as previous
(less <1 year) or current smoker). Weight and height
were self-reported by the patients in the questionnaire.
The overall population was stratified by the BMI
value, according to the World Health Association
classification:11 underweight (<18.5 kg/m2), normal
(18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2) and
obesity (IMC�30.0 kg/m2). Underweight patients were
excluded from the present analysis. In a cohort of
patients, the detailed atherosclerotic burden was eval-
uated and compared among the BMI classes. The local
ethics committee approved the study and all patients
gave written informed consent.
Scan protocol and image reconstruction
All scans were performed with a dual-source scanner
(Somatom Definition, Siemens Medical, Germany),
with the patient in dorsal decubitus and in deep inspir-
ation breath-hold. Sublingual nitroglycerin was admin-
istered to all patients except when contraindicated and
beta-blockers were administered to lower the heart rate
when indicated. During the scan acquisition, a bolus of
iodinated contrast (Visipaque, GE Healthcare, USA)
was injected at a 6ml/s infusion rate, followed by a
50ml saline flush. The dose of contrast was calculated
according to the following formula: (acquisition time-
þ 6 s delay) x flow (6ml/s). Contrast timing was per-
formed to optimize uniform contrast enhancement of
the coronary arteries. Dose reduction strategies-
including electrocardiogram-gated tube current modu-
lation, reduced tube voltage, and prospective axial trig-
gering-were used whenever feasible. Mean estimated
radiation dose was 5.3� 3.7mSv, contrast dose was
97.1� 14.4ml and heart rate was 67.8� 13.3 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75mm with
0.4mm increments. Post-processing was carried out
using Circulation software, with multiplanar recon-
structions, maximum intensity projection and volume
rendering technique.
Coronary artery analysis
All scans were analyzed in the same session by both a
cardiologist and a radiologist with Level III-equivalent
experience. The Society of Cardiovascular Computed
Tomography (SCCT) recommended classification12
was used regarding segmentation (16 segments), sten-
osis severity (<25%; 25–49%; 50–69%; 70–99%;
2 European Journal of Preventive Cardiology 0(00)
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100%) and plaque composition (calcified, non-calcified
or mixed). CAD was defined as the presence of any
coronary plaque identified in CCTA (both obstructive
and non-obstructive lesions; including non-calcified
plaque). Obstructive CAD was defined as the presence
of plaque with 50% stenosis. The discriminative
threshold for high coronary atherosclerotic burden
was established as the SIS with the previously tested
prognostic threshold of >5 segments with plaque.13 In
each coronary artery segment, coronary atherosclerosis
was defined as tissue structures >1mm2 that existed
either within the coronary artery lumen or adjacent to
the coronary artery lumen that could be discriminated
from surrounding pericardial tissue, epicardial fat or
the vessel lumen itself. Coronary atherosclerotic lesions
were quantified for stenosis by visual estimation.
Percent obstruction of coronary artery lumen was
based on a comparison of the luminal diameter of the
segment exhibiting obstruction to the luminal diameter
of the most normal-appearing site immediately prox-
imal to the plaque. The value of the Agatston calcium
score was obtained with the analysis of consecutive
non-contrast 3mm slices, with a reconstruction b35f
Kernel and a small (cardiac) FOV, with a dedicated
software (CaScoring- SiemensTM), where every area at
least with 1mm2 within a coronary vessel with a density
above 130 HU (Hounsfield Units) was selected.14
Statistical analysis
Continuous variables with normal distribution were
expressed as means and standard deviation (SD),
those with non-normal distribution as medians and
interquartile range (IQR). Normality was tested with
the Kolmogorov-Sminorv test. Categorical variables
were expressed as frequencies and percentages.
Statistical comparison of baseline characteristics and
outcomes was performed using the chi-square test or
Fisher’s exact test, when appropriate, for categorical
variables and the Mann-Whitney or Kruskal-Wallis
test for continuous variables. Multivariate analyze
(binary logistic regression model - enter method) was
performed to identify independent predictors of CAD
and independent predictors of obstructive CAD. In this
model all the statistically significant variables in the
univariate analysis were included. Two-tailed tests of
All consecutive patients referred for Cardiac CT
February 2007-October 2011
(n=2563)
Included (n=1706; 66.6%)
Stable patients referred for the evaluation of possible CAD
Equivocal, inconclusive or clinically
discordant stress tests
(n=1253; 73.5%)
CCTA as first line
investigation
(292; 17.2%)
Prior to non-coronary,
valvular or aortic surgery
(34; 2.0%)
Evaluation in
cardiomyopathies
(125; 7.3%)
Excluded (n=857; 33.4%)
· Cardiac CT for other than evaluation of possible CAD
(n=395; 15.4%)
· Previous MI, CABG, PCI (n=310, 12.1%)
· Emergency department (possible ACS) (n=108; 4.2%)
· Atrial fibrillation or other significant arrhythmias
compromising image quality (n=31; 1.2%)
· Underweight (n=13; 0.5%) 
Figure 1. Patient selection and study design.
CAD: coronary artery disease; CCTA: coronary computed tomography angiography; CT: computed tomography; PCI: percutaneous
coronary intervention.
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(CAD), the evidence is contradictory. Several studies
have suggested an ’obesity paradox’ due to a protective
effect of obesity against adverse outcomes, and the cor-
relation between body mass index (BMI) and survival
has been described as having a U-shaped curve.4,5
Additionally, the relationship between obesity and
CAD extension remains controversial. Several authors
suggest that, paradoxically, obese patients have a lower
CAD burden (Duke myocardial jeopardy scores) and
lower prevalence of high-risk coronary anatomy (sig-
nificant left main or triple vessel disease) compared to
non-obese patients.6,7
Recently, coronary computed tomography angiog-
raphy (CCTA) has become widely available and
adopted in the clinical practice, mainly due to the
high negative predictive value to rule out obstructive
CAD.8,9 In addition, CCTA allows also the identifica-
tion of non-obstructive CAD, providing in this way a
noninvasive quantification of the total coronary athero-
sclerotic burden. As showed in the large CONFIRM
Registry,10 both non-obstructive and obstructive
CAD, identified by CCTA, were associated with
worse cardiovascular outcomes, while the absence of
CAD was associated with a favorable prognosis. To
the best of our knowledge, there are no previous pub-
lished studies evaluating the relationship of BMI with
both the presence and extension of CAD, documented
by CCTA, and this was the aim of the present study.
Methods
Population
From February 2007 to October 2011 all consecutive
stable patients undergoing CCTA (dual source scanner)
for the evaluation of possible CAD were included in a
single centre prospective registry. Figure 1 shows
patient selection and study design. Patients referred
from the emergency department (possible acute coron-
ary syndrome) or indications other than evaluation for
possible CAD were excluded from this analysis. For the
purpose of this study, 1706 patients were included in
the context of: previous equivocal or inconclusive stress
tests or discordant with the clinical evaluation
(n¼ 1253; 73.5%), CCTA as first line investigation of
possible CAD (n¼ 294; 17.2%), preoperative CAD
assessment prior to non-coronary valvular or aortic
surgery (n¼ 34, 2.0%), evaluation of possible CAD in
cardiomyopathies (n¼ 125, 7.3%).
A detailed medical history with a risk factors ques-
tionnaire was obtained from the patients to assess for
the presence of: (a) diabetes mellitus (defined as a fast-
ing glucose level of �7.0mmol/l or the need for insulin
or oral hypoglycemic agents); (b) dyslipidemia (defined
as a total cholesterol level �5mmol/l or treatment with
lipid-lowering drugs); (c) hypertension (defined as
blood pressure �140/90mm Hg or the use of antihy-
pertensive medication); (d) Positive family history of
premature CAD (defined as the presence of CAD in
first-degree relatives younger than 55 (male) or 65
(female) years old); (e) smoking (defined as previous
(less <1 year) or current smoker). Weight and height
were self-reported by the patients in the questionnaire.
The overall population was stratified by the BMI
value, according to the World Health Association
classification:11 underweight (<18.5 kg/m2), normal
(18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2) and
obesity (IMC�30.0 kg/m2). Underweight patients were
excluded from the present analysis. In a cohort of
patients, the detailed atherosclerotic burden was eval-
uated and compared among the BMI classes. The local
ethics committee approved the study and all patients
gave written informed consent.
Scan protocol and image reconstruction
All scans were performed with a dual-source scanner
(Somatom Definition, Siemens Medical, Germany),
with the patient in dorsal decubitus and in deep inspir-
ation breath-hold. Sublingual nitroglycerin was admin-
istered to all patients except when contraindicated and
beta-blockers were administered to lower the heart rate
when indicated. During the scan acquisition, a bolus of
iodinated contrast (Visipaque, GE Healthcare, USA)
was injected at a 6ml/s infusion rate, followed by a
50ml saline flush. The dose of contrast was calculated
according to the following formula: (acquisition time-
þ 6 s delay) x flow (6ml/s). Contrast timing was per-
formed to optimize uniform contrast enhancement of
the coronary arteries. Dose reduction strategies-
including electrocardiogram-gated tube current modu-
lation, reduced tube voltage, and prospective axial trig-
gering-were used whenever feasible. Mean estimated
radiation dose was 5.3� 3.7mSv, contrast dose was
97.1� 14.4ml and heart rate was 67.8� 13.3 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75mm with
0.4mm increments. Post-processing was carried out
using Circulation software, with multiplanar recon-
structions, maximum intensity projection and volume
rendering technique.
Coronary artery analysis
All scans were analyzed in the same session by both a
cardiologist and a radiologist with Level III-equivalent
experience. The Society of Cardiovascular Computed
Tomography (SCCT) recommended classification12
was used regarding segmentation (16 segments), sten-
osis severity (<25%; 25–49%; 50–69%; 70–99%;
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100%) and plaque composition (calcified, non-calcified
or mixed). CAD was defined as the presence of any
coronary plaque identified in CCTA (both obstructive
and non-obstructive lesions; including non-calcified
plaque). Obstructive CAD was defined as the presence
of plaque with 50% stenosis. The discriminative
threshold for high coronary atherosclerotic burden
was established as the SIS with the previously tested
prognostic threshold of >5 segments with plaque.13 In
each coronary artery segment, coronary atherosclerosis
was defined as tissue structures >1mm2 that existed
either within the coronary artery lumen or adjacent to
the coronary artery lumen that could be discriminated
from surrounding pericardial tissue, epicardial fat or
the vessel lumen itself. Coronary atherosclerotic lesions
were quantified for stenosis by visual estimation.
Percent obstruction of coronary artery lumen was
based on a comparison of the luminal diameter of the
segment exhibiting obstruction to the luminal diameter
of the most normal-appearing site immediately prox-
imal to the plaque. The value of the Agatston calcium
score was obtained with the analysis of consecutive
non-contrast 3mm slices, with a reconstruction b35f
Kernel and a small (cardiac) FOV, with a dedicated
software (CaScoring- SiemensTM), where every area at
least with 1mm2 within a coronary vessel with a density
above 130 HU (Hounsfield Units) was selected.14
Statistical analysis
Continuous variables with normal distribution were
expressed as means and standard deviation (SD),
those with non-normal distribution as medians and
interquartile range (IQR). Normality was tested with
the Kolmogorov-Sminorv test. Categorical variables
were expressed as frequencies and percentages.
Statistical comparison of baseline characteristics and
outcomes was performed using the chi-square test or
Fisher’s exact test, when appropriate, for categorical
variables and the Mann-Whitney or Kruskal-Wallis
test for continuous variables. Multivariate analyze
(binary logistic regression model - enter method) was
performed to identify independent predictors of CAD
and independent predictors of obstructive CAD. In this
model all the statistically significant variables in the
univariate analysis were included. Two-tailed tests of
All consecutive patients referred for Cardiac CT
February 2007-October 2011
(n=2563)
Included (n=1706; 66.6%)
Stable patients referred for the evaluation of possible CAD
Equivocal, inconclusive or clinically
discordant stress tests
(n=1253; 73.5%)
CCTA as first line
investigation
(292; 17.2%)
Prior to non-coronary,
valvular or aortic surgery
(34; 2.0%)
Evaluation in
cardiomyopathies
(125; 7.3%)
Excluded (n=857; 33.4%)
· Cardiac CT for other than evaluation of possible CAD
(n=395; 15.4%)
· Previous MI, CABG, PCI (n=310, 12.1%)
· Emergency department (possible ACS) (n=108; 4.2%)
· Atrial fibrillation or other significant arrhythmias
compromising image quality (n=31; 1.2%)
· Underweight (n=13; 0.5%) 
Figure 1. Patient selection and study design.
CAD: coronary artery disease; CCTA: coronary computed tomography angiography; CT: computed tomography; PCI: percutaneous
coronary intervention.
Dores et al. 3
Hélder Dores 139
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
136 
MANUSCRIPT 12 
 
 
 
 
XML Template (2013) [12.6.2013–10:59am] [1–7]
//blrnas3/cenpro/ApplicationFiles/Journals/SAGE/3B2/CPRJ/Vol00000/130237/APPFile/SG-CPRJ130237.3d (CPR) [PREPRINTER stage]
significance are reported. For all comparisons, a p value
of <0.05 was considered statistically significant. When
appropriate, a 95% confidence interval (CI) was calcu-
lated. Statistical analysis was performed with SPSS
version 19.0 (SPSS Inc., Chicago, Illinois, USA).
Results
Study population
Of the 1706 patients included in the final analysis, the
median age was 59.0 (51.0–66.0) years and the majority
(57.2%) were male. Demographic and clinical charac-
teristics are depicted in the Table 1. The percentage
of patients with diabetes was 15.0% and there was
a high prevalence of both hypertension and dyslipide-
mia (60.5% and 59.8% respectively). The median
HeartScore was 2(1–4)%, and 17.2% patients had
high cardiovascular risk (HeartScore �5%). The
median BMI was 26.7 (24.4–29.4) kg/m2 and the strati-
fication according to the BMI classes was: normal
(n¼ 530, 31.1%), overweight (n¼ 802, 47.0%) and
obesity (n¼ 374, 21.9%).
CAD burden
In the overall population, the median calcium score was
4(0-100), 58.9% patients had CAD and 19.1% patients
had obstructive CAD. By univariate analysis, BMI was
significantly higher in patients with CAD (27.7� 4.3 vs
26.8� 4.3 kg/m2, p< 0.001); these patients were also
older, more often male and had higher prevalence of
diabetes, hypertension and dyslipidemia. Regarding the
presence of obstructive CAD, this was more prevalent
in the older patients, in males and in patients
with hypertension, diabetes, dyslipidemia and smoking.
However, BMI was not significantly different
among patients with and without obstructive CAD
(27.7� 4.3 vs 27.2� 4.3 kg/m2, p¼ 0.120) (Table 2).
By multivariate analysis (adjusted for age, male
gender, BMI, dyslipidemia, diabetes and hypertension),
BMI remain an independent predictor of CAD
(OR 1.03, 95% CI 1.01–1.06, p¼ 0.012) (Figure 2).
In a cohort of 319 patients in whom the detailed
atherosclerotic burden evaluation was performed
(4516 segments; 4077 evaluable), the distribution
according BMI classes was: normal (n¼ 107, 33.5%),
overweight (n¼ 146, 45.8%) and obesity (n¼ 66,
20.7%). Obstructive CAD was identified in 16.9% of
the patients and 45.1% had non-obstructive CAD. The
median number of coronary segments with lesions was
1.0 (0.0–4.0) and 15.4% patients had SIS >5. The dis-
tribution of the variable SIS >5 among the BMI classes
was: 18.7%, 13.7% and 13.6% for normal, overweight
and obesity respectively (p values for the specific classes
versus all other patients: 0.241, 0.450 and 0.663
respectively).
Discussion
Our findings suggest that in this population of stable
patients with low to intermediate cardiovascular risk
referred for CCTA for suspected CAD, BMI was an
independent predictor of CAD presence, but was not
correlated with CAD severity. There were no significant
differences across different BMI classes in the percent-
age of patients with obstructive CAD or in the overall
coronary atherosclerotic burden, as evaluated by the
segment involvement score.
In the general population, obesity is a well-known
risk factor for CAD, being associated with poor clinical
outcomes. In patients with documented CAD this rela-
tionship remains controversial, but the prevalence of
obesity is patients with CAD is still increasing and
the current management of obesity seems inadequate.15
Some previous studies described an ‘obesity paradox’
with better outcomes of obese patients when compared
with non-obese, frequently with an U-shaped relation-
ship. This paradoxical association between BMI and
Table 1. Demographic and clinical characteristics
Variables
All patients
(n¼ 1706)
Demographic
Age, median (IQR) years 59.0 (51.0–66.0)
Male gender, n (%) 976 (57.2)
Cardiovascular risk factors, n (%)
Diabetes mellitus 256 (15.0)
Hypertension 1032 (60.5)
Smoking 459 (26.9)
Dyslipidemia 1021 (59.8)
Family history of premature CAD 606 (35.5)
Cardiovascular risk
HeartScore, median (IQR) 2.0 (1.0–4.0)
HeartScore �5%, n (%) 293 (17.2)
Chest pain, n (%)
Asymptomatic 836 (49.0)
Non-cardiac 369 (21.6)
Atypical 363 (21.3)
Typical 138 (8.1)
BMI (kg/m2)
Median (IQR) 26.7 (24.4–29.4)
Normal, n (%) 530 (31.1)
Overweight, n (%) 802 (47.0)
Obesity, n (%) 374 (21.9)
BMI: body mass index; CAD: coronary artery disease; IQR: interquartile
range.
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survival in patients with CAD occurs irrespectively of
the treatment strategy and, in fact, among patients
undergoing percutaneous coronary intervention (PCI)
an increased BMI was associated with improved sur-
vival4 and a meta-analysis of patients undergoing PCI
showed a lower risk of death in patients with higher
BMI.5 Several explanations are frequently given for
this paradox. Adipose tissue is a recognized major
endocrine organ and obesity is associated with high
serum levels of low-density lipoproteins that have
anti-inflammatory effect.4,16 As an example, in patients
with heart failure, it has been demonstrated that obese
individuals have lower levels of tumor necrosis factor
and other inflammatory cytokines.16 On the other
hand, poor clinical outcomes in patients with lower
weight can be related to malnutrition or cachexia and
prevalence of comorbid conditions, such as occult
malignancy and heart failure.4
The controversy is not limited to the association
between obesity and clinical outcomes, but also
occurs with the relationship between obesity and ath-
erosclerotic CAD extension. Studies from Israel per-
formed by Rubinshtein et al.6 and from the USA by
Niraj et al.7 showed that obesity was associated with
less severe CAD among patients undergoing coronary
angiography. The better prognosis of obese patients in
these studies could be explained by the investigation
and treatment at earlier stages in the disease course.
Patients with higher BMI are also more frequently sub-
mitted to standard medical therapies, diagnostic coron-
ary angiography and revascularization procedures.17
Among patients undergoing coronary invasive angiog-
raphy, obese patients are younger and also have a lower
prevalence of other cardiovascular risk factors. This
evidence contributes to the lower prevalence of high-
risk coronary anatomy in patients with higher BMI in
some of the previous reports. The Duke jeopardy score
was frequently used in these studies, as an estimate
of the amount of myocardium at risk according to
the coronary artery stenosis location, and provided
Table 2. Characteristics distribution according to the presence of coronary artery disease and obstructive stenosis
Variables
CAD Non-CAD
p value
Obstructive Non-obstructive
p value(n¼ 1005) (n¼ 701) (n¼ 326) (n¼ 1380)
Age (years) (mean� SD) 61.5� 9.9 53.5� 11.9 <0.001 62.1� 9.9 57.3� 11.6 <0.001
Male gender, n (%) 648 (64.5) 328 (46.8) <0.001 239 (73.3) 737 (53.4) <0.001
Diabetes mellitus, n (%) 191 (19.0) 65 (9.3) <0.001 84 (25.8) 172 (12.5) <0.001
Hypertension, n (%) 669 (66.6) 363 (51.8) <0.001 226 (69.3) 806 (58.4) <0.001
Dyslipidemia, n (%) 664 (66.1) 357 (50.9) <0.001 222 (68.1) 799 (57.9) 0.001
Smoking, n (%) 287 (28.6) 172 (24.5) 0.065 111 (34.0) 348 (25.2) 0.001
Familiar history of CAD, n (%) 362 (36.0) 244 (34.8) 0.607 113 (34.7) 493 (35.7) 0.719
BMI (kg/m2) (mean� SD) 27.7� 4.3 26.8� 4.3 <0.001 27.7� 4.3 27.2� 4.3 0.120
BMI: body mass index; CAD: coronary artery disease; SD: standard deviation.
BMI OR 1.04, CI 95% 1.01-1.06, p=0.009
OR 1.07, CI 95% 1.06-1.08, p<0.001
OR 1.51, CI 95% 1.09-2.08, p=0.016
OR 1.69, CI 95% 1.36-2.09, p<0.001
Age
Diabetes
Dyslipidemia
0,5 1,0 1,5 2,0 2,5
Figure 2. Independent predictors of coronary artery disease (CAD) presence (multivariate analysis).
BMI: body mass index; CI: confidence interval; OR: odds ratio.
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significance are reported. For all comparisons, a p value
of <0.05 was considered statistically significant. When
appropriate, a 95% confidence interval (CI) was calcu-
lated. Statistical analysis was performed with SPSS
version 19.0 (SPSS Inc., Chicago, Illinois, USA).
Results
Study population
Of the 1706 patients included in the final analysis, the
median age was 59.0 (51.0–66.0) years and the majority
(57.2%) were male. Demographic and clinical charac-
teristics are depicted in the Table 1. The percentage
of patients with diabetes was 15.0% and there was
a high prevalence of both hypertension and dyslipide-
mia (60.5% and 59.8% respectively). The median
HeartScore was 2(1–4)%, and 17.2% patients had
high cardiovascular risk (HeartScore �5%). The
median BMI was 26.7 (24.4–29.4) kg/m2 and the strati-
fication according to the BMI classes was: normal
(n¼ 530, 31.1%), overweight (n¼ 802, 47.0%) and
obesity (n¼ 374, 21.9%).
CAD burden
In the overall population, the median calcium score was
4(0-100), 58.9% patients had CAD and 19.1% patients
had obstructive CAD. By univariate analysis, BMI was
significantly higher in patients with CAD (27.7� 4.3 vs
26.8� 4.3 kg/m2, p< 0.001); these patients were also
older, more often male and had higher prevalence of
diabetes, hypertension and dyslipidemia. Regarding the
presence of obstructive CAD, this was more prevalent
in the older patients, in males and in patients
with hypertension, diabetes, dyslipidemia and smoking.
However, BMI was not significantly different
among patients with and without obstructive CAD
(27.7� 4.3 vs 27.2� 4.3 kg/m2, p¼ 0.120) (Table 2).
By multivariate analysis (adjusted for age, male
gender, BMI, dyslipidemia, diabetes and hypertension),
BMI remain an independent predictor of CAD
(OR 1.03, 95% CI 1.01–1.06, p¼ 0.012) (Figure 2).
In a cohort of 319 patients in whom the detailed
atherosclerotic burden evaluation was performed
(4516 segments; 4077 evaluable), the distribution
according BMI classes was: normal (n¼ 107, 33.5%),
overweight (n¼ 146, 45.8%) and obesity (n¼ 66,
20.7%). Obstructive CAD was identified in 16.9% of
the patients and 45.1% had non-obstructive CAD. The
median number of coronary segments with lesions was
1.0 (0.0–4.0) and 15.4% patients had SIS >5. The dis-
tribution of the variable SIS >5 among the BMI classes
was: 18.7%, 13.7% and 13.6% for normal, overweight
and obesity respectively (p values for the specific classes
versus all other patients: 0.241, 0.450 and 0.663
respectively).
Discussion
Our findings suggest that in this population of stable
patients with low to intermediate cardiovascular risk
referred for CCTA for suspected CAD, BMI was an
independent predictor of CAD presence, but was not
correlated with CAD severity. There were no significant
differences across different BMI classes in the percent-
age of patients with obstructive CAD or in the overall
coronary atherosclerotic burden, as evaluated by the
segment involvement score.
In the general population, obesity is a well-known
risk factor for CAD, being associated with poor clinical
outcomes. In patients with documented CAD this rela-
tionship remains controversial, but the prevalence of
obesity is patients with CAD is still increasing and
the current management of obesity seems inadequate.15
Some previous studies described an ‘obesity paradox’
with better outcomes of obese patients when compared
with non-obese, frequently with an U-shaped relation-
ship. This paradoxical association between BMI and
Table 1. Demographic and clinical characteristics
Variables
All patients
(n¼ 1706)
Demographic
Age, median (IQR) years 59.0 (51.0–66.0)
Male gender, n (%) 976 (57.2)
Cardiovascular risk factors, n (%)
Diabetes mellitus 256 (15.0)
Hypertension 1032 (60.5)
Smoking 459 (26.9)
Dyslipidemia 1021 (59.8)
Family history of premature CAD 606 (35.5)
Cardiovascular risk
HeartScore, median (IQR) 2.0 (1.0–4.0)
HeartScore �5%, n (%) 293 (17.2)
Chest pain, n (%)
Asymptomatic 836 (49.0)
Non-cardiac 369 (21.6)
Atypical 363 (21.3)
Typical 138 (8.1)
BMI (kg/m2)
Median (IQR) 26.7 (24.4–29.4)
Normal, n (%) 530 (31.1)
Overweight, n (%) 802 (47.0)
Obesity, n (%) 374 (21.9)
BMI: body mass index; CAD: coronary artery disease; IQR: interquartile
range.
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survival in patients with CAD occurs irrespectively of
the treatment strategy and, in fact, among patients
undergoing percutaneous coronary intervention (PCI)
an increased BMI was associated with improved sur-
vival4 and a meta-analysis of patients undergoing PCI
showed a lower risk of death in patients with higher
BMI.5 Several explanations are frequently given for
this paradox. Adipose tissue is a recognized major
endocrine organ and obesity is associated with high
serum levels of low-density lipoproteins that have
anti-inflammatory effect.4,16 As an example, in patients
with heart failure, it has been demonstrated that obese
individuals have lower levels of tumor necrosis factor
and other inflammatory cytokines.16 On the other
hand, poor clinical outcomes in patients with lower
weight can be related to malnutrition or cachexia and
prevalence of comorbid conditions, such as occult
malignancy and heart failure.4
The controversy is not limited to the association
between obesity and clinical outcomes, but also
occurs with the relationship between obesity and ath-
erosclerotic CAD extension. Studies from Israel per-
formed by Rubinshtein et al.6 and from the USA by
Niraj et al.7 showed that obesity was associated with
less severe CAD among patients undergoing coronary
angiography. The better prognosis of obese patients in
these studies could be explained by the investigation
and treatment at earlier stages in the disease course.
Patients with higher BMI are also more frequently sub-
mitted to standard medical therapies, diagnostic coron-
ary angiography and revascularization procedures.17
Among patients undergoing coronary invasive angiog-
raphy, obese patients are younger and also have a lower
prevalence of other cardiovascular risk factors. This
evidence contributes to the lower prevalence of high-
risk coronary anatomy in patients with higher BMI in
some of the previous reports. The Duke jeopardy score
was frequently used in these studies, as an estimate
of the amount of myocardium at risk according to
the coronary artery stenosis location, and provided
Table 2. Characteristics distribution according to the presence of coronary artery disease and obstructive stenosis
Variables
CAD Non-CAD
p value
Obstructive Non-obstructive
p value(n¼ 1005) (n¼ 701) (n¼ 326) (n¼ 1380)
Age (years) (mean� SD) 61.5� 9.9 53.5� 11.9 <0.001 62.1� 9.9 57.3� 11.6 <0.001
Male gender, n (%) 648 (64.5) 328 (46.8) <0.001 239 (73.3) 737 (53.4) <0.001
Diabetes mellitus, n (%) 191 (19.0) 65 (9.3) <0.001 84 (25.8) 172 (12.5) <0.001
Hypertension, n (%) 669 (66.6) 363 (51.8) <0.001 226 (69.3) 806 (58.4) <0.001
Dyslipidemia, n (%) 664 (66.1) 357 (50.9) <0.001 222 (68.1) 799 (57.9) 0.001
Smoking, n (%) 287 (28.6) 172 (24.5) 0.065 111 (34.0) 348 (25.2) 0.001
Familiar history of CAD, n (%) 362 (36.0) 244 (34.8) 0.607 113 (34.7) 493 (35.7) 0.719
BMI (kg/m2) (mean� SD) 27.7� 4.3 26.8� 4.3 <0.001 27.7� 4.3 27.2� 4.3 0.120
BMI: body mass index; CAD: coronary artery disease; SD: standard deviation.
BMI OR 1.04, CI 95% 1.01-1.06, p=0.009
OR 1.07, CI 95% 1.06-1.08, p<0.001
OR 1.51, CI 95% 1.09-2.08, p=0.016
OR 1.69, CI 95% 1.36-2.09, p<0.001
Age
Diabetes
Dyslipidemia
0,5 1,0 1,5 2,0 2,5
Figure 2. Independent predictors of coronary artery disease (CAD) presence (multivariate analysis).
BMI: body mass index; CI: confidence interval; OR: odds ratio.
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independent prognostic information.18 The association
between BMI and CAD assessed by CCTA to our
knowledge was not previously reported. CCTA is a
noninvasive and accurate method to evaluate CAD,
with a good correlation with invasive angiography
(QCA) and intravascular ultrasound.12
In our study, after adjusting for traditional cardio-
vascular risk factors including age, gender, hyperten-
sion, diabetes, smoking, familiar history of CAD and
dyslipidemia, BMI as a continuous variable remained
an independent predictor for CAD presence but was
not a predictor of CAD severity. One possible explan-
ation for these findings could be related to the baseline
characteristics of the population: stable patients (most
of them without typical chest pain) and only a minority
with high cardiovascular risk, probably representing
early stages in the coronary disease evolution. This
population is significantly different from those referred
for invasive angiography who were included in the pre-
vious studies. On the other hand, BMI does not differ-
entiate central and peripheral adiposity. Measurements
of abdominal obesity and waist-hip ratio could be more
discriminant, as abdominal obesity has been more clo-
sely associated with cardiovascular events.19 In this
regard, computed tomography has been recognized as
a highly effective, accurate, and reproducible technique
for measuring visceral adiposity,20 and it has been
documented by previous authors that there is a correl-
ation between abdominal adiposity and the extent of
coronary atherosclerosis.21
Limitations
There are some limitations related to this report:
(a) single centre data with medium size cohort; (b) use
of BMI as the only marker of adiposity, instead of the
more specific markers of abdominal obesity that could
have a better correlation with CAD severity; (c) studied
population predominantly with low-intermediate car-
diovascular risk which could have underestimated the
coronary disease burden of patients with high BMI;
(d) referral bias, since the presence of obesity itself
could have played a role in the decision to refer for
evaluation, as obese patients are generally considered
to be at higher risk of CAD; (e) the risk factors dysli-
pidemia and hypertension were included in the analysis
as categorical variables which could have resulted in
some underestimation of their predictive power;
(f) lack of follow-up data to evaluate the prognostic
impact of BMI in clinical outcomes.
Conclusions
In this population of stable patients undergoing CCTA
for suspected CAD, BMI was an independent predictor
of the presence of CAD, but was not correlated with
severity. There were no significant differences in the
percentage of obstructive CAD or in the overall coron-
ary atherosclerotic burden, evaluated by the number of
segments with plaque, across the different BMI classes.
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independent prognostic information.18 The association
between BMI and CAD assessed by CCTA to our
knowledge was not previously reported. CCTA is a
noninvasive and accurate method to evaluate CAD,
with a good correlation with invasive angiography
(QCA) and intravascular ultrasound.12
In our study, after adjusting for traditional cardio-
vascular risk factors including age, gender, hyperten-
sion, diabetes, smoking, familiar history of CAD and
dyslipidemia, BMI as a continuous variable remained
an independent predictor for CAD presence but was
not a predictor of CAD severity. One possible explan-
ation for these findings could be related to the baseline
characteristics of the population: stable patients (most
of them without typical chest pain) and only a minority
with high cardiovascular risk, probably representing
early stages in the coronary disease evolution. This
population is significantly different from those referred
for invasive angiography who were included in the pre-
vious studies. On the other hand, BMI does not differ-
entiate central and peripheral adiposity. Measurements
of abdominal obesity and waist-hip ratio could be more
discriminant, as abdominal obesity has been more clo-
sely associated with cardiovascular events.19 In this
regard, computed tomography has been recognized as
a highly effective, accurate, and reproducible technique
for measuring visceral adiposity,20 and it has been
documented by previous authors that there is a correl-
ation between abdominal adiposity and the extent of
coronary atherosclerosis.21
Limitations
There are some limitations related to this report:
(a) single centre data with medium size cohort; (b) use
of BMI as the only marker of adiposity, instead of the
more specific markers of abdominal obesity that could
have a better correlation with CAD severity; (c) studied
population predominantly with low-intermediate car-
diovascular risk which could have underestimated the
coronary disease burden of patients with high BMI;
(d) referral bias, since the presence of obesity itself
could have played a role in the decision to refer for
evaluation, as obese patients are generally considered
to be at higher risk of CAD; (e) the risk factors dysli-
pidemia and hypertension were included in the analysis
as categorical variables which could have resulted in
some underestimation of their predictive power;
(f) lack of follow-up data to evaluate the prognostic
impact of BMI in clinical outcomes.
Conclusions
In this population of stable patients undergoing CCTA
for suspected CAD, BMI was an independent predictor
of the presence of CAD, but was not correlated with
severity. There were no significant differences in the
percentage of obstructive CAD or in the overall coron-
ary atherosclerotic burden, evaluated by the number of
segments with plaque, across the different BMI classes.
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Abstract
Objective: To evaluate the performance of traditional cardiovascular (CV) risk factors in iden-
tifying a higher than expected coronary atherosclerotic burden.
Methods: We assessed 2069 patients undergoing coronary CT angiography, with assessment of
calcium score (CS), for suspected coronary artery disease. A higher than expected atheroscle-
rotic burden was defined as CS >75th percentile (CS >P75) according to age and gender-adjusted
monograms. The ability of traditional CV risk factors to predict a CS >P75 was assessed in a cus-
tomized logistic regression model (‘‘Clinical Score’’) and by the calculation of SCORE (Systemic
Coronary Risk Evaluation). The population attributable risk (PAR) of risk factors for CS >P75 was
calculated.
Results: The median CS was 3.0 (IQR 0.0--98.0); 362 patients had CS >P75. The median SCORE
was 3.0 (IQR 1.0--4.0). With the exception of hypertension, all traditional CV risk factors were
independent predictors of CS >P75: diabetes, dyslipidemia, smoking and family history (OR
1.3--2.2, p≤0.026). The areas under the ROC curves for CS >P75 were 0.64 for the Clinical Score
(95% CI 0.61--0.67, p<0.001) and 0.53 for SCORE (95% CI 0.50--0.56, p=0.088). About a quarter
of patients with CS >P75 were in the two lower quartiles of the Clinical Score. Altogether, the
traditional risk factors explain 56% of the prevalence of CS >P75 (adjusted PAR 0.56).
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Conclusion: Despite the association of CV risk factors with a higher than expected atheroscle-
rotic burden, they appear to explain only half of its prevalence. Even when integrated in
scores, the predictive power of these risk factors was modest, exposing the limitations of risk
stratification based solely on demographic and clinical risk factors.
© 2014 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. All rights
reserved.
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Desempenho dos fatores de risco clássicos na identificac¸ão de uma carga
aterosclerótica coronária superior ao esperado
Resumo
Objetivo: O objetivo deste trabalho foi avaliar o desempenho dos fatores de risco cardiovas-
cular (CV) clássicos na identificac¸ão de carga aterosclerótica superior ao esperado.
Métodos: Avaliámos 2069 doentes (dts) que realizaram AngioTC cardíaca e ScCa para exclusão
de doenc¸a coronária. Definiu-se carga aterosclerótica superior ao esperado um ScCa acima do
percentil 75 (ScCa>p75) de acordo com nomogramas ajustados para o sexo e idade. A capacidade
dos fatores de risco clássicos preverem ScCa>p75 avaliou-se num modelo de regressão logística
customizado (score clínico) e pelo SCORE. Avaliou-se o Population Attributable Risk (PAR) dos
fatores de risco para ScCa>p75.
Resultados: A mediana de ScCa foi 3,0 [IIQ 0,0-98,0]; 362 dts com ScCa>p75. A mediana do
HeartScore foi 3,0 [IIQ 1,0-4,0]. Exceto a hipertensão arterial, todos os fatores de risco foram
preditores independentes de CaSc>p75: diabetes mellitus, dislipidemia, tabagismo e história
familiar (OR 1,3-2,2, p≤0,026). As áreas abaixo da curva ROC para SaCa>p75 foram 0,64 para
score clínico (IC95% 0,61-0,67; p<0,001) e 0,53 para SCORE (IC95% 0,50-0,56, p=0,088). Um
quarto dos dts com CaSc>p75 encontravam-se nos dois quartis de score clínico mais baixos.
No seu conjunto, os fatores de risco clássicos explicam 56% da prevalência de ScCa>p75 (PAR
ajustado 0,56).
Conclusão: Apesar de os fatores de risco CV se associarem a uma carga aterosclerótica supe-
rior ao esperado, justificam pouco mais de metade da sua prevalência. O poder preditor
destes fatores de risco é modesto, mesmo integrados em scores, revelando as limitac¸ões da
estratificac¸ão de risco baseada apenas em dados demográficos e fatores de risco clínicos.
© 2014 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. Todos os
direitos reservados.
Introduction
Coronary artery disease (CAD) remains the single most fre-
quent cause of premature mortality worldwide, reaching
epidemic proportions.1 Primary prevention measures have
had a favorable effect on the prognosis of patients with CAD.
Estimation of total cardiovascular (CV) risk is a cornerstone
of the assessment of patients with suspected CAD, enabling
adjustment of the intensity of preventive and therapeutic
measures.2 Risk scores that reflect the interaction of mul-
tiple CV risk factors are available for this purpose and are
frequently used in clinical practice.
Although modifiable CV risk factors account for most of
the risk of myocardial infarction (MI), risk prediction based
on scores including only demographic and clinical character-
istics have some limitations.3 The MONICA project4 showed
that only part of the variation in the time trends of coro-
nary event rates could be predicted by trends in risk factors.
In fact, CV risk can be higher than indicated by the charts
in several settings, for example in asymptomatic individ-
uals with preclinical evidence of atherosclerosis, such as the
presence of calcified coronary plaques.
The extent of coronary calcification correlates with total
coronary plaque burden, and has a high negative predic-
tive value for ruling out the presence of significant coronary
stenosis.5,6 Additionally, the calcium score (CS) also has a
prognostic impact, as it can show increased risk of MI.7,8
In previous studies, the CS was a predictor for premature
CAD independently of traditional clinical CV risk factors, and
combining the two appears to change the predicted risk to
an extent that may be clinically important, helping to decide
how aggressively primary prevention strategies should be
implemented.9,10
The aim of the present study was to assess the perfor-
mance of the traditional CV risk factors, alone or associated
in scores, in identifying a higher than expected coronary
atherosclerotic burden.
Methods
Study design and population
Between February 2007 and September 2012, 3012 consec-
utive patients undergoing coronary computed tomography
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Consecutive patients undergoing CCTA with assessment of CS
February 2007-September 2012
(n=3012)   
Excluded (n=943; 31.3%) 
– CCTA other than for assessment of possible CAD 
(n=464; 15.4%)
– Previous MI, CABG, or PCI (n=364, 12.1%) 
– Emergency department for possible ACS (n=115;
3.8%) 
Excluded (n=2069; 68.7%)
Stable patients referred for assessment of possible CAD  
CCTA as first-lin e
investigation
(n=353; 17.1%)  
Investigation of
cardiomyopathies
(n=149; 7.2%)   
Equivocal, inconclusive or
clinically discordant stress tests
(n=1526; 73.8%)
Prior to non-coronary
surgery
(n=41; 2.0%)
Figure 1 Patient selection and study design. ACS: acute coronary syndrome; CABG: coronary artery bypass grafting; CAD: coronary
artery disease; CCTA: coronary computed tomography angiography; CS: calcium score; MI: myocardial infarction; PCI: percutaneous
coronary intervention.
angiography (CCTA) for assessment of possible CAD were
prospectively enrolled in a single-center registry. Patients
referred from the emergency department for possible acute
coronary syndrome, those with indications other than assess-
ment for possible CAD, and those without CS assessment
were excluded from the present analysis. For the purpose
of this study, 2069 patients were included, the majority
of them (1526, 73.8%) assessed in the context of previous
stress tests that were equivocal, inconclusive or clini-
cally discordant with clinical assessment, while 353 (17.1%)
were undergoing first-line investigation of possible CAD.
Other exams were performed to investigate possible CAD
in patients with cardiomyopathies (149, 7.2%) and for pre-
operative assessment of CAD prior to non-coronary surgery
(41, 2.0%). Patient selection and study design are depicted
in Figure 1.
Cardiovascular risk assessment
A detailed medical history, including a CV risk factor ques-
tionnaire, was obtained from all patients to assess the
presence of: (1) diabetes (defined as fasting plasma glucose
≥7.0 mmol/l or use of oral hypoglycemic agents or insulin);
(2) dyslipidemia (defined as total cholesterol ≥5 mmol/l
or treatment with lipid-lowering drugs); (3) hypertension
(defined as blood pressure≥140/90 mmHg or the use of anti-
hypertensive medication); (4) family history of premature
CAD (defined as the presence of CAD in first-degree rela-
tives younger than 55 [male] or 65 [female] years); and (5)
smoking (defined as previous, less than one year, or current
smoker).
CV risk was assessed for the overall population using the
SCORE (Systemic Coronary Risk Evaluation) system,2 which
estimates the 10-year risk of CV death and is determined
by the interaction of various clinical risk factors (gender,
age, smoking status, blood pressure and total cholesterol).
As recommended in the European guidelines on cardiovascu-
lar disease prevention2 for stratification of the Portuguese
population, we used the chart for low-risk countries. The
local ethics committee approved the study and all patients
gave their written informed consent.
Scan protocol, image reconstruction and calcium
score assessment
Scans were performed with a dual-source scanner (SOMATOM
Definition®, Siemens Medical Systems, Germany), with the
patient in dorsal decubitus and in deep inspiration breath-
hold. All patients received sublingual nitroglycerin except
when contraindicated, and beta-blockers were adminis-
tered to lower heart rate when indicated. During the scan
acquisition, a bolus of iodinated contrast (Visipaque®, GE
Healthcare, USA) was infused at 6 ml/s, followed by a 50-ml
saline flush. The contrast dose was calculated according to
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Conclusion: Despite the association of CV risk factors with a higher than expected atheroscle-
rotic burden, they appear to explain only half of its prevalence. Even when integrated in
scores, the predictive power of these risk factors was modest, exposing the limitations of risk
stratification based solely on demographic and clinical risk factors.
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Introduction
Coronary artery disease (CAD) remains the single most fre-
quent cause of premature mortality worldwide, reaching
epidemic proportions.1 Primary prevention measures have
had a favorable effect on the prognosis of patients with CAD.
Estimation of total cardiovascular (CV) risk is a cornerstone
of the assessment of patients with suspected CAD, enabling
adjustment of the intensity of preventive and therapeutic
measures.2 Risk scores that reflect the interaction of mul-
tiple CV risk factors are available for this purpose and are
frequently used in clinical practice.
Although modifiable CV risk factors account for most of
the risk of myocardial infarction (MI), risk prediction based
on scores including only demographic and clinical character-
istics have some limitations.3 The MONICA project4 showed
that only part of the variation in the time trends of coro-
nary event rates could be predicted by trends in risk factors.
In fact, CV risk can be higher than indicated by the charts
in several settings, for example in asymptomatic individ-
uals with preclinical evidence of atherosclerosis, such as the
presence of calcified coronary plaques.
The extent of coronary calcification correlates with total
coronary plaque burden, and has a high negative predic-
tive value for ruling out the presence of significant coronary
stenosis.5,6 Additionally, the calcium score (CS) also has a
prognostic impact, as it can show increased risk of MI.7,8
In previous studies, the CS was a predictor for premature
CAD independently of traditional clinical CV risk factors, and
combining the two appears to change the predicted risk to
an extent that may be clinically important, helping to decide
how aggressively primary prevention strategies should be
implemented.9,10
The aim of the present study was to assess the perfor-
mance of the traditional CV risk factors, alone or associated
in scores, in identifying a higher than expected coronary
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Consecutive patients undergoing CCTA with assessment of CS
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(n=464; 15.4%)
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Figure 1 Patient selection and study design. ACS: acute coronary syndrome; CABG: coronary artery bypass grafting; CAD: coronary
artery disease; CCTA: coronary computed tomography angiography; CS: calcium score; MI: myocardial infarction; PCI: percutaneous
coronary intervention.
angiography (CCTA) for assessment of possible CAD were
prospectively enrolled in a single-center registry. Patients
referred from the emergency department for possible acute
coronary syndrome, those with indications other than assess-
ment for possible CAD, and those without CS assessment
were excluded from the present analysis. For the purpose
of this study, 2069 patients were included, the majority
of them (1526, 73.8%) assessed in the context of previous
stress tests that were equivocal, inconclusive or clini-
cally discordant with clinical assessment, while 353 (17.1%)
were undergoing first-line investigation of possible CAD.
Other exams were performed to investigate possible CAD
in patients with cardiomyopathies (149, 7.2%) and for pre-
operative assessment of CAD prior to non-coronary surgery
(41, 2.0%). Patient selection and study design are depicted
in Figure 1.
Cardiovascular risk assessment
A detailed medical history, including a CV risk factor ques-
tionnaire, was obtained from all patients to assess the
presence of: (1) diabetes (defined as fasting plasma glucose
≥7.0 mmol/l or use of oral hypoglycemic agents or insulin);
(2) dyslipidemia (defined as total cholesterol ≥5 mmol/l
or treatment with lipid-lowering drugs); (3) hypertension
(defined as blood pressure≥140/90 mmHg or the use of anti-
hypertensive medication); (4) family history of premature
CAD (defined as the presence of CAD in first-degree rela-
tives younger than 55 [male] or 65 [female] years); and (5)
smoking (defined as previous, less than one year, or current
smoker).
CV risk was assessed for the overall population using the
SCORE (Systemic Coronary Risk Evaluation) system,2 which
estimates the 10-year risk of CV death and is determined
by the interaction of various clinical risk factors (gender,
age, smoking status, blood pressure and total cholesterol).
As recommended in the European guidelines on cardiovascu-
lar disease prevention2 for stratification of the Portuguese
population, we used the chart for low-risk countries. The
local ethics committee approved the study and all patients
gave their written informed consent.
Scan protocol, image reconstruction and calcium
score assessment
Scans were performed with a dual-source scanner (SOMATOM
Definition®, Siemens Medical Systems, Germany), with the
patient in dorsal decubitus and in deep inspiration breath-
hold. All patients received sublingual nitroglycerin except
when contraindicated, and beta-blockers were adminis-
tered to lower heart rate when indicated. During the scan
acquisition, a bolus of iodinated contrast (Visipaque®, GE
Healthcare, USA) was infused at 6 ml/s, followed by a 50-ml
saline flush. The contrast dose was calculated according to
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the following formula: (acquisition time+6 s delay)×flow (6
ml/s). Contrast administration was timed to optimize uni-
form enhancement of the coronary arteries. Dose reduction
strategies -- including ECG-gated tube current modulation,
reduced tube voltage, and prospective axial triggering --
were used whenever feasible. Mean estimated radiation
dose was 5.1±3.9 mSv and the contrast dose was 97.0±14.0
ml. Mean heart rate was 67.3±12.7 bpm; 197 (9.5%) patients
received beta-blocker therapy before acquisition. Transaxial
images were reconstructed with a temporal resolution of 83
ms and slice thickness of 0.75 mm with 0.4 mm increments.
Post-processing was carried out using Circulation® software,
with multiplanar reconstructions, maximum intensity pro-
jection and volume rendering. All scans were analyzed in
the same session by both a cardiologist and a radiologist
with level III-equivalent experience. The CS was calculated
by summing the number of coronary segments with calcium.
A higher than expected atherosclerotic burden was defined
as a CS above the 75th percentile (CS >P75) according to
age- and gender-adjusted monograms.
Statistical analysis
Continuous variables with normal distribution were
expressed as means and standard deviation (SD) and those
with non-normal distribution as medians and interquartile
range (IQR). Normality was tested with the Kolmogorov-
Smirnov test. Categorical variables were expressed as
frequencies and percentages. Statistical comparisons were
performed using the chi-square test or Fisher’s exact test,
as appropriate, for categorical variables and the Mann-
Whitney or Kruskal-Wallis tests for continuous variables.
The ability of traditional CV risk factors to predict a CS
>P75 was assessed in a customized logistic regression model
(‘‘Clinical Score’’) and by calculating SCORE. Areas under
the receiver operating characteristic (ROC) curves of both
the Clinical Score and SCORE for prediction of CS >P75 were
determined. Additionally, the population attributable risk
(PAR) of the various clinical risk factors for a higher than
expected atherosclerotic burden was calculated. Two-tailed
tests of significance are reported. For all the comparisons, a
p value <0.05 was considered statistically significant. When
appropriate, 95% confidence intervals (CI) were calculated.
The statistical analysis was performed with SPSS version
21.0 (SPSS® Inc., Chicago, IL, USA).
Results
Baseline population characteristics
Demographic and clinical characteristics are depicted in
Table 1. Briefly, the mean age of the 2069 patients studied
was 58±11 years and 55.8% were male. Almost two-thirds
(65.9%) of the patients had more than one CV risk factor,
the most prevalent being hypertension (61.2%), followed
by dyslipidemia (59.2%), family history of premature CAD
(34.9%), smoking (25.7%) and diabetes (15.0%). Mean body
mass index (BMI) was 27.3±4.3 kg/m2; 24.2% patients were
obese (BMI ≥30.0 kg/m2). The median SCORE was 3.0 (IQR
1.0--4.0); 13.9% patients had high/very high CV risk (SCORE
≥5). Regarding clinical presentation, 44.2% patients were
Table 1 Demographic and clinical characteristics of the
study population.
Variables, n (%) All patients (n=2069)
Demographic
Age, years (mean ± SD) 58±11
Male 1155 (55.8)
Cardiovascular risk factors
Diabetes 311 (15.0)
Hypertension 1266 (61.2)
Smoking 532 (25.7)
Dyslipidemia 1222 (59.2)
Family history of premature CAD 723 (34.9)
BMI, kg/m2 (mean ± SD) 27.3±4.3
Obesity (BMI ≥30.0 kg/m2) 500 (24.2)
Cardiovascular risk
SCORE, median (IQR) 3.0 (1.0--4.0)
SCORE ≥5 494 (13.9)
Chest pain
Asymptomatic 914 (44.2)
Non-cardiac 581 (28.1)
Atypical 437 (21.1)
Typical 137 (6.6)
Low-intermediate pre-test probability
Diamond-Forrester 1970 (95.2)
Morise (<16) 1781 (86.1)
Calcium score
Median (IQR) 3.0 (0.0--98.0)
CS >P75 362 (17.5)
BMI: body mass index; CAD: coronary artery disease; CS: calcium
score; CV: cardiovascular; IQR: interquartile range; P75: 75th
percentile; SD: standard deviation.
asymptomatic, only 6.6% reporting typical chest pain. The
majority of the population had a low-intermediate pre-test
probability of CAD as assessed by the Diamond-Forrester
and Morise scores (95.2% and 86.1%, respectively). The
median CS was 3.0 (IQR 0.0--98.0), with 362 patients (17.5%)
having CS >P75.
Cardiovascular risk factor performance
With the exception of hypertension, all the traditional CV
risk factors -- diabetes, dyslipidemia, smoking and family
history of CAD -- were independent predictors of CS >P75, all
odds ratio (OR) 1.3--2.2, p≤0.026 (Figure 2). The predictive
power of both Clinical Score and SCORE for the presence
of CS >P75, as assessed by ROC curves, was low (Figure 3):
area under the curve (AUC) 0.64 for the Clinical Score (95% CI
0.61--0.67, p<0.001) and 0.53 for SCORE (95% CI 0.50--0.56,
p=0.088). Analyzing the population by quartile of the Clinical
Score, a quarter of patients with CS >P75 (24.3%) were in the
two lower quartiles (Figure 4). Altogether, the traditional CV
risk factors analyzed (hypertension, dyslipidemia, smoking,
diabetes and family history of premature CAD, and obesity)
explain only 56% of the prevalence of CS >P75 (adjusted PAR
0.56).
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Figure 2 Independent predictors of a higher than expected
coronary atherosclerotic burden (calcium score >75th per-
centile). CI: confidence interval; OR: odds ratio.
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Figure 3 Receiver operating characteristic curves for the
prediction of a higher than expected coronary atherosclerotic
burden (calcium score >75th percentile) by the Clinical Score
and SCORE.
Discussion
The present study shows that despite the association
between traditional CV risk factors and a higher than
expected atherosclerotic burden, as defined by a CS above
the 75th percentile according to age and gender-adjusted
monograms, these risk factors appear to explain only 56% of
its prevalence. Even when integrated in scores, the predic-
tive power of these traditional CV risk factors was relatively
modest, exposing the limitations of risk stratification based
solely on demographic and clinical risk factors.
The association of traditional risk factors in scores has
emerged as a central step in the stratification of CV risk and
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Figure 4 Distribution of patients with higher than expected
coronary atherosclerotic burden (calcium score >75th per-
centile) according to Clinical Score quartile (Q).
subsequent implementation of preventive actions. Several
risk assessment algorithms, such as those derived from the
Framingham Heart Study in the USA or from the Prospec-
tive Cardiovascular Münster (PROCAM) study in Germany,
and SCORE, are available for estimating multifactorial abso-
lute risk in clinical practice. In the European guidelines on
cardiovascular disease prevention,2 determination of SCORE
is recommended in asymptomatic adults without evidence
of CV disease, since risk stratification is an important mea-
sure, even in asymptomatic individuals. Sudden cardiac
death or acute MI can be the first manifestation of coronary
atherosclerosis, highlighting the importance of prevention.
However, the identification of asymptomatic individuals
with higher risk for CV events remains challenging.
Although several studies and registries, such as the land-
mark INTERHEART study,3 show that traditional CV risk
factors account for most of the risk of MI, risk prediction
based only on demographic and clinical factors appears
to have limitations. In a population of more than 120 000
patients enrolled in 14 international randomized clinical
trials of coronary heart disease and presenting with acute
coronary syndrome or undergoing percutaneous coronary
intervention, Khot et al.11 showed that 58% had none or
one of the CV risk factors diabetes, dyslipidemia, smoking
and hypertension. Additionally, another analysis by Akosah
et al.12 in a population of young adults with first acute MI
showed that only 25% met criteria to qualify for pharma-
cotherapy. Even in the presence of established clinical CV
risk factors, a significant number of coronary events are
unpredictable.
The limitations of risk scores based on clinical charac-
teristics highlights the potential utility of direct imaging
modalities, such as CCTA, for accurate identification of the
presence and extent of coronary atherosclerosis. In this con-
text, CS has emerged as a feasible and easy method for
assessment of the presence of CAD. A high CS is indicative of
advanced atherosclerotic lesions as identified by histologi-
cal criteria as fibroatheroma14; although it cannot localize
lesions that are stenotic or at risk of rupture, it may be
able to determine the total coronary atherosclerotic dis-
ease burden, and is linearly correlated with the occurrence
of hard clinical events.15,16 Although the absolute preva-
lence of severely stenotic plaques may be higher than that
of mildly stenotic plaques, there are more plaques with
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the following formula: (acquisition time+6 s delay)×flow (6
ml/s). Contrast administration was timed to optimize uni-
form enhancement of the coronary arteries. Dose reduction
strategies -- including ECG-gated tube current modulation,
reduced tube voltage, and prospective axial triggering --
were used whenever feasible. Mean estimated radiation
dose was 5.1±3.9 mSv and the contrast dose was 97.0±14.0
ml. Mean heart rate was 67.3±12.7 bpm; 197 (9.5%) patients
received beta-blocker therapy before acquisition. Transaxial
images were reconstructed with a temporal resolution of 83
ms and slice thickness of 0.75 mm with 0.4 mm increments.
Post-processing was carried out using Circulation® software,
with multiplanar reconstructions, maximum intensity pro-
jection and volume rendering. All scans were analyzed in
the same session by both a cardiologist and a radiologist
with level III-equivalent experience. The CS was calculated
by summing the number of coronary segments with calcium.
A higher than expected atherosclerotic burden was defined
as a CS above the 75th percentile (CS >P75) according to
age- and gender-adjusted monograms.
Statistical analysis
Continuous variables with normal distribution were
expressed as means and standard deviation (SD) and those
with non-normal distribution as medians and interquartile
range (IQR). Normality was tested with the Kolmogorov-
Smirnov test. Categorical variables were expressed as
frequencies and percentages. Statistical comparisons were
performed using the chi-square test or Fisher’s exact test,
as appropriate, for categorical variables and the Mann-
Whitney or Kruskal-Wallis tests for continuous variables.
The ability of traditional CV risk factors to predict a CS
>P75 was assessed in a customized logistic regression model
(‘‘Clinical Score’’) and by calculating SCORE. Areas under
the receiver operating characteristic (ROC) curves of both
the Clinical Score and SCORE for prediction of CS >P75 were
determined. Additionally, the population attributable risk
(PAR) of the various clinical risk factors for a higher than
expected atherosclerotic burden was calculated. Two-tailed
tests of significance are reported. For all the comparisons, a
p value <0.05 was considered statistically significant. When
appropriate, 95% confidence intervals (CI) were calculated.
The statistical analysis was performed with SPSS version
21.0 (SPSS® Inc., Chicago, IL, USA).
Results
Baseline population characteristics
Demographic and clinical characteristics are depicted in
Table 1. Briefly, the mean age of the 2069 patients studied
was 58±11 years and 55.8% were male. Almost two-thirds
(65.9%) of the patients had more than one CV risk factor,
the most prevalent being hypertension (61.2%), followed
by dyslipidemia (59.2%), family history of premature CAD
(34.9%), smoking (25.7%) and diabetes (15.0%). Mean body
mass index (BMI) was 27.3±4.3 kg/m2; 24.2% patients were
obese (BMI ≥30.0 kg/m2). The median SCORE was 3.0 (IQR
1.0--4.0); 13.9% patients had high/very high CV risk (SCORE
≥5). Regarding clinical presentation, 44.2% patients were
Table 1 Demographic and clinical characteristics of the
study population.
Variables, n (%) All patients (n=2069)
Demographic
Age, years (mean ± SD) 58±11
Male 1155 (55.8)
Cardiovascular risk factors
Diabetes 311 (15.0)
Hypertension 1266 (61.2)
Smoking 532 (25.7)
Dyslipidemia 1222 (59.2)
Family history of premature CAD 723 (34.9)
BMI, kg/m2 (mean ± SD) 27.3±4.3
Obesity (BMI ≥30.0 kg/m2) 500 (24.2)
Cardiovascular risk
SCORE, median (IQR) 3.0 (1.0--4.0)
SCORE ≥5 494 (13.9)
Chest pain
Asymptomatic 914 (44.2)
Non-cardiac 581 (28.1)
Atypical 437 (21.1)
Typical 137 (6.6)
Low-intermediate pre-test probability
Diamond-Forrester 1970 (95.2)
Morise (<16) 1781 (86.1)
Calcium score
Median (IQR) 3.0 (0.0--98.0)
CS >P75 362 (17.5)
BMI: body mass index; CAD: coronary artery disease; CS: calcium
score; CV: cardiovascular; IQR: interquartile range; P75: 75th
percentile; SD: standard deviation.
asymptomatic, only 6.6% reporting typical chest pain. The
majority of the population had a low-intermediate pre-test
probability of CAD as assessed by the Diamond-Forrester
and Morise scores (95.2% and 86.1%, respectively). The
median CS was 3.0 (IQR 0.0--98.0), with 362 patients (17.5%)
having CS >P75.
Cardiovascular risk factor performance
With the exception of hypertension, all the traditional CV
risk factors -- diabetes, dyslipidemia, smoking and family
history of CAD -- were independent predictors of CS >P75, all
odds ratio (OR) 1.3--2.2, p≤0.026 (Figure 2). The predictive
power of both Clinical Score and SCORE for the presence
of CS >P75, as assessed by ROC curves, was low (Figure 3):
area under the curve (AUC) 0.64 for the Clinical Score (95% CI
0.61--0.67, p<0.001) and 0.53 for SCORE (95% CI 0.50--0.56,
p=0.088). Analyzing the population by quartile of the Clinical
Score, a quarter of patients with CS >P75 (24.3%) were in the
two lower quartiles (Figure 4). Altogether, the traditional CV
risk factors analyzed (hypertension, dyslipidemia, smoking,
diabetes and family history of premature CAD, and obesity)
explain only 56% of the prevalence of CS >P75 (adjusted PAR
0.56).
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Figure 2 Independent predictors of a higher than expected
coronary atherosclerotic burden (calcium score >75th per-
centile). CI: confidence interval; OR: odds ratio.
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Figure 3 Receiver operating characteristic curves for the
prediction of a higher than expected coronary atherosclerotic
burden (calcium score >75th percentile) by the Clinical Score
and SCORE.
Discussion
The present study shows that despite the association
between traditional CV risk factors and a higher than
expected atherosclerotic burden, as defined by a CS above
the 75th percentile according to age and gender-adjusted
monograms, these risk factors appear to explain only 56% of
its prevalence. Even when integrated in scores, the predic-
tive power of these traditional CV risk factors was relatively
modest, exposing the limitations of risk stratification based
solely on demographic and clinical risk factors.
The association of traditional risk factors in scores has
emerged as a central step in the stratification of CV risk and
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Figure 4 Distribution of patients with higher than expected
coronary atherosclerotic burden (calcium score >75th per-
centile) according to Clinical Score quartile (Q).
subsequent implementation of preventive actions. Several
risk assessment algorithms, such as those derived from the
Framingham Heart Study in the USA or from the Prospec-
tive Cardiovascular Münster (PROCAM) study in Germany,
and SCORE, are available for estimating multifactorial abso-
lute risk in clinical practice. In the European guidelines on
cardiovascular disease prevention,2 determination of SCORE
is recommended in asymptomatic adults without evidence
of CV disease, since risk stratification is an important mea-
sure, even in asymptomatic individuals. Sudden cardiac
death or acute MI can be the first manifestation of coronary
atherosclerosis, highlighting the importance of prevention.
However, the identification of asymptomatic individuals
with higher risk for CV events remains challenging.
Although several studies and registries, such as the land-
mark INTERHEART study,3 show that traditional CV risk
factors account for most of the risk of MI, risk prediction
based only on demographic and clinical factors appears
to have limitations. In a population of more than 120 000
patients enrolled in 14 international randomized clinical
trials of coronary heart disease and presenting with acute
coronary syndrome or undergoing percutaneous coronary
intervention, Khot et al.11 showed that 58% had none or
one of the CV risk factors diabetes, dyslipidemia, smoking
and hypertension. Additionally, another analysis by Akosah
et al.12 in a population of young adults with first acute MI
showed that only 25% met criteria to qualify for pharma-
cotherapy. Even in the presence of established clinical CV
risk factors, a significant number of coronary events are
unpredictable.
The limitations of risk scores based on clinical charac-
teristics highlights the potential utility of direct imaging
modalities, such as CCTA, for accurate identification of the
presence and extent of coronary atherosclerosis. In this con-
text, CS has emerged as a feasible and easy method for
assessment of the presence of CAD. A high CS is indicative of
advanced atherosclerotic lesions as identified by histologi-
cal criteria as fibroatheroma14; although it cannot localize
lesions that are stenotic or at risk of rupture, it may be
able to determine the total coronary atherosclerotic dis-
ease burden, and is linearly correlated with the occurrence
of hard clinical events.15,16 Although the absolute preva-
lence of severely stenotic plaques may be higher than that
of mildly stenotic plaques, there are more plaques with
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mild than with severe stenosis. Data from the PROSPECT
study17 show that in patients presenting with acute coronary
syndrome and undergoing percutaneous coronary interven-
tion, major adverse CV events during follow-up were equally
attributable to recurrence at the site of culprit lesions and
to nonculprit, frequently angiographically mild, lesions. The
CONFIRM registry18 showed that both obstructive and nonob-
structive plaques are associated with higher mortality, with
risk profiles differing for age and gender, and the absence
of CAD is associated with a favorable prognosis. An inter-
esting finding was that more than two-thirds of patients did
not have obstructive disease, and when compared in sur-
vival analysis, the prognosis of patients with nonobstructive
stenosis was closer to that of those with significant single-
vessel disease than that of those with no coronary plaques. In
this context, even with low values, determination of CS may
help in deciding how aggressive primary prevention strate-
gies should be.
The relationship between CS and traditional CV risk fac-
tors, with CS increasing the prognostic value of traditional
clinical predictors, has been addressed in several studies.
The St. Francis Heart Study,19 a prospective population-
based study including 4613 asymptomatic individuals aged
between 50 and 70 and followed for 4.3 years, showed that
CS predicted CAD events independently of traditional risk
factors and C-reactive protein, was superior to the Fra-
mingham score in the prediction of events, and enhanced
stratification of those falling into the Framingham cate-
gories of low, intermediate, and high risk. Data from a large
registry15 of 25 253 asymptomatic patients followed for 6.8
years revealed that CS provides independent and incremen-
tal information in addition to traditional risk factors. In the
Rotterdam calcification study,7 the upper percentile range
of CS reflected a 12-fold increased risk of MI, also indepen-
dently of traditional risk factors, even in elderly people. In
the 1330 participants with intermediate risk (assessed by
the Framingham score) included in the MESA study,13 during
a median follow-up of 7.6 years, CS, ankle-brachial index,
high sensitivity C-reactive protein and family history of CAD
were independently associated with incident coronary heart
disease. Further analysis of this study showed that the addi-
tion of CS to the Framingham risk score plus race caused the
highest increase in the AUC and provided superior discrim-
ination and risk reclassification compared with other risk
markers. Therefore, CS constitutes a feasible non-invasive
tool that may lead to CV risk reclassification of a significant
number of individuals, with a number needed to scan for risk
reclassification of patients with intermediate risk estimated
at 4--6.20,21
The discrepancy between clinical data and documented
CS was also evident in our study, with the distribution of
advanced coronary atherosclerosis showing almost a quar-
ter of patients in the two lower quartiles of the Clinical
Score. Indeed, these patients with a known higher than
expected coronary atherosclerotic burden could not be iden-
tified without determination of the CS.
Although the diagnostic sensitivity of the CS in detecting
obstructive CAD is high, the frequency of false negatives
(significant CAD in the absence of CS) is not well estab-
lished. The CONFIRM registry18 showed nonobstructive
CAD in 13% and obstructive CAD in 3.5% of the 10 037
symptomatic patients without known CAD who had CS of
zero. In a previously analysis performed in our center20 of
864 patients with zero CS, 12.4% had coronary plaques on
contrast CT (1.6% obstructive). The independent predictors
of CAD were age >55 years, hypertension and dyslipidemia,
and in the presence of these three variables the probability
of having coronary plaques was 21%. However, it is impor-
tant to emphasize the low rate of clinical events in this
population without evidence of CS.15
Another important point concerning the CS is the possi-
ble effect of CS assessment on reduction of CV risk. This
issue was analyzed in the EISNER study,22 in which asymp-
tomatic patients were randomized to CS scan versus no
scan with comparison of the changes in CV risk at four
years of follow-up. The group of patients scanned showed a
net favorable improvement in risk, including a considerable
reduction in mean systolic blood pressure and low-density
lipoprotein cholesterol, and reduced waist circumference
(WC) for those with increased WC at baseline.
Although the results of the present study and previous
published data demonstrate the incremental value of the
CS over traditional clinical CV risk factors, the accuracy
and cost-effectiveness of this more expensive imaging test
in large populations has yet to be determined. Nonethe-
less, the inclusion of objective tools for identification of
subclinical CAD in CV risk stratification schemes seems log-
ical and necessary. This will allow identification of patients
with higher risk for fatal CV events, which unfortunately
are sometimes the first event. As Eugene Braunwald wrote,
‘‘treating such events is analogous to locking the barn door
after the horse has been stolen.’’23
This study has some limitations: it was a single-center
study with a medium-sized cohort; the study population had
predominantly low-intermediate cardiovascular risk; the
risk factors of dyslipidemia and hypertension were included
in the analysis as categorical variables, which could have led
to underestimation of their predictive power; and follow-up
data to assess the prognostic impact of the studied charac-
teristics on clinical outcomes were lacking.
In conclusion, despite the statistical association of CV
risk factors with a higher than expected atherosclerotic bur-
den, in the population studied they appear to explain only
half of its prevalence. Even when integrated in scores, the
predictive power of these risk factors is relatively modest,
exposing the limitations of risk stratification based solely on
demographic and clinical risk factors. This study provides
additional support for the use of CS as a tool for refining CV
risk prediction.
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mild than with severe stenosis. Data from the PROSPECT
study17 show that in patients presenting with acute coronary
syndrome and undergoing percutaneous coronary interven-
tion, major adverse CV events during follow-up were equally
attributable to recurrence at the site of culprit lesions and
to nonculprit, frequently angiographically mild, lesions. The
CONFIRM registry18 showed that both obstructive and nonob-
structive plaques are associated with higher mortality, with
risk profiles differing for age and gender, and the absence
of CAD is associated with a favorable prognosis. An inter-
esting finding was that more than two-thirds of patients did
not have obstructive disease, and when compared in sur-
vival analysis, the prognosis of patients with nonobstructive
stenosis was closer to that of those with significant single-
vessel disease than that of those with no coronary plaques. In
this context, even with low values, determination of CS may
help in deciding how aggressive primary prevention strate-
gies should be.
The relationship between CS and traditional CV risk fac-
tors, with CS increasing the prognostic value of traditional
clinical predictors, has been addressed in several studies.
The St. Francis Heart Study,19 a prospective population-
based study including 4613 asymptomatic individuals aged
between 50 and 70 and followed for 4.3 years, showed that
CS predicted CAD events independently of traditional risk
factors and C-reactive protein, was superior to the Fra-
mingham score in the prediction of events, and enhanced
stratification of those falling into the Framingham cate-
gories of low, intermediate, and high risk. Data from a large
registry15 of 25 253 asymptomatic patients followed for 6.8
years revealed that CS provides independent and incremen-
tal information in addition to traditional risk factors. In the
Rotterdam calcification study,7 the upper percentile range
of CS reflected a 12-fold increased risk of MI, also indepen-
dently of traditional risk factors, even in elderly people. In
the 1330 participants with intermediate risk (assessed by
the Framingham score) included in the MESA study,13 during
a median follow-up of 7.6 years, CS, ankle-brachial index,
high sensitivity C-reactive protein and family history of CAD
were independently associated with incident coronary heart
disease. Further analysis of this study showed that the addi-
tion of CS to the Framingham risk score plus race caused the
highest increase in the AUC and provided superior discrim-
ination and risk reclassification compared with other risk
markers. Therefore, CS constitutes a feasible non-invasive
tool that may lead to CV risk reclassification of a significant
number of individuals, with a number needed to scan for risk
reclassification of patients with intermediate risk estimated
at 4--6.20,21
The discrepancy between clinical data and documented
CS was also evident in our study, with the distribution of
advanced coronary atherosclerosis showing almost a quar-
ter of patients in the two lower quartiles of the Clinical
Score. Indeed, these patients with a known higher than
expected coronary atherosclerotic burden could not be iden-
tified without determination of the CS.
Although the diagnostic sensitivity of the CS in detecting
obstructive CAD is high, the frequency of false negatives
(significant CAD in the absence of CS) is not well estab-
lished. The CONFIRM registry18 showed nonobstructive
CAD in 13% and obstructive CAD in 3.5% of the 10 037
symptomatic patients without known CAD who had CS of
zero. In a previously analysis performed in our center20 of
864 patients with zero CS, 12.4% had coronary plaques on
contrast CT (1.6% obstructive). The independent predictors
of CAD were age >55 years, hypertension and dyslipidemia,
and in the presence of these three variables the probability
of having coronary plaques was 21%. However, it is impor-
tant to emphasize the low rate of clinical events in this
population without evidence of CS.15
Another important point concerning the CS is the possi-
ble effect of CS assessment on reduction of CV risk. This
issue was analyzed in the EISNER study,22 in which asymp-
tomatic patients were randomized to CS scan versus no
scan with comparison of the changes in CV risk at four
years of follow-up. The group of patients scanned showed a
net favorable improvement in risk, including a considerable
reduction in mean systolic blood pressure and low-density
lipoprotein cholesterol, and reduced waist circumference
(WC) for those with increased WC at baseline.
Although the results of the present study and previous
published data demonstrate the incremental value of the
CS over traditional clinical CV risk factors, the accuracy
and cost-effectiveness of this more expensive imaging test
in large populations has yet to be determined. Nonethe-
less, the inclusion of objective tools for identification of
subclinical CAD in CV risk stratification schemes seems log-
ical and necessary. This will allow identification of patients
with higher risk for fatal CV events, which unfortunately
are sometimes the first event. As Eugene Braunwald wrote,
‘‘treating such events is analogous to locking the barn door
after the horse has been stolen.’’23
This study has some limitations: it was a single-center
study with a medium-sized cohort; the study population had
predominantly low-intermediate cardiovascular risk; the
risk factors of dyslipidemia and hypertension were included
in the analysis as categorical variables, which could have led
to underestimation of their predictive power; and follow-up
data to assess the prognostic impact of the studied charac-
teristics on clinical outcomes were lacking.
In conclusion, despite the statistical association of CV
risk factors with a higher than expected atherosclerotic bur-
den, in the population studied they appear to explain only
half of its prevalence. Even when integrated in scores, the
predictive power of these risk factors is relatively modest,
exposing the limitations of risk stratification based solely on
demographic and clinical risk factors. This study provides
additional support for the use of CS as a tool for refining CV
risk prediction.
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Low previous cardiovascular risk of patients with ST-elevation
myocardial infarction
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Background Myocardial infarction is frequently the initial
form of presentation of coronary artery disease (CAD).
Systemic Coronary Risk Estimation (SCORE) risk tables are
used in primary prevention and provide an estimate of
cardiovascular (CV) risk through known risk factors. The
aim of this study was to evaluate the performance of the
SCORE, calculated using data previous to the event, to
estimate CV risk of a population of patients presenting with
ST-elevation myocardial infarction (STEMI) as the first
manifestation of CAD.
Methods and results From a prospective registry
including 3056 patients with STEMI subjected to coronary
angiography between 2004 and 2014, 1628 patients with
STEMI as the first manifestation of CAD were included after
the exclusion of patients with known CAD (n= 748, 24.5%),
patients with high-risk equivalents (n= 930, 30.4%), and
patients with normal coronaries (n= 57, 1.87%). The
individual risk profile was calculated using data previous to
the event and patients were classified into three established
subgroups: low risk (SCORE<5%; n= 1162, 71.4%), high
risk (SCORE 5–10%; n= 409, 25.1%), and very high risk
(SCORE≥ 10%; n= 57, 3.5%).
Conclusion In a population of patients with STEMI as the
first manifestation of CAD, the CV risk stratification with the
SCORE risk charts, if calculated before the event, would
classify as low risk more than two-thirds of the patients
(71.4%) and only 3.5% would be classified as very high-risk
patients. The high prevalence of low-risk patients indicates
the current challenge of CV risk stratification, underlying the
need for additional tools in primary prevention to better
identify patients at risk. Coron Artery Dis 00:000–000
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Introduction
Cardiovascular diseases (CVDs) remain the leading cause
of mortality worldwide, and in Europe, CVDs are
responsible for about four million deaths annually, over a
third of them from coronary artery disease (CAD) [1–3].
Primary prevention has been proven to have a favorable
prognostic influence in patients with CAD [4–7]. The
Systemic Coronary Risk Estimation (SCORE) charts
were developed using epidemiological data from several
European countries and reflect the interaction of tradi-
tional demographic and clinical risk factors, allowing for
the estimation of total cardiovascular (CV) risk [8].
Although this is a useful tool for the primary prevention
of CVD, leading to the adjustment of the preventive
measures, ST-elevation myocardial infarction (STEMI)
is frequently the first manifestation of CAD and
many patients were previously asymptomatic and not
considered to be at high CV risk [9].
The aim of this study was to evaluate the performance of
the SCORE calculated using the demographic and clin-
ical data before the event to estimate CV risk of a
population of patients presenting with STEMI as the first
manifestation of CAD.
Methods
Study population and design
Between January of 2004 and December of 2014, all
consecutive patients submitted to invasive coronary
angiography in the context of presumed STEMI were
screened (n= 3056). For the purpose of the present
study, patients with previous manifestations of CAD
(n= 748, 24.5%), those without CAD (n= 57, 1.87%) and
individuals with features that admittedly assign an ele-
vated risk requiring an aggressive risk factor control
(cerebrovascular and peripheral artery disease, diabetes,
or chronic kidney disease; n= 930, 30.4%) were exclu-
ded. The final population included 1628 patients (Fig. 1).
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Patient information was collected in the ACROSS
(Angiography and Coronary Revascularization Registry of
Santa Cruz Hospital) Registry, in which demographic,
clinical, angiographic, and procedure-related variables are
prospectively collected using a dedicated cath-lab-based
computer database as we published previously (Cardiobase;
Infortucano, Lisbon, Portugal) [10].
Cardiovascular risk stratification
The assumed previous SCORE was retrospectively
calculated in the study population using the most recent
clinical data before the index hospitalization. When blood
samples for the lipid profile were not available, the
self-reported previous dyslipidemia and/or used of lipid-
lowering drugs was used as a surrogate for high cholesterol
and assigned a valued from the middle-up in the chart.
The same assumption was made for blood pressure, in
case the patient was not aware of previous values. This
assumption of using high cholesterol and blood pressure
as categorical variables rarely changed the final subgroup
of the patient as many were in any case classified in the
low-risk subgroup (< 5%) on the basis of age and sex. As
proposed in the European Guidelines on CVD preven-
tion in clinical practice, the SCORE chart for countries at
low CVD risk was used. Patients were stratified into the
following risk classes: low-moderate risk (< 5%), high risk
(≥5%), and very high risk (≥10%) [2,8].
Statistical analysis
Continuous variables with a normal distribution were
expressed as mean ± SD. Discrete variables were
expressed as frequencies and percentages. All the ana-
lyses carried out were retrospective. When appropriate,
the 95% confidence interval was calculated. Statistical
analysis was carried out using the SPSS software (version
21.0; SPSS Inc., Chicago, Illinois, USA).
Results
Of the 3056 patients admitted with STEMI between
2004 and 2014, 1628 patients were included in this ana-
lysis. Patients with known coronary disease (n= 748,
24.5%), with a traditionally known higher risk of CV risk
(n= 930, 30.4%) as a manifestation of vascular disease in
other territories (cerebrovascular or peripheral artery
disease) or potential equivalents of coronary disease
(diabetes or chronic kidney disease), and patients with
normal coronaries (n= 57, 1.87%) were excluded (Fig. 1).
Most of the patients were men (n=1209, 74.3%), with a
median age of 61.2±13.3 years and a median BMI of
26.4±4 kg/m2. Hypertension was present in 798 (49%)
patients, tobacco abuse in 719 (45%) patients, dyslipidemia in
654 (40.2%) patients, and a family history of premature CVD
in 133 (8.2%) patients. All patients and study population
baseline characteristics are detailed in Table 1.
The distribution of patients according to the CV risk
classes defined by the SCORE was as follows: low-
moderate risk: 1162 patients (71.4%), high risk: 409
(25.1%), and very high risk: 57 (3.5%) (Fig. 2).
Discussion
The main findings of our study are as follows: (a) nearly
half (53.3%) of the patients presented for coronary
angiography with an STEMI, which was the first mani-
festation of CAD; (b) among these, CV risk stratification
using the SCORE risk charts, if calculated before the
Fig. 1
Study flowchart. High-risk equivalents are: diabetes mellitus, chronic kidney disease, previous myocardial infarction, bypass surgery or coronary
intervention, cerebrovascular disease, peripheral artery disease. ICA, invasive coronary angiography; STEMI, ST-elevation myocardial infarction
2 Coronary Artery Disease 2017, Vol 00 No 00
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event, would classify as low risk more than two-thirds of
these inaugural patients (71.4%) and only 3.5% would be
classified as very high-risk patients.
The SCORE risk charts are a useful tool for primary
prevention as they reflect the interaction of several tra-
ditional demographic and clinical risk factors, allowing for
the estimation of total CV risk and subsequent decisions
on the level of aggressiveness of preventive measures
and surveillance [8].
Although many advances in diagnostic and therapeutic
management of CAD have been made in recent years,
STEMI is still frequently the first manifestation of CAD
and many patients were previously asymptomatic and not
considered to be at high CV risk. The identification of
patients at risk would be beneficial as they might become
eligible for the several available preventive pharmacolo-
gical measures that are known to lower CV risk, such as
statins and antiplatelet agents [11–13].
This strikingly low percentage of STEMI patients with
high and very high-risk profile underlines the inability of
traditional risk factors, even when optimized in risk scores,
to predict CV risk, on the one hand, and the contrast
between individual and population risk on the other. In
fact, although high-risk patients have a higher relative risk
of experience an event, from a population perspective,
many events occur in the much larger in number subgroups
of low-risk to intermediate-risk populations [14–16].
Several risk scores and predictive models are available for
CV population risk stratification, allowing a better
selection of patients who might benefit from more
aggressive preventive measures [8,17,18]. These tools are
based on demographic and clinical risk factors with a
proven prognostic impact in population-based analysis. In
the European guidelines on CVD prevention in clinical
practice, the total risk estimation is recommended using
the SCORE for asymptomatic adults without evidence of
CVD, but the benefit of these stratification tools is still
controversial [2,15]. Although some authors were able to
show that the risk stratification with SCORE leads to
beneficial changes in medication during follow-up, others
failed to find an association between the SCORE and
coronary artery calcium [19,20]. In addition, McClelland
et al. [21] also noted incongruity between calcium scoring
and the Framingham risk score, another widely recog-
nized predictive model. In a study by Akosah et al. [22]
examining the risk profile of a population of young adults
with inaugural myocardial infarction, only 25% were
identified as having a risk with criteria to qualify for
pharmacotherapy. It is noteworthy that in this study, 23%
of these young adults with STEMI had low-density
lipoprotein cholesterol lower than 100 mg/dl. In another
study, Khot et al. [23] pointed out that more than half of
patients from a population with CVD had less than or
Table 1 Baseline characteristics
Characteristics
All patients
(N=3056)
Excluded
patients
(N=1428)
Study
population
(N=1628) P value
Sex: male 2243 (73.3) 1034 (72.4) 1209 (74.3) 0.25
Age (years) 62.9 ±12.9 64.8 ±12.2 61.2 ±13.3 <0.001
Diabetes mellitus 700 (22.9) 700 (49) –
Hypertension 1804 (59) 1006 (70.4) 798 (49) <0.001
Dyslipidemia 1435 (46.9) 781 (54.7) 654 (40.2) <0.001
Smoker 1138 (37.2) 418 (29.3) 719 (45) <0.001
Chronic kidney
disease
102 (3.3) 102 (7.1) –
Peripheral artery
disease
125 (4.1) 125 (8.8) –
BMI (kg/m2) 27± 4 27.3 ±4.3 26.4 ±4 <0.001
Previous MI 569 (18.6) 569 (39.8) –
Previous PCI 527 (17.2) 527 (36.9) –
Previous CABG 85 (2.8) 85 (6) –
Previous
cerebrovascular
disease
192 (6.3) 192 (13.4) –
Family history of
CVD
214 (7) 81 (5.7) 133 (8.2) 0.007
Characteristics are presented in absolute number and percentage; age and BMI
are expressed in mean ±SD.
Chronic kidney disease considered if estimated glomerular filtration rate≤60
ml/min/1.73 m2.
CABG, coronary artery bypass surgery; CVD, cardiovascular disease; MI,
myocardial infarction; PCI, percutaneous coronary intervention.
Fig. 2
Study population distribution according to baseline characteristics and SCORE risk subgroups. Risk classification according to SCORE. CAD,
coronary artery disease; SCORE, Systemic Coronary Risk Estimation; STEMI, ST-elevation myocardial infarction.
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Patient information was collected in the ACROSS
(Angiography and Coronary Revascularization Registry of
Santa Cruz Hospital) Registry, in which demographic,
clinical, angiographic, and procedure-related variables are
prospectively collected using a dedicated cath-lab-based
computer database as we published previously (Cardiobase;
Infortucano, Lisbon, Portugal) [10].
Cardiovascular risk stratification
The assumed previous SCORE was retrospectively
calculated in the study population using the most recent
clinical data before the index hospitalization. When blood
samples for the lipid profile were not available, the
self-reported previous dyslipidemia and/or used of lipid-
lowering drugs was used as a surrogate for high cholesterol
and assigned a valued from the middle-up in the chart.
The same assumption was made for blood pressure, in
case the patient was not aware of previous values. This
assumption of using high cholesterol and blood pressure
as categorical variables rarely changed the final subgroup
of the patient as many were in any case classified in the
low-risk subgroup (< 5%) on the basis of age and sex. As
proposed in the European Guidelines on CVD preven-
tion in clinical practice, the SCORE chart for countries at
low CVD risk was used. Patients were stratified into the
following risk classes: low-moderate risk (< 5%), high risk
(≥5%), and very high risk (≥10%) [2,8].
Statistical analysis
Continuous variables with a normal distribution were
expressed as mean ± SD. Discrete variables were
expressed as frequencies and percentages. All the ana-
lyses carried out were retrospective. When appropriate,
the 95% confidence interval was calculated. Statistical
analysis was carried out using the SPSS software (version
21.0; SPSS Inc., Chicago, Illinois, USA).
Results
Of the 3056 patients admitted with STEMI between
2004 and 2014, 1628 patients were included in this ana-
lysis. Patients with known coronary disease (n= 748,
24.5%), with a traditionally known higher risk of CV risk
(n= 930, 30.4%) as a manifestation of vascular disease in
other territories (cerebrovascular or peripheral artery
disease) or potential equivalents of coronary disease
(diabetes or chronic kidney disease), and patients with
normal coronaries (n= 57, 1.87%) were excluded (Fig. 1).
Most of the patients were men (n=1209, 74.3%), with a
median age of 61.2±13.3 years and a median BMI of
26.4±4 kg/m2. Hypertension was present in 798 (49%)
patients, tobacco abuse in 719 (45%) patients, dyslipidemia in
654 (40.2%) patients, and a family history of premature CVD
in 133 (8.2%) patients. All patients and study population
baseline characteristics are detailed in Table 1.
The distribution of patients according to the CV risk
classes defined by the SCORE was as follows: low-
moderate risk: 1162 patients (71.4%), high risk: 409
(25.1%), and very high risk: 57 (3.5%) (Fig. 2).
Discussion
The main findings of our study are as follows: (a) nearly
half (53.3%) of the patients presented for coronary
angiography with an STEMI, which was the first mani-
festation of CAD; (b) among these, CV risk stratification
using the SCORE risk charts, if calculated before the
Fig. 1
Study flowchart. High-risk equivalents are: diabetes mellitus, chronic kidney disease, previous myocardial infarction, bypass surgery or coronary
intervention, cerebrovascular disease, peripheral artery disease. ICA, invasive coronary angiography; STEMI, ST-elevation myocardial infarction
2 Coronary Artery Disease 2017, Vol 00 No 00
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event, would classify as low risk more than two-thirds of
these inaugural patients (71.4%) and only 3.5% would be
classified as very high-risk patients.
The SCORE risk charts are a useful tool for primary
prevention as they reflect the interaction of several tra-
ditional demographic and clinical risk factors, allowing for
the estimation of total CV risk and subsequent decisions
on the level of aggressiveness of preventive measures
and surveillance [8].
Although many advances in diagnostic and therapeutic
management of CAD have been made in recent years,
STEMI is still frequently the first manifestation of CAD
and many patients were previously asymptomatic and not
considered to be at high CV risk. The identification of
patients at risk would be beneficial as they might become
eligible for the several available preventive pharmacolo-
gical measures that are known to lower CV risk, such as
statins and antiplatelet agents [11–13].
This strikingly low percentage of STEMI patients with
high and very high-risk profile underlines the inability of
traditional risk factors, even when optimized in risk scores,
to predict CV risk, on the one hand, and the contrast
between individual and population risk on the other. In
fact, although high-risk patients have a higher relative risk
of experience an event, from a population perspective,
many events occur in the much larger in number subgroups
of low-risk to intermediate-risk populations [14–16].
Several risk scores and predictive models are available for
CV population risk stratification, allowing a better
selection of patients who might benefit from more
aggressive preventive measures [8,17,18]. These tools are
based on demographic and clinical risk factors with a
proven prognostic impact in population-based analysis. In
the European guidelines on CVD prevention in clinical
practice, the total risk estimation is recommended using
the SCORE for asymptomatic adults without evidence of
CVD, but the benefit of these stratification tools is still
controversial [2,15]. Although some authors were able to
show that the risk stratification with SCORE leads to
beneficial changes in medication during follow-up, others
failed to find an association between the SCORE and
coronary artery calcium [19,20]. In addition, McClelland
et al. [21] also noted incongruity between calcium scoring
and the Framingham risk score, another widely recog-
nized predictive model. In a study by Akosah et al. [22]
examining the risk profile of a population of young adults
with inaugural myocardial infarction, only 25% were
identified as having a risk with criteria to qualify for
pharmacotherapy. It is noteworthy that in this study, 23%
of these young adults with STEMI had low-density
lipoprotein cholesterol lower than 100 mg/dl. In another
study, Khot et al. [23] pointed out that more than half of
patients from a population with CVD had less than or
Table 1 Baseline characteristics
Characteristics
All patients
(N=3056)
Excluded
patients
(N=1428)
Study
population
(N=1628) P value
Sex: male 2243 (73.3) 1034 (72.4) 1209 (74.3) 0.25
Age (years) 62.9 ±12.9 64.8 ±12.2 61.2 ±13.3 <0.001
Diabetes mellitus 700 (22.9) 700 (49) –
Hypertension 1804 (59) 1006 (70.4) 798 (49) <0.001
Dyslipidemia 1435 (46.9) 781 (54.7) 654 (40.2) <0.001
Smoker 1138 (37.2) 418 (29.3) 719 (45) <0.001
Chronic kidney
disease
102 (3.3) 102 (7.1) –
Peripheral artery
disease
125 (4.1) 125 (8.8) –
BMI (kg/m2) 27± 4 27.3 ±4.3 26.4 ±4 <0.001
Previous MI 569 (18.6) 569 (39.8) –
Previous PCI 527 (17.2) 527 (36.9) –
Previous CABG 85 (2.8) 85 (6) –
Previous
cerebrovascular
disease
192 (6.3) 192 (13.4) –
Family history of
CVD
214 (7) 81 (5.7) 133 (8.2) 0.007
Characteristics are presented in absolute number and percentage; age and BMI
are expressed in mean ±SD.
Chronic kidney disease considered if estimated glomerular filtration rate≤60
ml/min/1.73 m2.
CABG, coronary artery bypass surgery; CVD, cardiovascular disease; MI,
myocardial infarction; PCI, percutaneous coronary intervention.
Fig. 2
Study population distribution according to baseline characteristics and SCORE risk subgroups. Risk classification according to SCORE. CAD,
coronary artery disease; SCORE, Systemic Coronary Risk Estimation; STEMI, ST-elevation myocardial infarction.
Low previous CV risk of patients with STEMI Rodrigues et al. 3
Copyright r 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Hélder Dores 155
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
152 
MANUSCRIPT 14 
 
 
 
 
equal to one risk factor. In line with these studies, the
MONICA project showed that only part of the variation
in the time trends of coronary event rates could be
predicted by trends in risk factors [24].
These results emphasize the need for better strategies for
risk stratification and one likely candidate might be the
identification of atherosclerotic burden by calcium scor-
ing or cardiac computed tomography [16,25,26]. These
might provide a better estimation of the risk to proper
guide and dose our primary prevention attitude in the
future, pending clinical and cost-effectiveness validation
of these strategies.
This study has some limitations: (i) this was a single-
center retrospective study; (ii) the risk factors of high
cholesterol and blood pressure were based on previous
laboratory values or measurements, either patient-
referred or clinical registries based, and in cases when
there were no previous laboratory values and blood
pressure specified, they were included in the analysis as
categorical variables (meaning having or not the risk
factor), which could have led to underestimation of their
predictive power. Although this might influence the final
value of each patient, it was rarely significant enough to
move the patients across some risk category, especially as
most of them were of low risk in any case on the basis of
their demographic variables.
In this population of patients with myocardial infarction
as the first manifestation of CAD, CV risk stratification
using the SCORE risk charts, if calculated before the
event, would classify as low risk more than two-thirds of
the patients (71.4%) and only 3.5% would be classified as
very high-risk patients. The high prevalence of low-risk
patients indicates the current challenge of CV risk
stratification, underlying the need for additional tools in
primary prevention to better identify patients at risk.
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Abstract
Introduction: Diagnostic tests that use ionizing radiation play a central role in cardiology and
their use has grown in recent years, leading to increasing concerns about their potential stochas-
tic effects.
The aims of this study were to compare the radiation dose of three diagnostic tests: sin-
gle photon emission computed tomography (SPECT), invasive coronary angiography (ICA) and
cardiac computed tomography (cardiac CT) and their evolution over time, and to assess the
influence of body mass index on radiation dose.
Methods: We assessed consecutive patients included in three prospective registries (SPECT, ICA
and cardiac CT) over a period of two years. Radiation dose was converted to mSv and compared
between the three registries. Differences over time were evaluated by comparing the first with
the fourth semester.
Results: A total of 6196 exams were evaluated: 35% SPECT, 53% ICA and 22% cardiac CT. Mean
radiation dose was 10.7±1.2 mSv for SPECT, 8.1±6.4 mSv for ICA, and 5.4±3.8 mSv for cardiac
CT (p<0.001 for all). With regard to the radiation dose over time, there was a very small
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equal to one risk factor. In line with these studies, the
MONICA project showed that only part of the variation
in the time trends of coronary event rates could be
predicted by trends in risk factors [24].
These results emphasize the need for better strategies for
risk stratification and one likely candidate might be the
identification of atherosclerotic burden by calcium scor-
ing or cardiac computed tomography [16,25,26]. These
might provide a better estimation of the risk to proper
guide and dose our primary prevention attitude in the
future, pending clinical and cost-effectiveness validation
of these strategies.
This study has some limitations: (i) this was a single-
center retrospective study; (ii) the risk factors of high
cholesterol and blood pressure were based on previous
laboratory values or measurements, either patient-
referred or clinical registries based, and in cases when
there were no previous laboratory values and blood
pressure specified, they were included in the analysis as
categorical variables (meaning having or not the risk
factor), which could have led to underestimation of their
predictive power. Although this might influence the final
value of each patient, it was rarely significant enough to
move the patients across some risk category, especially as
most of them were of low risk in any case on the basis of
their demographic variables.
In this population of patients with myocardial infarction
as the first manifestation of CAD, CV risk stratification
using the SCORE risk charts, if calculated before the
event, would classify as low risk more than two-thirds of
the patients (71.4%) and only 3.5% would be classified as
very high-risk patients. The high prevalence of low-risk
patients indicates the current challenge of CV risk
stratification, underlying the need for additional tools in
primary prevention to better identify patients at risk.
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Abstract
Introduction: Diagnostic tests that use ionizing radiation play a central role in cardiology and
their use has grown in recent years, leading to increasing concerns about their potential stochas-
tic effects.
The aims of this study were to compare the radiation dose of three diagnostic tests: sin-
gle photon emission computed tomography (SPECT), invasive coronary angiography (ICA) and
cardiac computed tomography (cardiac CT) and their evolution over time, and to assess the
influence of body mass index on radiation dose.
Methods: We assessed consecutive patients included in three prospective registries (SPECT, ICA
and cardiac CT) over a period of two years. Radiation dose was converted to mSv and compared
between the three registries. Differences over time were evaluated by comparing the first with
the fourth semester.
Results: A total of 6196 exams were evaluated: 35% SPECT, 53% ICA and 22% cardiac CT. Mean
radiation dose was 10.7±1.2 mSv for SPECT, 8.1±6.4 mSv for ICA, and 5.4±3.8 mSv for cardiac
CT (p<0.001 for all). With regard to the radiation dose over time, there was a very small
∗ Corresponding author.
E-mail address: paraujogoncalves@yahoo.co.uk (P. de Araújo Gonc¸alves).
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reduction in SPECT (10.7 to 10.5 mSv, p=0.004), a significant increase (25%) in ICA (7.0 to 8.8
mSv; p<0.001), and a significant reduction (29%) in cardiac CT (6.5 to 4.6 mSv, p<0.001). Obesity
was associated with a significantly higher radiation dose in all three exams.
Conclusions: Cardiac CT had a lower mean effective radiation dose than invasive coronary
angiography, which in turn had a lower mean effective dose than SPECT.
There was a significant increase in radiation doses in the ICA registry and a significant decrease
in the cardiac CT registry over time.
© 2013 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L. All rights
reserved.
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Resumo
Introduc¸ão: Os exames diagnósticos que usam radiac¸ão ionizante têm um papel central na
cardiologia e a par do seu uso crescente, tem aumentado a preocupac¸ão pelos seus potenciais
efeitos estocásticos.
Os objetivos deste estudo foram: 1) Comparar a dose de radiac¸ão de três exames: Cintigrafia
de perfusão miocárdica (SPECT), coronariografia invasiva (CAT) e tomografia computorizada
cardíaca (AngioTC) e a sua evoluc¸ão temporal. 2) Avaliar o impacto do índice de massa corporal
na dose de radiac¸ão.
Métodos: Doentes consecutivos incluídos em três registos prospetivos (SPECT, CAT e AngioTC)
durante dois anos. A dose de radiac¸ão foi convertida a mSv e comparada entre os três registos.
A evoluc¸ão temporal foi avaliada por comparac¸ão do 1.◦ e 4.◦ semestres.
Resultados: Foram avaliados 6196 exames: 35% SPECT, 53% CAT e 22% AngioTC. A dose de
radiac¸ão foi: 10,7 ± 1,2 mSv para o SPECT; 8,1 ± 6,4 mSv para o CAT; 5,4 ± 3,8 mSv para
a AngioTC (p < 0,001 todas comparac¸ões).
Evoluc¸ão temporal da dose de radiac¸ão: reduc¸ão muito ligeira no SPECT (10,7 para 10,5
mSv; p = 0,004); aumento significativo (25%) no CAT (7,0 para 8,8 mSv; p < 0,001); reduc¸ão
significativa (29%) na AngioTC (6,5 para 4,6 mSv; p < 0,001). A obesidade associou-se a níveis
de radiac¸ão significativamente mais elevados nos três exames.
Conclusão: O exame associado a uma menor dose de radiac¸ão foi a AngioTC, seguida do CAT
que, por sua vez, foi menor que a do SPECT. Houve um aumento significativo da dose de radiac¸ão
no registo CAT e uma reduc¸ão significativa no registo da AngioTC ao longo do tempo.
© 2013 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L. Todos os
direitos reservados.
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Introduction
In recent years, the development of imaging techniques
using ionizing radiation has resulted in considerable progress
in the diagnosis and treatment of heart disease. Three
commonly used diagnostic modalities that involve ioniz-
ing radiation are used for assessing patients with possible
coronary artery disease (CAD): single photon emission com-
puted tomography (SPECT), cardiac computed tomography
(cardiac CT) and invasive coronary angiography (ICA), the
latter being considered the gold standard for the diagnosis
of CAD.1
Different radiation doses have been reported for each of
these exams, ranging from 5 to 10 mSv for ICA, 6 to 15 mSv
for SPECT, and 4 to 21 mSv for cardiac CT.2--5 With more fre-
quent use of these exams, there have been growing concerns
about the radiation’s potential secondary effects, especially
the stochastic effects of high cumulative doses over time.6,7
We have previously reported on the effective radiation
dose associated with cardiac CT in a single-center registry,
documenting a significant decrease in dose over time, and
were able to identify the predictors of higher dose.8
New scanners and acquisition protocols have recently
been developed which lead to significant reductions in radi-
ation dose associated with cardiac CT.9,10
The aims of this study were to evaluate and compare
the radiation dose used in three diagnostic tests -- SPECT,
ICA and cardiac CT -- and their evolution over time, and to
assess the influence of body mass index on radiation dose.
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Table 1 Demographic and clinical characteristics of the study population.
Cardiac CT (n=1344) ICA (n=3267) SPECT (n=1585)
Age (years, mean ± SD) 59±12 66±12 64±9
Male (%) 60% 61% 63%
BMI (kg/m2) 27.3±4.3 27.3±4.2 27.5±4.4
Diabetes (%) 16% 29% N/A
Hypertension (%) 57% 72% N/A
Dyslipidemia (%) 54% 57% N/A
Smoking (%) 27% 31% N/A
Previous MI (%) 3% 17% N/A
Previous PCI (%) 7% 18% N/A
Previous CABG (%) 3% 7% N/A
Values are means (SD) or percentages. BMI: body mass index; CABG: coronary artery bypass grafting; CT: computed tomography; ICA:
invasive coronary angiography; MI: myocardial infarction; N/A: not available; PCI: percutaneous coronary intervention; SPECT: single
photon emission computed tomography.
Methods
From three prospective registries of SPECT, ICA and cardiac
CT, we selected for this analysis the exams performed dur-
ing a two-year period (October 1, 2008 to September 30,
2010) in which the indication was assessment of possible
CAD.
The exams were performed with an SMV DST-XL gamma
camera using 99m Tc-tetrofosmin with stress/rest or
rest/stress protocols (SPECT registry), a Siemens Coroskop
TOP/ARTIS dFC system (ICA registry), and a Siemens
Somatom Definition dual-source scanner (cardiac CT reg-
istry). The effective radiation dose was converted to mSv in
accordance with current literature and the manufacturer’s
product information and compared between the registries.
Briefly, a factor of 0.014 mSv/Gy cm was used for the
conversion of cardiac CT dose-length product,9,11 a factor of
0.183 mSv/Gy cm2 was used for the conversion of ICA dose-
area product,12,13 and factors of 0.0060 mSv/MBq−1 (after
exercise) and 0.0071 mSv/MBq−1 (at rest) were used for
the conversion of injected activity in SPECT.14--16 To eval-
uate the evolution of radiation doses over time, the study
period was divided into four semesters according to the date
of the exam and effective radiation dose was compared
between the first and last semesters in each registry. All
prospectively collected variables in the respective registries
were analyzed, looking for predictors of dose change over
time.
Statistical analysis
Continuous variables are presented as mean ± standard
deviation (unless otherwise specified), and categorical
variables as number (n) or frequency (%).
Continuous variables were analyzed using the
Mann--Whitney or Kruskal--Wallis nonparametric tests.
The chi-square test was used to assess differences in
frequencies.
Statistical significance was accepted for two-sided p val-
ues <0.05.
The statistical analysis was performed using SPSS Statis-
tics 17.0 for Windows.
Results
During the two-year period of this analysis, 6196 exams were
performed: 3267 (52.7%) ICA, 1585 (25.6%) SPECT and 1344
(21.7%) cardiac CT. The demographic and clinical character-
istics of the study population are presented in Table 1.
Mean effective radiation dose was 8.2±5.6 mSv for the
whole population, 10.7±1.2 mSv for SPECT, 8.1±6.4 mSv for
ICA and 5.4±3.8 mSv for cardiac CT (p<0.001 for all compar-
isons, Figure 1).
Division of the study period into semesters showed that
there was a small but significant reduction in mean effec-
tive radiation dose over time for SPECT (10.7 to 10.5 mSv;
p<0.01). In cardiac CT there was a significant 29% decrease in
mean effective radiation dose (6.5 to 4.6 mSv, p<0.001) and
in ICA a significant 25% increase (7.0 to 8.8 mSv; p<0.001)
(Table 2 and Figure 2).
The factors associated with the 25% increase in mean
effective radiation dose with ICA from the first to the fourth
semester were the higher proportions of positive exams,
radial vascular access and exams performed by fellows in
Figure 1 Mean effective radiation dose used in each exam
studied. CT: computed tomography; ICA: invasive coronary
angiography; SPECT: single photon emission computed tomogra-
phy.
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reduction in SPECT (10.7 to 10.5 mSv, p=0.004), a significant increase (25%) in ICA (7.0 to 8.8
mSv; p<0.001), and a significant reduction (29%) in cardiac CT (6.5 to 4.6 mSv, p<0.001). Obesity
was associated with a significantly higher radiation dose in all three exams.
Conclusions: Cardiac CT had a lower mean effective radiation dose than invasive coronary
angiography, which in turn had a lower mean effective dose than SPECT.
There was a significant increase in radiation doses in the ICA registry and a significant decrease
in the cardiac CT registry over time.
© 2013 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L. All rights
reserved.
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Resumo
Introduc¸ão: Os exames diagnósticos que usam radiac¸ão ionizante têm um papel central na
cardiologia e a par do seu uso crescente, tem aumentado a preocupac¸ão pelos seus potenciais
efeitos estocásticos.
Os objetivos deste estudo foram: 1) Comparar a dose de radiac¸ão de três exames: Cintigrafia
de perfusão miocárdica (SPECT), coronariografia invasiva (CAT) e tomografia computorizada
cardíaca (AngioTC) e a sua evoluc¸ão temporal. 2) Avaliar o impacto do índice de massa corporal
na dose de radiac¸ão.
Métodos: Doentes consecutivos incluídos em três registos prospetivos (SPECT, CAT e AngioTC)
durante dois anos. A dose de radiac¸ão foi convertida a mSv e comparada entre os três registos.
A evoluc¸ão temporal foi avaliada por comparac¸ão do 1.◦ e 4.◦ semestres.
Resultados: Foram avaliados 6196 exames: 35% SPECT, 53% CAT e 22% AngioTC. A dose de
radiac¸ão foi: 10,7 ± 1,2 mSv para o SPECT; 8,1 ± 6,4 mSv para o CAT; 5,4 ± 3,8 mSv para
a AngioTC (p < 0,001 todas comparac¸ões).
Evoluc¸ão temporal da dose de radiac¸ão: reduc¸ão muito ligeira no SPECT (10,7 para 10,5
mSv; p = 0,004); aumento significativo (25%) no CAT (7,0 para 8,8 mSv; p < 0,001); reduc¸ão
significativa (29%) na AngioTC (6,5 para 4,6 mSv; p < 0,001). A obesidade associou-se a níveis
de radiac¸ão significativamente mais elevados nos três exames.
Conclusão: O exame associado a uma menor dose de radiac¸ão foi a AngioTC, seguida do CAT
que, por sua vez, foi menor que a do SPECT. Houve um aumento significativo da dose de radiac¸ão
no registo CAT e uma reduc¸ão significativa no registo da AngioTC ao longo do tempo.
© 2013 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L. Todos os
direitos reservados.
List of abbreviations
BMI Body mass index
CAD coronary artery disease
CT computed tomography
ICA invasive coronary angiography
SPECT single photon emission computed tomography
Introduction
In recent years, the development of imaging techniques
using ionizing radiation has resulted in considerable progress
in the diagnosis and treatment of heart disease. Three
commonly used diagnostic modalities that involve ioniz-
ing radiation are used for assessing patients with possible
coronary artery disease (CAD): single photon emission com-
puted tomography (SPECT), cardiac computed tomography
(cardiac CT) and invasive coronary angiography (ICA), the
latter being considered the gold standard for the diagnosis
of CAD.1
Different radiation doses have been reported for each of
these exams, ranging from 5 to 10 mSv for ICA, 6 to 15 mSv
for SPECT, and 4 to 21 mSv for cardiac CT.2--5 With more fre-
quent use of these exams, there have been growing concerns
about the radiation’s potential secondary effects, especially
the stochastic effects of high cumulative doses over time.6,7
We have previously reported on the effective radiation
dose associated with cardiac CT in a single-center registry,
documenting a significant decrease in dose over time, and
were able to identify the predictors of higher dose.8
New scanners and acquisition protocols have recently
been developed which lead to significant reductions in radi-
ation dose associated with cardiac CT.9,10
The aims of this study were to evaluate and compare
the radiation dose used in three diagnostic tests -- SPECT,
ICA and cardiac CT -- and their evolution over time, and to
assess the influence of body mass index on radiation dose.
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Table 1 Demographic and clinical characteristics of the study population.
Cardiac CT (n=1344) ICA (n=3267) SPECT (n=1585)
Age (years, mean ± SD) 59±12 66±12 64±9
Male (%) 60% 61% 63%
BMI (kg/m2) 27.3±4.3 27.3±4.2 27.5±4.4
Diabetes (%) 16% 29% N/A
Hypertension (%) 57% 72% N/A
Dyslipidemia (%) 54% 57% N/A
Smoking (%) 27% 31% N/A
Previous MI (%) 3% 17% N/A
Previous PCI (%) 7% 18% N/A
Previous CABG (%) 3% 7% N/A
Values are means (SD) or percentages. BMI: body mass index; CABG: coronary artery bypass grafting; CT: computed tomography; ICA:
invasive coronary angiography; MI: myocardial infarction; N/A: not available; PCI: percutaneous coronary intervention; SPECT: single
photon emission computed tomography.
Methods
From three prospective registries of SPECT, ICA and cardiac
CT, we selected for this analysis the exams performed dur-
ing a two-year period (October 1, 2008 to September 30,
2010) in which the indication was assessment of possible
CAD.
The exams were performed with an SMV DST-XL gamma
camera using 99m Tc-tetrofosmin with stress/rest or
rest/stress protocols (SPECT registry), a Siemens Coroskop
TOP/ARTIS dFC system (ICA registry), and a Siemens
Somatom Definition dual-source scanner (cardiac CT reg-
istry). The effective radiation dose was converted to mSv in
accordance with current literature and the manufacturer’s
product information and compared between the registries.
Briefly, a factor of 0.014 mSv/Gy cm was used for the
conversion of cardiac CT dose-length product,9,11 a factor of
0.183 mSv/Gy cm2 was used for the conversion of ICA dose-
area product,12,13 and factors of 0.0060 mSv/MBq−1 (after
exercise) and 0.0071 mSv/MBq−1 (at rest) were used for
the conversion of injected activity in SPECT.14--16 To eval-
uate the evolution of radiation doses over time, the study
period was divided into four semesters according to the date
of the exam and effective radiation dose was compared
between the first and last semesters in each registry. All
prospectively collected variables in the respective registries
were analyzed, looking for predictors of dose change over
time.
Statistical analysis
Continuous variables are presented as mean ± standard
deviation (unless otherwise specified), and categorical
variables as number (n) or frequency (%).
Continuous variables were analyzed using the
Mann--Whitney or Kruskal--Wallis nonparametric tests.
The chi-square test was used to assess differences in
frequencies.
Statistical significance was accepted for two-sided p val-
ues <0.05.
The statistical analysis was performed using SPSS Statis-
tics 17.0 for Windows.
Results
During the two-year period of this analysis, 6196 exams were
performed: 3267 (52.7%) ICA, 1585 (25.6%) SPECT and 1344
(21.7%) cardiac CT. The demographic and clinical character-
istics of the study population are presented in Table 1.
Mean effective radiation dose was 8.2±5.6 mSv for the
whole population, 10.7±1.2 mSv for SPECT, 8.1±6.4 mSv for
ICA and 5.4±3.8 mSv for cardiac CT (p<0.001 for all compar-
isons, Figure 1).
Division of the study period into semesters showed that
there was a small but significant reduction in mean effec-
tive radiation dose over time for SPECT (10.7 to 10.5 mSv;
p<0.01). In cardiac CT there was a significant 29% decrease in
mean effective radiation dose (6.5 to 4.6 mSv, p<0.001) and
in ICA a significant 25% increase (7.0 to 8.8 mSv; p<0.001)
(Table 2 and Figure 2).
The factors associated with the 25% increase in mean
effective radiation dose with ICA from the first to the fourth
semester were the higher proportions of positive exams,
radial vascular access and exams performed by fellows in
Figure 1 Mean effective radiation dose used in each exam
studied. CT: computed tomography; ICA: invasive coronary
angiography; SPECT: single photon emission computed tomogra-
phy.
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Table 2 Mean effective radiation dose for each exam over the four semesters.
1st semester 2nd semester 3rd semester 4th semester p (1st vs. 4th)
SPECT 10.7± 1.1 10.7± 1.4 10.7± 1.3 10.5± 0.9 0.004
ICA 7.0± 6.0 7.6± 5.6 9.0± 6.9 8.7± 6.9 <0.001
Cardiac CT 6.5± 3.7 6.2± 4.2 5.0± 4.1 4.6± 3.0 <0.001
CT: computed tomography; ICA: invasive coronary angiography; SPECT: single photon emission computed tomography.
Figure 2 Time trends in mean effective radiation dose used in
each exam. CT: computed tomography; ICA: invasive coronary
angiography; SPECT: single photon emission computed tomogra-
phy.
training (Table 3). In the first semester 39% of ICA pro-
gressed to percutaneous coronary intervention, while in the
fourth semester this proportion increased to 42% (p<0.001).
Regarding vascular access, in the first semester only 1% of
ICA were performed by radial access, which increased to
46% in the fourth semester. In our population, the use of
radial vascular access was associated with a mean increase
of 15% in effective radiation dose (from 7.8mSv with femoral
access to 9.0 with radial access, p<0.001). Finally, the pro-
portion of exams performed by trainee operators increased
from 26% in the first semester to 52% in the fourth. In this
registry, when the exam was performed by a trainee opera-
tor there was a mean increase of 29% in effective radiation
dose (from 7.3 mSv with a senior operator to 9.4 mSv with
a trainee operator, p<0.001).
Figure 3 Mean effective radiation doses for each exam and
different body mass index classes. BMI: body mass index; CT:
computed tomography; ICA: invasive coronary angiography;
SPECT: single photon emission computed tomography.
The only variable associated with the decrease in effec-
tive radiation dose for cardiac CT was the use of prospective
(step-and-shoot) acquisition: the use of a prospective acqui-
sition protocol was associated with a decrease of 60% in
effective radiation dose. In the first semester no exams were
performed with this protocol, while in the fourth semester
45% were acquired prospectively (Table 3).
The influence of body mass index on mean effective radi-
ation dose was also evaluated. There was a significantly
higher dose in obese patients (BMI ≥30 kg/m2) compared
to overweight patients, which in turn was higher that in
patients with normal weight (BMI <25 kg/m2) (Figure 3).
Discussion
In this analysis, we found significantly different effective
radiation doses associated with common diagnostic tests
used in cardiology. The dose was highest for SPECT, followed
by ICA and lowest for cardiac CT. Furthermore, we found
Table 3 Variables associated with increase in ICA radiation dose and decrease in cardiac CT radiation dose.
mSv 1st semester 4th semester
ICA
Proportion of patients undergoing PCI ND 39% 42%
Exams performed by fellows in training ↑29% 26% 52%
Proportion of radial vascular access ↑15% 1% 46%
Cardiac CT Prospective acquisition ↓60% 0% 45%
CT: computed tomography; ICA: invasive coronary angiography.
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some time trends in the mean effective radiation dose asso-
ciated with ICA and cardiac CT related to particular clinical
and procedural methodologies.
The biological effects of ionizing radiation are related
to the cumulative effective dose, and doses above 100 mSv
have been linked to stochastic effects including the develop-
ment of cancer, while the effects of lower radiation levels,
common in diagnostic X-ray imaging, are much less clear.4,17
Although other theoretical models based on dose-threshold
and hormetic effects have been proposed, the more con-
servative linear no-threshold model, which assumes that no
level of radiation is without risk, is widely accepted.4,17
On this basis, procedures that use ionizing radiation
should be performed in accordance with the ‘‘as low as
reasonably achievable’’ philosophy, and physicians ordering
and performing cardiac imaging diagnostic tests should be
familiar with the associated radiation doses and with ways
in which they can be minimized.
The mean effective radiation dose we found for each
exam is in agreement with previous studies.3,4,6,18 Further-
more, we confirmed that certain variables influence the
effective radiation dose delivered by these exams. For ICA,
the effective radiation dose increased with the use of radial
access and with less experienced operators, which is in line
with published data.13,19 The higher radiation dose in the
ICA registry over time was also associated with a higher
proportion of positive exams; although we did not quan-
tify the difference between positive and negative ICA, we
can assume that positive tests needed more cine angiograms
of the coronary arteries, with a consequent increase in the
radiation dose used.
For cardiac CT, the introduction and increasingly fre-
quent use of a prospective protocol during the study period
was associated in our experience with a significant decrease
in the effective radiation dose for this exam, as has been
demonstrated by other authors.20--22 Finally, for SPECT, the
dose change over time was very small, which is to be
expected since there were no changes in protocol during
the study period.
It is worth noting that during the same period, doses asso-
ciated with stress-only and rest-only SPECT studies were
significantly lower (with mean effective doses of 2.3±0.9
mSv and 5.8±1.0 mSv, respectively) but they were not con-
sidered for the purpose of this study, and the small number
of patients involved (n=49 and n=63, respectively) would not
have had a significant impact on the overall SPECT radiation
dose.
Mean effective radiation doses were significantly higher
for obese patients in all the exams analyzed. This was espe-
cially true for cardiac CT and ICA, with an almost two-fold
increase in radiation dose compared to their normal-weight
counterparts. In the SPECT registry, the effect of BMI was
less pronounced. This should be taken in consideration when
selecting the appropriate diagnostic exam, especially for
those at higher risk from radiation exposure, like women
and younger patients.23 In line with this, particular atten-
tion should be paid to cardiac CT dose, since patients in our
registry undergoing cardiac CT were significantly younger
than those in the ICA and SPECT registries.
Although the present study focuses on comparison of the
radiation dose between three different diagnostic exams,
other features should be taken into account when comparing
different imaging modalities. As cardiac CT and ICA require
the administration of iodinated contrast, care should be
taken in the presence of impaired renal function or his-
tory of allergies; likewise, the probability of CAD is also an
important factor, as SPECT and ICA are more appropriate for
patients with higher probability of CAD.24,25 Thus, all these
features (radiation dose, need for iodinated contrast and
CAD probability) should be taken into consideration when
selecting the most appropriate exam for each patient.
Conclusions
In these registries of diagnostic tests commonly used in car-
diology, the mean effective radiation dose used in cardiac
CT was lower than that used in ICA, which in turn was
lower than the doses used in SPECT. There was a signifi-
cant increase over time in the mean effective radiation dose
associated with ICA, mainly related to the increased use of
radial access, and a decrease in cardiac CT doses as a con-
sequence of the implementation of a prospective protocol.
Obesity was associated with a significantly higher radiation
dose in all three exams.
Ethical disclosures
Protection of human and animal subjects. The authors
declare that the procedures followed were in accordance
with the regulations of the relevant clinical research ethics
committee and with those of the Code of Ethics of the World
Medical Association (Declaration of Helsinki).
Confidentiality of data. The authors declare that they have
followed the protocols of their work center on the publica-
tion of patient data and that all the patients included in the
study received sufficient information and gave their written
informed consent to participate in the study.
Right to privacy and informed consent. The authors have
obtained the written informed consent of the patients or
subjects mentioned in the article. The corresponding author
is in possession of this document.
Conflicts of interest
The authors have no conflicts of interest to declare.
References
1. Task Force on Myocardial Revascularization of the European
Society of Cardiology (ESC), the European Association for
Cardio-Thoracic Surgery (EACTS), European Association for
Percutaneous Cardiovascular Intervention (EAPCI), Wijns W,
et al. Guidelines on myocardial revascularization. Eur Heart J.
2010;31:2501--55.
2. Hirshfeld Jr JW, Balter S, Brinker JA, et al. ACCF/AHA/HRS/SCAI
clinical competence statement on physician knowledge to
optimize patient safety and image quality in fluoroscopically
guided invasive cardiovascular procedures: a report of the
American College of Cardiology Foundation/American Heart
Association/American College of Physicians Task Force on Clin-
ical Competence and Training. Circulation. 2005;111:511--32.
Document downloaded from http://www.elsevier.es, day 12/12/2017. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Tese para obtenção do grau de Doutor em Medicina na Especialidade em Investigação Clínica160
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
156 
MANUSCRIPT 15 
 
 
 
 
984 P. de Araújo Gonc¸alves et al.
Table 2 Mean effective radiation dose for each exam over the four semesters.
1st semester 2nd semester 3rd semester 4th semester p (1st vs. 4th)
SPECT 10.7± 1.1 10.7± 1.4 10.7± 1.3 10.5± 0.9 0.004
ICA 7.0± 6.0 7.6± 5.6 9.0± 6.9 8.7± 6.9 <0.001
Cardiac CT 6.5± 3.7 6.2± 4.2 5.0± 4.1 4.6± 3.0 <0.001
CT: computed tomography; ICA: invasive coronary angiography; SPECT: single photon emission computed tomography.
Figure 2 Time trends in mean effective radiation dose used in
each exam. CT: computed tomography; ICA: invasive coronary
angiography; SPECT: single photon emission computed tomogra-
phy.
training (Table 3). In the first semester 39% of ICA pro-
gressed to percutaneous coronary intervention, while in the
fourth semester this proportion increased to 42% (p<0.001).
Regarding vascular access, in the first semester only 1% of
ICA were performed by radial access, which increased to
46% in the fourth semester. In our population, the use of
radial vascular access was associated with a mean increase
of 15% in effective radiation dose (from 7.8mSv with femoral
access to 9.0 with radial access, p<0.001). Finally, the pro-
portion of exams performed by trainee operators increased
from 26% in the first semester to 52% in the fourth. In this
registry, when the exam was performed by a trainee opera-
tor there was a mean increase of 29% in effective radiation
dose (from 7.3 mSv with a senior operator to 9.4 mSv with
a trainee operator, p<0.001).
Figure 3 Mean effective radiation doses for each exam and
different body mass index classes. BMI: body mass index; CT:
computed tomography; ICA: invasive coronary angiography;
SPECT: single photon emission computed tomography.
The only variable associated with the decrease in effec-
tive radiation dose for cardiac CT was the use of prospective
(step-and-shoot) acquisition: the use of a prospective acqui-
sition protocol was associated with a decrease of 60% in
effective radiation dose. In the first semester no exams were
performed with this protocol, while in the fourth semester
45% were acquired prospectively (Table 3).
The influence of body mass index on mean effective radi-
ation dose was also evaluated. There was a significantly
higher dose in obese patients (BMI ≥30 kg/m2) compared
to overweight patients, which in turn was higher that in
patients with normal weight (BMI <25 kg/m2) (Figure 3).
Discussion
In this analysis, we found significantly different effective
radiation doses associated with common diagnostic tests
used in cardiology. The dose was highest for SPECT, followed
by ICA and lowest for cardiac CT. Furthermore, we found
Table 3 Variables associated with increase in ICA radiation dose and decrease in cardiac CT radiation dose.
mSv 1st semester 4th semester
ICA
Proportion of patients undergoing PCI ND 39% 42%
Exams performed by fellows in training ↑29% 26% 52%
Proportion of radial vascular access ↑15% 1% 46%
Cardiac CT Prospective acquisition ↓60% 0% 45%
CT: computed tomography; ICA: invasive coronary angiography.
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some time trends in the mean effective radiation dose asso-
ciated with ICA and cardiac CT related to particular clinical
and procedural methodologies.
The biological effects of ionizing radiation are related
to the cumulative effective dose, and doses above 100 mSv
have been linked to stochastic effects including the develop-
ment of cancer, while the effects of lower radiation levels,
common in diagnostic X-ray imaging, are much less clear.4,17
Although other theoretical models based on dose-threshold
and hormetic effects have been proposed, the more con-
servative linear no-threshold model, which assumes that no
level of radiation is without risk, is widely accepted.4,17
On this basis, procedures that use ionizing radiation
should be performed in accordance with the ‘‘as low as
reasonably achievable’’ philosophy, and physicians ordering
and performing cardiac imaging diagnostic tests should be
familiar with the associated radiation doses and with ways
in which they can be minimized.
The mean effective radiation dose we found for each
exam is in agreement with previous studies.3,4,6,18 Further-
more, we confirmed that certain variables influence the
effective radiation dose delivered by these exams. For ICA,
the effective radiation dose increased with the use of radial
access and with less experienced operators, which is in line
with published data.13,19 The higher radiation dose in the
ICA registry over time was also associated with a higher
proportion of positive exams; although we did not quan-
tify the difference between positive and negative ICA, we
can assume that positive tests needed more cine angiograms
of the coronary arteries, with a consequent increase in the
radiation dose used.
For cardiac CT, the introduction and increasingly fre-
quent use of a prospective protocol during the study period
was associated in our experience with a significant decrease
in the effective radiation dose for this exam, as has been
demonstrated by other authors.20--22 Finally, for SPECT, the
dose change over time was very small, which is to be
expected since there were no changes in protocol during
the study period.
It is worth noting that during the same period, doses asso-
ciated with stress-only and rest-only SPECT studies were
significantly lower (with mean effective doses of 2.3±0.9
mSv and 5.8±1.0 mSv, respectively) but they were not con-
sidered for the purpose of this study, and the small number
of patients involved (n=49 and n=63, respectively) would not
have had a significant impact on the overall SPECT radiation
dose.
Mean effective radiation doses were significantly higher
for obese patients in all the exams analyzed. This was espe-
cially true for cardiac CT and ICA, with an almost two-fold
increase in radiation dose compared to their normal-weight
counterparts. In the SPECT registry, the effect of BMI was
less pronounced. This should be taken in consideration when
selecting the appropriate diagnostic exam, especially for
those at higher risk from radiation exposure, like women
and younger patients.23 In line with this, particular atten-
tion should be paid to cardiac CT dose, since patients in our
registry undergoing cardiac CT were significantly younger
than those in the ICA and SPECT registries.
Although the present study focuses on comparison of the
radiation dose between three different diagnostic exams,
other features should be taken into account when comparing
different imaging modalities. As cardiac CT and ICA require
the administration of iodinated contrast, care should be
taken in the presence of impaired renal function or his-
tory of allergies; likewise, the probability of CAD is also an
important factor, as SPECT and ICA are more appropriate for
patients with higher probability of CAD.24,25 Thus, all these
features (radiation dose, need for iodinated contrast and
CAD probability) should be taken into consideration when
selecting the most appropriate exam for each patient.
Conclusions
In these registries of diagnostic tests commonly used in car-
diology, the mean effective radiation dose used in cardiac
CT was lower than that used in ICA, which in turn was
lower than the doses used in SPECT. There was a signifi-
cant increase over time in the mean effective radiation dose
associated with ICA, mainly related to the increased use of
radial access, and a decrease in cardiac CT doses as a con-
sequence of the implementation of a prospective protocol.
Obesity was associated with a significantly higher radiation
dose in all three exams.
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Abstract To describe a coronary computed tomography
angiography (CCTA)-adapted Leaman score (CT-LeSc) as
a tool to quantify total coronary atherosclerotic burden with
information regarding localization, type of plaque and
degree of stenosis and to identify clinical predictors of a
high coronary atherosclerotic burden as assessed by the
CT-LeSc. Single center prospective registry including a
total of 772 consecutive patients undergoing CCTA (Dual-
source CT) from April 2011 to March 2012. For the pur-
pose of this study, 581 stable patients referred for suspected
coronary artery disease (CAD) without previous myocar-
dial infarction or revascularization procedures were inclu-
ded. Pre-test CAD probability was determined using both
the Diamond–Forrester extended CAD consortium method
(DF-CAD consortium model) and the Morise score. Car-
diovascular risk was assessed with the HeartScore. The cut-
off for the 3rd tercile (CT-LeSc C8.3) was used to define a
population with a high coronary atherosclerotic burden.
The median CT-LeSc in this population (n = 581, 8,136
coronary segments evaluated; mean age 57.6 ± 11.1;
55.8 % males; 14.6 % with diabetes) was 2.2 (IQR 0–6.8).
In patients with CAD (n = 341), the median CT-LeSc was
5.8 (IQR 3.2–9.6). Among patients with nonobstructive
CAD, most were classified in the lowest terciles (T1,
43.0 %; T2, 36.1 %), but 20.9 % were in the highest tercile
(T3). The majority of the patients with obstructive CAD
were classified in T3 (78.2 %), but 21.8 % had a CT-LeSc
in lower terciles (T1 or T2). The independent predictors of
a high CT-LeSc were: Male sex (OR 1.73; 95 % CI
1.04–2.90) diabetes (OR 2.91; 95 % CI 1.61–5.23),
hypertension (OR 2.54; 95 % CI 1.40–4.63), Morise score
C16 (OR 1.97; 95 % CI 1.06–3.67) and HeartScore C5
(OR 2.42; 95 % CI 1.41–4.14). We described a cardiac CT
adapted Leaman score as a tool to quantify total (obstruc-
tive and nonobstructive) coronary atherosclerotic burden,
reflecting the comprehensive information about localiza-
tion, degree of stenosis and type of plaque provided by
CCTA. Male sex, hypertension, diabetes, a HeartScore
C5 % and a Morise score C16 were associated with a high
coronary atherosclerotic burden, as assessed by the CT-
LeSc. About one fifth of the patients with nonobstructive
CAD had a CT-LeSc in the highest tercile, and this could
potentially lead to a reclassification of the risk profile of
this subset of patients identified by CCTA, once the
prognostic value of the CT-LeSc is validated.
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Abstract To describe a coronary computed tomography
angiography (CCTA)-adapted Leaman score (CT-LeSc) as
a tool to quantify total coronary atherosclerotic burden with
information regarding localization, type of plaque and
degree of stenosis and to identify clinical predictors of a
high coronary atherosclerotic burden as assessed by the
CT-LeSc. Single center prospective registry including a
total of 772 consecutive patients undergoing CCTA (Dual-
source CT) from April 2011 to March 2012. For the pur-
pose of this study, 581 stable patients referred for suspected
coronary artery disease (CAD) without previous myocar-
dial infarction or revascularization procedures were inclu-
ded. Pre-test CAD probability was determined using both
the Diamond–Forrester extended CAD consortium method
(DF-CAD consortium model) and the Morise score. Car-
diovascular risk was assessed with the HeartScore. The cut-
off for the 3rd tercile (CT-LeSc C8.3) was used to define a
population with a high coronary atherosclerotic burden.
The median CT-LeSc in this population (n = 581, 8,136
coronary segments evaluated; mean age 57.6 ± 11.1;
55.8 % males; 14.6 % with diabetes) was 2.2 (IQR 0–6.8).
In patients with CAD (n = 341), the median CT-LeSc was
5.8 (IQR 3.2–9.6). Among patients with nonobstructive
CAD, most were classified in the lowest terciles (T1,
43.0 %; T2, 36.1 %), but 20.9 % were in the highest tercile
(T3). The majority of the patients with obstructive CAD
were classified in T3 (78.2 %), but 21.8 % had a CT-LeSc
in lower terciles (T1 or T2). The independent predictors of
a high CT-LeSc were: Male sex (OR 1.73; 95 % CI
1.04–2.90) diabetes (OR 2.91; 95 % CI 1.61–5.23),
hypertension (OR 2.54; 95 % CI 1.40–4.63), Morise score
C16 (OR 1.97; 95 % CI 1.06–3.67) and HeartScore C5
(OR 2.42; 95 % CI 1.41–4.14). We described a cardiac CT
adapted Leaman score as a tool to quantify total (obstruc-
tive and nonobstructive) coronary atherosclerotic burden,
reflecting the comprehensive information about localiza-
tion, degree of stenosis and type of plaque provided by
CCTA. Male sex, hypertension, diabetes, a HeartScore
C5 % and a Morise score C16 were associated with a high
coronary atherosclerotic burden, as assessed by the CT-
LeSc. About one fifth of the patients with nonobstructive
CAD had a CT-LeSc in the highest tercile, and this could
potentially lead to a reclassification of the risk profile of
this subset of patients identified by CCTA, once the
prognostic value of the CT-LeSc is validated.
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Introduction
Coronary atherosclerosis is the leading cause of mortality
and it is expected to remain the most important disease in
the upcoming years [1]. Frequently, the first manifestation
of coronary disease is an acute coronary syndrome (ACS),
and many patients were previously asymptomatic [2]. An
early detection of coronary disease is of utmost relevance
and a non-invasive diagnostic test is desirable.
In the recent years, coronary computed tomography
angiography (CCTA) has become widely available and
adopted. The main reason for this is the high predictive
accuracy of detection of obstructive coronary artery disease
(CAD) compared to conventional invasive coronary angi-
ography [3, 4]. In addition, CCTA allows also the identi-
fication of nonobstructive CAD and in this way it can
provide a noninvasive quantification of the total coronary
atherosclerotic burden. Since the percentage of patients
with nonobstructive CAD is very high, there is a need for
tools to stratify cardiovascular risk by the degree of plaque
burden [5]. The information regarding the localization,
severity and composition of coronary plaques identified
with CCTA can be collected in scores to reflect the total
coronary plaque burden, and some have been already
developed and validated [6].
Conventional cardiovascular (CV) risk factors relate to
the risk of subsequent CV events and they can be combined
in tools as it has been done in the Heart Score [7]. Not-
withstanding these observations, accurate prediction of
major coronary events on the individual patient level, as
opposed to population based studies, remains challenging.
Therefore the aim of this study is two folded: (1) To
describe a CCTA-adapted Leaman score (CT-LeSc) as a
tool to quantify total coronary atherosclerotic burden
including information regarding localization, type of pla-
que and degree of stenosis and; (2) To identify clinical
predictors of a high coronary atherosclerotic burden as
assessed by CT-LeSc in a population of stable patients
referred for CCTA for suspected CAD.
Methods
Population
Single center prospective registry including a total of 772
consecutive patients undergoing CCTA (with Dual source
CT) from April 2011 to March 2012. Patients were excluded
if: (1) previous myocardial infarction and/or revasculariza-
tion procedures (n = 70); (2) referred for Cardiac CT for
other indications than the evaluation of possible CAD (car-
diac CT for atrial fibrillation ablation or transcatheter aortic
valvular implantation procedures; n = 88); (3) referred for
suspected ACS (n = 24); (4) with atrial fibrillation or other
significant arrhythmias during scan acquisition that com-
promised image quality (n = 9). This resulted in a 24.7 % of
the total population being excluded.
For the purpose of this study, 581 stable patients refer-
red for suspected CAD were included in the context of: (1)
Previous equivocal or inconclusive stress tests or discor-
dant with the clinical evaluation (n = 417; 71.8 %); (2)
Cardiac CT as 1st line investigation of possible CAD
(n = 136; 23.4 %); (3) Preoperative CAD assessment prior
to noncoronary valvular or aortic surgery (n = 17; 2.9 %);
(4) Evaluation of possible CAD in cardiomyopathies
(DCM or HCM; n = 11; 1.9 %; Fig. 1: Patient selection
and study design).
The study was approved by the local ethics committee
and all patients gave a written informed consent.
A detailed medical history with a risk factors question-
naire was obtained from the patients to assess for the pres-
ence of: (1) Diabetes mellitus (defined as a fasting glucose
level of C7 mmol/l or the need for insulin or oral hypogly-
cemic agents) [8]; (2) Dyslipidemia (defined as a total cho-
lesterol level C5 mmol/l or treatment with lipid-lowering
drugs) [9]; (3) Hypertension (defined as blood pressure
C140/90 mm Hg or the use of antihypertensive medication)
[10]; (4) Obesity (body mass indexC30 kg/m2); (5) positive
family history of premature CAD (defined as the presence of
CAD in first-degree relatives younger than 55 [male] or 65
[female] years of age) [11]; (6) smoking (defined as previous
[less\1 year] or current smoker.
Pre-test probability of CAD was determined using both
the Diamond and Forrester extended CAD consortium
method (DF-CAD consortium model) [12] and the Morise
score [13]. The cardiovascular risk was assessed with the
HeartScore [7]. As the CAD probability and CV risk of our
population was shifted to lower probability and risk, the
cut-offs used were: (1) for DF-CAD consortium model
categories C30–70 and C70 % were gathered in a Inter-
mediate to High (C30 %) probability group.
For the Morise, the population was divided in terciles,
and for the HeartScore the established high risk cut-off of
C5 % was used.
Scan protocol and image reconstruction
All scans were performed with a dual-source scanner
(Somatom Definition, Siemens Medical, Germany), with
the patient in dorsal decubitus and in deep inspiration
breath-hold. Sublingual nitroglycerin was administered to
all patients except when contraindicated and intravenous
metoprolol (5 mg, with a titration dose up to 20 mg) was
administered in patients with heart rate[65 beats/min.
During the scan acquisition, a bolus of iodinated con-
trast (Visipaque, GE Healthcare, USA) was injected at a
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6 ml/s infusion rate, followed by a 50-ml saline flush. The
dose of contrast was calculated according to the following
formula: (acquisition time ?6 s delay) 9 flow (6 ml/s).
Contrast timing was performed to optimize uniform con-
trast enhancement of the coronary arteries.
Dose reduction strategies—including electrocardiogram-
gated tube current modulation, reduced tube voltage,
and prospective axial triggering—were used whenever fea-
sible. Mean estimated radiation dose was 4.6 ± 3.7 mSv,
contrast dose was 98.9 ± 14.4 ml and heart rate was
65.6 ± 10.6 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75 mm with
0.4 mm increments.
Post-processing was carried out using Circulation
software, with multiplanar reconstructions, maximum
intensity projection and volume rendering technique.
Coronary artery analysis
All scans were analyzed in the same session by both a car-
diologist and a radiologist with Level III-equivalent expe-
rience. The Society of Cardiovascular Computed
Tomography recommended classification was used regard-
ing segmentation (16 segments), stenosis severity (\25,
25–49, 50–69, 70–99, 100 %) and plaque composition
(calcified, non calcified, mixed plaque) [14].
In each coronary artery segment, coronary atherosclerosis
was defined as a tissue structure[1 mm2 that existed either
within the coronary artery lumen or adjacent to the coronary
artery lumen that could be discriminated from surrounding
pericardial tissue, epicardial fat, or the vessel lumen itself
[6]. Coronary atherosclerotic lesions were quantified for
stenosis by visual estimation. Percent obstruction of coro-
nary artery lumen was based on a comparison of the luminal
diameter of the segment exhibiting obstruction to the luminal
diameter of the most normal-appearing site immediately
proximal to the plaque.
CCTA adapted Leaman score (CT-LeSc)
For the CT adaptation of the LeSc, we used three sets of
weighting factors, all noninvasively provided by CCTA:
(1) localization of the coronary plaques as originally
described [15]. In this study, a modification was made to
account for balanced dominance. In cases of balanced
dominance, not taken in account in the original Leaman or
in the Syntax scores, we assumed an intermediate value
between right and left dominance which changed the val-
ues for the posterior descending and the proximal, mid and
Fig. 1 Patient selection and
study design. CAD coronary
artery disease, TAVI
transcatheter aortic valve
implantation, aFib atrial
fibrillation, MI myocardial
infarction, CABG coronary
artery bypass grafting, PCI
percutaneous coronary
intervention, ACS acute
coronary syndromes
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Introduction
Coronary atherosclerosis is the leading cause of mortality
and it is expected to remain the most important disease in
the upcoming years [1]. Frequently, the first manifestation
of coronary disease is an acute coronary syndrome (ACS),
and many patients were previously asymptomatic [2]. An
early detection of coronary disease is of utmost relevance
and a non-invasive diagnostic test is desirable.
In the recent years, coronary computed tomography
angiography (CCTA) has become widely available and
adopted. The main reason for this is the high predictive
accuracy of detection of obstructive coronary artery disease
(CAD) compared to conventional invasive coronary angi-
ography [3, 4]. In addition, CCTA allows also the identi-
fication of nonobstructive CAD and in this way it can
provide a noninvasive quantification of the total coronary
atherosclerotic burden. Since the percentage of patients
with nonobstructive CAD is very high, there is a need for
tools to stratify cardiovascular risk by the degree of plaque
burden [5]. The information regarding the localization,
severity and composition of coronary plaques identified
with CCTA can be collected in scores to reflect the total
coronary plaque burden, and some have been already
developed and validated [6].
Conventional cardiovascular (CV) risk factors relate to
the risk of subsequent CV events and they can be combined
in tools as it has been done in the Heart Score [7]. Not-
withstanding these observations, accurate prediction of
major coronary events on the individual patient level, as
opposed to population based studies, remains challenging.
Therefore the aim of this study is two folded: (1) To
describe a CCTA-adapted Leaman score (CT-LeSc) as a
tool to quantify total coronary atherosclerotic burden
including information regarding localization, type of pla-
que and degree of stenosis and; (2) To identify clinical
predictors of a high coronary atherosclerotic burden as
assessed by CT-LeSc in a population of stable patients
referred for CCTA for suspected CAD.
Methods
Population
Single center prospective registry including a total of 772
consecutive patients undergoing CCTA (with Dual source
CT) from April 2011 to March 2012. Patients were excluded
if: (1) previous myocardial infarction and/or revasculariza-
tion procedures (n = 70); (2) referred for Cardiac CT for
other indications than the evaluation of possible CAD (car-
diac CT for atrial fibrillation ablation or transcatheter aortic
valvular implantation procedures; n = 88); (3) referred for
suspected ACS (n = 24); (4) with atrial fibrillation or other
significant arrhythmias during scan acquisition that com-
promised image quality (n = 9). This resulted in a 24.7 % of
the total population being excluded.
For the purpose of this study, 581 stable patients refer-
red for suspected CAD were included in the context of: (1)
Previous equivocal or inconclusive stress tests or discor-
dant with the clinical evaluation (n = 417; 71.8 %); (2)
Cardiac CT as 1st line investigation of possible CAD
(n = 136; 23.4 %); (3) Preoperative CAD assessment prior
to noncoronary valvular or aortic surgery (n = 17; 2.9 %);
(4) Evaluation of possible CAD in cardiomyopathies
(DCM or HCM; n = 11; 1.9 %; Fig. 1: Patient selection
and study design).
The study was approved by the local ethics committee
and all patients gave a written informed consent.
A detailed medical history with a risk factors question-
naire was obtained from the patients to assess for the pres-
ence of: (1) Diabetes mellitus (defined as a fasting glucose
level of C7 mmol/l or the need for insulin or oral hypogly-
cemic agents) [8]; (2) Dyslipidemia (defined as a total cho-
lesterol level C5 mmol/l or treatment with lipid-lowering
drugs) [9]; (3) Hypertension (defined as blood pressure
C140/90 mm Hg or the use of antihypertensive medication)
[10]; (4) Obesity (body mass indexC30 kg/m2); (5) positive
family history of premature CAD (defined as the presence of
CAD in first-degree relatives younger than 55 [male] or 65
[female] years of age) [11]; (6) smoking (defined as previous
[less\1 year] or current smoker.
Pre-test probability of CAD was determined using both
the Diamond and Forrester extended CAD consortium
method (DF-CAD consortium model) [12] and the Morise
score [13]. The cardiovascular risk was assessed with the
HeartScore [7]. As the CAD probability and CV risk of our
population was shifted to lower probability and risk, the
cut-offs used were: (1) for DF-CAD consortium model
categories C30–70 and C70 % were gathered in a Inter-
mediate to High (C30 %) probability group.
For the Morise, the population was divided in terciles,
and for the HeartScore the established high risk cut-off of
C5 % was used.
Scan protocol and image reconstruction
All scans were performed with a dual-source scanner
(Somatom Definition, Siemens Medical, Germany), with
the patient in dorsal decubitus and in deep inspiration
breath-hold. Sublingual nitroglycerin was administered to
all patients except when contraindicated and intravenous
metoprolol (5 mg, with a titration dose up to 20 mg) was
administered in patients with heart rate[65 beats/min.
During the scan acquisition, a bolus of iodinated con-
trast (Visipaque, GE Healthcare, USA) was injected at a
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6 ml/s infusion rate, followed by a 50-ml saline flush. The
dose of contrast was calculated according to the following
formula: (acquisition time ?6 s delay) 9 flow (6 ml/s).
Contrast timing was performed to optimize uniform con-
trast enhancement of the coronary arteries.
Dose reduction strategies—including electrocardiogram-
gated tube current modulation, reduced tube voltage,
and prospective axial triggering—were used whenever fea-
sible. Mean estimated radiation dose was 4.6 ± 3.7 mSv,
contrast dose was 98.9 ± 14.4 ml and heart rate was
65.6 ± 10.6 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75 mm with
0.4 mm increments.
Post-processing was carried out using Circulation
software, with multiplanar reconstructions, maximum
intensity projection and volume rendering technique.
Coronary artery analysis
All scans were analyzed in the same session by both a car-
diologist and a radiologist with Level III-equivalent expe-
rience. The Society of Cardiovascular Computed
Tomography recommended classification was used regard-
ing segmentation (16 segments), stenosis severity (\25,
25–49, 50–69, 70–99, 100 %) and plaque composition
(calcified, non calcified, mixed plaque) [14].
In each coronary artery segment, coronary atherosclerosis
was defined as a tissue structure[1 mm2 that existed either
within the coronary artery lumen or adjacent to the coronary
artery lumen that could be discriminated from surrounding
pericardial tissue, epicardial fat, or the vessel lumen itself
[6]. Coronary atherosclerotic lesions were quantified for
stenosis by visual estimation. Percent obstruction of coro-
nary artery lumen was based on a comparison of the luminal
diameter of the segment exhibiting obstruction to the luminal
diameter of the most normal-appearing site immediately
proximal to the plaque.
CCTA adapted Leaman score (CT-LeSc)
For the CT adaptation of the LeSc, we used three sets of
weighting factors, all noninvasively provided by CCTA:
(1) localization of the coronary plaques as originally
described [15]. In this study, a modification was made to
account for balanced dominance. In cases of balanced
dominance, not taken in account in the original Leaman or
in the Syntax scores, we assumed an intermediate value
between right and left dominance which changed the val-
ues for the posterior descending and the proximal, mid and
Fig. 1 Patient selection and
study design. CAD coronary
artery disease, TAVI
transcatheter aortic valve
implantation, aFib atrial
fibrillation, MI myocardial
infarction, CABG coronary
artery bypass grafting, PCI
percutaneous coronary
intervention, ACS acute
coronary syndromes
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distal RCA segments as well as for the left main and
proximal and distal segments of the circumflex; (2) type of
plaque (i.e. noncalcified, calcified or mixed plaques). To
take in account the cardiac CT added information related to
plaque composition, an additional weighting factor of 1.5
was added to predominantly noncalcified of mixed plaques
and a factor of 1 to predominantly calcified plaques,
reflecting the assumption of less plaque vulnerability of the
later ones [16, 17]; (3) degree of stenosis (\50 C% ste-
nosis). In the presence of obstructive CAD (C50 % ste-
nosis), the score in each segment was multiplied by 1 and
for nonobstructive CAD it was multiplied by a factor of
0.615. This factor reflects the relative proportion in the
published hazard ratios for mortality in the large CON-
FIRM registry [5] for obstructive versus nonobstructive
CAD (2.6 vs 1.6 respectively) and it was assumed to reflect
the relative prognostic impact of nonobstructive CAD
(Table 1).
The CT-LeSc on a patient level was calculated as the
sum of the partial CT-LeSc of all evaluable coronary
segments. Two cases examples are shown in Fig. 2.
Statistical analysis
Continuous variables are presented as mean ± SD or
medians (interquartile range) and categorical variables as
frequencies with percentages.
The non-parametric Mann–Whitney or Kruskal–Wallis
tests were used to compare continuous variables, and the Chi
square test to evaluate differences in frequencies. Differ-
ences were regarded significant when p\ 0.05 (two-tailed).
Since there are no previous validated cut-offs for the
presently described CCTA score, the population with CAD
was divided in terciles. A high CT-LeSc was defined with
the cut-off for the 3rd tercile (a score C8.3, n = 116;
34.8 % of the CAD population) and patients in this group
were compared with the remaining population.
Multivariate analyses (binary logistic regressionmodel—
enter method) were performed to identify independent pre-
dictors of a high CT-LeSc using the demographic and clin-
ical variables presented in Table 2 that had a p value\0.2 at
univariate analyses. A second multivariable analyses was
performed to identify independent predictors among the
clinical scores of CAD probability (Diamond–Forrester
CAD consortium model and Morise score) and the CV risk
score HeartScore.
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) was
used for all statistical analyses.
Results
In the final study population of 581 patients, 8,136 coronary
segments were evaluated. Segments \2 mm (n = 742;
9.1 %) or with suboptimal image quality related to artefacts
or severe calcification (n = 120; 1.5 %) were excluded.
Most of patients were male (55.8 %) and mean age was
57.6 ± 11.1, and 14.6 % were diabetics. This was predom-
inantly a population with low to intermediate CAD proba-
bility since 60.1 % had a DF-CAD consortium\30 and
87.6 % had a Morise score\16. A high cardiovascular risk,
as assessed by anHeartScoreC5 %,was present in 25.5 %of
the patients. In this population, themedian calcium scorewas
1 (IQR 0–93), 23.4 % had a calcium score (CaSc)C100 and
14.3 % had a CaSc C75th percentile. In the population with
CAD, the median CaSc was 64 (IQR 8–200; Table 2).
CT-LeSc
Overall (n = 581), the median CT-LeSc in this population
was 2.2 (IQR 0–6.8). In patients with CAD (n = 341), the
Table 1 CT-adapted Leaman Score (CT-LeSc) weighting factors
Segment Right
dominance
Left
dominance
Balanced
Coronary segments
RCA proximal 1 0 0.5
RCA mid 1 0 0.5
RCA distal 1 0 0.5
PDA 1 na 0.5
Left main 5 6 5.5
LAD proximal 3.5 3.5 3.5
LAD mid 2.5 2.5 2.5
LAD distal 1 1 1
1st diagonal 1 1 1
2nd diagonal 0.5 0.5 0.5
LCx proximal 1.5 2.5 2.0
1st obtuse marginal 1 1 1
LCx distal 0.5 1.5 1
2nd obtuse marginal 1 1 1
PDA from LCA na 1 na
PL branch from
LCA
na 0.5 0.5
PL branch
from RCA
0.5 na na
Intermediate branch 1 1 1
Stenosis severity
Obstructive CAD 1
Nonobstructive CAD 0.615
Plaque composition
Non-calcified or mixed 1.5
Calcified 1
RCA right coronary artery, PDA posterior descending artery, LAD left
anterior descending, LCx left circumflex, PL postero-lateral, CAD
coronary artery disease
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median CT-LeSc was 5.8 (IQR 3.2–9.6). Within this pop-
ulation the median CT-LeSc in patients with non-obstruc-
tive disease (n = 263) was 4.6 (IQR 2.9–7.7) and in
patients with obstructive disease (n = 78) it was 11.7 (IQR
8.7–14.4). The terciles in population with CAD were: T1
B3.7 (0.3–3.7); T2 (3.8–8.3); T3 C8.3 (8.3–24.1).
Regarding the distribution of patients with nonobstruc-
tive versus obstructive CAD across the CT-LeSc terciles,
most of the patients with nonobstructive CAD were in T1
(n = 113, 43.0 %) or T2 (n = 95, 36.1 %), but about one
fifth (n = 55, 20.9 %) were in the highest tercile (T3, CT-
LeScC8.3). On the other hand, although most of the patients
with obstructive CAD were classified in T3, 21.8 % had a
CT-LeSc in lower terciles (T1, 2.6 %; T2, 19.2 %; Fig. 3).
The median CT-LeSc was significantly higher in males
and in the presence of diabetes and hypertension, as well as
in patients with a high cardiovascular risk assessed by an
HeartScore C5 %. The median CT-LeSc was also signifi-
cantly higher in patients with a CaSc C100 and CaSc
C75th percentile (Fig. 4: Median CT-LeSc in different
patient subgroups).
Univariate predictors
In the univariate analysis, a high CT-LeSc was associated
with older age (C60 years), diabetes and hypertension. The
percentage of male patients and patients with dyslipidemia
was also higher in the high CT-LeSc group, but not sta-
tistically significant. Patients in the high CT group had also
a higher pre-test CAD probability (DF-CAD consortium
C30 % and Morise score C16) as well as higher CV risk,
reflected in the significantly higher percentage of patients
with a HeartScore C5 %. Of note, some traditional risk
factor as obesity, smoking status and family history of
premature CAD were not differently distributed in the two
groups, and this was also the case for chest pain (Table 3).
Multivariate predictors
By multivariate analysis, the independent predictors of a
high CT-LeSc were: male sex; diabetes, hypertension,
Morise score C16 and HeartScore C5 (Table 4; Fig. 5). Of
note, regarding the modifiable risk factors, patients with
Fig. 2 Three cases examples of patients with nonobstructive CAD
stratified by different coronary atherosclerotic burden scores. In panel
A, a patient with a single lesion in the mid-RCA (weighting for
localization 9 type of plaque 9 stenosis severity = 1 9 1.5 9
0.615 = 0.92); In panel B, a patient with a single proximal LAD
lesion (CT-LeSc = 3.5 9 1 9 0.615 = 2.15). In panel C, a patient
with left dominance and 5 nonobstructive lesions with a total
CT-LeSc = LM (6 9 1.5 9 0.615) ? prox. LAD (3.5 9 1.5 9
0.615) ? mid-LAD (2.5 9 1 9 0.615) ? 1st Diag. (1 9 1 9 0.615) ?
1st OM (1 9 1 9 0.615) = 11.5. CAD coronary artery disease,
CT-LeSc CT Leaman score, SIS segment involvement score, SSS
segment stenosis score, LM left main, LAD left anterior descending,
LCx left circunflex, RCA right coronary artery, 1st Diag. first diagonal
branch, 1st OM first obtuse marginal branch
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distal RCA segments as well as for the left main and
proximal and distal segments of the circumflex; (2) type of
plaque (i.e. noncalcified, calcified or mixed plaques). To
take in account the cardiac CT added information related to
plaque composition, an additional weighting factor of 1.5
was added to predominantly noncalcified of mixed plaques
and a factor of 1 to predominantly calcified plaques,
reflecting the assumption of less plaque vulnerability of the
later ones [16, 17]; (3) degree of stenosis (\50 C% ste-
nosis). In the presence of obstructive CAD (C50 % ste-
nosis), the score in each segment was multiplied by 1 and
for nonobstructive CAD it was multiplied by a factor of
0.615. This factor reflects the relative proportion in the
published hazard ratios for mortality in the large CON-
FIRM registry [5] for obstructive versus nonobstructive
CAD (2.6 vs 1.6 respectively) and it was assumed to reflect
the relative prognostic impact of nonobstructive CAD
(Table 1).
The CT-LeSc on a patient level was calculated as the
sum of the partial CT-LeSc of all evaluable coronary
segments. Two cases examples are shown in Fig. 2.
Statistical analysis
Continuous variables are presented as mean ± SD or
medians (interquartile range) and categorical variables as
frequencies with percentages.
The non-parametric Mann–Whitney or Kruskal–Wallis
tests were used to compare continuous variables, and the Chi
square test to evaluate differences in frequencies. Differ-
ences were regarded significant when p\ 0.05 (two-tailed).
Since there are no previous validated cut-offs for the
presently described CCTA score, the population with CAD
was divided in terciles. A high CT-LeSc was defined with
the cut-off for the 3rd tercile (a score C8.3, n = 116;
34.8 % of the CAD population) and patients in this group
were compared with the remaining population.
Multivariate analyses (binary logistic regressionmodel—
enter method) were performed to identify independent pre-
dictors of a high CT-LeSc using the demographic and clin-
ical variables presented in Table 2 that had a p value\0.2 at
univariate analyses. A second multivariable analyses was
performed to identify independent predictors among the
clinical scores of CAD probability (Diamond–Forrester
CAD consortium model and Morise score) and the CV risk
score HeartScore.
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) was
used for all statistical analyses.
Results
In the final study population of 581 patients, 8,136 coronary
segments were evaluated. Segments \2 mm (n = 742;
9.1 %) or with suboptimal image quality related to artefacts
or severe calcification (n = 120; 1.5 %) were excluded.
Most of patients were male (55.8 %) and mean age was
57.6 ± 11.1, and 14.6 % were diabetics. This was predom-
inantly a population with low to intermediate CAD proba-
bility since 60.1 % had a DF-CAD consortium\30 and
87.6 % had a Morise score\16. A high cardiovascular risk,
as assessed by anHeartScoreC5 %,was present in 25.5 %of
the patients. In this population, themedian calcium scorewas
1 (IQR 0–93), 23.4 % had a calcium score (CaSc)C100 and
14.3 % had a CaSc C75th percentile. In the population with
CAD, the median CaSc was 64 (IQR 8–200; Table 2).
CT-LeSc
Overall (n = 581), the median CT-LeSc in this population
was 2.2 (IQR 0–6.8). In patients with CAD (n = 341), the
Table 1 CT-adapted Leaman Score (CT-LeSc) weighting factors
Segment Right
dominance
Left
dominance
Balanced
Coronary segments
RCA proximal 1 0 0.5
RCA mid 1 0 0.5
RCA distal 1 0 0.5
PDA 1 na 0.5
Left main 5 6 5.5
LAD proximal 3.5 3.5 3.5
LAD mid 2.5 2.5 2.5
LAD distal 1 1 1
1st diagonal 1 1 1
2nd diagonal 0.5 0.5 0.5
LCx proximal 1.5 2.5 2.0
1st obtuse marginal 1 1 1
LCx distal 0.5 1.5 1
2nd obtuse marginal 1 1 1
PDA from LCA na 1 na
PL branch from
LCA
na 0.5 0.5
PL branch
from RCA
0.5 na na
Intermediate branch 1 1 1
Stenosis severity
Obstructive CAD 1
Nonobstructive CAD 0.615
Plaque composition
Non-calcified or mixed 1.5
Calcified 1
RCA right coronary artery, PDA posterior descending artery, LAD left
anterior descending, LCx left circumflex, PL postero-lateral, CAD
coronary artery disease
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median CT-LeSc was 5.8 (IQR 3.2–9.6). Within this pop-
ulation the median CT-LeSc in patients with non-obstruc-
tive disease (n = 263) was 4.6 (IQR 2.9–7.7) and in
patients with obstructive disease (n = 78) it was 11.7 (IQR
8.7–14.4). The terciles in population with CAD were: T1
B3.7 (0.3–3.7); T2 (3.8–8.3); T3 C8.3 (8.3–24.1).
Regarding the distribution of patients with nonobstruc-
tive versus obstructive CAD across the CT-LeSc terciles,
most of the patients with nonobstructive CAD were in T1
(n = 113, 43.0 %) or T2 (n = 95, 36.1 %), but about one
fifth (n = 55, 20.9 %) were in the highest tercile (T3, CT-
LeScC8.3). On the other hand, although most of the patients
with obstructive CAD were classified in T3, 21.8 % had a
CT-LeSc in lower terciles (T1, 2.6 %; T2, 19.2 %; Fig. 3).
The median CT-LeSc was significantly higher in males
and in the presence of diabetes and hypertension, as well as
in patients with a high cardiovascular risk assessed by an
HeartScore C5 %. The median CT-LeSc was also signifi-
cantly higher in patients with a CaSc C100 and CaSc
C75th percentile (Fig. 4: Median CT-LeSc in different
patient subgroups).
Univariate predictors
In the univariate analysis, a high CT-LeSc was associated
with older age (C60 years), diabetes and hypertension. The
percentage of male patients and patients with dyslipidemia
was also higher in the high CT-LeSc group, but not sta-
tistically significant. Patients in the high CT group had also
a higher pre-test CAD probability (DF-CAD consortium
C30 % and Morise score C16) as well as higher CV risk,
reflected in the significantly higher percentage of patients
with a HeartScore C5 %. Of note, some traditional risk
factor as obesity, smoking status and family history of
premature CAD were not differently distributed in the two
groups, and this was also the case for chest pain (Table 3).
Multivariate predictors
By multivariate analysis, the independent predictors of a
high CT-LeSc were: male sex; diabetes, hypertension,
Morise score C16 and HeartScore C5 (Table 4; Fig. 5). Of
note, regarding the modifiable risk factors, patients with
Fig. 2 Three cases examples of patients with nonobstructive CAD
stratified by different coronary atherosclerotic burden scores. In panel
A, a patient with a single lesion in the mid-RCA (weighting for
localization 9 type of plaque 9 stenosis severity = 1 9 1.5 9
0.615 = 0.92); In panel B, a patient with a single proximal LAD
lesion (CT-LeSc = 3.5 9 1 9 0.615 = 2.15). In panel C, a patient
with left dominance and 5 nonobstructive lesions with a total
CT-LeSc = LM (6 9 1.5 9 0.615) ? prox. LAD (3.5 9 1.5 9
0.615) ? mid-LAD (2.5 9 1 9 0.615) ? 1st Diag. (1 9 1 9 0.615) ?
1st OM (1 9 1 9 0.615) = 11.5. CAD coronary artery disease,
CT-LeSc CT Leaman score, SIS segment involvement score, SSS
segment stenosis score, LM left main, LAD left anterior descending,
LCx left circunflex, RCA right coronary artery, 1st Diag. first diagonal
branch, 1st OM first obtuse marginal branch
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diabetes had a threefold and patients with hypertension a
2.5-fold higher probability of having a high CT-LeSc.
A high HeartScore (C5 %) and a high Morise score
(C16) were associated respectively with a 2.5 and twofold
higher probability of having a high coronary atheroscle-
rotic burden, as assessed by the CT-LeSc.
Discussion
The main findings of this study are: (1) Calculation of a
cardiac CT adapted Leaman score as a tool to quantify total
(obstructive and nonobstructive) coronary atherosclerotic
burden, reflecting the comprehensive information about
localization, degree of stenosis and type of plaque provided
by CCTA is feasible; (2) There was a significant associa-
tion between the CT-LeSc and diabetes, a well recognized
subset of advanced coronary atherosclerotic burden. A high
CV risk (HeartScore) and a high CAD probability (Morise
score) were also both associated with nearly a 2–2.5 fold
higher probability of having a high coronary atheroscle-
rotic burden, as assessed by the CT-LeSc.
Although the exclusion of obstructive CAD remains
presently the main indication to refer a patient for CCTA,
this noninvasive diagnostic tool can also provide infor-
mation regarding the presence of nonobstructive plaques,
detecting CAD at earlier disease stages. Although on a per
lesion basis, vulnerability is positively associated with the
degree of stenosis, on a per patient level most of the acute
events come from nonobstructive lesions [18–20]. It is also
recognized that many of the nonstenotic lesions can have a
high plaque burden, underestimated by luminal angio-
grams, since they undergo expansive or positive outward
enlargement, and such remodeling is a potential surrogate
marker of plaque vulnerability [21]. In the multicenter
virtual histology intravascular ultrasound (VH-IVUS)
PROSPECT study [22], a large plaque burden, a small
lumen area and the presence of a thin cap fibroatheroma
were independent predictors of future nonculprit lesion
major adverse cardiac events (MACE). In this study,
lesions that led to MACE had a high plaque burden by
Table 2 Demographic, clinical and CCTA characteristics of the
study population
All patients (n = 581)
Demographic
Age 57.6 ± 11.1
Male sex 324 (55.8)
Risk factors
Obesity (BMI C30) 109 (18.8)
Diabetes 85 (14.6)
Hypertension 364 (62.7)
Dyslipidemia 360 (62.0)
Smoking 138 (23.8)
Family history of premature CAD 194 (33.4)
Chest pain
Asymptomatic 270 (46.5)
Noncardiac 169 (29.1)
Atypical 109 (18.8)
Typical 33 (5.7)
CAD probability
DF-CAD consortium C70 % 11 (1.9)
DF-CAD consortium 30–70 % 221 (38.0)
DF-CAD consortium\30 % 349 (60.1)
Morise score C16 72 (12.4)
Morise score 9–15 369 (63.5)
Morise score 0–8 140 (24.1)
CV risk
Heart score C5 % 148 (25.5)
Calcium score
Median 1 (0–93)
Median in patients with CAD 64 (8–200)
CaSc C100 136 (23.4)
CaSc C75th percentile 83 (14.3)
CCTA
Normal/no plaque 240 (41.3)
Nonobstructive CAD 263 (45.3)
Obstructive CAD 78 (13.4)
Technical data
Heart rate (bpm) 65.6 ± 10.6
Contrast dose (ml) 98.9 ± 14.4
Radiation dose (mSv) 4.6 ± 3.7
Values are mean ± SD, median (IQR) or n (%)
CAD coronary artery disease, BMI body mass index, DF-CAD con-
sortium Diamond–Forrester CAD consortium model, CV cardiovas-
cular, CCTA coronary computed tomography angiography, CaSc
calcium score, bpm beats per minute, mSv milisievert
Fig. 3 Distribution of the two subgroups of patients (nonobstructive
and obstructive CAD), according to CT-LeSc terciles (T1 ? T2 vs
T3). CAD coronary artery disease, T1 1st tercile, T2 2nd tercile, T3
3rd tercile
1580 Int J Cardiovasc Imaging (2013) 29:1575–1584
123
Author's personal copy
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
165 
MANUSCRIPT 16 
 
 
 
 
IVUS, but were mild by baseline angiography (mean
diameter stenosis 32 %). The prognostic value of nonob-
structive CAD has also been recently reinforced from large
cardiac CT registries (CONFIRM) and meta-analysis [23].
In the large international multicenter CONFIRM regis-
try, all-cause mortality was significantly higher for patients
with nonobstructive CAD, as compared with patients
without coronary atherosclerosis. One notable finding in
this registry is the superimposed survival curves of non-
obstructive and 1 vessel obstructive CAD, reinforcing the
prognostic impact of nonobstructive coronary lesions [6].
Why a plaque burden CT score?
The main reason is because CAD represents a very heter-
ogeneous condition and there is a need to structure the
quantification of the plaque burden and to integrate the
most important information collected by CT and finally to
homogenize the reporting of CT findings.
There are already some CT scores developed and
prognostically validated namely the segment involvement
score (SIS) and the segment stenosis score (SSS), but they
only reflect some aspects of the coronary atherosclerotic
burden, the former only takes into account the number of
segments with plaque and the latter the degree of stenosis
[6]. The CT-LeSc reflects some of the aspects that are
partially included in the SIS (number of segments with
plaque) and the SSS (degree of stenosis), and combines
these two aspects, and also the localization, on a more
comprehensive score.
Why these three components?
Individually, localization of the plaque within the coronary
tree, the type of plaques and degree of stenosis are strong
predictors of future coronary events.
Since CCTA is able to reliably collect information on
these three aspects, a comprehensive score should be able
to integrate these components.
Fig. 4 Median CT-LeSc in different patient subgroups. DM diabetes mellitus, HTA hypertension, CA score calcium score, CT-LeSc CT Leaman
score
Table 3 Univariate analysis
CT LeSc
T1 ? 2
(\8.3)
CT
LeSc C
T3 (C8.3)
p
Age C60 126 (56.0) 79 (68.1) 0.031
Male sex 138 (61.3) 81 (69.8) 0.121
BMI C30 41 (18.3) 25 (22.1) 0.404
Diabetes 26 (11.6) 36 (31.0) \0.001
Hypertension 144 (64.0) 98 (84.5) \0.001
Dyslipidemia 146 (64.9) 87 (75.0) 0.057
Smoking 53 (23.6) 31 (26.7) 0.520
Family history of premature
CAD
77 (34.2) 37 (31.9) 0.666
Chest pain 106 (47.3) 59 (51.3) 0.487
DF-CAD consortium C30 % 66 (29.3) 64 (55.2) \0.001
Morise score C16 105 (46.7) 78 (67.2) \0.001
Heart score C5 29 (12.9) 24 (20.7) 0.060
Values are n (%); CAD coronary artery disease, BMI body mass
index, DF-CAD consortium-diamond–Forrester CAD consortium
model
Table 4 Multivariate analysis—independent predictors of a high CT-
LeSc (3rd tercile, score C8.3)
OR (95 % CI) p
Demographic and clinical variables
Age C60 1.370 0.819–2.291 0.230
Male sex 1.732 1.035–2.901 0.037
Diabetes 2.905 1.612–5.234 \0.001
Hypertension 2.543 1.395–4.634 0.002
Dyslipidemia 1.563 0.919–2.660 0.099
Clinical scores
Heart score C5 2.416 1.411–4.135 0.001
DF-CAD consortium C30 % 1.590 0.918–2.754 0.098
Morise C16 1.971 1.060–3.666 0.032
OR odds ratio, DF-CAD consortium Diamond–Forrester CAD con-
sortium model
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diabetes had a threefold and patients with hypertension a
2.5-fold higher probability of having a high CT-LeSc.
A high HeartScore (C5 %) and a high Morise score
(C16) were associated respectively with a 2.5 and twofold
higher probability of having a high coronary atheroscle-
rotic burden, as assessed by the CT-LeSc.
Discussion
The main findings of this study are: (1) Calculation of a
cardiac CT adapted Leaman score as a tool to quantify total
(obstructive and nonobstructive) coronary atherosclerotic
burden, reflecting the comprehensive information about
localization, degree of stenosis and type of plaque provided
by CCTA is feasible; (2) There was a significant associa-
tion between the CT-LeSc and diabetes, a well recognized
subset of advanced coronary atherosclerotic burden. A high
CV risk (HeartScore) and a high CAD probability (Morise
score) were also both associated with nearly a 2–2.5 fold
higher probability of having a high coronary atheroscle-
rotic burden, as assessed by the CT-LeSc.
Although the exclusion of obstructive CAD remains
presently the main indication to refer a patient for CCTA,
this noninvasive diagnostic tool can also provide infor-
mation regarding the presence of nonobstructive plaques,
detecting CAD at earlier disease stages. Although on a per
lesion basis, vulnerability is positively associated with the
degree of stenosis, on a per patient level most of the acute
events come from nonobstructive lesions [18–20]. It is also
recognized that many of the nonstenotic lesions can have a
high plaque burden, underestimated by luminal angio-
grams, since they undergo expansive or positive outward
enlargement, and such remodeling is a potential surrogate
marker of plaque vulnerability [21]. In the multicenter
virtual histology intravascular ultrasound (VH-IVUS)
PROSPECT study [22], a large plaque burden, a small
lumen area and the presence of a thin cap fibroatheroma
were independent predictors of future nonculprit lesion
major adverse cardiac events (MACE). In this study,
lesions that led to MACE had a high plaque burden by
Table 2 Demographic, clinical and CCTA characteristics of the
study population
All patients (n = 581)
Demographic
Age 57.6 ± 11.1
Male sex 324 (55.8)
Risk factors
Obesity (BMI C30) 109 (18.8)
Diabetes 85 (14.6)
Hypertension 364 (62.7)
Dyslipidemia 360 (62.0)
Smoking 138 (23.8)
Family history of premature CAD 194 (33.4)
Chest pain
Asymptomatic 270 (46.5)
Noncardiac 169 (29.1)
Atypical 109 (18.8)
Typical 33 (5.7)
CAD probability
DF-CAD consortium C70 % 11 (1.9)
DF-CAD consortium 30–70 % 221 (38.0)
DF-CAD consortium\30 % 349 (60.1)
Morise score C16 72 (12.4)
Morise score 9–15 369 (63.5)
Morise score 0–8 140 (24.1)
CV risk
Heart score C5 % 148 (25.5)
Calcium score
Median 1 (0–93)
Median in patients with CAD 64 (8–200)
CaSc C100 136 (23.4)
CaSc C75th percentile 83 (14.3)
CCTA
Normal/no plaque 240 (41.3)
Nonobstructive CAD 263 (45.3)
Obstructive CAD 78 (13.4)
Technical data
Heart rate (bpm) 65.6 ± 10.6
Contrast dose (ml) 98.9 ± 14.4
Radiation dose (mSv) 4.6 ± 3.7
Values are mean ± SD, median (IQR) or n (%)
CAD coronary artery disease, BMI body mass index, DF-CAD con-
sortium Diamond–Forrester CAD consortium model, CV cardiovas-
cular, CCTA coronary computed tomography angiography, CaSc
calcium score, bpm beats per minute, mSv milisievert
Fig. 3 Distribution of the two subgroups of patients (nonobstructive
and obstructive CAD), according to CT-LeSc terciles (T1 ? T2 vs
T3). CAD coronary artery disease, T1 1st tercile, T2 2nd tercile, T3
3rd tercile
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IVUS, but were mild by baseline angiography (mean
diameter stenosis 32 %). The prognostic value of nonob-
structive CAD has also been recently reinforced from large
cardiac CT registries (CONFIRM) and meta-analysis [23].
In the large international multicenter CONFIRM regis-
try, all-cause mortality was significantly higher for patients
with nonobstructive CAD, as compared with patients
without coronary atherosclerosis. One notable finding in
this registry is the superimposed survival curves of non-
obstructive and 1 vessel obstructive CAD, reinforcing the
prognostic impact of nonobstructive coronary lesions [6].
Why a plaque burden CT score?
The main reason is because CAD represents a very heter-
ogeneous condition and there is a need to structure the
quantification of the plaque burden and to integrate the
most important information collected by CT and finally to
homogenize the reporting of CT findings.
There are already some CT scores developed and
prognostically validated namely the segment involvement
score (SIS) and the segment stenosis score (SSS), but they
only reflect some aspects of the coronary atherosclerotic
burden, the former only takes into account the number of
segments with plaque and the latter the degree of stenosis
[6]. The CT-LeSc reflects some of the aspects that are
partially included in the SIS (number of segments with
plaque) and the SSS (degree of stenosis), and combines
these two aspects, and also the localization, on a more
comprehensive score.
Why these three components?
Individually, localization of the plaque within the coronary
tree, the type of plaques and degree of stenosis are strong
predictors of future coronary events.
Since CCTA is able to reliably collect information on
these three aspects, a comprehensive score should be able
to integrate these components.
Fig. 4 Median CT-LeSc in different patient subgroups. DM diabetes mellitus, HTA hypertension, CA score calcium score, CT-LeSc CT Leaman
score
Table 3 Univariate analysis
CT LeSc
T1 ? 2
(\8.3)
CT
LeSc C
T3 (C8.3)
p
Age C60 126 (56.0) 79 (68.1) 0.031
Male sex 138 (61.3) 81 (69.8) 0.121
BMI C30 41 (18.3) 25 (22.1) 0.404
Diabetes 26 (11.6) 36 (31.0) \0.001
Hypertension 144 (64.0) 98 (84.5) \0.001
Dyslipidemia 146 (64.9) 87 (75.0) 0.057
Smoking 53 (23.6) 31 (26.7) 0.520
Family history of premature
CAD
77 (34.2) 37 (31.9) 0.666
Chest pain 106 (47.3) 59 (51.3) 0.487
DF-CAD consortium C30 % 66 (29.3) 64 (55.2) \0.001
Morise score C16 105 (46.7) 78 (67.2) \0.001
Heart score C5 29 (12.9) 24 (20.7) 0.060
Values are n (%); CAD coronary artery disease, BMI body mass
index, DF-CAD consortium-diamond–Forrester CAD consortium
model
Table 4 Multivariate analysis—independent predictors of a high CT-
LeSc (3rd tercile, score C8.3)
OR (95 % CI) p
Demographic and clinical variables
Age C60 1.370 0.819–2.291 0.230
Male sex 1.732 1.035–2.901 0.037
Diabetes 2.905 1.612–5.234 \0.001
Hypertension 2.543 1.395–4.634 0.002
Dyslipidemia 1.563 0.919–2.660 0.099
Clinical scores
Heart score C5 2.416 1.411–4.135 0.001
DF-CAD consortium C30 % 1.590 0.918–2.754 0.098
Morise C16 1.971 1.060–3.666 0.032
OR odds ratio, DF-CAD consortium Diamond–Forrester CAD con-
sortium model
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Regarding localization, the original Leaman score was
developed as a score to quantify obstructive coronary dis-
ease identified with invasive angiography [15]. In this
score, with the rational of relative blood supply to the left
ventricle, all coronary segments were given a weighting
factor, reflecting the relative contribution of blood flow to
the left ventricle of each vessel segment, taking also in
account the specific right or left dominance systems.
Recently, this score was used as the segment weighting
factor for the development of the syntax score [24] which
has been proven to have a strong prognostic value in dif-
ferent clinical scenarios [25, 26]. In our score, values were
also provided for balanced dominance, reflecting more
adequately the anatomical variants of the coronary tree.
Plaque composition has been found in both pathological
and clinical studies associated with cardiac events [22, 27].
CCTA has shown to be able to characterize plaque com-
position [28]. Thin cap fibroatheroma is the most common
pathological substrate of ACS and in CCTA these plaques
appear as noncalcified or mixed plaques [16]. In a recent
study by Maurovich-Horvat et al. [16], the frequency of a
napkin-ting sign, a CCTA feature of advanced lesions by
histology, was similar between noncalcified and mixed
plaques, which also reinforces our weighting factor in the
CT-LeSc for plaque composition that was the same
between these two types (a factor of 1.5), and different
from predominantly calcified plaques (a factor of 1).
Regarding the degree of stenosis, we assumed in our
scoring system a factor reflecting the proportion of the
hazard ratios for obstructive versus nonobstructive observed
in the recently large scale CONFIRM registry. By gathering
all the nonobstructive (\25, 25–49 %) and obstructive
(50–69, 70–99, 100 %) in the same risk categories, this
scoring system is expected to have a good intra and inter-
observer correlation, since the other two weighting factors
(localization and plaque calcification) have also an excellent
reproducibility and are usually described in CCTA
reporting.
Clinical implications
Many tools are already available to help stratifying patients
at risk of a CV event and some scores have been already
developed gathering the information provided by the dif-
ferent traditional risk factors, like the Framingham score or
the HeartScore. Notwithstanding these observations,
accurate prediction of major coronary events on the indi-
vidual patient level, as opposed to population based stud-
ies, remains challenging.
The clinical implications of a score that reflect the extent
of coronary atherosclerotic burden is related to the fact that
this way we can have a tool to quantify and compare this
burden, which is particularly useful when reporting a
CCTA of a patient without obstructive CAD, but in whom
the extent of nonobstructive CAD could lead to a reclas-
sification of his risk profile and thereby his cardiovascular
treatment.
Of note in our study is the fact that although the CT-
LeSc, by having the degree of stenosis in its composition,
tends to favour patients with obstructive CAD, we were
able to demonstrate that a significant percentage (20.9 %)
of patients with nonobstructive CAD had in fact a CT-LeSc
in the highest tercile (T3). Conversely, among patients with
obstructive CAD, about one fifth had a coronary
Fig. 5 Independent predictors
of a high CT-LeSc (score C8.3).
CT-LeSc CT Leaman score
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atherosclerotic burden, as assessed by the CT-LeSc, in
lower terciles.
The CT-LeSc, by having a weight related to the locali-
zation, it reflects not only the extent of CAD but also the
expected clinical consequences in case that the more
proximal lesions evolve to a significant stenosis or become
unstable and trigger a coronary event.
In our study, a high HeartScore and a high Morise score
were both associated with nearly a 2–2.5 fold higher prob-
ability of having a high coronary atherosclerotic burden, as
assessed by the CT-LeSc. This could be expected for the
HeartScore, as it was develop as a tool to predict cardio-
vascular risk. In the case of the Morise score, is was
developed and validated as a clinical tool to estimate the
probability of CAD, but it has also been linked to cardio-
vascular outcomes [29]. The Diamond–Forrester was not an
independent predictor of a high CT-LeSc and although we
used the recently calibrated CAD consortium model [12], is
has been developed and calibrated for obstructive CAD
identified with invasive angiography and doesn’t take in
account the cardiovascular risk factors in its composition.
Limitations
There are a number of limitations related to this report: (1)
This is a single center data withmedium size cohort; (2) High
prevalence of low CAD probability/CV risk patients. The
population included in our study was mainly composed of
patients with low to intermediate CAD probability and CV
risk. Nevertheless, CAD was present in nearly 60 % of the
patients and this reflects the daily practice and the recom-
mendations that high CAD probability patients have not an
appropriate indication for CCTA [30]; (3) For the weighting
factor of plaque composition, we used amultiplication factor
of 1.5 for mixed and noncalcified plaques. Although this was
an arbitrary factor, this is in line with several CCTA prog-
nostic studies that demonstrated lower hazard ratios for
calcified plaques and reflects an assumption of less plaque
vulnerability of calcified plaques. (4) Lack of prognostic
validation: the aim of this study was to describe a CCTA
score to quantify total coronary atherosclerotic burden and to
identify its clinical predictors. Future studies will be needed
to provide a prognostic validation of this describedCT-LeSc.
Conclusions
The calculation of the CCTA-adapted Leaman score as a
tool to quantify total (obstructive and nonobstructive)
coronary atherosclerotic burden, reflecting the compre-
hensive information about localization, degree of stenosis
and type of plaque provided by CCTA is feasible. There
was a significant association between the CT-LeSc and
some traditional demographic and clinical risk factors. In
face of this association, we expect this score to be a useful
tool to quantify the coronary atherosclerotic burden eval-
uated by CCTA and it is expected to convey prognostic
information, and this should be evaluated in future studies.
About one fifth of the patients with nonobstructive CAD
had a CT-LeSc in the highest tercile, which could poten-
tially lead to a reclassification of the risk profile of these
subset of patients identified by CCTA, once the prognostic
value of the CT-LeSc is validated.
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Regarding localization, the original Leaman score was
developed as a score to quantify obstructive coronary dis-
ease identified with invasive angiography [15]. In this
score, with the rational of relative blood supply to the left
ventricle, all coronary segments were given a weighting
factor, reflecting the relative contribution of blood flow to
the left ventricle of each vessel segment, taking also in
account the specific right or left dominance systems.
Recently, this score was used as the segment weighting
factor for the development of the syntax score [24] which
has been proven to have a strong prognostic value in dif-
ferent clinical scenarios [25, 26]. In our score, values were
also provided for balanced dominance, reflecting more
adequately the anatomical variants of the coronary tree.
Plaque composition has been found in both pathological
and clinical studies associated with cardiac events [22, 27].
CCTA has shown to be able to characterize plaque com-
position [28]. Thin cap fibroatheroma is the most common
pathological substrate of ACS and in CCTA these plaques
appear as noncalcified or mixed plaques [16]. In a recent
study by Maurovich-Horvat et al. [16], the frequency of a
napkin-ting sign, a CCTA feature of advanced lesions by
histology, was similar between noncalcified and mixed
plaques, which also reinforces our weighting factor in the
CT-LeSc for plaque composition that was the same
between these two types (a factor of 1.5), and different
from predominantly calcified plaques (a factor of 1).
Regarding the degree of stenosis, we assumed in our
scoring system a factor reflecting the proportion of the
hazard ratios for obstructive versus nonobstructive observed
in the recently large scale CONFIRM registry. By gathering
all the nonobstructive (\25, 25–49 %) and obstructive
(50–69, 70–99, 100 %) in the same risk categories, this
scoring system is expected to have a good intra and inter-
observer correlation, since the other two weighting factors
(localization and plaque calcification) have also an excellent
reproducibility and are usually described in CCTA
reporting.
Clinical implications
Many tools are already available to help stratifying patients
at risk of a CV event and some scores have been already
developed gathering the information provided by the dif-
ferent traditional risk factors, like the Framingham score or
the HeartScore. Notwithstanding these observations,
accurate prediction of major coronary events on the indi-
vidual patient level, as opposed to population based stud-
ies, remains challenging.
The clinical implications of a score that reflect the extent
of coronary atherosclerotic burden is related to the fact that
this way we can have a tool to quantify and compare this
burden, which is particularly useful when reporting a
CCTA of a patient without obstructive CAD, but in whom
the extent of nonobstructive CAD could lead to a reclas-
sification of his risk profile and thereby his cardiovascular
treatment.
Of note in our study is the fact that although the CT-
LeSc, by having the degree of stenosis in its composition,
tends to favour patients with obstructive CAD, we were
able to demonstrate that a significant percentage (20.9 %)
of patients with nonobstructive CAD had in fact a CT-LeSc
in the highest tercile (T3). Conversely, among patients with
obstructive CAD, about one fifth had a coronary
Fig. 5 Independent predictors
of a high CT-LeSc (score C8.3).
CT-LeSc CT Leaman score
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atherosclerotic burden, as assessed by the CT-LeSc, in
lower terciles.
The CT-LeSc, by having a weight related to the locali-
zation, it reflects not only the extent of CAD but also the
expected clinical consequences in case that the more
proximal lesions evolve to a significant stenosis or become
unstable and trigger a coronary event.
In our study, a high HeartScore and a high Morise score
were both associated with nearly a 2–2.5 fold higher prob-
ability of having a high coronary atherosclerotic burden, as
assessed by the CT-LeSc. This could be expected for the
HeartScore, as it was develop as a tool to predict cardio-
vascular risk. In the case of the Morise score, is was
developed and validated as a clinical tool to estimate the
probability of CAD, but it has also been linked to cardio-
vascular outcomes [29]. The Diamond–Forrester was not an
independent predictor of a high CT-LeSc and although we
used the recently calibrated CAD consortium model [12], is
has been developed and calibrated for obstructive CAD
identified with invasive angiography and doesn’t take in
account the cardiovascular risk factors in its composition.
Limitations
There are a number of limitations related to this report: (1)
This is a single center data withmedium size cohort; (2) High
prevalence of low CAD probability/CV risk patients. The
population included in our study was mainly composed of
patients with low to intermediate CAD probability and CV
risk. Nevertheless, CAD was present in nearly 60 % of the
patients and this reflects the daily practice and the recom-
mendations that high CAD probability patients have not an
appropriate indication for CCTA [30]; (3) For the weighting
factor of plaque composition, we used amultiplication factor
of 1.5 for mixed and noncalcified plaques. Although this was
an arbitrary factor, this is in line with several CCTA prog-
nostic studies that demonstrated lower hazard ratios for
calcified plaques and reflects an assumption of less plaque
vulnerability of calcified plaques. (4) Lack of prognostic
validation: the aim of this study was to describe a CCTA
score to quantify total coronary atherosclerotic burden and to
identify its clinical predictors. Future studies will be needed
to provide a prognostic validation of this describedCT-LeSc.
Conclusions
The calculation of the CCTA-adapted Leaman score as a
tool to quantify total (obstructive and nonobstructive)
coronary atherosclerotic burden, reflecting the compre-
hensive information about localization, degree of stenosis
and type of plaque provided by CCTA is feasible. There
was a significant association between the CT-LeSc and
some traditional demographic and clinical risk factors. In
face of this association, we expect this score to be a useful
tool to quantify the coronary atherosclerotic burden eval-
uated by CCTA and it is expected to convey prognostic
information, and this should be evaluated in future studies.
About one fifth of the patients with nonobstructive CAD
had a CT-LeSc in the highest tercile, which could poten-
tially lead to a reclassification of the risk profile of these
subset of patients identified by CCTA, once the prognostic
value of the CT-LeSc is validated.
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Abstract The absence of coronary calcification is associ-
ated with an excellent prognosis. However, a calcium score
of zero does not exclude the presence of coronary artery
disease (CAD) or the possibility of future cardiovascular
events. Our aimwas to study the prevalence and predictors of
coronary artery disease in patients with a calcium score of
zero. Prospective registry consisted of 3,012 consecutive
patients that underwent cardiac CT (dual source CT). Stable
patients referred for evaluation of possible CAD that had a
calcium score of zero (n = 864) were selected for this
analysis. The variables that were statistically significant
were included in a multivariable logistic regression model.
From 864 patientswith a calcium score of zero, 107 (12.4 %)
had coronary plaques on the contrast CT (10.8 %, n = 93
with nonobstructive CAD and 1.6 %, n = 14 with obstruc-
tive CAD). By logistic regression analysis, the independent
predictors of CAD in this population were age[55 years
[odds ratio (OR) 1.63 (1.05–2.52)], hypertension [OR 1.64
(1.05–2.56)] and dyslipidemia [OR 1.54 (1.00–2.36)]. In the
presence of these 3 variables, the probability of having cor-
onary plaques was 21 %. The absence of coronary artery
calcification does not exclude the presence of coronary artery
disease, but the prevalence of obstructive disease is very low.
In this population, the independent predictors of CAD in the
setting of a calcium score of zero were hypertension, dysli-
pidemia, and age above 55 years. In the presence of these 3
predictors, the probability of havingCADwas almost 2 times
higher than in the general population.
Keywords Zero calcium score  Coronary artery
disease  Noncalcified plaque
Introduction
Coronary artery disease (CAD) is a major cause of death in
developed countries and it is expected to remain the most
important disease in the upcoming years [1].
Quantification of coronary artery calcium [calcium scor-
ing (CaSc)] can provide a measure of the atherosclerotic
plaque burden, since coronary arterial calcification occurs
almost exclusively in atherosclerotic plaques [2, 3]. Also, it
has been demonstrated in many large clinical trials, that
CaSc is a strong predictor of cardiovascular events [4–7].
On the other hand, the absence of calcium in the coronary
arteries, although it does not rule out atherosclerotic disease,
is consistent with an excellent long-term prognosis [8] and
has a high sensitivity and negative predictive value for
excluding obstructive CAD. This fact prompted some recent
guidelines to suggest that a calcium score of zero might
exclude the need for coronary angiography in symptomatic
patients [9]. Nevertheless, in previous studies, a high varia-
tion was reported in the incidence of obstructive CAD in
patientswith aCaSc of zero, ranging from2 to 32 % [10–15].
For instance, in the recent CONFIRM registry, it was shown
that in patients with a CaSc of zero, obstructive CAD is
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Abstract The absence of coronary calcification is associ-
ated with an excellent prognosis. However, a calcium score
of zero does not exclude the presence of coronary artery
disease (CAD) or the possibility of future cardiovascular
events. Our aimwas to study the prevalence and predictors of
coronary artery disease in patients with a calcium score of
zero. Prospective registry consisted of 3,012 consecutive
patients that underwent cardiac CT (dual source CT). Stable
patients referred for evaluation of possible CAD that had a
calcium score of zero (n = 864) were selected for this
analysis. The variables that were statistically significant
were included in a multivariable logistic regression model.
From 864 patientswith a calcium score of zero, 107 (12.4 %)
had coronary plaques on the contrast CT (10.8 %, n = 93
with nonobstructive CAD and 1.6 %, n = 14 with obstruc-
tive CAD). By logistic regression analysis, the independent
predictors of CAD in this population were age[55 years
[odds ratio (OR) 1.63 (1.05–2.52)], hypertension [OR 1.64
(1.05–2.56)] and dyslipidemia [OR 1.54 (1.00–2.36)]. In the
presence of these 3 variables, the probability of having cor-
onary plaques was 21 %. The absence of coronary artery
calcification does not exclude the presence of coronary artery
disease, but the prevalence of obstructive disease is very low.
In this population, the independent predictors of CAD in the
setting of a calcium score of zero were hypertension, dysli-
pidemia, and age above 55 years. In the presence of these 3
predictors, the probability of havingCADwas almost 2 times
higher than in the general population.
Keywords Zero calcium score  Coronary artery
disease  Noncalcified plaque
Introduction
Coronary artery disease (CAD) is a major cause of death in
developed countries and it is expected to remain the most
important disease in the upcoming years [1].
Quantification of coronary artery calcium [calcium scor-
ing (CaSc)] can provide a measure of the atherosclerotic
plaque burden, since coronary arterial calcification occurs
almost exclusively in atherosclerotic plaques [2, 3]. Also, it
has been demonstrated in many large clinical trials, that
CaSc is a strong predictor of cardiovascular events [4–7].
On the other hand, the absence of calcium in the coronary
arteries, although it does not rule out atherosclerotic disease,
is consistent with an excellent long-term prognosis [8] and
has a high sensitivity and negative predictive value for
excluding obstructive CAD. This fact prompted some recent
guidelines to suggest that a calcium score of zero might
exclude the need for coronary angiography in symptomatic
patients [9]. Nevertheless, in previous studies, a high varia-
tion was reported in the incidence of obstructive CAD in
patientswith aCaSc of zero, ranging from2 to 32 % [10–15].
For instance, in the recent CONFIRM registry, it was shown
that in patients with a CaSc of zero, obstructive CAD is
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possible and is associated with increased cardiovascular
events [16]. The aim of this study was to assess the preva-
lence and predictors of coronary artery disease in a popula-
tion of stable patients referred for evaluation of possible
CAD who had a calcium score of zero.
Methods
Study design and patient population
Single center prospective registry including 3,012 consecu-
tive patients undergoing dual source coronary CT angiog-
raphy (CCTA) from February 2007 to March 2012. For this
analysis, 864 stable patients (with symptoms and/or positive
or inconclusive stress tests) referred for evaluation of pos-
sible CAD that had a calcium score of zero were included.
Exclusion criteria included: (1) preoperative CAD
assessment prior to noncoronary valvular or aortic surgery
(n = 51); (2) evaluation of possible CAD in cardiomyopa-
thies (dilated cardiomyopathy or hypertrophic cardiomyop-
athy) (n = 162); (3) cardiac CT for atrial fibrillation ablation
(n = 330); (4) previous myocardial infarction and/or
revascularization procedures (n = 257); (5) suspected ACS
(n = 70); (6) other indications (n = 102). Patients with
atrial fibrillation or other significant arrhythmias during scan
acquisition or artifacts that significantly compromised image
quality were also excluded, as every patient with a CaSc[0
(Fig. 1).
The study was approved by the local ethics committee
and all patients gave a written informed consent.
A detailed medical history with a questionnaire investi-
gating risk factors was obtained from the patients to assess
for the presence of: (1) Diabetesmellitus (defined as a fasting
glucose level of C126 mg/dl or the need for insulin or oral
hypoglycemic agents) [17]; (2) Dyslipidemia (defined as a
total cholesterol level C200 mg/dl or treatment with lipid-
lowering drugs) [18]; (3) Hypertension (defined as blood
pressure C140/90 mmHg or the use of antihypertensive
medication) [19]; (4) Obesity (bodymass indexC30 kg/m2);
(5) positive family history of premature CAD (defined as the
presence of CAD in first-degree relatives younger than 55
(male) or 65 (female) years of age) [20]; (6) smoking
(defined as previous (less\1 year) or current smoker).
Pre-test probability of CAD was determined using both
the modified Diamond and Forrester [21] and the Morise
score [22]. The cardiovascular risk was assessed with the
Heart Score [23]. In the modified Diamond–Forrester,
patients were classified into very low (\5 %), low (\10 %),
intermediate (10–90 %) and high probability ([90 %). For
the Morise score, patients were classified into low (scores
0–8), intermediate (scores 9–15) and high probability (scores
C16). For the Heart Score, the cut-off of C5 % (high-risk)
was used.
Fig. 1 Patient selection and
study design
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Scan protocol and image reconstruction
All scans were performed with the first generation of dual-
source scanner (Somatom Definition, Siemens Medical,
Germany), with the patient in dorsal decubitus and in deep
inspiration breath-hold.
The calcium score acquisition consisted of step and
shoot—prospective ECG triggering at 70 % of the R–R
interval if the heart rate was below 80 beats per min (bpm)
or at 40 % of the R–R interval if the heart rate was higher.
From the topogram, a cranio-caudal scan was obtained
from the carina to the plane just below the heart silhouette,
with 120 kV and 128 mAs/rot tube current, with CARE-
Dose 4D mAs modulation. The value of the calcium score
was obtained with the analysis of consecutive non-contrast
3 mm slices, with a reconstruction b35f Kernel and a small
(cardiac) FOV, with a dedicated software (CaSc–Siemens),
where every area at least with 3 mm2 within a coronary
vessel with a density above 130 HU (Hounsfield Units)
was selected.
For CCTA, sublingual nitroglycerin was administered to
all patients, except when contraindicated, and intravenous
metoprolol (5 mg, with a titration dose up to 20 mg) was
administered in patients with heart rate[70 bpm.
During the scan acquisition, a bolus of iodinated contrast
was injected at a 6 ml/s infusion rate, followed by a 50-ml
saline flush. The dose of contrast was calculated according to
the following formula: (acquisition time ? 6 s delay) 9
flow (6 ml/s). A ROI was defined in the ascending aorta for
the bolus trigger technique, set at 120 HU.
Dose reduction strategies—including electrocardio-
gram-gated tube current modulation, reduced tube voltage,
and prospective axial triggering—were used whenever
feasible.
Mean estimated radiation dose was 0.8 ± 0.5 mSv for
CaSc and 4.6 ± 3.8 mSv for CT scan. Mean contrast dose
was 96.2 ± 13.6 ml and heart rate was 67.8 ± 12.9 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75 mm with
0.4 mm increments. Post-processing was carried out using
Circulation software, with multiplanar reconstructions,
maximum intensity projection and volume rendering
technique. All scans were analysed independently in the
same session by both a cardiologist and a radiologist with
level III equivalent experience by the Society of Cardio-
vascular Computed Tomography. In case of disagreement,
a joint reading was performed and a consensus decision
was reached.
In each coronary artery segment, coronary atheroscle-
rosis was defined as tissue structures[1 mm2 that existed
either within the coronary artery lumen or adjacent to the
coronary artery lumen that could be discriminated from
surrounding pericardial tissue, epicardial fat, or the vessel
lumen itself [24]. Coronary atherosclerotic lesions were
quantified for stenosis by visual estimation. Percent
obstruction of coronary artery lumen was based on a
comparison of the luminal diameter of the segment
exhibiting obstruction to the luminal diameter of the most
normal-appearing site immediately proximal to the plaque.
Obstructive CAD was defined by presence of at least one
plaque with C50 % stenosis.
Statistical analysis
Continuous variables with normal distribution were
expressed as mean ± standard deviation. Categorical vari-
ables were expressed as percentages and their frequencies
were compared with the Chi square test.
Binary logistic regression models were built to eluci-
date independent predictors of CAD without coronary
calcification.
The objective of this model was the assessment of
clinical variables that aid to predict the presence of CAD in
patients with a calcium score of zero. All the demographic,
risk factors and clinical variables present in Table 2 that
had a p \0.1 in univariate analysis were included in a
multivariate logistic regression model (Enter method).
Statistical analysis was performed with SPSS 17.0
software for Windows (SPSS Inc., Chicago, IL, USA).
Results
Baseline and procedural characteristics
In the final study population of 864 patients, most of the
patients were female (55 %) and mean age was
53.8 ± 11.0 years. The prevalence of traditional risk factors
was low, with only 9.0 % of patients with diabetes. This was
predominantly a low risk population with few high risk
patients (only 9.0 % with the Morise score and 3.1 % with
the modified Diamond–Forrester had a high CAD probabil-
ity). Likewise, most of the patients were not considered as
high cardiovascular risk, as assessed by theHeart Score (only
11.9 % had a Heart Score C5 %)—Table 1.
Coronary plaques were detected on CCTA in 107
patients (12.4 %): 10.8 % (n = 93) with nonobstructive
CAD and 1.6 % (n = 14) with obstructive CAD—Fig. 2.
Considering the degree of stenosis of the obstructive CAD
group, 64 % (n = 9) had a 50–70 % stenosis and 36 %
(n = 5) a[70 % stenosis. Considering the extent of dis-
ease, all these patients had obstructive CAD in only 1
vessel and 93 % had a single lesion. Regarding the distri-
bution, most of the obstructive CAD lesions were found in
proximal or mid segment locations (87 %), and the most
affected artery was the right coronary artery 50 % (n = 7).
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possible and is associated with increased cardiovascular
events [16]. The aim of this study was to assess the preva-
lence and predictors of coronary artery disease in a popula-
tion of stable patients referred for evaluation of possible
CAD who had a calcium score of zero.
Methods
Study design and patient population
Single center prospective registry including 3,012 consecu-
tive patients undergoing dual source coronary CT angiog-
raphy (CCTA) from February 2007 to March 2012. For this
analysis, 864 stable patients (with symptoms and/or positive
or inconclusive stress tests) referred for evaluation of pos-
sible CAD that had a calcium score of zero were included.
Exclusion criteria included: (1) preoperative CAD
assessment prior to noncoronary valvular or aortic surgery
(n = 51); (2) evaluation of possible CAD in cardiomyopa-
thies (dilated cardiomyopathy or hypertrophic cardiomyop-
athy) (n = 162); (3) cardiac CT for atrial fibrillation ablation
(n = 330); (4) previous myocardial infarction and/or
revascularization procedures (n = 257); (5) suspected ACS
(n = 70); (6) other indications (n = 102). Patients with
atrial fibrillation or other significant arrhythmias during scan
acquisition or artifacts that significantly compromised image
quality were also excluded, as every patient with a CaSc[0
(Fig. 1).
The study was approved by the local ethics committee
and all patients gave a written informed consent.
A detailed medical history with a questionnaire investi-
gating risk factors was obtained from the patients to assess
for the presence of: (1) Diabetesmellitus (defined as a fasting
glucose level of C126 mg/dl or the need for insulin or oral
hypoglycemic agents) [17]; (2) Dyslipidemia (defined as a
total cholesterol level C200 mg/dl or treatment with lipid-
lowering drugs) [18]; (3) Hypertension (defined as blood
pressure C140/90 mmHg or the use of antihypertensive
medication) [19]; (4) Obesity (bodymass indexC30 kg/m2);
(5) positive family history of premature CAD (defined as the
presence of CAD in first-degree relatives younger than 55
(male) or 65 (female) years of age) [20]; (6) smoking
(defined as previous (less\1 year) or current smoker).
Pre-test probability of CAD was determined using both
the modified Diamond and Forrester [21] and the Morise
score [22]. The cardiovascular risk was assessed with the
Heart Score [23]. In the modified Diamond–Forrester,
patients were classified into very low (\5 %), low (\10 %),
intermediate (10–90 %) and high probability ([90 %). For
the Morise score, patients were classified into low (scores
0–8), intermediate (scores 9–15) and high probability (scores
C16). For the Heart Score, the cut-off of C5 % (high-risk)
was used.
Fig. 1 Patient selection and
study design
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Scan protocol and image reconstruction
All scans were performed with the first generation of dual-
source scanner (Somatom Definition, Siemens Medical,
Germany), with the patient in dorsal decubitus and in deep
inspiration breath-hold.
The calcium score acquisition consisted of step and
shoot—prospective ECG triggering at 70 % of the R–R
interval if the heart rate was below 80 beats per min (bpm)
or at 40 % of the R–R interval if the heart rate was higher.
From the topogram, a cranio-caudal scan was obtained
from the carina to the plane just below the heart silhouette,
with 120 kV and 128 mAs/rot tube current, with CARE-
Dose 4D mAs modulation. The value of the calcium score
was obtained with the analysis of consecutive non-contrast
3 mm slices, with a reconstruction b35f Kernel and a small
(cardiac) FOV, with a dedicated software (CaSc–Siemens),
where every area at least with 3 mm2 within a coronary
vessel with a density above 130 HU (Hounsfield Units)
was selected.
For CCTA, sublingual nitroglycerin was administered to
all patients, except when contraindicated, and intravenous
metoprolol (5 mg, with a titration dose up to 20 mg) was
administered in patients with heart rate[70 bpm.
During the scan acquisition, a bolus of iodinated contrast
was injected at a 6 ml/s infusion rate, followed by a 50-ml
saline flush. The dose of contrast was calculated according to
the following formula: (acquisition time ? 6 s delay) 9
flow (6 ml/s). A ROI was defined in the ascending aorta for
the bolus trigger technique, set at 120 HU.
Dose reduction strategies—including electrocardio-
gram-gated tube current modulation, reduced tube voltage,
and prospective axial triggering—were used whenever
feasible.
Mean estimated radiation dose was 0.8 ± 0.5 mSv for
CaSc and 4.6 ± 3.8 mSv for CT scan. Mean contrast dose
was 96.2 ± 13.6 ml and heart rate was 67.8 ± 12.9 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75 mm with
0.4 mm increments. Post-processing was carried out using
Circulation software, with multiplanar reconstructions,
maximum intensity projection and volume rendering
technique. All scans were analysed independently in the
same session by both a cardiologist and a radiologist with
level III equivalent experience by the Society of Cardio-
vascular Computed Tomography. In case of disagreement,
a joint reading was performed and a consensus decision
was reached.
In each coronary artery segment, coronary atheroscle-
rosis was defined as tissue structures[1 mm2 that existed
either within the coronary artery lumen or adjacent to the
coronary artery lumen that could be discriminated from
surrounding pericardial tissue, epicardial fat, or the vessel
lumen itself [24]. Coronary atherosclerotic lesions were
quantified for stenosis by visual estimation. Percent
obstruction of coronary artery lumen was based on a
comparison of the luminal diameter of the segment
exhibiting obstruction to the luminal diameter of the most
normal-appearing site immediately proximal to the plaque.
Obstructive CAD was defined by presence of at least one
plaque with C50 % stenosis.
Statistical analysis
Continuous variables with normal distribution were
expressed as mean ± standard deviation. Categorical vari-
ables were expressed as percentages and their frequencies
were compared with the Chi square test.
Binary logistic regression models were built to eluci-
date independent predictors of CAD without coronary
calcification.
The objective of this model was the assessment of
clinical variables that aid to predict the presence of CAD in
patients with a calcium score of zero. All the demographic,
risk factors and clinical variables present in Table 2 that
had a p \0.1 in univariate analysis were included in a
multivariate logistic regression model (Enter method).
Statistical analysis was performed with SPSS 17.0
software for Windows (SPSS Inc., Chicago, IL, USA).
Results
Baseline and procedural characteristics
In the final study population of 864 patients, most of the
patients were female (55 %) and mean age was
53.8 ± 11.0 years. The prevalence of traditional risk factors
was low, with only 9.0 % of patients with diabetes. This was
predominantly a low risk population with few high risk
patients (only 9.0 % with the Morise score and 3.1 % with
the modified Diamond–Forrester had a high CAD probabil-
ity). Likewise, most of the patients were not considered as
high cardiovascular risk, as assessed by theHeart Score (only
11.9 % had a Heart Score C5 %)—Table 1.
Coronary plaques were detected on CCTA in 107
patients (12.4 %): 10.8 % (n = 93) with nonobstructive
CAD and 1.6 % (n = 14) with obstructive CAD—Fig. 2.
Considering the degree of stenosis of the obstructive CAD
group, 64 % (n = 9) had a 50–70 % stenosis and 36 %
(n = 5) a[70 % stenosis. Considering the extent of dis-
ease, all these patients had obstructive CAD in only 1
vessel and 93 % had a single lesion. Regarding the distri-
bution, most of the obstructive CAD lesions were found in
proximal or mid segment locations (87 %), and the most
affected artery was the right coronary artery 50 % (n = 7).
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Left anterior descendent was affected in 5 patients, while
left main was affected in one patient and the circumflex
artery in other patient.
There were no significant differences in the prevalence
of CAD in patients referred for CCTA because of positive/
inconclusive stress tests (93/722 = 12.9 %) versus patients
referred without previous stress tests (14/142 = 9.9 %),
p = 0.403.
We further analyzed the distribution of CAD in the
different pretest probability subgroups. Using those defined
by Morise, the prevalence of CAD (any plaque) was 7.9,
14.3 and 20.5 % in low, intermediate and high pretest
probability patients, respectively. Regarding obstructive
CAD, a higher prevalence was also found in patients with
high pretest probability, but this increase was not statisti-
cally significant (Table 2).
Univariate analysis
Patients with CAD were older (prevalence of ageC55 years
64 vs. 47 %, p = 0.001) than patients without CAD and had
a higher prevalence of dyslipidemia (65 vs. 51 %,
p = 0.010) and hypertension (67 vs. 51 %, p = 0.002).
The pre-test CAD probability assessed both by the
Morise score and the modified Diamond–Forrester was
higher in the CAD group and these patients had a 2–4 times
higher probability of being of a high CAD probability
group. Cardiovascular risk, estimated by the Heart Score,
was also significantly higher in patients with CAD.
Although there was a trend in this group towards a higher
prevalence of diabetes and male gender, these differences
were not statistically significant—Table 3.
Multivariate analysis
Bymultivariate analysis, the independent predictors of CAD
in patients with a calcium score of zero were age C55 (OR
1.631, 95 % CI 1.054–2.524, p = 0.028), hypertension (OR
Table 1 Demographic, clinical and CCTA characteristics of the
study population
All patients (n = 864)
Demographic
Age 53.8 ± 11.0
Male sex 389 (45.0)
Risk factors
Obesity (BMI C 30) 160 (18.5)
Diabetes 78 (9.0)
Hypertension 459 (53.1)
Dyslipidemia 454 (52.5)
Smoking 206 (23.8)
Family history of premature CAD 284 (32.9)
Chest pain
Asymptomatic 441 (51.0)
Noncardiac 194 (22.5)
Atypical 182 (21.1)
Typical 47 (5.4)
CAD probability—Morise
Score C16 78 (9.0)
Score 9–15 446 (51.6)
Score 0–8 340 (39.4)
CAD probability—modified Diamond Forrester
Very low 188 (21.8)
Low 391 (45.3)
Intermediate 257 (29.7)
High 27 (3.1)
CV risk
Heart Score C5 % 103 (11.9)
CCTA
Normal/no plaque 757 (87.6)
Non obstructive CAD 93 (10.8)
Obstructive CAD 14 (1.6)
Technical data
Heart rate (bpm) 67.8 ± 12.9
Contrast dose (ml) 96.2 ± 13.6
Radiation dose—CTA (mSv) 4.6 ± 3.8
Radiation dose—CaSc (mSv) 0.8 ± 0.5
Values are mean ± SD or n (%)
BMI body mass index, CAD coronary artery disease, CV cardiovas-
cular, CCTA coronary computed tomography angiography, bpm beats
per minute, mSv milisievert
87,6%
12,4%
10,8%
1,6%
Fig. 2 Distribution of CT angiographic findings
Table 2 Prevalence of CAD according to the pretest probability
(Morise)
Pretest probability Nonobstructive CAD Obstructive CAD
Low (n = 340) 27 (7.9 %) 6 (1.8 %)
Intermediate (n = 446) 64 (14.3 %) 6 (1.3 %)
High (n = 78) 16 (20.5 %) 2 (2.6 %)
p 0.002 0.708
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1.641, 95 % CI 1.051–2.560, p = 0.029) and dyslipidemia
(OR 1.538, 95 %CI 1.002–2.361, p = 0.049) (Fig. 3). In the
presence of these 3 variables (n = 176 patients, 20.4 % of
the population), the probability of having coronary plaques
was 21 % (vs. 12.4 % in the total studied population). We
also analyzed the prevalence of CAD according to the
presence of none, one, two or three of these risk factors. The
results are shown in Table 4.
Discussion
In this single center cohort of stable patients without
known CAD, referred for cardiac CT angiography, we
found a very low prevalence of obstructive CAD (1.6 %) in
the subset with a CaSc of zero. When considering the
degree of stenosis, only 0.6 % had a stenosis[70 %.
The prevalence and clinical significance of obstructive
CAD on coronary CT angiography among patients with a
calcium score of zero has been evaluated in several
cohorts, but with conflicting results, depending on the
population included. Data from Nieman et al. [14], the
CONFIRM registry [16], Rubinshtein et al. [13] and Akram
et al. [11], are in line with our results, with a low preva-
lence of obstructive CAD (2, 3.5, 7.2 and 8.2 %, respec-
tively). Our prevalence was even lower, and this might be
explained by a high prevalence of patients with a low
pretest probability of CAD.
In contrast, in the work of Harberl et al. [10] and
Gottlieb et al. [12], there was a high prevalence of CAD
(32 and 19.4 %, respectively), which can be related to the
fact that these studies included patients referred for con-
ventional angiography, including patients with possible
acute coronary syndromes.
In our population, the prevalence of CAD in patients
with positive/inconclusive stress tests (exercise electro-
cardiography in most cases) was not significantly different
from that of patients referred to CCTA without previous
tests, as in the study from Nieman et al. [14].
Calcium scoring enables a noninvasive quantification of
the total coronary atherosclerotic burden, although it
underestimates the burden of disease, by not measuring
noncalcified plaques [25]. Nevertheless, it has been shown
to outperform traditional risk stratification tools, such as
clinical risk factor assessment, ankle-brachial index, car-
otid intima-media thickness and high-sensitivity C-reactive
protein, as a predictor of cardiovascular events [4, 5].
Our data suggests that, although the absence of calcium
does not exclude the presence of CAD, it was associated
with a very low probability of obstructive lesions. This was
especially true in cases of low and intermediate pretest
CAD probability, as in the study from Werkhoven et al.
[15] in which the prevalence of obstructive CAD, in the
absence of calcium, was only 3.4 and 3.8 % in patients
with low and intermediate pretest CAD probability,
respectively. This is in line with the excellent prognosis
that has been demonstrated for patients with a calcium
score of zero [8].
In our population, older age (C55 years), hypertension
and dyslipidemia were independent predictors of CAD in
Table 3 Univariate analysis
No CAD
(n = 757)
CAD
(n = 107)
p
Demographic
Age C55 years 355 (47.0) 68 (63.6) 0.001
Male gender 335 (44.3) 54 (50.5) 0.254
Risk factors
Diabetes 64 (8.5) 14 (13.1) 0.147
Obesity (BMI C 30) 139 (18.4) 21 (19.6) 0.790
Hypertension 387 (51.1) 72 (67.3) 0.002
Dyslipidemia 385 (50.9) 69 (64.5) 0.010
Smoking 184 (24.3) 22 (20.6) 0.467
Family history of
premature CAD
248 (32.8) 36 (33.6) 0.913
Symptoms
Chest pain 371 (49.0) 52 (48.6) 1.000
CAD probability—Morise
Score C16 62 (8.2) 16 (15.0) 0.002
Score 9–15 382 (50.5) 64 (59.8)
Score 0–8 313 (41.3) 27 (25.2)
CAD probability—modified Diamond Forrester
Very low 171 (22.6 %) 17 (15.9) 0.005
Low 342 (45.2) 49 (45.8)
Intermediate 225 (29.8) 32 (29.9)
High 18 (2.4) 9 (8.4)
CV risk
Heart Score C5 79 (10.4) 24 (22.4) 0.001
Values are mean ± SD or n (%)
CAD coronary artery disease, BMI body mass index, CV
cardiovascular
Bold indicates p value with statistical significance
0.50 1.00 1.50 2.00 2.50
Hypertension 1.64
1
(1.051-
2.560)
Age   55 1.63
1
(1.054-
2.524)
Dyslipidemia 1.53
8
(1.002-
2.361)
OR (95% CI)
≥
Fig. 3 Independent predictors of CAD in patients with a CaSc of
zero
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Left anterior descendent was affected in 5 patients, while
left main was affected in one patient and the circumflex
artery in other patient.
There were no significant differences in the prevalence
of CAD in patients referred for CCTA because of positive/
inconclusive stress tests (93/722 = 12.9 %) versus patients
referred without previous stress tests (14/142 = 9.9 %),
p = 0.403.
We further analyzed the distribution of CAD in the
different pretest probability subgroups. Using those defined
by Morise, the prevalence of CAD (any plaque) was 7.9,
14.3 and 20.5 % in low, intermediate and high pretest
probability patients, respectively. Regarding obstructive
CAD, a higher prevalence was also found in patients with
high pretest probability, but this increase was not statisti-
cally significant (Table 2).
Univariate analysis
Patients with CAD were older (prevalence of ageC55 years
64 vs. 47 %, p = 0.001) than patients without CAD and had
a higher prevalence of dyslipidemia (65 vs. 51 %,
p = 0.010) and hypertension (67 vs. 51 %, p = 0.002).
The pre-test CAD probability assessed both by the
Morise score and the modified Diamond–Forrester was
higher in the CAD group and these patients had a 2–4 times
higher probability of being of a high CAD probability
group. Cardiovascular risk, estimated by the Heart Score,
was also significantly higher in patients with CAD.
Although there was a trend in this group towards a higher
prevalence of diabetes and male gender, these differences
were not statistically significant—Table 3.
Multivariate analysis
Bymultivariate analysis, the independent predictors of CAD
in patients with a calcium score of zero were age C55 (OR
1.631, 95 % CI 1.054–2.524, p = 0.028), hypertension (OR
Table 1 Demographic, clinical and CCTA characteristics of the
study population
All patients (n = 864)
Demographic
Age 53.8 ± 11.0
Male sex 389 (45.0)
Risk factors
Obesity (BMI C 30) 160 (18.5)
Diabetes 78 (9.0)
Hypertension 459 (53.1)
Dyslipidemia 454 (52.5)
Smoking 206 (23.8)
Family history of premature CAD 284 (32.9)
Chest pain
Asymptomatic 441 (51.0)
Noncardiac 194 (22.5)
Atypical 182 (21.1)
Typical 47 (5.4)
CAD probability—Morise
Score C16 78 (9.0)
Score 9–15 446 (51.6)
Score 0–8 340 (39.4)
CAD probability—modified Diamond Forrester
Very low 188 (21.8)
Low 391 (45.3)
Intermediate 257 (29.7)
High 27 (3.1)
CV risk
Heart Score C5 % 103 (11.9)
CCTA
Normal/no plaque 757 (87.6)
Non obstructive CAD 93 (10.8)
Obstructive CAD 14 (1.6)
Technical data
Heart rate (bpm) 67.8 ± 12.9
Contrast dose (ml) 96.2 ± 13.6
Radiation dose—CTA (mSv) 4.6 ± 3.8
Radiation dose—CaSc (mSv) 0.8 ± 0.5
Values are mean ± SD or n (%)
BMI body mass index, CAD coronary artery disease, CV cardiovas-
cular, CCTA coronary computed tomography angiography, bpm beats
per minute, mSv milisievert
87,6%
12,4%
10,8%
1,6%
Fig. 2 Distribution of CT angiographic findings
Table 2 Prevalence of CAD according to the pretest probability
(Morise)
Pretest probability Nonobstructive CAD Obstructive CAD
Low (n = 340) 27 (7.9 %) 6 (1.8 %)
Intermediate (n = 446) 64 (14.3 %) 6 (1.3 %)
High (n = 78) 16 (20.5 %) 2 (2.6 %)
p 0.002 0.708
Int J Cardiovasc Imaging
123
Author's personal copy
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
173 
MANUSCRIPT 17 
 
 
 
 
1.641, 95 % CI 1.051–2.560, p = 0.029) and dyslipidemia
(OR 1.538, 95 %CI 1.002–2.361, p = 0.049) (Fig. 3). In the
presence of these 3 variables (n = 176 patients, 20.4 % of
the population), the probability of having coronary plaques
was 21 % (vs. 12.4 % in the total studied population). We
also analyzed the prevalence of CAD according to the
presence of none, one, two or three of these risk factors. The
results are shown in Table 4.
Discussion
In this single center cohort of stable patients without
known CAD, referred for cardiac CT angiography, we
found a very low prevalence of obstructive CAD (1.6 %) in
the subset with a CaSc of zero. When considering the
degree of stenosis, only 0.6 % had a stenosis[70 %.
The prevalence and clinical significance of obstructive
CAD on coronary CT angiography among patients with a
calcium score of zero has been evaluated in several
cohorts, but with conflicting results, depending on the
population included. Data from Nieman et al. [14], the
CONFIRM registry [16], Rubinshtein et al. [13] and Akram
et al. [11], are in line with our results, with a low preva-
lence of obstructive CAD (2, 3.5, 7.2 and 8.2 %, respec-
tively). Our prevalence was even lower, and this might be
explained by a high prevalence of patients with a low
pretest probability of CAD.
In contrast, in the work of Harberl et al. [10] and
Gottlieb et al. [12], there was a high prevalence of CAD
(32 and 19.4 %, respectively), which can be related to the
fact that these studies included patients referred for con-
ventional angiography, including patients with possible
acute coronary syndromes.
In our population, the prevalence of CAD in patients
with positive/inconclusive stress tests (exercise electro-
cardiography in most cases) was not significantly different
from that of patients referred to CCTA without previous
tests, as in the study from Nieman et al. [14].
Calcium scoring enables a noninvasive quantification of
the total coronary atherosclerotic burden, although it
underestimates the burden of disease, by not measuring
noncalcified plaques [25]. Nevertheless, it has been shown
to outperform traditional risk stratification tools, such as
clinical risk factor assessment, ankle-brachial index, car-
otid intima-media thickness and high-sensitivity C-reactive
protein, as a predictor of cardiovascular events [4, 5].
Our data suggests that, although the absence of calcium
does not exclude the presence of CAD, it was associated
with a very low probability of obstructive lesions. This was
especially true in cases of low and intermediate pretest
CAD probability, as in the study from Werkhoven et al.
[15] in which the prevalence of obstructive CAD, in the
absence of calcium, was only 3.4 and 3.8 % in patients
with low and intermediate pretest CAD probability,
respectively. This is in line with the excellent prognosis
that has been demonstrated for patients with a calcium
score of zero [8].
In our population, older age (C55 years), hypertension
and dyslipidemia were independent predictors of CAD in
Table 3 Univariate analysis
No CAD
(n = 757)
CAD
(n = 107)
p
Demographic
Age C55 years 355 (47.0) 68 (63.6) 0.001
Male gender 335 (44.3) 54 (50.5) 0.254
Risk factors
Diabetes 64 (8.5) 14 (13.1) 0.147
Obesity (BMI C 30) 139 (18.4) 21 (19.6) 0.790
Hypertension 387 (51.1) 72 (67.3) 0.002
Dyslipidemia 385 (50.9) 69 (64.5) 0.010
Smoking 184 (24.3) 22 (20.6) 0.467
Family history of
premature CAD
248 (32.8) 36 (33.6) 0.913
Symptoms
Chest pain 371 (49.0) 52 (48.6) 1.000
CAD probability—Morise
Score C16 62 (8.2) 16 (15.0) 0.002
Score 9–15 382 (50.5) 64 (59.8)
Score 0–8 313 (41.3) 27 (25.2)
CAD probability—modified Diamond Forrester
Very low 171 (22.6 %) 17 (15.9) 0.005
Low 342 (45.2) 49 (45.8)
Intermediate 225 (29.8) 32 (29.9)
High 18 (2.4) 9 (8.4)
CV risk
Heart Score C5 79 (10.4) 24 (22.4) 0.001
Values are mean ± SD or n (%)
CAD coronary artery disease, BMI body mass index, CV
cardiovascular
Bold indicates p value with statistical significance
0.50 1.00 1.50 2.00 2.50
Hypertension 1.64
1
(1.051-
2.560)
Age   55 1.63
1
(1.054-
2.524)
Dyslipidemia 1.53
8
(1.002-
2.361)
OR (95% CI)
≥
Fig. 3 Independent predictors of CAD in patients with a CaSc of
zero
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this subset of patients without calcium, and in the presence
of these 3 predictors, the probability of having CAD was
almost 2 times higher than in the general population.
Nevertheless, the odds ratios for the independent predictors
were rather modest and other traditional CAD risk factors
were not found to be independent predictors. This way, we
could hypothesize that coronary plaques without calcium
could be a different phenotypical subset of CAD. Another
possibility could be that these patients with coronary pla-
ques in the absence of calcium represent CAD at earlier
stages, since calcium is considered to be associated with
more advanced forms of atherosclerotic lesions [2]. In fact,
in our population, all the patients with obstructive CAD
had only 1 vessel disease, most (93 %) with a single lesion,
and only a minority (36 %) had[70 % stenosis.
One last hypothesis could be that these plaques can have
microcalcifications below the threshold of cardiac CT
spacial resolution, as in the case example (Fig. 4), in which
small spots of calcium were only detected by intravascular
ultrasound (IVUS) virtual histology.
Limitations
There are a number of limitations related to this report: (1)
this is a single center retrospective study with medium size
cohort; (2) our population in mainly of low CAD proba-
bility and CV risk; the very low percentage of obstructive
CAD found can not be extrapolated to cohorts with more
patients with higher CAD probability and CV risk (3) the
definition of CAD was made using CCTA and not invasive
angiography, which may lead to false-positive findings,
although this is unlikely in the absence of calcium; (4) lack
of prognostic information, since we did not evaluate the
prognostic importance of obstructive CAD in patients with
a CaSc of zero.
Table 4 Prevalence of CAD according to the presence of risk factors found to be independent predictors
Independent preditors No CAD Nonobstructive CAD Obstructive CAD Total p
0 158 (96.9 %) 5 (3.1 %) 0 (0 %) 163 \0.001
1 210 (86.8 %) 25 (10.3 %) 7 (2.9 %) 242
2 250 (88.3 %) 28 (9.9 %) 5 (1.8 %) 283
3 139 (79.0 %) 35 (19.9 %) 2 (1.1 %) 176
757 93 14 864
Fig. 4 Non-calcified plaque on
cardiac CT (on the right) in a
patient with a CaSc of zero; the
angiography (on the left)
confirmed the presence of a
50–70 % stenosis in the mid-
RCA; intravascular ultrasound
with virtual histology (in the
middle) suggests the presence of
microcalcifications
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Conclusions
In this population of stable patients referred for evaluation
of possible CAD that had a calcium score of zero, 12.4 %
had coronary plaques and 1.6 % had obstructive (C50 %)
CAD.
Therefore, and despite the known high negative pre-
dictive value of CaSc for coronary events, the absence of
coronary artery calcification does not exclude the presence
of coronary artery disease, but the prevalence of obstruc-
tive disease is very low.
In this population, we found that age C55, hypertension,
dyslipidemia were independent predictors of CAD in the
setting of a calcium score of zero. In the presence of these 3
predictors, the probability of having CAD was almost 2
times higher than in the total studied population.
Conflict of interest All the authors declare that they have no con-
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this subset of patients without calcium, and in the presence
of these 3 predictors, the probability of having CAD was
almost 2 times higher than in the general population.
Nevertheless, the odds ratios for the independent predictors
were rather modest and other traditional CAD risk factors
were not found to be independent predictors. This way, we
could hypothesize that coronary plaques without calcium
could be a different phenotypical subset of CAD. Another
possibility could be that these patients with coronary pla-
ques in the absence of calcium represent CAD at earlier
stages, since calcium is considered to be associated with
more advanced forms of atherosclerotic lesions [2]. In fact,
in our population, all the patients with obstructive CAD
had only 1 vessel disease, most (93 %) with a single lesion,
and only a minority (36 %) had[70 % stenosis.
One last hypothesis could be that these plaques can have
microcalcifications below the threshold of cardiac CT
spacial resolution, as in the case example (Fig. 4), in which
small spots of calcium were only detected by intravascular
ultrasound (IVUS) virtual histology.
Limitations
There are a number of limitations related to this report: (1)
this is a single center retrospective study with medium size
cohort; (2) our population in mainly of low CAD proba-
bility and CV risk; the very low percentage of obstructive
CAD found can not be extrapolated to cohorts with more
patients with higher CAD probability and CV risk (3) the
definition of CAD was made using CCTA and not invasive
angiography, which may lead to false-positive findings,
although this is unlikely in the absence of calcium; (4) lack
of prognostic information, since we did not evaluate the
prognostic importance of obstructive CAD in patients with
a CaSc of zero.
Table 4 Prevalence of CAD according to the presence of risk factors found to be independent predictors
Independent preditors No CAD Nonobstructive CAD Obstructive CAD Total p
0 158 (96.9 %) 5 (3.1 %) 0 (0 %) 163 \0.001
1 210 (86.8 %) 25 (10.3 %) 7 (2.9 %) 242
2 250 (88.3 %) 28 (9.9 %) 5 (1.8 %) 283
3 139 (79.0 %) 35 (19.9 %) 2 (1.1 %) 176
757 93 14 864
Fig. 4 Non-calcified plaque on
cardiac CT (on the right) in a
patient with a CaSc of zero; the
angiography (on the left)
confirmed the presence of a
50–70 % stenosis in the mid-
RCA; intravascular ultrasound
with virtual histology (in the
middle) suggests the presence of
microcalcifications
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Conclusions
In this population of stable patients referred for evaluation
of possible CAD that had a calcium score of zero, 12.4 %
had coronary plaques and 1.6 % had obstructive (C50 %)
CAD.
Therefore, and despite the known high negative pre-
dictive value of CaSc for coronary events, the absence of
coronary artery calcification does not exclude the presence
of coronary artery disease, but the prevalence of obstruc-
tive disease is very low.
In this population, we found that age C55, hypertension,
dyslipidemia were independent predictors of CAD in the
setting of a calcium score of zero. In the presence of these 3
predictors, the probability of having CAD was almost 2
times higher than in the total studied population.
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Resumo A tomografia computorizada cardíaca (angioTC cardíaca) permite documentar a
presenc¸a de doenc¸a coronária, independentemente do seu grau de estenose. Recentemente,
foi validado o valor prognóstico da doenc¸a coronária não obstrutiva documentada por angi-
oTC cardíaca. No entanto, não existem ainda recomendac¸ões claras acerca da abordagem
destes doentes, nomeadamente sobre o início de medidas farmacológicas mais agressivas em
prevenc¸ão primária. A abordagem destes doentes permanece controversa, sobretudo nos casos
em que existe uma discrepância entre o risco cardiovascular e a carga aterosclerótica objetivada
na angioTC.
Os autores descrevem o caso de um doente com discrepância entre a extensão da ateroscle-
rose coronária objetivada e a sua estimativa de acordo com os scores de probabilidade pré-teste
e de eventos cardiovasculares. Tratando-se de um indivíduo com documentac¸ão de aterosclerose
coronária acima do esperado - score de cálcio superior ao percentil 90 e doenc¸a coronária não
obstrutiva na angioTC cardíaca, mas por outro lado, assintomático e sem fatores de risco nem
antecedentes cardiovasculares, com uma estimativa de risco cardiovascular muito baixa e atleta
de competic¸ão, torna-se difícil decidir acerca do risco/benefício de medidas farmacológicas de
prevenc¸ão primária.
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Resumo A tomografia computorizada cardíaca (angioTC cardíaca) permite documentar a
presenc¸a de doenc¸a coronária, independentemente do seu grau de estenose. Recentemente,
foi validado o valor prognóstico da doenc¸a coronária não obstrutiva documentada por angi-
oTC cardíaca. No entanto, não existem ainda recomendac¸ões claras acerca da abordagem
destes doentes, nomeadamente sobre o início de medidas farmacológicas mais agressivas em
prevenc¸ão primária. A abordagem destes doentes permanece controversa, sobretudo nos casos
em que existe uma discrepância entre o risco cardiovascular e a carga aterosclerótica objetivada
na angioTC.
Os autores descrevem o caso de um doente com discrepância entre a extensão da ateroscle-
rose coronária objetivada e a sua estimativa de acordo com os scores de probabilidade pré-teste
e de eventos cardiovasculares. Tratando-se de um indivíduo com documentac¸ão de aterosclerose
coronária acima do esperado - score de cálcio superior ao percentil 90 e doenc¸a coronária não
obstrutiva na angioTC cardíaca, mas por outro lado, assintomático e sem fatores de risco nem
antecedentes cardiovasculares, com uma estimativa de risco cardiovascular muito baixa e atleta
de competic¸ão, torna-se difícil decidir acerca do risco/benefício de medidas farmacológicas de
prevenc¸ão primária.
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Non-obstructive coronary artery disease documented by cardiac computed
tomography: Discrepancy between atherosclerotic burden and cardiovascular risk
Abstract Cardiac computed tomography (CT) documents the presence of coronary artery dise-
ase, regardless of the degree of stenosis. The prognostic value of non-obstructive coronary
artery disease documented by cardiac CT has recently been validated. However, there are
still no clear guidelines on the management of such patients, particularly concerning initiation
of more aggressive pharmacological measures for primary prevention. The approach to these
patients remains controversial, especially in cases in which there is a discrepancy between
cardiovascular risk and the atherosclerotic burden as documented by cardiac CT.
The authors describe the case of a patient with a discrepancy between the extent of
documented coronary atherosclerosis and that estimated according to pretest probability and
cardiovascular risk scores. As this individual had more severe coronary atherosclerosis than
expected (calcium score above the 90th percentile and non-obstructive coronary artery dise-
ase on cardiac CT) but was a competitive athlete and otherwise asymptomatic and without risk
factors or cardiovascular history, with a very low estimated cardiovascular risk, it was difficult
to decide on the risks and benefits of pharmacological primary prevention.
© 2012 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L. All rights
reserved.
Caso clínico
Descreve-se o caso de um homem de 47 anos, sem fatores
de risco cardiovascular ou antecedentes pessoais/familiares
relevantes, desportista de alta competic¸ão, praticante de
Ironman -- triatlo de longas distâncias composto por natac¸ão
(3 800m), ciclismo (180 km) e corrida (42,2 km). O doente
negava a toma de medicac¸ão regular e o abuso de subs-
tâncias aditivas como tabaco, álcool ou estimulantes como
sendo esteroides anabolizantes. Na sequência de um quadro
de infec¸ão respiratória e a pedido do seu médico assistente
(Medicina Geral e Familiar), realizou uma tomografia com-
putorizada (TC) torácica, em que foi relatada como achado
extrapulmonar a presenc¸a de «calcificac¸ão das artérias
coronárias». Por este motivo, realizou uma angioTC cardíaca
para quantificac¸ão da calcificac¸ão coronária e exclusão da
presenc¸a de doenc¸a coronária obstrutiva. O score de cál-
cio foi de 226, distribuído por todas as artérias coronárias
epicárdicas, com predomínio na artéria descendente ante-
rior proximal (Figura 1). De acordo com os normogramas
publicados1, este valor estava muito acima do esperado para
o sexo masculino nesta faixa etária (superior ao percentil
90). Este valor seria o expectável (percentil 50) para um
indivíduo na sexta década de vida.
Na aquisic¸ão com contraste foi possível excluir doenc¸a
coronária obstrutiva. Documentou-se a presenc¸a de placas
mistas, mas predominantemente calcificadas, dispersas por
toda a árvore coronária, sobretudo no tronco comum e no
segmento proximal da artéria descendente anterior. Foram
evidentes placas com remodelagem positiva (Figuras 2 e 3).
Com o resultado deste exame, o doente recorreu a
consulta de cardiologia. Encontrava-se assintomático e, ao
exame objetivo, não apresentava alterac¸ões relevantes: TA
140/80mmHg, FC 60 bpm, IMC 23,7 kg/m2; auscultac¸ão car-
díaca com S1S2 rítmicos, sem sopros e auscultac¸ão pulmonar
com murmúrio vesicular mantido, simétrico e sem ruídos
adventícios audíveis; membros sem edemas periféricos, pul-
sos distais palpáveis, amplos e simétricos.
O doente tinha realizado recentemente (há menos de
6 meses) exames laboratoriais, prova de esforc¸o e ecocar-
diograma, pedidos no âmbito de avaliac¸ão em medicina
do trabalho. Nos exames laboratoriais havia a destacar:
hemoglobina 14,0 g/dl, glicemia em jejum 84mg/dl, coles-
terol total 217mg/dl, colesterol LDL 116mg/dl, colesterol
HDL 116mg/dl e triglicéridos 70mg/dl. A prova de esforc¸o
foi efetuada segundo o protocolo Bruce, teve a durac¸ão
de 21min, atingiu 19,3MET, normal evoluc¸ão cronotrópica
(101% da FC máxima prevista) e normal evoluc¸ão tensi-
onal (TA basal 130/80mmHg e 200/80mmHg no pico de
esforc¸o). Não apresentou queixas durante a realizac¸ão da
prova, nomeadamente angor, nem ocorreram alterac¸ões
electrocardiográficas sugestivas de isquemia nem disritmias.
O ecocardiograma revelou alterac¸ões típicas de corac¸ão de
atleta -- hipertrofia ventricular esquerda excêntrica ligeira,
sem dilatac¸ão ventricular, com frac¸ão de ejec¸ão e func¸ão
diastólica normais, assim como dilatac¸ão auricular esquerda
ligeira (Figura 4).
Pelo cálculo de scores de probabilidade de doenc¸a
coronária, o doente encontra-se numa categoria de
baixa probabilidade, sobretudo atendendo à idade e à
ausência de sintomas: Score de Diamond-Forrester -- baixa
probabilidade; Score de Morise -- score 6 (baixa probabili-
dade se < 8).
O risco de eventos cardiovasculares estimado foi
igualmente baixo: HeartScore -- 1%; Framingham -- 4%,
nomeadamente atendendo à idade, à ausência de fatores
de risco e a um perfil lipídico favorável.
Apesar de se tratar de um indivíduo assintomático e com
baixo risco cardiovascular, pela presenc¸a de doenc¸a ateros-
clerótica coronária na angioTC cardíaca com um score de
cálcio elevado, além da manutenc¸ão de medidas preven-
tivas para o controlo dos fatores de risco cardiovascular,
optou-se por iniciar terapêutica farmacológica com estatina
(rosuvastatina 5mg/d). Foi também recomendada a reduc¸ão
da intensidade da prática desportiva, nomeadamente em
contexto de alta competic¸ão.
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Figura 1 Score de cálcio -- distribuic¸ão pelas artérias coronárias epicárdicas. Cx: circunflexa; LAD: descendente anterior; LM:
tronco comum; RCA: coronária direita.
Discussão
O caso apresentado descreve um quadro clínico com
uma importante discrepância entre a carga ateroscleró-
tica coronária objetivada na angioTC cardíaca e o baixo
risco cardiovascular estimado. Este caso levanta várias
questões controversas e com resposta ainda inconclusiva,
nomeadamente em relac¸ão à indicac¸ão para realizac¸ão de
angioTC cardíaca e à abordagem de doentes em que se
documenta doenc¸a coronária não obstrutiva, sendo repre-
sentativo de um subgrupo de doentes com que cada vez
mais somos confrontados e para os quais ainda não existem
recomendac¸ões claras.
O primeiro passo a adotar na avaliac¸ão de um doente
com suspeita de doenc¸a coronária deve ser a avaliac¸ão clí-
nica exaustiva com o cálculo da probabilidade pré-teste para
a presenc¸a de doenc¸a coronária e a estimativa da ocorrên-
cia de eventos cardiovasculares. Existem inúmeros scores
que permitem fazer esta estratificac¸ão de risco, sendo os
mais usados na determinac¸ão da probabilidade pré-teste
para a presenc¸a de doenc¸a coronária o Diamond-Forrester e
o Morise e na estimativa da probabilidade para a ocorrência
Figura 2 AngioTC cardíaca: A -- placas predominantemente calcificadas dispersas no segmento proximal da artéria descendente
anterior, sem condicionar estenose significativa; B -- placa mista, excêntrica, com remodelagem positiva; C e D -- artérias circunflexa
e coronária direita (vaso dominante) com placas mistas minor, sem estenoses significativas.
Documento descarregado de http://http://www.elsevier.pt el 09/09/2013. Cópia para uso pessoal, está totalmente proibida a transmissão deste documento por qualquer meio ou forma.
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Non-obstructive coronary artery disease documented by cardiac computed
tomography: Discrepancy between atherosclerotic burden and cardiovascular risk
Abstract Cardiac computed tomography (CT) documents the presence of coronary artery dise-
ase, regardless of the degree of stenosis. The prognostic value of non-obstructive coronary
artery disease documented by cardiac CT has recently been validated. However, there are
still no clear guidelines on the management of such patients, particularly concerning initiation
of more aggressive pharmacological measures for primary prevention. The approach to these
patients remains controversial, especially in cases in which there is a discrepancy between
cardiovascular risk and the atherosclerotic burden as documented by cardiac CT.
The authors describe the case of a patient with a discrepancy between the extent of
documented coronary atherosclerosis and that estimated according to pretest probability and
cardiovascular risk scores. As this individual had more severe coronary atherosclerosis than
expected (calcium score above the 90th percentile and non-obstructive coronary artery dise-
ase on cardiac CT) but was a competitive athlete and otherwise asymptomatic and without risk
factors or cardiovascular history, with a very low estimated cardiovascular risk, it was difficult
to decide on the risks and benefits of pharmacological primary prevention.
© 2012 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L. All rights
reserved.
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de risco cardiovascular ou antecedentes pessoais/familiares
relevantes, desportista de alta competic¸ão, praticante de
Ironman -- triatlo de longas distâncias composto por natac¸ão
(3 800m), ciclismo (180 km) e corrida (42,2 km). O doente
negava a toma de medicac¸ão regular e o abuso de subs-
tâncias aditivas como tabaco, álcool ou estimulantes como
sendo esteroides anabolizantes. Na sequência de um quadro
de infec¸ão respiratória e a pedido do seu médico assistente
(Medicina Geral e Familiar), realizou uma tomografia com-
putorizada (TC) torácica, em que foi relatada como achado
extrapulmonar a presenc¸a de «calcificac¸ão das artérias
coronárias». Por este motivo, realizou uma angioTC cardíaca
para quantificac¸ão da calcificac¸ão coronária e exclusão da
presenc¸a de doenc¸a coronária obstrutiva. O score de cál-
cio foi de 226, distribuído por todas as artérias coronárias
epicárdicas, com predomínio na artéria descendente ante-
rior proximal (Figura 1). De acordo com os normogramas
publicados1, este valor estava muito acima do esperado para
o sexo masculino nesta faixa etária (superior ao percentil
90). Este valor seria o expectável (percentil 50) para um
indivíduo na sexta década de vida.
Na aquisic¸ão com contraste foi possível excluir doenc¸a
coronária obstrutiva. Documentou-se a presenc¸a de placas
mistas, mas predominantemente calcificadas, dispersas por
toda a árvore coronária, sobretudo no tronco comum e no
segmento proximal da artéria descendente anterior. Foram
evidentes placas com remodelagem positiva (Figuras 2 e 3).
Com o resultado deste exame, o doente recorreu a
consulta de cardiologia. Encontrava-se assintomático e, ao
exame objetivo, não apresentava alterac¸ões relevantes: TA
140/80mmHg, FC 60 bpm, IMC 23,7 kg/m2; auscultac¸ão car-
díaca com S1S2 rítmicos, sem sopros e auscultac¸ão pulmonar
com murmúrio vesicular mantido, simétrico e sem ruídos
adventícios audíveis; membros sem edemas periféricos, pul-
sos distais palpáveis, amplos e simétricos.
O doente tinha realizado recentemente (há menos de
6 meses) exames laboratoriais, prova de esforc¸o e ecocar-
diograma, pedidos no âmbito de avaliac¸ão em medicina
do trabalho. Nos exames laboratoriais havia a destacar:
hemoglobina 14,0 g/dl, glicemia em jejum 84mg/dl, coles-
terol total 217mg/dl, colesterol LDL 116mg/dl, colesterol
HDL 116mg/dl e triglicéridos 70mg/dl. A prova de esforc¸o
foi efetuada segundo o protocolo Bruce, teve a durac¸ão
de 21min, atingiu 19,3MET, normal evoluc¸ão cronotrópica
(101% da FC máxima prevista) e normal evoluc¸ão tensi-
onal (TA basal 130/80mmHg e 200/80mmHg no pico de
esforc¸o). Não apresentou queixas durante a realizac¸ão da
prova, nomeadamente angor, nem ocorreram alterac¸ões
electrocardiográficas sugestivas de isquemia nem disritmias.
O ecocardiograma revelou alterac¸ões típicas de corac¸ão de
atleta -- hipertrofia ventricular esquerda excêntrica ligeira,
sem dilatac¸ão ventricular, com frac¸ão de ejec¸ão e func¸ão
diastólica normais, assim como dilatac¸ão auricular esquerda
ligeira (Figura 4).
Pelo cálculo de scores de probabilidade de doenc¸a
coronária, o doente encontra-se numa categoria de
baixa probabilidade, sobretudo atendendo à idade e à
ausência de sintomas: Score de Diamond-Forrester -- baixa
probabilidade; Score de Morise -- score 6 (baixa probabili-
dade se < 8).
O risco de eventos cardiovasculares estimado foi
igualmente baixo: HeartScore -- 1%; Framingham -- 4%,
nomeadamente atendendo à idade, à ausência de fatores
de risco e a um perfil lipídico favorável.
Apesar de se tratar de um indivíduo assintomático e com
baixo risco cardiovascular, pela presenc¸a de doenc¸a ateros-
clerótica coronária na angioTC cardíaca com um score de
cálcio elevado, além da manutenc¸ão de medidas preven-
tivas para o controlo dos fatores de risco cardiovascular,
optou-se por iniciar terapêutica farmacológica com estatina
(rosuvastatina 5mg/d). Foi também recomendada a reduc¸ão
da intensidade da prática desportiva, nomeadamente em
contexto de alta competic¸ão.
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Figura 1 Score de cálcio -- distribuic¸ão pelas artérias coronárias epicárdicas. Cx: circunflexa; LAD: descendente anterior; LM:
tronco comum; RCA: coronária direita.
Discussão
O caso apresentado descreve um quadro clínico com
uma importante discrepância entre a carga ateroscleró-
tica coronária objetivada na angioTC cardíaca e o baixo
risco cardiovascular estimado. Este caso levanta várias
questões controversas e com resposta ainda inconclusiva,
nomeadamente em relac¸ão à indicac¸ão para realizac¸ão de
angioTC cardíaca e à abordagem de doentes em que se
documenta doenc¸a coronária não obstrutiva, sendo repre-
sentativo de um subgrupo de doentes com que cada vez
mais somos confrontados e para os quais ainda não existem
recomendac¸ões claras.
O primeiro passo a adotar na avaliac¸ão de um doente
com suspeita de doenc¸a coronária deve ser a avaliac¸ão clí-
nica exaustiva com o cálculo da probabilidade pré-teste para
a presenc¸a de doenc¸a coronária e a estimativa da ocorrên-
cia de eventos cardiovasculares. Existem inúmeros scores
que permitem fazer esta estratificac¸ão de risco, sendo os
mais usados na determinac¸ão da probabilidade pré-teste
para a presenc¸a de doenc¸a coronária o Diamond-Forrester e
o Morise e na estimativa da probabilidade para a ocorrência
Figura 2 AngioTC cardíaca: A -- placas predominantemente calcificadas dispersas no segmento proximal da artéria descendente
anterior, sem condicionar estenose significativa; B -- placa mista, excêntrica, com remodelagem positiva; C e D -- artérias circunflexa
e coronária direita (vaso dominante) com placas mistas minor, sem estenoses significativas.
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Figura 3 Imagens de reconstruc¸ão volumétrica da árvore coronária demonstrando placas ateroscleróticas dispersas na coronária
esquerda, não condicionando estenoses significativas.
de eventos cardiovasculares o HeartScore e o Framingham.
O doente em causa, de acordo com todos estes scores,
encontra-se na categoria de baixa probabilidade de doenc¸a
coronária e de baixo risco para eventos cardiovasculares.
No caso descrito, o primeiro ponto que importa analisar e
discutir é a indicac¸ão deste doente para o cálculo do score de
cálcio e a realizac¸ão de angioTC cardíaca. Nos doentes assin-
tomáticos e com baixo risco cardiovascular não está indicada
a avaliac¸ão do score de cálcio nem a realizac¸ão de angioTC
cardíaca. Nas recomendac¸ões para a avaliac¸ão do risco car-
diovascular em adultos assintomáticos da American Heart
Association, neste contexto, ambos os exames têm classe
de recomendac¸ão iii, não devendo, portanto, ser realizados2.
A maior acessibilidade existente atualmente para o pedido e
a realizac¸ão de exames complementares de diagnóstico leva
a que, por vezes, estes sejam realizados de forma indiscri-
minada e sem indicac¸ão, sendo difícil a interpretac¸ão dos
seus resultados. No caso descrito, após a realizac¸ão destes
exames, o doente passou para um patamar de risco supe-
rior ao indicado pelos scores de avaliac¸ão e de predic¸ão
de risco cardiovascular. Por um lado, o valor do score de
cálcio associa-se diretamente a maior mortalidade a longo
prazo3. Por outro lado, além do pior prognóstico comprovado
pela presenc¸a de doenc¸a coronária obstrutiva determinada
Figura 4 Ecocardiograma transtorácico revelando hipertrofia ventricular esquerda excêntrica (A), dilatac¸ão auricular esquerda
(B), fluxo Doppler transmitral e padrão de enchimento normais (C e D).
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pela angioTC cardíaca, também a presenc¸a de doenc¸a não
obstrutiva se associa a maior mortalidade, comparativa-
mente aos doentes sem estenoses coronárias. Estes dados
foram comprovados pelo registo multicêntrico CONFIRM,
recentemente publicado, após a análise de 23 854 doentes4.
Portanto, as alterac¸ões encontradas neste doente, score de
cálcio elevado e placas não obstrutivas, terão impacto nega-
tivo no seu prognóstico.
Com estes dados, surge também a questão sobre
quais deverão ser as medidas preventivas a implemen-
tar. A presenc¸a de doenc¸a aterosclerótica representa uma
manifestac¸ão subclínica de doenc¸a coronária e pode ser
considerada como um qualifier, colocando o doente num
patamar de risco superior, com indicac¸ão para estratégias
preventivas diferentes dos doentes com o mesmo perfil
de risco, mas sem estas alterac¸ões5. Independentemente
do perfil lipídico, que neste caso é normal, salientando-se
mesmo o elevado valor do colesterol HDL, comum em
atletas, poderá estar indicado o início de terapêutica far-
macológica com estatina, além das medidas preventivas
comuns de controlo dos fatores de risco cardiovascular6,7.
Assim, além do controlo destes fatores de risco através
da manutenc¸ão de hábitos de vida saudáveis, a estratégia
adotada incluiu o início de terapêutica com estatina. Esta
atitude advém da comprovada reduc¸ão do grau de estenose
e do volume da placa aterosclerótica nos doentes medica-
dos com estatina8. Outra classe farmacológica com benefício
comprovado em doentes com doenc¸a coronária conhecida
são os antiagregantes plaquetários. No entanto, segundo
as recomendac¸ões da Sociedade Europeia de Cardiologia
para a prevenc¸ão da doenc¸a cardiovascular, deverão ser
apenas prescritos aos doentes com doenc¸a coronária estabe-
lecida ou risco cardiovascular elevado (HeartScore > 10%)5.
Neste sentido e adicionalmente aos efeitos adversos não
desprezíveis destes fármacos, sobretudo num doente poten-
cialmente exposto a eventuais complicac¸ões hemorrágicas
pelo tipo de desporto que pratica, optou-se pela sua não
prescric¸ão.
Outro ponto importante é avaliar a indicac¸ão para a sus-
pensão ou reduc¸ão do exercício físico, nomeadamente em
contexto de alta competic¸ão. O triatlo, segundo a 36.a Con-
ferência de Bethesda, é um desporto caracterizado tanto
por uma elevada intensidade dinâmica como estática9. Por
outro lado, o Ironman (triatlo levado ao extremo) correspon-
derá a cargas de intensidade ainda mais elevadas. Segundo
esta conferência, os atletas de baixo risco cardiovascular
com doenc¸a coronária, como o caso do doente apresentado,
podem realizar desporto competitivo de baixa intensidade
dinâmica e de baixa/moderada intensidade estática, mas
deverão evitar provas com intensidade competitiva elevada.
Nas mesmas recomendac¸ões releva-se também o papel do
score de cálcio na avaliac¸ão dos atletas, devendo os cuida-
dos ser acrescidos quando os valores são superiores a 1009.
Assim, o doente foi aconselhado a suspender provas de alta
competic¸ão e a reduzir a intensidade do exercício efetuado.
Conclusão
A determinac¸ão do risco cardiovascular e da probabilidade
pré-teste constituem o primeiro passo na avaliac¸ão dos
doentes com suspeita de doenc¸a coronária. A presenc¸a de
doenc¸a coronária não obstrutiva tem impacto prognóstico,
devendo estes doentes, mesmo com risco cardiovascular
baixo, ser alvo de medidas preventivas mais intensas. Con-
tudo, a melhor abordagem a adotar, especialmente iniciar
terapêutica farmacológica, permanece mal definida. Adici-
onalmente, na presenc¸a de doentes que praticam desporto
de alta competic¸ão, a controvérsia estende-se ao tipo de
recomendac¸ão relativamente à reduc¸ão da sua prática. Pro-
vavelmente, a melhor atitude deverá ser a avaliac¸ão de
cada doente caso a caso, de acordo com o tipo de desporto
efetuado e a intensidade do mesmo.
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Figura 3 Imagens de reconstruc¸ão volumétrica da árvore coronária demonstrando placas ateroscleróticas dispersas na coronária
esquerda, não condicionando estenoses significativas.
de eventos cardiovasculares o HeartScore e o Framingham.
O doente em causa, de acordo com todos estes scores,
encontra-se na categoria de baixa probabilidade de doenc¸a
coronária e de baixo risco para eventos cardiovasculares.
No caso descrito, o primeiro ponto que importa analisar e
discutir é a indicac¸ão deste doente para o cálculo do score de
cálcio e a realizac¸ão de angioTC cardíaca. Nos doentes assin-
tomáticos e com baixo risco cardiovascular não está indicada
a avaliac¸ão do score de cálcio nem a realizac¸ão de angioTC
cardíaca. Nas recomendac¸ões para a avaliac¸ão do risco car-
diovascular em adultos assintomáticos da American Heart
Association, neste contexto, ambos os exames têm classe
de recomendac¸ão iii, não devendo, portanto, ser realizados2.
A maior acessibilidade existente atualmente para o pedido e
a realizac¸ão de exames complementares de diagnóstico leva
a que, por vezes, estes sejam realizados de forma indiscri-
minada e sem indicac¸ão, sendo difícil a interpretac¸ão dos
seus resultados. No caso descrito, após a realizac¸ão destes
exames, o doente passou para um patamar de risco supe-
rior ao indicado pelos scores de avaliac¸ão e de predic¸ão
de risco cardiovascular. Por um lado, o valor do score de
cálcio associa-se diretamente a maior mortalidade a longo
prazo3. Por outro lado, além do pior prognóstico comprovado
pela presenc¸a de doenc¸a coronária obstrutiva determinada
Figura 4 Ecocardiograma transtorácico revelando hipertrofia ventricular esquerda excêntrica (A), dilatac¸ão auricular esquerda
(B), fluxo Doppler transmitral e padrão de enchimento normais (C e D).
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pela angioTC cardíaca, também a presenc¸a de doenc¸a não
obstrutiva se associa a maior mortalidade, comparativa-
mente aos doentes sem estenoses coronárias. Estes dados
foram comprovados pelo registo multicêntrico CONFIRM,
recentemente publicado, após a análise de 23 854 doentes4.
Portanto, as alterac¸ões encontradas neste doente, score de
cálcio elevado e placas não obstrutivas, terão impacto nega-
tivo no seu prognóstico.
Com estes dados, surge também a questão sobre
quais deverão ser as medidas preventivas a implemen-
tar. A presenc¸a de doenc¸a aterosclerótica representa uma
manifestac¸ão subclínica de doenc¸a coronária e pode ser
considerada como um qualifier, colocando o doente num
patamar de risco superior, com indicac¸ão para estratégias
preventivas diferentes dos doentes com o mesmo perfil
de risco, mas sem estas alterac¸ões5. Independentemente
do perfil lipídico, que neste caso é normal, salientando-se
mesmo o elevado valor do colesterol HDL, comum em
atletas, poderá estar indicado o início de terapêutica far-
macológica com estatina, além das medidas preventivas
comuns de controlo dos fatores de risco cardiovascular6,7.
Assim, além do controlo destes fatores de risco através
da manutenc¸ão de hábitos de vida saudáveis, a estratégia
adotada incluiu o início de terapêutica com estatina. Esta
atitude advém da comprovada reduc¸ão do grau de estenose
e do volume da placa aterosclerótica nos doentes medica-
dos com estatina8. Outra classe farmacológica com benefício
comprovado em doentes com doenc¸a coronária conhecida
são os antiagregantes plaquetários. No entanto, segundo
as recomendac¸ões da Sociedade Europeia de Cardiologia
para a prevenc¸ão da doenc¸a cardiovascular, deverão ser
apenas prescritos aos doentes com doenc¸a coronária estabe-
lecida ou risco cardiovascular elevado (HeartScore > 10%)5.
Neste sentido e adicionalmente aos efeitos adversos não
desprezíveis destes fármacos, sobretudo num doente poten-
cialmente exposto a eventuais complicac¸ões hemorrágicas
pelo tipo de desporto que pratica, optou-se pela sua não
prescric¸ão.
Outro ponto importante é avaliar a indicac¸ão para a sus-
pensão ou reduc¸ão do exercício físico, nomeadamente em
contexto de alta competic¸ão. O triatlo, segundo a 36.a Con-
ferência de Bethesda, é um desporto caracterizado tanto
por uma elevada intensidade dinâmica como estática9. Por
outro lado, o Ironman (triatlo levado ao extremo) correspon-
derá a cargas de intensidade ainda mais elevadas. Segundo
esta conferência, os atletas de baixo risco cardiovascular
com doenc¸a coronária, como o caso do doente apresentado,
podem realizar desporto competitivo de baixa intensidade
dinâmica e de baixa/moderada intensidade estática, mas
deverão evitar provas com intensidade competitiva elevada.
Nas mesmas recomendac¸ões releva-se também o papel do
score de cálcio na avaliac¸ão dos atletas, devendo os cuida-
dos ser acrescidos quando os valores são superiores a 1009.
Assim, o doente foi aconselhado a suspender provas de alta
competic¸ão e a reduzir a intensidade do exercício efetuado.
Conclusão
A determinac¸ão do risco cardiovascular e da probabilidade
pré-teste constituem o primeiro passo na avaliac¸ão dos
doentes com suspeita de doenc¸a coronária. A presenc¸a de
doenc¸a coronária não obstrutiva tem impacto prognóstico,
devendo estes doentes, mesmo com risco cardiovascular
baixo, ser alvo de medidas preventivas mais intensas. Con-
tudo, a melhor abordagem a adotar, especialmente iniciar
terapêutica farmacológica, permanece mal definida. Adici-
onalmente, na presenc¸a de doentes que praticam desporto
de alta competic¸ão, a controvérsia estende-se ao tipo de
recomendac¸ão relativamente à reduc¸ão da sua prática. Pro-
vavelmente, a melhor atitude deverá ser a avaliac¸ão de
cada doente caso a caso, de acordo com o tipo de desporto
efetuado e a intensidade do mesmo.
Responsabilidades éticas
Protec¸ão dos seres humanos e animais. Os autores decla-
ram que os procedimentos seguidos estavam de acordo com
os regulamentos estabelecidos pelos responsáveis da Comis-
são de Investigac¸ão Clínica e Ética e de acordo com os da
Associac¸ão Médica Mundial e da Declarac¸ão de Helsínquia.
Confidencialidade dos dados. Os autores declaram ter
seguido os protocolos de seu centro de trabalho acerca da
publicac¸ão dos dados de pacientes e que todos os pacien-
tes incluídos no estudo receberam informac¸ões suficientes
e deram o seu consentimento informado por escrito para
participar nesse estudo.
Direito à privacidade e consentimento escrito. Os autores
declaram ter recebido consentimento escrito dos pacientes
e/ou sujeitos mencionados no artigo. O autor para corres-
pondência deve estar na posse deste documento.
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No entanto, a metodologia para a avaliac¸ão pré-competitiva dos atletas veteranos não é con-
sensual e diversos marcadores de risco, adicionais aos fatores de risco CV clínicos tradicionais,
poderão melhorar a estratificac¸ão de risco nesta populac¸ão. Neste artigo revêm-se os dados
publicados sobre DAC em atletas, com relevância para a relac¸ão entre a dose de exercício e
DAC, bem como as implicac¸ões para a avaliac¸ão pré-competitiva de atletas veteranos.
© 2017 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier Espan˜a, S.L.U. Todos os
direitos reservados.
Introduction
Regular physical activity and exercise training have various
health benefits, and are recommended for primary and sec-
ondary cardiovascular (CV) prevention.1,2 The benefits of
exercise are mediated by multiple mechanisms, with favor-
able impact both in the general population and in patients
with established CV disease in the context of cardiac rehabil-
itation. Among these effects are the prevention and control
of various CV risk factors, including reduction in the inci-
dence of obesity and diabetes and improved lipid and blood
pressure profiles, as well as reduction of acute coronary
events and increased survival.2
In response to the constant campaigns promoting the
benefits of physical activity and exercise training, the num-
ber of people participating regularly in sports has grown
in recent decades. Consequently, the spectrum of athletes
has widened to include not only young adults, but also chil-
dren and the elderly, with more individuals taking up regular
exercise in middle age and continuing until late in life.
Evidence of this tendency is the large number of veteran ath-
letes involved in high dynamic component disciplines such
as cycling, marathon, triathlon and Ironman races.3,4
Although much is now known about exercise-induced
physiological cardiac adaptations, the long-term effects of
prolonged and excessive intense exercise training remain
unclear. Recent evidence points to a potential U-shaped
relationship between the dose of exercise and the occur-
rence of clinical CV events, which could be related to the
presence and severity of coronary artery disease (CAD).
This is an important issue, since CAD is responsible for
the greatest proportion (approximately 80%) of sudden car-
diac death (SCD) in veteran athletes, a less studied athletic
population.
The recent development of new CV imaging tests, includ-
ing non-enhanced cardiac computed tomography (CT) with
calcium scoring (CS) and enhanced cardiac CT (coronary
CT angiography [CCTA]), has enabled non-invasive detection
and better characterization of the presence and severity
of CAD.5 This could be a game-changer for risk stratifi-
cation in veteran athletes, changing the paradigm from
traditional stratification based on clinical CV risk factors and
exercise electrocardiographic testing, which has well-known
limitations.6
In the present paper we review the published data on CAD
in athletes, focusing on the relationship between the dose
of exercise and CAD, the potential mechanisms involved and
the implications for pre-participation screening of veteran
athletes, highlighting the role of CS and CCTA.
The paradox of sudden cardiac death
in athletes
Despite the proven benefits of regular physical exercise and
although athletes are the paradigm of healthy individuals,
this population is not risk-free and can suffer severe clini-
cal conditions including SCD.5,7 Although SCD is uncommon
in young athletes (incidence 2-5/100 000 per year), it is a
tragic event, with high visibility due to media attention.
Most sports-related cardiac arrests occur in individuals not
performing regular exercise, and in epidemiological terms,
SCD during sports accounts for only a small proportion of
cases in the general population.
Several studies have confirmed both the increased risk of
exercise-associated myocardial infarction and SCD and the
beneficial effect of regular exercise in risk reduction. Data
from Italy revealed a 2.8-fold greater risk of SCD in young
competitive athletes compared to non-athletes.8 However,
it should be stressed that exercise is not the cause of death,
but is a precipitating factor in susceptible individuals with
previously undiagnosed cardiac disease. It should also be
recognized that the overall beneficial effects of exercise in
the population outweigh the increased risk.
In young athletes the most common causes of SCD are
hereditary diseases, mainly cardiomyopathies and primary
arrhythmic diseases, while in veteran athletes the great
majority is caused by CAD.5,9--12 For the purpose of this paper,
we define a veteran athlete as an individual more than 35
years old participating in sports at a competitive level or as a
leisure activity. The majority of sports-related SCD occurs in
older athletes, but as many of the deaths are unwitnessed,
the magnitude of the problem is probably underestimated.12
Beyond the difference in the athletes’ age, other important
epidemiological features of SCD in athletes are the higher
frequency in males (9:1 to females) and occurrence during
or immediately after exercise and mainly in high dynamic
component sports.5
Identification of athletes with higher CV risk is a crucial
goal of pre-participation screening.13,14 Although controver-
sial, due to the long-standing disagreement between Europe
and the US, the methodology recommended by the European
Society of Cardiology (ESC) for screening of young athletes
includes medical history (personal and family), physical
examination, and 12-lead electrocardiogram (ECG).13 Cen-
tral to the disagreement is the ECG, due to the high rate
of false positive results. The main question is not whether
the ECG should be included, but how it should be inter-
preted; the adoption of more restrictive criteria decreases
the false-positive rate without reducing sensitivity and with
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Figure 1 Comparison between coronary plaque rupture with exertion and at rest (reprinted from Burke et al.22). HP: hemorrhage
into plaque; L: lumen; Th: thrombus.
a favorable impact on cost-effectiveness.15--19 Regarding the
pre-participation screening of veteran athletes the contro-
versy is greater, as will be discussed below.
Coronary artery disease in athletes
SCD or acute myocardial infarction may be the first clin-
ical presentation of CAD. The rupture of non-obstructive
coronary plaques is the most common pathophysiological
mechanism involved, which explains the previous absence
of symptoms such as angina, usually present in individu-
als with obstructive CAD.9,20,21 Superficial plaque erosion
and intraplaque hemorrhage are other mechanisms associ-
ated with coronary plaque instability, but ischemia due to
an imbalance between oxygen supply and demand has also
been described as one of the main causes of acute exercise-
related cardiac arrest.20
Plaque rupture during exertion typically occurs in the
central part of a thin fibrous cap with numerous vasa
vasorum, while plaque rupture at rest occurs more in the
periphery, at the junction between the fibrous cap and the
arterial wall (Figure 1).12,22
Although the concept of advanced atherosclerosis in
veteran athletes is somewhat counter-intuitive, various
stress factors and pathophysiological mechanisms induced
by chronic and extreme endurance exercise may play a crit-
ical role.
Among the potential mechanisms triggering exertion-
related acute coronary syndromes are increased throm-
bogenicity, sympathetic activation, electrolyte imbalance,
hyperdynamic circulation, shear stress and imbalance
between the antioxidative and oxidative effects of
exercise.12 An analysis performed in men with CAD exposed
to physical exercise showed an improvement in antioxi-
dant and vascular effects, a benefit which can be blunted
with increased exercise intensity.23 Intense and prolonged
exercise increases oxidative stress and release of inflamma-
tory mediators such as oxygen free radicals and cytokines,
a process documented in patients with CAD. Beyond the
potential involvement of these exercise-related factors, it
should be borne in mind that, as in the general population,
the development of CAD in athletes is multifactorial, and
can be affected by clinical CV risk factors, genetic pre-
disposition, normal aging processes, infections and toxins
(Figure 2).
Exercise training leads to the release of cardiac biomark-
ers, particularly troponin, an invaluable tool for the
assessment of patients with myocardial infarction. In the
context of exertion, this appears to be a benign process, but
the underlying mechanisms are still poorly understood. Tro-
ponin elevation is likely to result from increased myocyte
turnover, cellular release of proteolytic troponin degrada-
tion products, cellular wall permeability and formation and
release of membranous blebs.24--26 Interestingly, the extent
of troponin release is strongly related to intensity of exer-
cise, and it is not clear if recurrent episodes would lead to
long-term adverse cardiac effects.
Even with lower incidences, it is important to empha-
size that besides the atherosclerotic process, there are other
coronary abnormalities associated with SCD in athletes that
should be considered and excluded, such as anomalous coro-
nary artery origin, vasospasm, bridging, coronary dissection
and vasculitis, which are beyond the scope of the present
review.27,28
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Figure 2 Factors potentially involved in the development of
coronary artery disease in athletes. CV: cardiovascular.
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No entanto, a metodologia para a avaliac¸ão pré-competitiva dos atletas veteranos não é con-
sensual e diversos marcadores de risco, adicionais aos fatores de risco CV clínicos tradicionais,
poderão melhorar a estratificac¸ão de risco nesta populac¸ão. Neste artigo revêm-se os dados
publicados sobre DAC em atletas, com relevância para a relac¸ão entre a dose de exercício e
DAC, bem como as implicac¸ões para a avaliac¸ão pré-competitiva de atletas veteranos.
© 2017 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier Espan˜a, S.L.U. Todos os
direitos reservados.
Introduction
Regular physical activity and exercise training have various
health benefits, and are recommended for primary and sec-
ondary cardiovascular (CV) prevention.1,2 The benefits of
exercise are mediated by multiple mechanisms, with favor-
able impact both in the general population and in patients
with established CV disease in the context of cardiac rehabil-
itation. Among these effects are the prevention and control
of various CV risk factors, including reduction in the inci-
dence of obesity and diabetes and improved lipid and blood
pressure profiles, as well as reduction of acute coronary
events and increased survival.2
In response to the constant campaigns promoting the
benefits of physical activity and exercise training, the num-
ber of people participating regularly in sports has grown
in recent decades. Consequently, the spectrum of athletes
has widened to include not only young adults, but also chil-
dren and the elderly, with more individuals taking up regular
exercise in middle age and continuing until late in life.
Evidence of this tendency is the large number of veteran ath-
letes involved in high dynamic component disciplines such
as cycling, marathon, triathlon and Ironman races.3,4
Although much is now known about exercise-induced
physiological cardiac adaptations, the long-term effects of
prolonged and excessive intense exercise training remain
unclear. Recent evidence points to a potential U-shaped
relationship between the dose of exercise and the occur-
rence of clinical CV events, which could be related to the
presence and severity of coronary artery disease (CAD).
This is an important issue, since CAD is responsible for
the greatest proportion (approximately 80%) of sudden car-
diac death (SCD) in veteran athletes, a less studied athletic
population.
The recent development of new CV imaging tests, includ-
ing non-enhanced cardiac computed tomography (CT) with
calcium scoring (CS) and enhanced cardiac CT (coronary
CT angiography [CCTA]), has enabled non-invasive detection
and better characterization of the presence and severity
of CAD.5 This could be a game-changer for risk stratifi-
cation in veteran athletes, changing the paradigm from
traditional stratification based on clinical CV risk factors and
exercise electrocardiographic testing, which has well-known
limitations.6
In the present paper we review the published data on CAD
in athletes, focusing on the relationship between the dose
of exercise and CAD, the potential mechanisms involved and
the implications for pre-participation screening of veteran
athletes, highlighting the role of CS and CCTA.
The paradox of sudden cardiac death
in athletes
Despite the proven benefits of regular physical exercise and
although athletes are the paradigm of healthy individuals,
this population is not risk-free and can suffer severe clini-
cal conditions including SCD.5,7 Although SCD is uncommon
in young athletes (incidence 2-5/100 000 per year), it is a
tragic event, with high visibility due to media attention.
Most sports-related cardiac arrests occur in individuals not
performing regular exercise, and in epidemiological terms,
SCD during sports accounts for only a small proportion of
cases in the general population.
Several studies have confirmed both the increased risk of
exercise-associated myocardial infarction and SCD and the
beneficial effect of regular exercise in risk reduction. Data
from Italy revealed a 2.8-fold greater risk of SCD in young
competitive athletes compared to non-athletes.8 However,
it should be stressed that exercise is not the cause of death,
but is a precipitating factor in susceptible individuals with
previously undiagnosed cardiac disease. It should also be
recognized that the overall beneficial effects of exercise in
the population outweigh the increased risk.
In young athletes the most common causes of SCD are
hereditary diseases, mainly cardiomyopathies and primary
arrhythmic diseases, while in veteran athletes the great
majority is caused by CAD.5,9--12 For the purpose of this paper,
we define a veteran athlete as an individual more than 35
years old participating in sports at a competitive level or as a
leisure activity. The majority of sports-related SCD occurs in
older athletes, but as many of the deaths are unwitnessed,
the magnitude of the problem is probably underestimated.12
Beyond the difference in the athletes’ age, other important
epidemiological features of SCD in athletes are the higher
frequency in males (9:1 to females) and occurrence during
or immediately after exercise and mainly in high dynamic
component sports.5
Identification of athletes with higher CV risk is a crucial
goal of pre-participation screening.13,14 Although controver-
sial, due to the long-standing disagreement between Europe
and the US, the methodology recommended by the European
Society of Cardiology (ESC) for screening of young athletes
includes medical history (personal and family), physical
examination, and 12-lead electrocardiogram (ECG).13 Cen-
tral to the disagreement is the ECG, due to the high rate
of false positive results. The main question is not whether
the ECG should be included, but how it should be inter-
preted; the adoption of more restrictive criteria decreases
the false-positive rate without reducing sensitivity and with
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Figure 1 Comparison between coronary plaque rupture with exertion and at rest (reprinted from Burke et al.22). HP: hemorrhage
into plaque; L: lumen; Th: thrombus.
a favorable impact on cost-effectiveness.15--19 Regarding the
pre-participation screening of veteran athletes the contro-
versy is greater, as will be discussed below.
Coronary artery disease in athletes
SCD or acute myocardial infarction may be the first clin-
ical presentation of CAD. The rupture of non-obstructive
coronary plaques is the most common pathophysiological
mechanism involved, which explains the previous absence
of symptoms such as angina, usually present in individu-
als with obstructive CAD.9,20,21 Superficial plaque erosion
and intraplaque hemorrhage are other mechanisms associ-
ated with coronary plaque instability, but ischemia due to
an imbalance between oxygen supply and demand has also
been described as one of the main causes of acute exercise-
related cardiac arrest.20
Plaque rupture during exertion typically occurs in the
central part of a thin fibrous cap with numerous vasa
vasorum, while plaque rupture at rest occurs more in the
periphery, at the junction between the fibrous cap and the
arterial wall (Figure 1).12,22
Although the concept of advanced atherosclerosis in
veteran athletes is somewhat counter-intuitive, various
stress factors and pathophysiological mechanisms induced
by chronic and extreme endurance exercise may play a crit-
ical role.
Among the potential mechanisms triggering exertion-
related acute coronary syndromes are increased throm-
bogenicity, sympathetic activation, electrolyte imbalance,
hyperdynamic circulation, shear stress and imbalance
between the antioxidative and oxidative effects of
exercise.12 An analysis performed in men with CAD exposed
to physical exercise showed an improvement in antioxi-
dant and vascular effects, a benefit which can be blunted
with increased exercise intensity.23 Intense and prolonged
exercise increases oxidative stress and release of inflamma-
tory mediators such as oxygen free radicals and cytokines,
a process documented in patients with CAD. Beyond the
potential involvement of these exercise-related factors, it
should be borne in mind that, as in the general population,
the development of CAD in athletes is multifactorial, and
can be affected by clinical CV risk factors, genetic pre-
disposition, normal aging processes, infections and toxins
(Figure 2).
Exercise training leads to the release of cardiac biomark-
ers, particularly troponin, an invaluable tool for the
assessment of patients with myocardial infarction. In the
context of exertion, this appears to be a benign process, but
the underlying mechanisms are still poorly understood. Tro-
ponin elevation is likely to result from increased myocyte
turnover, cellular release of proteolytic troponin degrada-
tion products, cellular wall permeability and formation and
release of membranous blebs.24--26 Interestingly, the extent
of troponin release is strongly related to intensity of exer-
cise, and it is not clear if recurrent episodes would lead to
long-term adverse cardiac effects.
Even with lower incidences, it is important to empha-
size that besides the atherosclerotic process, there are other
coronary abnormalities associated with SCD in athletes that
should be considered and excluded, such as anomalous coro-
nary artery origin, vasospasm, bridging, coronary dissection
and vasculitis, which are beyond the scope of the present
review.27,28
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Figure 2 Factors potentially involved in the development of
coronary artery disease in athletes. CV: cardiovascular.
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Figure 3 Potential cardiovascular effects of regular intense
exercise training. ARVC: arrhythmogenic right ventricular car-
diomyopathy; CAD: coronary artery disease; CV: cardiovascular;
SCD: sudden cardiac death.
Relationship between amount of exercise
and coronary artery disease
The relationship between amount of exercise and CAD is
still not well established. In principle, as a drug becomes
ineffective at a dose below that recommended, or toxic in
the case of overdose, the same could happen with physical
exercise. It is known that relatively modest doses of regu-
lar exercise are sufficient to induce benefits, but the upper
limit above which the adverse effects outweigh the benefits
has not been determined.29--32 There is emerging evidence
that with increasing doses of exercise, the relative bene-
fits decrease.30 Humans may not be genetically adapted for
sustained intense exercise, and if so, it is worth considering
how much exercise could actually be harmful and what the
desired therapeutic window of exercise would be.
Extreme exercise leads to various cardiac changes (his-
tological, structural and functional). These are mainly
physiological adaptations, but maladaptation can also occur,
increasing susceptibility to atrial and ventricular arrhyth-
mias. Myocardial fibrosis, inflammation, marked ventricular
remodeling and accumulation of coronary calcium are
potentially related to extreme exercise (Figure 3).
Some authors have argued that there exists a type of
cardiotoxicity induced by extreme exercise, and the rela-
tionship between dose of exercise and incidence of clinical
events has been described as a U-shaped curve.33,34 Moder-
ate exercise appears to be better than none, but vigorous
exercise may actually be harmful, at least for some individ-
uals. From a public health perspective, we emphasize that
although these findings raise some concerns about the bene-
fits of high-end endurance sports, they do not undermine the
substantial beneficial effects of regular exercise on all-cause
mortality in the vast majority of older athletes.
Regarding mortality, this U-shaped relationship is clear
for running distances, speeds and frequencies.35 In the
Copenhagen City Heart Study,36 moderate joggers had lower
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Figure 4 Hypothetical representation of the relationship
between the dose of exercise and the incidence and severity
of coronary artery disease. CAD: coronary artery disease.
mortality than sedentary nonjoggers and strenuous joggers.
Although the evidence is weaker, the same relationship
has been proposed for the presence and severity of CAD
(Figure 4). In fact, the dose of exercise has a central role,
as most cardiac arrests during marathons occur in the last
quartile of races, although this could also be explained by
cumulative electrolyte disturbances during the race.37
In daily clinical practice, it is not uncommon to iden-
tify athletes with a higher than expected atherosclerotic
burden. Figure 5 illustrates a CCTA of an asymptomatic
47-year-old male competitive Ironman athlete, with a dis-
crepancy between total CV risk based on SCORE (<1%) and
extent of CAD.38
The potential association between intense exercise train-
ing and CAD does not appear to be an incidental finding.
In recent years, several authors have described a higher
than expected CAD incidence and severity in veteran ath-
letes involved in endurance sports. Mohlenkamp et al.39
studied 108 veterans who ran at least five marathons over
the previous three years, compared with a control group of
non-athletes. CS was similar in both groups with adjustment
for age, but significantly higher in the athletes after adjust-
ment for Framingham risk score (mean CS: 36 vs. 12, p=0.02;
CS ≥100: 36% vs. 22%, p=0.01; CS >percentile 75: 25% vs.
15%, p=0.01). During a mean follow-up of 21 months, ath-
letes with CS ≥100 had a higher rate of CV events. Tsiflikas
et al.40 studied male marathoners aged over 45 years and
detected CAD in half of them, including 24% with plaques
in the proximal coronary segments. Merghani et al.41 docu-
mented a U-shaped curve for the relationship between dose
of exercise and CS in veteran athletes. A CS >percentile 70
was two or three times more frequent in athletes training
>30 miles/week vs. <20 miles/week (39% vs. 13%; p=0.037).
In the recent published MARC study,42 CCTA detected occult
CAD in almost one in five asymptomatic sportsmen aged ≥45
years after a normal sports medical evaluation that included
resting and exercise ECG. The number needed to treat in
order to prevent one CV event compares favorably to that
of other screening tests.
Despite these findings, several questions remain unan-
swered. These results imply that endurance athletes may
not be protected from accumulation of coronary calcium,
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Figure 5 Coronary computed tomography angiography of a competitive Ironman veteran athlete with low cardiovascular risk
based on SCORE (<1%), but with a higher than expected atherosclerotic burden (calcium score >percentile 90), with plaques in all
the epicardial coronaries, including >5 segments with plaque (segment involvement score >5) and involvement of the left main and
proximal left anterior descending arteries (adapted from Dores et al.38).
but it is important to recognize that the evidence does not
show that endurance athletics has an adverse impact on
either CS or CV events.12 It should also be emphasized that
as well as being few in number, the published studies show
inconsistencies: different inclusion criteria, regular exer-
cise training begun at different ages, small samples, and
different characterizations of exercise training.43 This issue
requires a thorough analysis and more evidence, and is an
emerging area of research in sports cardiology.
Cardiovascular risk stratification of veteran
athletes
The epidemiological differences between young and veteran
athletes justify the adoption of different pre-participation
screening methodologies in the two groups. The large num-
ber of middle-aged individuals engaged in leisure-time
sports makes the screening of this population an emerging
task. Although the main cause of SCD in veteran athletes is
coronary events, the focus of this screening should rule out
subclinical CAD.12,44 Currently, a stepwise approach is sug-
gested for the assessment of middle-aged/senior individuals
involved in leisure or competitive sports:
• Step 1: Self-assessment using pre-specified question-
naires;
• Step 2: Assessment by a physician (personal and family his-
tory, physical examination, SCORE calculation and resting
ECG);
• Step 3: Maximal exercise testing.
The identification and management of CAD in asymp-
tomatic individuals (athletes or non-athletes) is a difficult
task and there is still no agreement on the correct approach
to adopt.45 Total risk estimation using multiple risk fac-
tors is recommended by the ESC for asymptomatic adults
without evidence of CV disease (class I, level of evidence
C).2 However, the predictive capacity of this conventional
methodology based on clinical scores such as the Framing-
ham risk score and SCORE is modest, failing to identify a
significant proportion of individuals with established CAD. If
these scores had been calculated on the day before an acute
myocardial infarction, most patients would have had low-
moderate risk, without indication for the implementation
of preventive or therapeutic measures.46--48
Regarding the CV assessment of middle-aged/senior indi-
viduals engaged in leisure-time sports, the ESC recommends
self-assessment of habitual physical activity level and risk
factors, followed by SCORE calculation. Individuals with
an increased risk for coronary events embarking on mod-
erate/intense physical activity should undergo a maximal
exercise test and possibly further cardiac investigation.49
Although this methodology may be valid in veteran athletes,
it does not take into consideration specific characteristics
such as dose of exercise, type of sport and length of exercise
training. It seems obvious that more intensive investigation
should be performed in athletes with moderate-high CV risk,
particularly for those who are naïve or involved in high-
level endurance sports. The main question is which further
investigations should be performed.
Despite its recognized prognostic value, the utility of the
ECG for screening asymptomatic subjects without known
CAD is limited. Up to half of individuals with angiograph-
ically normal coronary arteries show changes on the ECG,
one-third of those with CAD have normal baseline ECG, and
the majority of coronary events occur in the absence of prior
electrocardiographic abnormalities. In addition, all stress
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Figure 3 Potential cardiovascular effects of regular intense
exercise training. ARVC: arrhythmogenic right ventricular car-
diomyopathy; CAD: coronary artery disease; CV: cardiovascular;
SCD: sudden cardiac death.
Relationship between amount of exercise
and coronary artery disease
The relationship between amount of exercise and CAD is
still not well established. In principle, as a drug becomes
ineffective at a dose below that recommended, or toxic in
the case of overdose, the same could happen with physical
exercise. It is known that relatively modest doses of regu-
lar exercise are sufficient to induce benefits, but the upper
limit above which the adverse effects outweigh the benefits
has not been determined.29--32 There is emerging evidence
that with increasing doses of exercise, the relative bene-
fits decrease.30 Humans may not be genetically adapted for
sustained intense exercise, and if so, it is worth considering
how much exercise could actually be harmful and what the
desired therapeutic window of exercise would be.
Extreme exercise leads to various cardiac changes (his-
tological, structural and functional). These are mainly
physiological adaptations, but maladaptation can also occur,
increasing susceptibility to atrial and ventricular arrhyth-
mias. Myocardial fibrosis, inflammation, marked ventricular
remodeling and accumulation of coronary calcium are
potentially related to extreme exercise (Figure 3).
Some authors have argued that there exists a type of
cardiotoxicity induced by extreme exercise, and the rela-
tionship between dose of exercise and incidence of clinical
events has been described as a U-shaped curve.33,34 Moder-
ate exercise appears to be better than none, but vigorous
exercise may actually be harmful, at least for some individ-
uals. From a public health perspective, we emphasize that
although these findings raise some concerns about the bene-
fits of high-end endurance sports, they do not undermine the
substantial beneficial effects of regular exercise on all-cause
mortality in the vast majority of older athletes.
Regarding mortality, this U-shaped relationship is clear
for running distances, speeds and frequencies.35 In the
Copenhagen City Heart Study,36 moderate joggers had lower
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Figure 4 Hypothetical representation of the relationship
between the dose of exercise and the incidence and severity
of coronary artery disease. CAD: coronary artery disease.
mortality than sedentary nonjoggers and strenuous joggers.
Although the evidence is weaker, the same relationship
has been proposed for the presence and severity of CAD
(Figure 4). In fact, the dose of exercise has a central role,
as most cardiac arrests during marathons occur in the last
quartile of races, although this could also be explained by
cumulative electrolyte disturbances during the race.37
In daily clinical practice, it is not uncommon to iden-
tify athletes with a higher than expected atherosclerotic
burden. Figure 5 illustrates a CCTA of an asymptomatic
47-year-old male competitive Ironman athlete, with a dis-
crepancy between total CV risk based on SCORE (<1%) and
extent of CAD.38
The potential association between intense exercise train-
ing and CAD does not appear to be an incidental finding.
In recent years, several authors have described a higher
than expected CAD incidence and severity in veteran ath-
letes involved in endurance sports. Mohlenkamp et al.39
studied 108 veterans who ran at least five marathons over
the previous three years, compared with a control group of
non-athletes. CS was similar in both groups with adjustment
for age, but significantly higher in the athletes after adjust-
ment for Framingham risk score (mean CS: 36 vs. 12, p=0.02;
CS ≥100: 36% vs. 22%, p=0.01; CS >percentile 75: 25% vs.
15%, p=0.01). During a mean follow-up of 21 months, ath-
letes with CS ≥100 had a higher rate of CV events. Tsiflikas
et al.40 studied male marathoners aged over 45 years and
detected CAD in half of them, including 24% with plaques
in the proximal coronary segments. Merghani et al.41 docu-
mented a U-shaped curve for the relationship between dose
of exercise and CS in veteran athletes. A CS >percentile 70
was two or three times more frequent in athletes training
>30 miles/week vs. <20 miles/week (39% vs. 13%; p=0.037).
In the recent published MARC study,42 CCTA detected occult
CAD in almost one in five asymptomatic sportsmen aged ≥45
years after a normal sports medical evaluation that included
resting and exercise ECG. The number needed to treat in
order to prevent one CV event compares favorably to that
of other screening tests.
Despite these findings, several questions remain unan-
swered. These results imply that endurance athletes may
not be protected from accumulation of coronary calcium,
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Figure 5 Coronary computed tomography angiography of a competitive Ironman veteran athlete with low cardiovascular risk
based on SCORE (<1%), but with a higher than expected atherosclerotic burden (calcium score >percentile 90), with plaques in all
the epicardial coronaries, including >5 segments with plaque (segment involvement score >5) and involvement of the left main and
proximal left anterior descending arteries (adapted from Dores et al.38).
but it is important to recognize that the evidence does not
show that endurance athletics has an adverse impact on
either CS or CV events.12 It should also be emphasized that
as well as being few in number, the published studies show
inconsistencies: different inclusion criteria, regular exer-
cise training begun at different ages, small samples, and
different characterizations of exercise training.43 This issue
requires a thorough analysis and more evidence, and is an
emerging area of research in sports cardiology.
Cardiovascular risk stratification of veteran
athletes
The epidemiological differences between young and veteran
athletes justify the adoption of different pre-participation
screening methodologies in the two groups. The large num-
ber of middle-aged individuals engaged in leisure-time
sports makes the screening of this population an emerging
task. Although the main cause of SCD in veteran athletes is
coronary events, the focus of this screening should rule out
subclinical CAD.12,44 Currently, a stepwise approach is sug-
gested for the assessment of middle-aged/senior individuals
involved in leisure or competitive sports:
• Step 1: Self-assessment using pre-specified question-
naires;
• Step 2: Assessment by a physician (personal and family his-
tory, physical examination, SCORE calculation and resting
ECG);
• Step 3: Maximal exercise testing.
The identification and management of CAD in asymp-
tomatic individuals (athletes or non-athletes) is a difficult
task and there is still no agreement on the correct approach
to adopt.45 Total risk estimation using multiple risk fac-
tors is recommended by the ESC for asymptomatic adults
without evidence of CV disease (class I, level of evidence
C).2 However, the predictive capacity of this conventional
methodology based on clinical scores such as the Framing-
ham risk score and SCORE is modest, failing to identify a
significant proportion of individuals with established CAD. If
these scores had been calculated on the day before an acute
myocardial infarction, most patients would have had low-
moderate risk, without indication for the implementation
of preventive or therapeutic measures.46--48
Regarding the CV assessment of middle-aged/senior indi-
viduals engaged in leisure-time sports, the ESC recommends
self-assessment of habitual physical activity level and risk
factors, followed by SCORE calculation. Individuals with
an increased risk for coronary events embarking on mod-
erate/intense physical activity should undergo a maximal
exercise test and possibly further cardiac investigation.49
Although this methodology may be valid in veteran athletes,
it does not take into consideration specific characteristics
such as dose of exercise, type of sport and length of exercise
training. It seems obvious that more intensive investigation
should be performed in athletes with moderate-high CV risk,
particularly for those who are naïve or involved in high-
level endurance sports. The main question is which further
investigations should be performed.
Despite its recognized prognostic value, the utility of the
ECG for screening asymptomatic subjects without known
CAD is limited. Up to half of individuals with angiograph-
ically normal coronary arteries show changes on the ECG,
one-third of those with CAD have normal baseline ECG, and
the majority of coronary events occur in the absence of prior
electrocardiographic abnormalities. In addition, all stress
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tests, by definition, depend on the presence of obstructive
CAD and therefore they are not designed to detect nonob-
structive CAD, which has been associated with worse CV
outcome in several CCTA studies.50--54
Usually, athletes with high CV risk undergo an exer-
cise ECG test, an exam of established prognostic value,
widespread availability and low cost. Several studies have
reported an increased relative risk of coronary death for
asymptomatic subjects with a positive test. However, the
accuracy of exercise testing for CAD detection in populations
with low pretest probability, such as asymptomatic athletes
involved in high-intensity sports, is limited.55--57 To overcome
some of these limitations the measurement of biomarkers
(e.g. high-sensitivity C-reactive protein and natriuretic pep-
tides) has been proposed, but the gain in CAD detection and
the practical applicability were low.58,59
Apart from the conventional scores based on clinical risk
factors, it is known that some risk modifiers detected by
emerging tests such as CS and carotid atherosclerotic plaque
detection can improve the calculation of total CV risk.
The role of calcium score and cardiac
computed tomography in screening veteran
athletes
Determination of total atherosclerotic burden is an option
for screening veteran athletes, helping to detect coronary
calcifications, a recognizedmarker of subclinical atheroscle-
rosis. CS is a non-invasive marker of CAD with proven
prognostic impact, predicting CV events and death, indepen-
dently of and incremental to conventional risk factors.60--63
CS is a risk modifier that can be considered in individuals
with SCORE around 5%-10%. In the PESA study64 in individ-
uals aged 40-54 years, 63% had subclinical atherosclerosis
after assessment of multivascular territories, and CAD was
detected in 18% of individuals, most of themwith low SCORE.
The landmark MESA study65 showed superior discrimination
and reclassification of CV risk in intermediate-risk individu-
als using subclinical markers. CS had higher predictive power
than other markers such as carotid intima-media thickness
and ankle-brachial index, in agreement with the results of
the Rotterdam study.66 Additionally, CS improves the adop-
tion of preventive measures, leading to better control of
several CV risk factors, as shown in the EISNER study.67,68
It is important to stress that not all coronary plaques
are calcified, nor is CS an indicator of plaque instability.
Moreover, although much less frequent than calcified or
mixed plaques, non-calcified plaques are more prone to
instability leading to acute coronary events. In this context,
CCTA provides useful additional information, enabling bet-
ter characterization of the coronary tree and plaques.26,69
Beyond obstructive CAD, the presence and quantity of non-
obstructive plaques also has prognostic value, as shown
in the CONFIRM registry70 and in other CCTA studies using
atherosclerotic burden indices like the segment involve-
ment score53 or the CT-adapted Leaman score (CT-LeSc).54
The comprehensive information provided by CCTA, includ-
ing location, type and number of plaques, can be clustered
in CCTA atherosclerotic burden scores like the CT-LeSc,71
which can help identify individuals with nonobstructive CAD
at higher risk of CV events and therefore contribute to risk
stratification.54
A recent study by Ermolao et al.57 in asymptomatic
middle-aged athletes with ST-segment anomalies during
maximal exercise test (diagnostic or equivocal) revealed
CAD in only 32% of the subjects. In the MARC study,42 in
318 middle-aged sportsmen with low SCORE who underwent
CCTA following normal pre-participation screening, 94% had
low CV risk and 18.9% had CAD (CS ≥100 or ≥50% luminal
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(≥ 40 years old;
endurance sports)
Family and personal history
Physical examination
12-lead ECG
Global CV risk assessment
SCORE
Negative findings
and
SCORE ≤1% 
ELIGIBLE
Further
evaluation/prevent
ive medication
No evidence
of CV disease
CAD* or other
CV disease
Positive findings
and/or
SCORE >1%
Further
assessment
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*Luminal stenosis >50%, CS>75 percentile, SIS >5, CT-leSc >5.
Figure 6 Algorithm proposed for veteran athlete screening. CAD: coronary artery disease; CCTA: coronary computed tomography
angiography; CT-LeSc: computed tomography-adapted Leaman score; CV: cardiovascular; ECG: electrocardiogram; SIS: segment
involvement score.
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Figure 7 Coronary computed tomography angiography of a non-competitive athlete performed with a new-generation scanner
(SOMATOM Force, Siemens Healthcare), using an ultra-low radiation dose of 0.5 mSv. Left: volume rendering technique images and
study protocol; middle: nonobstructive mixed plaque in the proximal segment of the right coronary artery; right: nonobstructive
calcified plaque in the proximal left anterior descending artery. LAD: left anterior descending artery; RCA: right coronary artery.
stenosis), almost one in five individuals. In this setting, some
authors have proposed the inclusion of CCTA in the screening
of veteran endurance athletes with moderate-high CV risk.
However, as Braber et al.42 showed, even veteran athletes
with low CV risk could benefit from CCTA, increasing the
controversy concerning the target population of this exam.
Based on these data, mainly derived from studies performed
in athletes aged >40 years involved in endurance sports and
with a wide spectrum of CV risk (including low risk), a hypo-
thetical flowchart for veteran athletes screening is proposed
in Figure 6.
Another important feature of CCTA is the ability to detect
other important coronary abnormalities in the screening of
athletes, such as malignant variants of anomalous origin of
the coronaries and coronary bridging, both described as pos-
sible causes of SCD in athletes.
In addition, and also of considerable importance, recent
technological developments in scanner technology (both
hardware and software) have led to impressive reduc-
tions in radiation dose, the main limitation of CCTA.72,73
Figure 7 presents an example of a CCTA performed with
a new-generation scanner, showing high image quality with
ultra-low radiation and contrast doses (0.5 mSv and 50 cc,
respectively).
Finally, although we have reviewed the published evi-
dence linking physical exercise and the presence and
severity of CAD, several issues remain unanswered and war-
rant further research. It is the view of the authors that
although CV risk stratification of veteran athletes is at
present still based on traditional risk factors and rest ECG,
cardiac CT may play a role in the future. To clarify this
important issue, further research is needed focusing on
three lines of investigation: first, to explore the possible U-
shaped association between the dose of exercise and CAD;
second, to establish the added value of CS and CCTA in
screening of veteran athletes; and third, to demonstrate
that the use of these newer CT-based imaging modalities
can further improve risk stratification of this important sub-
set of presumed healthy individuals, who may in fact be at
risk of CV events.
Conclusions
The benefits of exercise in the overall population are indis-
putable, but in athletes with CV disease exercise can also
be associated with adverse clinical events, including SCD.
In veterans, a growing group of athletes, CAD is the most
common cause of SCD, and there appears to be an U-shaped
relationship with the dose of exercise. Detection of subclin-
ical CAD should be the main objective of veteran athlete
screening, since the performance of classical CV risk strati-
fication based on clinical factors appears to be suboptimal.
Emerging data show an important role for CS and CCTA in
this setting. Coupled with the impressive technical improve-
ments in scanner technology in recent years, these have the
potential to make cardiac CT a game-changer in the risk
stratification of veteran athletes, with the ultimate goal of
reducing the burden of CV events in this population, and
should be the focus of further investigation in the near
future.
References
1. Thompson P. Exercise and physical activity in the preven-
tion and treatment of atherosclerotic cardiovascular disease: a
statement from the Council on Clinical Cardiology. Arterioscler
Thromb Vasc Biol. 2003;23:42--9.
Document downloaded from http://www.elsevier.es, day 16/01/2018. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Tese para obtenção do grau de Doutor em Medicina na Especialidade em Investigação Clínica192
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging
CARDIOVASCULAR RISK ASSESSMENT IN ATHLETES – The Role of Electrocardiography and Imaging 
Hélder Dores 
 
188 
MANUSCRIPT 19 
 
 
 
  
Please cite this article in press as: Dores H, et al. Coronary artery disease in athletes: An adverse effect of intense
exercise? Rev Port Cardiol. 2018. https://doi.org/10.1016/j.repc.2017.06.006
ARTICLE IN PRESS+ModelREPC-1070; No. of Pages 9
6 H. Dores et al.
tests, by definition, depend on the presence of obstructive
CAD and therefore they are not designed to detect nonob-
structive CAD, which has been associated with worse CV
outcome in several CCTA studies.50--54
Usually, athletes with high CV risk undergo an exer-
cise ECG test, an exam of established prognostic value,
widespread availability and low cost. Several studies have
reported an increased relative risk of coronary death for
asymptomatic subjects with a positive test. However, the
accuracy of exercise testing for CAD detection in populations
with low pretest probability, such as asymptomatic athletes
involved in high-intensity sports, is limited.55--57 To overcome
some of these limitations the measurement of biomarkers
(e.g. high-sensitivity C-reactive protein and natriuretic pep-
tides) has been proposed, but the gain in CAD detection and
the practical applicability were low.58,59
Apart from the conventional scores based on clinical risk
factors, it is known that some risk modifiers detected by
emerging tests such as CS and carotid atherosclerotic plaque
detection can improve the calculation of total CV risk.
The role of calcium score and cardiac
computed tomography in screening veteran
athletes
Determination of total atherosclerotic burden is an option
for screening veteran athletes, helping to detect coronary
calcifications, a recognizedmarker of subclinical atheroscle-
rosis. CS is a non-invasive marker of CAD with proven
prognostic impact, predicting CV events and death, indepen-
dently of and incremental to conventional risk factors.60--63
CS is a risk modifier that can be considered in individuals
with SCORE around 5%-10%. In the PESA study64 in individ-
uals aged 40-54 years, 63% had subclinical atherosclerosis
after assessment of multivascular territories, and CAD was
detected in 18% of individuals, most of themwith low SCORE.
The landmark MESA study65 showed superior discrimination
and reclassification of CV risk in intermediate-risk individu-
als using subclinical markers. CS had higher predictive power
than other markers such as carotid intima-media thickness
and ankle-brachial index, in agreement with the results of
the Rotterdam study.66 Additionally, CS improves the adop-
tion of preventive measures, leading to better control of
several CV risk factors, as shown in the EISNER study.67,68
It is important to stress that not all coronary plaques
are calcified, nor is CS an indicator of plaque instability.
Moreover, although much less frequent than calcified or
mixed plaques, non-calcified plaques are more prone to
instability leading to acute coronary events. In this context,
CCTA provides useful additional information, enabling bet-
ter characterization of the coronary tree and plaques.26,69
Beyond obstructive CAD, the presence and quantity of non-
obstructive plaques also has prognostic value, as shown
in the CONFIRM registry70 and in other CCTA studies using
atherosclerotic burden indices like the segment involve-
ment score53 or the CT-adapted Leaman score (CT-LeSc).54
The comprehensive information provided by CCTA, includ-
ing location, type and number of plaques, can be clustered
in CCTA atherosclerotic burden scores like the CT-LeSc,71
which can help identify individuals with nonobstructive CAD
at higher risk of CV events and therefore contribute to risk
stratification.54
A recent study by Ermolao et al.57 in asymptomatic
middle-aged athletes with ST-segment anomalies during
maximal exercise test (diagnostic or equivocal) revealed
CAD in only 32% of the subjects. In the MARC study,42 in
318 middle-aged sportsmen with low SCORE who underwent
CCTA following normal pre-participation screening, 94% had
low CV risk and 18.9% had CAD (CS ≥100 or ≥50% luminal
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Figure 6 Algorithm proposed for veteran athlete screening. CAD: coronary artery disease; CCTA: coronary computed tomography
angiography; CT-LeSc: computed tomography-adapted Leaman score; CV: cardiovascular; ECG: electrocardiogram; SIS: segment
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Figure 7 Coronary computed tomography angiography of a non-competitive athlete performed with a new-generation scanner
(SOMATOM Force, Siemens Healthcare), using an ultra-low radiation dose of 0.5 mSv. Left: volume rendering technique images and
study protocol; middle: nonobstructive mixed plaque in the proximal segment of the right coronary artery; right: nonobstructive
calcified plaque in the proximal left anterior descending artery. LAD: left anterior descending artery; RCA: right coronary artery.
stenosis), almost one in five individuals. In this setting, some
authors have proposed the inclusion of CCTA in the screening
of veteran endurance athletes with moderate-high CV risk.
However, as Braber et al.42 showed, even veteran athletes
with low CV risk could benefit from CCTA, increasing the
controversy concerning the target population of this exam.
Based on these data, mainly derived from studies performed
in athletes aged >40 years involved in endurance sports and
with a wide spectrum of CV risk (including low risk), a hypo-
thetical flowchart for veteran athletes screening is proposed
in Figure 6.
Another important feature of CCTA is the ability to detect
other important coronary abnormalities in the screening of
athletes, such as malignant variants of anomalous origin of
the coronaries and coronary bridging, both described as pos-
sible causes of SCD in athletes.
In addition, and also of considerable importance, recent
technological developments in scanner technology (both
hardware and software) have led to impressive reduc-
tions in radiation dose, the main limitation of CCTA.72,73
Figure 7 presents an example of a CCTA performed with
a new-generation scanner, showing high image quality with
ultra-low radiation and contrast doses (0.5 mSv and 50 cc,
respectively).
Finally, although we have reviewed the published evi-
dence linking physical exercise and the presence and
severity of CAD, several issues remain unanswered and war-
rant further research. It is the view of the authors that
although CV risk stratification of veteran athletes is at
present still based on traditional risk factors and rest ECG,
cardiac CT may play a role in the future. To clarify this
important issue, further research is needed focusing on
three lines of investigation: first, to explore the possible U-
shaped association between the dose of exercise and CAD;
second, to establish the added value of CS and CCTA in
screening of veteran athletes; and third, to demonstrate
that the use of these newer CT-based imaging modalities
can further improve risk stratification of this important sub-
set of presumed healthy individuals, who may in fact be at
risk of CV events.
Conclusions
The benefits of exercise in the overall population are indis-
putable, but in athletes with CV disease exercise can also
be associated with adverse clinical events, including SCD.
In veterans, a growing group of athletes, CAD is the most
common cause of SCD, and there appears to be an U-shaped
relationship with the dose of exercise. Detection of subclin-
ical CAD should be the main objective of veteran athlete
screening, since the performance of classical CV risk strati-
fication based on clinical factors appears to be suboptimal.
Emerging data show an important role for CS and CCTA in
this setting. Coupled with the impressive technical improve-
ments in scanner technology in recent years, these have the
potential to make cardiac CT a game-changer in the risk
stratification of veteran athletes, with the ultimate goal of
reducing the burden of CV events in this population, and
should be the focus of further investigation in the near
future.
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 KEY RESULTS AND CLINICAL IMPLICATIONS 
 
The main results and clinical implications of the original manuscripts presented in this 
document were as follows: 
§ Anterior T-wave inversion was present in 2.3% of young white population, more 
commonly in women and athletes. Almost 80% was confined to leads V1-V2 and 
had a poor diagnostic yield for cardiac pathology, implying that this pattern could 
be a normal variant or physiological phenomenon in asymptomatic white 
individuals without a family history of cardiomyopathy or premature SCD. In 
contrast, anterior T-wave inversion beyond V2 was rare, particularly in men, and 
may warrant investigation. 
§ There was a positive correlation between greater intensity and level of sport with 
increased prevalence of ECG abnormalities. Although the lower frequency of 
abnormal ECGs, this relationship persisted with the use of more restrictive 
criteria for ECG interpretation in athletes (‘refined criteria’). Exercise-related 
characteristics should be known and taken into account during the evaluation of 
athletes to help early identification of those who may be more prone to develop 
ECG abnormalities and to prevent unnecessary subsequent investigations and 
unwarranted disqualification from competitive sport. 
§ The interpretation of ECG in athletes among physicians, mainly cardiologists, was 
suboptimal. A quarter of the ECGs were not correctly assessed and the variability 
in interpretation was high. Specific criteria for the interpretation of ECG in 
athletes were applied by less than half of the physicians. Standardization of ECG 
interpretation in athletes is needed to improve the accuracy of this exam in 
preparticipation evaluation and to reduce the rate of false positive cases. 
§ Even among experienced cardiologists, the reliability in interpretation of ECGs in 
a large cohort of highly trained young athletes was only moderate. The resultant 
cascade of downstream investigations was highly physician dependent, which 
markedly impacts on the workload and cost of ECG screening. 
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§ Electrical cardiac adaptations were frequent in a population of young military. 
The application of more restrictive criteria for interpretation of ECG - Seattle 
criteria and ‘refined’ criteria, reduced significantly the rate of false-positive cases 
compared to the ESC recommendations, less restrictive (approximately two 
thirds, from 15% to 5%). The application of specific criteria may have a favorable 
socioeconomic impact reducing the health cost burden and the number of 
disability days.  
§ Exercise training induced different structural LV remodeling in young special 
forces soldiers and competitive athletes - eccentric in military and concentric in 
basketballers. Although the LV myocardial mechanics did not show a significant 
difference in the two groups separately, when analyzed together there was a 
significant decrease in GLS. Knowledge of the characteristics of exercise should 
be considered during the echocardiographic evaluation of athletes. Among the 
several echocardiographic modalities, new parameters as GLS are promising.  
§ The GLS was significantly lower in athletes with higher level of exercise training 
(national or international and ≥20 training-hours per week). Thirty-one percent 
of the athletes had GLS below 17%, more frequently in the group of higher level 
of exercise training, with higher LV and left atrium volumes, lower E wave and A 
wave peak velocities and E/eʹ ratio. Although the value of GLS in athletes may 
overlap pathological conditions, the association between lower values and 
enhanced diastolic performance allows the discrimination between physiologic 
adaptations and pathology. 
§ The comprehensive information regarding the presence, severity and type of 
coronary plaques noninvasively provided by CCTA made possible a detailed 
characterization of the CAD pattern in diabetic patients at earlier stage of 
disease. This feature of CCTA is promising for subclinical detection of CAD and 
deeper characterization of coronary atherosclerotic burden in other populations. 
§ In a population of stable patients undergoing CCTA for suspected CAD, body 
mass index was an independent predictor of CAD, but was not correlated with 
its severity. There were no significant differences in the percentage of 
 
obstructive CAD or in overall coronary atherosclerotic burden across the 
different body mass index classes. CCTA led to a better clarification of the 
controversial relationship between some CV risk factors as overweight and 
obesity and severity of CAD. 
§ Despite the association of several clinical CV risk factors with a higher than 
expected coronary atherosclerotic burden evaluated by cardiac CT, they 
explained only half of its prevalence. Even when integrated in scores, the 
predictive power of these risk factors is relatively modest, exposing the 
limitations of risk stratification based solely on demographic and clinical 
characteristics. 
§ In patients with myocardial infarction as the first manifestation of CAD, CV risk 
stratification using the SCORE, if calculated before the event, classified more 
than two-thirds of the patients as low risk and a minority as very high risk. The 
high prevalence of low risk patients indicates a current challenge of CV risk 
stratification, underlying the need for additional tools in primary prevention to 
better identify patients at risk. 
§ The mean effective radiation dose used in cardiac CT was lower than in invasive 
coronary angiography, which in turn was lower than in single photon emission 
computed tomography. There was a significant reduction over time in mean 
effective radiation dose associated with cardiac CT after implementation of a 
prospective protocol. Beyond these software improvements, the ‘new’ 
generation CT scanners made possible the acquisition of cardiac CT exams at 
ultra-low radiation dose, which is of utmost importance if CCTA is to be included 
in clinical practice to evaluate populations with lower CV risk. 
§ The calculation of CT-LeSc, as a tool to quantify total coronary atherosclerotic 
burden (obstructive and non-obstructive), reflecting the comprehensive 
information about localization, degree of stenosis and type of plaque provided 
by CCTA, was feasible. There was a significant association between the CT-LeSc 
and some traditional demographic and clinical risk factors, being expected to 
have a significant prognostic impact. About one fifth of patients with non-
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obstructive CAD had CT-LeSc in the highest tercile, which could potentially lead 
to a reclassification of the risk profile of these apparently low risk individuals.  
§ In stable patients with zero CAC score, 12.4% had coronary plaques, but only 
1.6% had obstructive CAD. Age over 55 years old, hypertension and dyslipidemia 
were independent predictors of CAD in the setting of zero CAC score. In the 
presence of these predictors, the probability of CAD was almost two times higher 
than in the total studied population.  
§ The prevalence of subclinical CAD detected by cardiac CT in middle-aged male 
veteran athletes with low to intermediate CV risk was high (42%). A quarter of 
the athletes had high coronary atherosclerotic burden, defined as the 
conjugation of several variables derived from the CAC score and CCTA. The 
extension and the severity of CAD did not significantly differ according to the 
volume of exercise. 
§ The majority of the veteran athletes with high coronary atherosclerotic burden 
evaluated by CCTA had no CV risk factors or significant changes in exercise 
testing. Since CAD is the leading cause of SCD in this subset of athletes and due 
to the limitations of risk stratification limited to clinical factors and exercise 
testing, adjustments of preparticipation methodology are probably required. 
Inclusion of more objective markers as parameters derived from cardiac CT may 
be useful in early detection of CAD in veteran athletes, leading to risk 
reclassification and early implementation of preventive measures. 
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CV risk assessment is essential to identify athletes with increased risk or subclinical 
disease associated with the occurrence of clinical events including SCD. Though 
uncommon, SCD is the most devastating sport related event, widely publicized by the 
media with the implication that such a fatality can be preventable. Despite the different 
methodologies adopted by several countries and sports organizations, preparticipation 
evaluation of athletes is globally mandatory.  
The interpretation of ECG in athletes is frequently challenging and limited by false 
positive cases related with physiological adaptations induced by exercise training. 
Understanding these adaptations and its association with demographics and sports-
related characteristics is very important. The use of specific and more restrictive criteria 
for the interpretation of ECG in athletes can overcome some limitations, improving the 
accuracy in preparticipation evaluation and leading to socioeconomic benefits. 
Although the progressive advances regarding the ECG in athletes, several points remain 
to clarify, as the association between some specific electrocardiographic patterns with 
pathological conditions and its prognostic impact. Larger populations of athletes with 
different demographic characteristics (e.g. children, women) and involved in sports 
usually under-represented (e.g. isometric sports) should be further investigated. Formal 
medical training and development of a standardized diagnostic pathway for ECG 
interpretation is essential to support physicians involved in athletes’ evaluation. 
Structural cardiac remodelling, the most typical feature of the ‘athlete’s heart’, varies 
according to the type of exercise training. Since some physiological adaptations can 
overlap findings present in pathological conditions, namely cardiomyopathies, a 
comprehensive evaluation is needed to improve this differential diagnosis. 
Echocardiography remains the most useful imaging test for this purpose and advanced 
modalities such as myocardial deformation may improve the early recognition of 
pathology. However, GLS should be interpreted with caution because the normal values 
in athletes are not established and a ‘grey zone’ may exist, potentially representing 
other physiological adaptation to exercise training. Application of ‘new’ 
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echocardiographic tools in athlete’s evaluation is promising, but it should be deeply 
tested. The role of cardiac magnetic resonance as the gold-standard imaging test for 
structural and functional cardiac evaluation should be studied, being a potential line of 
research to follow. 
CV risk stratification based on clinical risk factors, isolated or integrated in scores, has 
some limitations. The relatively modest predictive power of this methodology has been 
highlighted in patients presenting with STEMI as first manifestation of CAD. Cardiac-CT 
(CAC score and CCTA) is useful to quantify the total coronary atherosclerotic burden, 
leading to the reclassification of risk profile in some individuals. Several CT derived 
scores are validated and allow a detailed characterization of the coronary 
atherosclerotic burden. 
As CAD is the leading cause of SCD in veteran athletes, preparticipation evaluation of 
these athletes should focus CV risk stratification and early detection of CAD. Cardiac CT 
demonstrated a higher than expected prevalence of CAD in veteran athletes, 
approximately one fourth with high coronary atherosclerotic burden. The association 
between volume of exercise and CAD, with the potential influence of some exercise-
related characteristics in the development of CAD, deserve further investigation. 
The conventional methodology of veteran athlete’s evaluation based on CV clinical risk 
factors and exercise testing seems to limit the identification of individuals with 
established and significant CAD. Inclusion of more objective markers in preparticipation 
evaluation of these athletes, as data derived from cardiac CT, is promising for more early 
and accurate risk stratification. Such understanding will become of utmost importance 
and will provide a more effective way to identify the individuals at the highest risk.  
Despite the advances over the last years in the field of sports cardiology, there is still a 
lot to be learned about CV risk assessment in athletes. Beyond this issue, sports 
cardiology covers an emerging broad range of areas that remain to clarify and will 
certainly mark the clinical research in near future. 
This is not the end, but just a new beginning, since we believe that several doors were 
opened, providing future research opportunities! 
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